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Abstract 
 
Enamides are an important class of functional group commonly present in natural 
products and drug candidates. In particular, enamides and dienamides are 
common in many anti-parasitic and anti-cancer natural products and 
pharmaceutical drug leads. 
 
 
 
The enamide moiety is strictly related to the biological activity of such compounds 
as it is directly involved in their mode of action. Due to the great importance of the 
enamide moiety in biological and medicinal chemistry, a deep interest has risen in 
the synthetic community in the past two decades and a wide variety of 
methodologies for the preparation of enamides have been developed so far. 
However, current methods suffer from poor efficiency and stereocontrol, in 
particular in the case of the thermodynamically unfavoured (Z)-enamides.  
The work reported herein details the development of a new methodology for the 
stereoselective synthesis of β-halo-enamides and β,β-dihalo-enamides from which 
it is possible to synthesise, via Pd-mediated cross-coupling reactions, more 
complex structures, such as β-yn-enamides, stereodefined (E,Z)-dienamides and 
branched products. In addition, oxazoles can be achieved via basic treatment of β-
halo-enamides. 
iii 
 
 
 
The methodology has been successfully applied to the total syntheses of simple 
enamide-containing natural products, such as lansiumamide A, lansiumamide B 
and alatamide. 
 
 
 
The total synthesis of a more complex family of enamide-containing natural 
products, such as the antifungal, antibiotic and cytotoxic crocacins, was also 
explored. The attention was focused firstly on (+)-crocacin C that is the primary 
amide and can be envisioned as the synthetic precursor of the other crocacins, 
and secondly on (+)-crocacin D, that is the most active and promising of the family. 
Two novel syntheses of (+)-crocacin C and (+)-crocacin D are therefore reported.  
 
 
 
The synthesis of simplified unnatural analogues with some promising insecticidal 
activity is also described. 
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1 Introduction 
 
1.1 Enamides 
 
 
Enamides show a good balance of stability and reactivity, a combination which 
accounts for their increasing importance in organic synthesis and medicinal 
chemistry. Enamides offer a wide variety of alternatives for the inclusion of 
nitrogen-based moiety into organic systems. These compounds can be seen as 
electron-deficient enamines, in which the alkene is substituted with a nitrogen 
functionality containing an electron withdrawing group such as imidazolidinone, 
oxazolidinone, lactam or amide. If we consider the cyclic systems the enamide 
double bond is constrained within a heterocycle, but if we consider the acyclic 
systems, where there is a β-substituted N-alkenyl side chain, both (E)- and (Z)- 
isomers can occur (Figure 1). In fact, one of the major problems associated with 
the preliminary syntheses of enamides was the lack of configurational control, 
together with low yields. 
 
 
 
Figure 1. Different types of enamides. 
 
Enamides are an important class of functional group due to their high reactivity 
which allows their use in the preparation of heterocyclic compounds.  
Enamides show nucleophilic reactivity due to the enamine character (stabilised by 
the EWG) (Figure 2) and often reactivity in similar fashion to simple C=C bonds, 
behaviour which provides further options for the incorporation of N-functionality 
into complex systems. 
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Figure 2. Nucleophilic reactivity of enamides. 
 
Enamides are also often present in natural products and drug candidates. In 
particular, enamides and dienamides are common in a number of anti-parasitic 
and anti-cancer natural products and pharmaceutical drug leads[1a,b] (Figure 3). 
 
 
 
 
 
Figure 3. Enamides in natural and pharmaceutical products. 
 
The enamide moiety is often responsible for the biological activity observed in 
those compounds through direct involvement in their mode of action. 
Mechanistically, it has been postulated that protonation of the enamide moiety 
leads to the highly electrophilic N-acyliminium ion which, in turn, can undergo 
A. E. Pasqua 2013 Chapter I Introduction 
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enzymatic nucleophilic attack to form the conjugated adduct responsible for 
activity. 
A typical example of the important role played by the enamide moiety in the 
biological activity of natural products is represented by the comparison of the IC50 
of the potent anti-cancer agent salicylihalamide A 1, with two analogues 6 and 7. 
In analogue 6, in which the enamide moiety is preserved, the biological activity 
remains almost unaltered, while in the analogue 7 which lacks of the enamide 
moiety the biological activity against human cancer cells is severely reduced[2] 
(Figure 4).  
 
 
 
 
 
Figure 4. Importance of the enamide moiety for biological activity. 
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1.2 Methods of synthesis of enamides 
 
Three major approaches have been considered for the synthesis of enamides. The 
most straightforward disconnection is through cleavage of the carbonyl C-N bond, 
which implies N-acylation of an enamine, or its equivalent. 
The second disconnection is across the double bond which can be obtained in 
many ways including the elimination of either α- or β-substituents from saturated 
starting materials, the condensation of amides and aldehydes, and transition-
metal-catalysed isomerisations of common N-allylated amides. 
The third disconnection involves the scission of the N-C bond, which can be 
formed by coupling reactions using transition-metal-chemistry (Figure 5). 
 
 
 
Figure 5. Three major disconnections in the enamides. 
 
Reflecting their importance, a wide variety of methods for the synthesis of 
enamides has been developed in recent years. The following is a selection of the 
most common and representative approaches taken to date.[3a] 
Some of the methodologies are based on N-acylation reactions, such as the 
acylation of imines; other strategies are based on cross- coupling reactions, such 
as the palladium(II)-catalysed amidation of alkenes and the copper(I)-catalysed 
coupling of vinyl iodides and amides; finally, there are methods involving 
elimination reactions such as the Peterson olefination. 
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Copper(I)-catalysed coupling of vinyl iodides and amides (Porco) 
 
Porco and co-workers, in 2000, proposed a copper(I)-catalysed coupling of vinyl 
iodides and amides for the synthesis of enamides,[3a,b] as shown in Scheme 1. 
 
 
 
Scheme 1. Porco’s synthesis of enamides and proposed mechanisms. 
 
Through the application of this methodology, a large variety of (E)-enamides were 
prepared in moderate to good yields. The most commonly used coupling agent for 
this reaction is Liebeskind’s copper(I) thiophene carboxylate (CuTC) while the 
base of choice is cesium carbonate. The mechanism of the transformation has not 
yet been proven, however two hypotheses have been proposed. The first 
hypothesis is that the cesium carboxamide reacts with the CuTC to form a 
cuprate-like intermediate which, in turn, interacts with the vinyl iodide to give, via 
four-centered ipso-substitution, the final product. A second, more recently 
postulated mechanism, involves the oxidative addition of the vinyl iodide unit to the 
CuTC complex, followed by displacement of a copper iodide intermediate by the 
cesium carboxamide and final reductive elimination (Scheme 1). Porco’s 
methodology has proven suitable for the introduction of enamide moieties under 
mild conditions, making it a very useful tool even during the late stages of a 
A. E. Pasqua 2013 Chapter I Introduction 
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synthesis. This procedure was applied during the syntheses of the salicylate 
enamide macrolides, a novel class of antitumor natural products such as 
lobatamides A-F,[4a,b] oximidines I-III,[5a,b] and CJ-12,950.[6]  
 
 
 
Figure 6. Application of Porco’s procedure in total synthesis. 
 
Buchwald later reported a copper(I)-catalysed coupling for the synthesis of 
enamides based on the use of vinyl iodides or bromides using N,N’-dimethyl 
ethylenediamine as a ligand.[7] Buchwald’s method was an improvement on the 
Porco procedure as it allowed for the generation of (Z)-enamides. A year later, Ma 
and co-workers developed a variation of Buchwald’s methodology based on the 
use of a different ligand, N,N-dimethylglycine.[8] The most recent variation on this 
approach was introduced by Batey and it is based on the use of potassium 
alkenyltrifluoroborates, which are extremely stable salts and can be used in 
copper(I)-catalysed cross-coupling reactions with amides to generate (E)-
enamides in excellent yields under mild, base-free conditions.[9] 
 
 
Palladium(II)-catalysed amidation of alkenes (Stahl) 
 
In 2003, Stahl’s group introduced the first general method for the intermolecular 
oxidative amination of styrenes.[10] Stahl method involves a palladium(II)-catalysed 
coupling in the presence of molecular oxygen as the stoichiometric oxidant, 
compatible with a wide variety of nitrogen nucleophiles, such as oxazolidin-2-one, 
pyrrolidinone and phthalimide. The catalytic activity can be enhanced by a catalytic 
amount of Brønsted base (Et3N) in the reaction, and, in addition, the 
regioselectivity can be tuned as the base is believed to provide the driving force to 
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achieve the Markovnikov product. Unfortunately, the mechanistic details of this 
transformation have not yet been established. This methodology was used to 
access 3-(1-phenylvinyl)oxazolidin-2-one in one step and in excellent yield 
(Scheme 2). 
 
 
 
Scheme 2. Stahl’s oxidative amination of styrenes. 
 
 
Titanium(II)-mediated coupling of ynamides and aldehydes (Sato) 
 
In 2003, Sato proposed a novel synthesis of enamides via the titanium(II)-
mediated coupling of ynamides and yne-sulfonamides with either carbonyl 
compounds or alkynes. The stereochemical outcome of the transformation 
depends on an intermediate ynamide-titanium complex, which couples with an 
aldehyde in a regio- and stereoselective fashion so as to afford a single 
stereodefined trisubstituted enamide[11] (Scheme 3). 
 
 
 
Scheme 3. Sato’s synthesis of enamides. 
 
 
Base-promoted elimination of substituted alcohols (Collier, Campbell) 
 
Collier and Campbell developed a base-promoted elimination of substituted 
alcohols for the synthesis of enamides.[12] This method is based on the in situ 
generation of a mesylate intermediate starting from the amino ester 21 and its 
subsequent elimination (Scheme 4). Similar approaches have also been 
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documented including the dehydration of free alcohols as well as eliminations 
involving glycosides, esters, and several other derivatives. The Collier and 
Campbell method proved to be a good strategy for the mild preparation of 
enantiopure, non-proteinogenic α-aminoacids, potential building blocks in natural 
and pharmaceutical products. 
 
 
 
Scheme 4. Collier’s synthesis of enamides. 
 
 
Condensation of amides and aldehydes (Zezza, Smith) 
 
In 1987, Zezza and Smith introduced a simple synthesis of (E)-enamides by 
condensing lactams with aldehydes under mild conditions.[13] A large number of 
solvents, acids and reaction conditions were investigated, however toluene and a 
catalytic amount of 4-toluenesulfonic acid (with azeotropic removal of water) 
proved to be the best conditions. This methodology is useful for both aryl and alkyl 
aldehydes, which can easily undergo the condensation. In a typical example, 
piperidin-2-one 23 can be condensed with phenylacetaldehyde 24 to afford 
enamide 25 (Scheme 5). 
 
 
 
Scheme 5. Smith’s synthesis of enamides. 
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Alkenation via Horner-Woodsworth-Emmons conditions (Hruby) 
 
In 2002, Hruby’s group, reported the Horner-Wadsworth-Emmons alkenation of 2-
bromobenzaldehyde 26 with phosphorylacetate 27, which provided enamide 28 in 
high yield and good stereocontrol in favour of the (Z)-adduct[14] (Scheme 6). 
 
 
 
Scheme 6. Hruby’s synthesis of enamides. 
 
This methodology was exploited in the total syntheses of (+)-sinefungin[15] 29 and 
azinomyzin A[16] 30 (Figure 7). 
 
 
 
Figure 7. Targets accessed via HWE chemistry.  
 
 
Hetero [4+2] cycloaddition (Hong) 
 
In 2004, Hong proposed an inverse-electron-demand hetero-Diels-Alder approach 
for the synthesis of enamides. Hong’s initial approach involves the reaction 
between N-sulfonyl-1-azabuta-1,3-diene 32 and dimethylfulvene 31, to generate 
the cyclic enamide 33. The process  was particularly high yielding when promoted 
by microwave irradiation.[17] The reaction was both regio- and stereoselective and 
provided an efficient route to the cyclopenta[b]pyridine 33 (Scheme 7). 
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Scheme 7. Hong’s inverse-electron-demand hetero-Diels-Alder. 
 
Mechanistically, the cycloaddition occurs via an endo-head-to-head transition 
state. The endo transition state is aided by the presence of secondary orbital 
interactions between the azadiene and the C5-C6 double bond of the fulvene 
which stabilises the transition state. A second stabilising interaction between the 
ester carbonyl moiety and the C1-C2 double bond of the fulvene further reinforces 
the endo transitional bias. These orbital interactions are not feasible in the 
disfavoured exo-head-to-head and endo-head-to-tail transition states, respectively. 
 
 
Acylation of imines (Funk) 
 
In 2001, Funk reported the N-acylation of imine 34 with benzoyl chloride to afford 
the enamide 35[18] in reasonable yield (Scheme 8).  A variety of 2,2-dimethyl-1,3-
dioxane-derived enamides were obtained using these conditions. 
 
 
 
Scheme 8. Funk’s acylation of imines. 
 
 
 
 
A. E. Pasqua 2013 Chapter I Introduction 
 
12 
 
Dyotropic rearrangement (Danishefsky) 
 
In 2004, Danishefsky reported a novel rearrangement of silylated amides into (Z)-
enamides.[19] This rearrangement is a beautiful example of a formal, stepwise, 
thermally promoted 10-electron double-sigmatropic, or dyotropic, rearrangement. 
The transformation is based on a key, 1,4-silyl shift in which the triethylsilyl group 
is transferred from C to O. This TES migration leads to the formation of the allyl 
carbanion species 37 which then undergoes a 1,4-hydrogen shift to afford 
intermediate 38. A final N-protonation affords the desired cis-enamide 39 
(Scheme 9).  
 
 
 
Scheme 9. Danishefsky’s dyotropic rearrangement. 
 
Despite the high temperature required, this methodology proved to be highly 
suitable for the introduction of cis-enamide moieties in complex targets. 
Danishefsky went to apply this methodology during the syntheses of the 
proteasome inhibitors TMC-95A 40 and TMC-95B 41 (Figure 8).[19] 
 
 
 
Figure 8. Danishefsky’s proteasome inhibitor targets. 
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Amide additions to alkynes (Jacobi) 
 
In 1996, Jacobi proposed a 5-exo-dig cyclisation promoted by tetrabutylammonium 
fluoride, leading from an acetylenic amide such as the alkynylated amide 42, to the 
monocyclic enamide 5-methylenepyrrolidone 43 (Scheme 10).[20] 
 
 
 
Scheme 10. Jacobi’s synthesis of enamides. 
 
This kind of cyclisation is particularly useful for highly substituted substrates, 
particularly those containing geminal dimethyl substituents, which cause the 
Thorpe-Ingold effect to take place. The gem-dimethyl substitution, leads to angle 
compression and reduction in the entropy of rotation in the open-chain compound, 
and subsequent increased strain, thus facilitating the cyclisation. 
Cyclic enamides are useful intermediates for the synthesis of naturally occurring 
chlorins, isobacteriochlorins and corrins. Considering its mild conditions, the 
Jacobi methodology was applied to the syntheses of natural products such as the 
corrin cobrin acid 44, which is a precursor of vitamin B12[20] (Figure 9). 
 
 
 
Figure 9. Cobric acid precursor of vitamin B12 (corrin). 
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Synthesis of enamides by a Peterson reaction manifold (Fürstner) 
 
In 2001, Fürstner reported the stereoselective synthesis of enamides under mild, 
aprotic and basic conditions. Fürstner’s methodology is based on a silicon-directed 
epoxide ring opening with sodium azide, followed by reduction of the resultant 
azide to the corresponding amine, N-acylation and Peterson elimination to afford 
enamide 47. This methodology offers great stereocontrol and broad scope, but 
has the disadvantage of requiring a multi-step sequence.[21] 
 
 
 
Scheme 11. Fürstner’s synthesis of enamides. 
 
Rhodium-catalysed carbozincation of ynamides (Lam) 
 
In 2008, Lam’s group proposed an approach to the synthesis of multisubstituted 
enamides via carbometalation of cyclic ynamides using Rh(cod)(acac) as the 
catalyst and Me2Zn, Et2Zn or nBu2Zn as reagent. The reaction proceeds smoothly 
in generally good yields and regioselectivity, but has a limited scope. In fact, when 
acyclic systems were considered there was loss of regiocontrol, leading to the 
formation of regioisomeric mixtures.[22a,b] 
 
 
 
Scheme 12. Lam’s carbometalation of ynamides. 
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Titanium-mediated conversion of ketones into enamides with ammonia and 
acetic anhydride (Reeves) 
 
In 2012, Reeves introduced an unconventional Ti-mediated synthesis of N-acyl 
enamides with ammonia. Reeves’ strategy is based on condensation of a ketone 
with ammonia to give either an imine or enamine, followed by N-acetylation with 
acetic anhydride. This has proven to be a reliable approach for the specific 
synthesis of N-acyl enamides.[23] 
 
 
 
Scheme 13. Reeves’ synthesis of enamides. 
 
Organometallic addition to isocyanates (Taylor) 
 
In 2000, Taylor and co-workers exploited Grignard additions to vinyl isocyanates 
for the preparation of unsaturated enamides. The sequence began with the Curtius 
rearrangement of acyl azide 52 to afford the corresponding vinyl isocyanate 53 
which, in turn, was subjected to Grignard addition to generate the desired enamide 
54 (Scheme 14). This procedure guaranteed good (E)-stereocontrol but was, 
however, a multi-step sequence which suffered from moderate to low overall yields 
from commercially available starting materials.[24] 
 
 
 
Scheme 14. Taylor’s addition to isocyanates. 
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Hydroamidation of alkynes (Gooßen) 
 
One of the most convergent and atom-efficient syntheses of enamides was 
proposed by Gooßen and is based on the ruthenium-catalysed anti-Markovnikov 
hydroamidation of terminal alkynes.[25] The choice of ligand determines the 
stereochemical outcome of the reaction with bulky ligands favouring the (Z)-isomer 
(Scheme 15). 
 
 
 
Scheme 15. Gooßen’s hydroamidation of alkynes. 
 
Wittig-type olefination reactions (Marquez) 
 
Previous work in the Marquez group focused on the exploitation of N-formyl imides 
as pseudoaldehydes. N-Formyl imides were found to easily undergo Wittig-type 
olefination reactions for the generation of enamides and dienamides in moderate 
to excellent yields and with fair to good stereocontrol.[1a-c] 
 
 
 
Scheme 16. Marquez’s synthesis of enamides and dienamides. 
 
The project began in 2007 with the development of an efficient approach to the 
stereocontrolled synthesis of enamides starting from lactam and amide units 
through the use of intermediate imides.[1a,c] The formylation-olefination sequence 
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was initially applied to cyclic systems with fair overall yields and complete 
stereocontrol in favour of the (E)-isomers (Scheme 17). 
 
 
 
Scheme 17. Marquez’s synthesis of cyclic enamides. 
 
Subsequently, the methodology was applied to acyclic amides to afford the 
desired enamide products in fair overall yields and E/Z stereocontrol. The 
reduction in selectivity observed in the acyclic systems could potentially be 
explained by the starting imide geometry, however, the precise reason for this 
stereochemical outcome is so far not completely understood. 
 
 
 
Scheme 18. Marquez’s synthesis of acyclic enamides. 
 
The same Wittig olefination was applied to the synthesis of trisubstituted acyclic 
(E)-enamides. Significantly, an increased selectivity was observed with respect to 
the disubstituted enamides, suggesting that the final E/Z product ratio arises due 
to the olefination transition state, rather than by the conformation of the starting 
imide alone (Scheme 19). 
 
 
 
Scheme 19. Marquez’s synthesis of trisubstituted acyclic enamides. 
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In 2009, the work was extended to the one-pot synthesis of dienamides starting 
from N-formyl imides and conjugated ylides. In all cases, the procedure afforded 
the (Z,E)-isomer as the major or sole isomer (Scheme 20). [1b] 
 
 
 
Scheme 20. Marquez’s synthesis of dienamides. 
 
The generation of the (Z,E)-isomer was a surprising result as the major isomer 
was expected to be the (E,E)-dienamide, due to the use of a stabilised ylide which 
usually leads to the preferential formation of the thermodynamically stable (E) 
double bond. While no modeling studies have been carried out, there are some 
considerations that can be made. It was postulated that the presence of nitrogen in 
the starting imide could affect the transition state of the olefination leading to a 
different stereochemical outcome with respect to the typical result predicted for a 
traditional aldehyde/ylide system. The most plausible hypothesis, thus far, is that 
the nitrogen can be involved in hydrogen bonding interactions with the carbonyl 
oxygen of the ylide so to affect the transition state (Figure 10). [26] 
 
 
 
Figure 10. Marquez’s proposed transition state for the synthesis of (Z,E)-
dienamides. 
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1.3 The chemistry of enamides
[27]
 
 
 
Enamides can be considered as functionalisable enamines, and for this reason 
they can participate in a wide variety of interesting transformations with 
electrophiles. Kobayashi’s group was the first to introduce, in 2004, the 
enantioselective use of enamides as nucleophiles in copper(II)-catalysed reactions 
with aldehydes.[27a,b] This preliminary work suffered from low to medium levels of 
enantioselectivity. On the other hand, the same group optimised the methodology 
with the use of imine electrophiles, which allowed the formation of β-amino imines 
under similar chiral copper(II)-catalyst systems that failed with simple aldehydes. 
The reaction proceeded with excellent yield and high enantioselectivity (Scheme 
21).  
 
 
 
Scheme 21. Kobayashi’s use of enamides as nucleophiles. 
 
Kobayashi’s procedure proved to be a robust strategy for the synthesis of optically 
active 1,3-diamine derivatives, which are useful building blocks for the synthesis of 
natural products and drug candidates. The detailed mechanism for the 
transformation has not been established yet, but the most plausible hypothesis 
involves an aza-ene type pathway. 
Subsequently, in 2008, Terada proposed the use of enamides as excellent 
nucleophiles for chiral Brønsted acid promoted enantioselective additions to 
glyoxals.[28] The following is an example of the methodology applied to the 
organocatalytic synthesis of β-hydroxy ketone 77 using a Binol-based phosphonic 
acid catalyst (Scheme 22).
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Scheme 22. Terada’s enantioselective addition to glyoxals. 
 
The high enantioselectivity of the reaction is strictly dependent on the two 
hydrogen-bonding interactions between the glyoxylate and the phosphoric acid. As 
a result, one enantiotopic face of the aldehyde (Re face) is shielded by a phenyl 
substituent while the opposite face (Si face) is completely free (Figure 11). 
 
 
 
Figure 11. Nucleophilic attack from the Si face. 
 
These initial studies have been optimised and expanded so to generate an 
impressive enantioselective synthesis of piperidines using aldimine 78 and 
enamide 79. In this case, after the initial Mannich reaction of enamide 79 and 
imine 78, the resulting β-amino imine product undergoes subsequent nucleophilic 
attack by a second equivalent of enamide 79, followed by cyclisation to form the 
final piperidine 80 rapidly and in excellent yield and enantioselectivity[29] (Scheme 
23).  
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Scheme 23. Terada’s synthesis of piperidines. 
 
Enamides can also be considered as good electrophiles. For example, Zhou in 
2007, reported the use of chiral Brønsted acids to promote the conversion of 
enamides to chiral iminium ion electrophiles, which in turn, can participate to 
Friedel-Crafts reactions for the construction of quaternary carbon atoms[30] 
(Scheme 24). 
 
 
Scheme 24. Zhou’s use of enamides as electrophiles. 
 
The chiral Brønsted acid catalyst creates two hydrogen bond interactions with 
indole 81 and enamide 82. The enamide is in equilibrium with the corresponding 
ketimine, which is activated upon protonation, so to accept nucleophilic attack of 
the indole from the Re face to afford the (S)-configuration of the stereocentre. 
Enamides are also considered very useful substrates in a variety of transition 
metal mediated alkene transformations. For example, Bennasar demonstrated that 
enamides can participate in ring closing metathesis reactions, by proposing a one-
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pot Petasis-methylenation of 84 followed by ring closing metathesis to afford the 
final dihydroquinoline 85 (Scheme 25).[31] 
 
 
 
Scheme 25. Bennasar’s use of enamides. 
 
Bennasar’s conditions have proven to be extremely useful and have formed part of 
key strategies towards the syntheses of complex natural products, such as 
paliurine and palau’amine, as reported by Evano[32a,b] and Overman[33] respectively 
(Figure 12). 
 
 
 
Figure 12. Evano and Overman targets accessed via Bennasar’s chemistry. 
 
Hsung and co-workers have been pioneers in exploring the synthetic utility of 
enamides as substrates in organic transformations. In one of their initial studies, 
Hsung reported the treatment of oxazolidinone-derived enamide 88 with mCPBA 
to afford the corresponding epoxide, which subsequently underwent opening with 
m-chlorobenzoic acid to generate mono-acylated diol 89.[34] Hsung has also been 
actively studying the cyclopropanation of chiral oxazolidinone enamides using a 
variety of conditions (i.e. Simmons-Smith), to generate the desired cyclopropyl 
adducts in high diastereoselectivity (Scheme 26).[35a,b] 
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Scheme 26. Hsung’s use of enamides. 
 
Recently, the use of enamides in pericyclic reactions has become an important 
area of research. Often, pericyclic reactions result in the transformation of the 
enamide Csp2-N bond into a Csp3-N bond, which allows the formation of new 
nitrogen containing stereocentres, and in an increase in the overall molecular 
complexity. 
Rawal studied the use of enamides in Diels-Alder reactions as reactive dienes. 
The reaction was found to be highly endo selective, with no evidence of exo 
adduct. The process is catalysed by a Cr(III)-salen complex, which is also 
responsible for the stereochemical outcome of the reaction. Mechanistically, initial 
coordination of the chromium complex with the aldehyde unit 93 results in 
dienophile activation. At this point, diene 92 approaches dienophile 93 from the 
more readily accessible surface of the scaffold, (i.e. over the imine moiety and 
away from the bulky tert-butyl groups). The large steric bias results in single 
product formation (Scheme 27).[36] 
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Scheme 27. Rawal’s use of enamides in Diels-Alder reactions. 
 
Meyer and Cossy proposed the first sigmatropic rearrangement which 
incorporated an enamide moiety. As part of their work, enamide 95 was converted 
to amino alcohol 96 by means of a [2,3]-Wittig rearrangement. Mechanistically, in 
order to understand the stereochemical outcome of the reaction, the envelope 
conformation of the five-membered ring transition state model, in which the alkynyl 
group occupies an exo orientation, must be considered (Scheme 28).[37] 
 
 
 
Scheme 28. Meyer and Cossy [2,3]-Wittig rearrangement of enamides. 
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In 2008, Carbery reported the use of enamides in the Ireland-Claisen [3,3]-
rearrangement. In Carbery’s approach, enamide 97 was cleanly rearranged into 
the desired allylic amine 98 in good yield and with very high diastereoselectivity 
(Scheme 29).[38] 
 
 
 
Scheme 29. Carbery’s Ireland-Claisen rearrangement of enamides. 
 
Enamides have also proven to be highly valuable substrates in electrocyclic 
transformations. Funk subjected 2,3-pyrroline 99 to a thermal 6π-electrocyclic ring 
closure, which provided trikentrin alkaloid indole framework 100. Mechanistically, 
the process consists of two steps: the first is an electrocyclic closure to give a 
diene intermediate, which subsequently undergoes aromatisation with concomitant 
oxidative desilylation to afford the indoline aldehyde 100 (Scheme 30).[39] 
 
 
Scheme 30. Funk’s use of enamides in a thermal 6π-electrocyclic ring closure. 
 
The versatility of Funk’s approach was demonstrated when it was applied to the 
syntheses of complex natural products such as welwistatin[40] 101 and 
dragmacidin E[41] 102. 
 
Figure 13.   Targets accessed via Funk’s chemistry.  
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Recently, enamides have also been used in radical transformations. One of the 
most significant examples in this area was proposed by Ishibashi during his 
synthesis of the alkaloid lennoxamine 105. Ishibashi’s synthesis proceeds via a 
radical 7-endo cyclisation followed by a homolytic aromatic substitution (Scheme 
31).[42] 
 
 
 
Scheme 31. Ishibashi’s synthesis of lennoxamine. 
 
In recent years, enamides have gained importance as useful tools in the synthesis 
of heterocycles. In 2007, Movassaghi pioneered the use of enamides in the 
synthesis of pyridines (Scheme 32). In Movassaghi’s strategy, enamides are 
converted to the corresponding N-vinyl iminium triflates, via activation by 
trifluoromethanesulfonic anhydride in the presence of 2-chloropyridine, to generate 
the putative iminium intermediate, which undergoes condensation with electron-
rich hetero-substituted alkynes or alkenes to form substituted pyridines.[43] 
 
 
 
Scheme 32. Movassaghi’s synthesis of pyridines. 
 
In the same year, Buchwald proposed a novel synthesis of pyrroles starting from 
bis-Boc-hydrazine. The process is based on two sequential copper(I)-catalysed 
vinylations to afford the resulting hydrazine bisenamide, which, in turn, undergoes 
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a [3,3]-sigmatropic rearrangement, followed by cyclisation and final aromatisation 
(Scheme 33).[44] 
 
 
 
Scheme 33. Buchwald’s synthesis of pyrroles. 
 
Enamides have also been utilised in photochemistry, particularly as substrates in 
the Paternò-Büchi reaction. Using this approach, in 2001, Bach utilised 
enecarbamate 112 to form amino oxetanes 113 in good yield and with reasonable 
diastereocontrol (Scheme 34).[45] 
 
 
 
Scheme 34. Bach’s use of enamides in the Paternò-Büchi reaction. 
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1.4 Halo-enamides 
 
 
Halo-enamides are extremely versatile and useful enamide derivatives which can 
be utilised for the generation of highly functionalised intermediates in materials, 
synthetic and medicinal chemistry. However, despite their great potential to play a 
key role in the synthesis of more elaborated enamide derivatives, there remains a 
lack of reliable approaches and methods available for their efficient and practical 
synthesis.[3a]  
 
α-Halo-enamides 
 
Most of the work on halo-enamides reported in the literature revolves around the 
synthesis of α-halo-enamides. Amongst the pioneers in the synthesis of 
halogenated enamides is Hsung who, in 2003, highlighted yet another synthetic 
utility of ynamides by reporting their unexpected hydrohalogenation in mild 
conditions with magnesium halide salts.[46] As part of Hsung’s attempts to achieve 
the [2+2]-cycloaddition of ynamide 114 with cyclohexenone, MgBr2 was added as 
Lewis acid catalyst. Although the reaction failed to afford the desired cycloadduct 
115, it generated the corresponding α-halo-enamide 116 in reasonable yield albeit 
with poor stereoselectivity (Scheme 35).  
 
 
 
Scheme 35. Hsung’s unexpected α-halogenation of ynamides. 
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Hsung reported that in situ generation of HX from the magnesium salt MgX2 with 
serendipitous trace amounts of water in the reaction was responsible for the 
unexpected hydrohalogenation. Hsung was able to optimise the procedure as to 
generate α-halo-enamides in good yield and with excellent (E)-selectivity. No β-
halo-enamides could be detected in Hsung’s studies (Scheme 36). 
 
 
 
Scheme 36. Hsung’s α-halo-enamide synthesis from ynamides. 
 
Interestingly, although Hsung’s methodology was efficient for the introduction of 
chlorides, bromides and iodides, it was never used to achieve hydrofluorination. 
However, in 2012, Evano and co-workers introduced a new methodology for the 
regio- and stereoselective generation of (E)-α-fluoro-enamides via 
hydrofluorination of ynamides using anhydrous HF (Scheme 37).[47] 
 
 
 
Scheme 37. Evano’s hydrofluorination of ynamides. 
 
Another example for the preparation of α-halo-enamides via hydrohalogenation of 
ynamides was recently reported by Flynn.  
Flynn’s approach is based on the use of HBr formed in situ from TMSBr and 
methanol (Scheme 38).[48] 
 
 
 
Scheme 38. Flynn’s hydrobromination of ynamides. 
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β-Halo-enamides 
 
In contrast to α-halo-enamides, there have been only a small number of efficient 
methods for the synthesis of β-halo-enamides reported in literature. A typical 
example of the great difficulties involved in the preparation of these functionalities 
was presented by Smith in his synthesis of the lateral chain of the lituarines. The 
synthesis began with cis-2 iodomethylacrylate 124 which was converted into 
enamide 127 through a copper mediated coupling. Ester hydrolysis followed by 
iododecarboxylation then afforded the β-iodo-enamide 127 in a poor 14% yield 
over the non-trivial 3 step sequence (Scheme 39).[49] 
 
 
 
Scheme 39. Smith’s synthesis of β-iodo-enamide 127. 
 
Then, in 2003, Trenkle reported a single example for the preparation of β-halo-
enamide 131 based on the Thorpe condensation of difluoro-enamine 130.  The 
transformation required two steps and proceeded in good overall yield (Scheme 
40).[50] 
 
 
 
Scheme 40. Trenkle’s synthesis of β-fluoro-enamide 131. 
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One year later, Ferreira and co-workers reported their studies on the antimicrobial 
benzo[b]thienyl dehydrophenylalanines, the preparation of which involved β-
bromo-enamide 133 as a reactive intermediate. The halo-enamide was prepared 
by means of a three step sequence with moderate stereocontrol (Scheme 41).[51] 
 
 
 
Scheme 41. Ferreira’s synthesis of β-bromo-enamide 133. 
 
In 2004, Turner explored the use of β-halo-enamides as reactive intermediates for 
the preparation of branched amino acids. Turner’s approach began with 
dehydration of L-threonine methyl ester 134 to afford the enoate intermediate 135 
which, in turn, was halogenated to afford the corresponding enamide 136 in 
moderate yield. Unfortunately, Turner’s approach resulted in enamide formation 
with no stereocontrol (Scheme 42).[52] 
 
 
 
Scheme 42. Turner’s synthesis of β-halo-enamides. 
 
In 2008, Grela reported the first successful example of olefin cross-metathesis with 
chloroalkenes. Using this approach, Grela reported a single example of (Z)-β-halo-
enamide formation using Grela’s catalyst 139. Grela’s catalyst has been described 
as the boosted version of Hoveyda’s catalysts. The reaction proceeds with 
complete stereocontrol, however, in poor yield and suffers from poor substrate 
scope (Scheme 43).[53] 
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Scheme 43. Grela’s synthesis of β-halo-enamides. 
 
Daoust, on the other hand, took advantage of copper promoted conditions to 
couple trans-1,2-diiodoethene 142 with both cyclic and acyclic amides to yield (E)-
β-iodo-enamides 145 and 146 (Scheme 44). Unfortunately, Daoust’s method 
requires the use of 1,2-diiodoethene 142, for which only the synthesis of the trans-
isomer has been reported.[54] 
 
 
 
Scheme 44. Daoust’s synthesis of (E)-β-iodo-enamides. 
 
In conclusion, until now, the existing methodologies for the synthesis of β-halo-
enamides are characterised by a series of drawbacks such as poor yields, lack of 
flexibility and stereocontrol, low substrate scope and often require multi-step 
procedures. 
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β,β-Dihalo-enamides 
 
Although gem-dihalo-olefins have long been considered important and versatile 
building blocks in palladium-catalysed tandem reactions, nitrogen-substituted gem-
dihalo-olefins did not receive great attention from the scientific community in the 
past. However, in the last two decades there has been a rise of interest in the 
exploitation of nitrogen-containing cyclic and acyclic systems and, thus far, some 
valid examples of the preparation of β,β-dihalo-enamides have been reported in 
literature. The first example of dihalo-enamide formation was reported in 2000 by 
Brückner during his synthesis of N-ethynyl-tosylamides. Brückner’s approach is 
based on the use of Ramirez olefination conditions on N-formyl-tosylamides to 
generate dichloro- and dibromo-vinylamides in high yields (Scheme 45).[55] 
 
 
 
Scheme 45. Brückner’s synthesis of β,β-dihalo-enamides. 
 
A few years later, Cossy used β,β-dihalo-enamides for the preparation of 
branched enamides and ynamides. Cossy’s β,β-dihalo-enamides were also 
accessed via Ramirez olefination conditions. Unfortunately, Cossy found the 
presence of an electron-withdrawing group on the nitrogen to be absolutely 
necessary for the success of the methodology, which somewhat limited the scope 
of the reaction (Scheme 46).[56] 
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Scheme 46. Cossy’s use of β,β-dihalo-enamides. 
 
In 2010, Lautens and co-workers also studied the synthesis of β,β-dibromo-
enamides 156 through the Ramirez protocol and explored their reactivity. This led 
to the generation of 2-oxazolones 157 in moderate to excellent yield and α-
aminoketones 159 in poor to good yield. Lautens corroborated that the Ramirez 
olefination is applicable only to N-protected N-formyl imides. Furthermore, only 
carbonyl derived protecting groups have proven suitable during the transformation 
(Scheme 47).[57] 
 
 
 
Scheme 47. Lautens’ methodology. 
 
In conclusion, the synthesis of β,β-dihalo-enamides via Ramirez olefination 
proposed by Brückner, Cossy and Lautens proved to be an efficient methodology 
for the generation of specific gem-dihalo-enamides, but lacked a suitably wide 
scope due to the necessity of an electron-withdrawing protecting group on the 
nitrogen. 
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2 Results and Discussion 
 
2.1 The Marquez group approach 
 
 
Enamides, dienamides and en-ynamides are highly reactive and important building 
blocks in synthetic, biological and medicinal chemistry as well as materials 
science.  Despite this extensive chemical breadth, there is the lack of a simple, 
high yielding and efficient method able to deliver these units quickly, and as single 
components. 
The number of different approaches reported for the synthesis of enamides and 
dienamides reflects their importance and relevance as target units and 
functional intermediates in materials, synthetic, and medicinal chemistry.  
Unfortunately, the synthetic methodologies developed thus far enjoy varying 
degrees of success, particularly concerning the yield and control of double 
bond geometry.  In a number of cases, no control over the geometry of the 
double bond generated is exhibited. β-Halo-enamides, on the other hand, are 
extremely versatile units, which provide a viable synthetic platform from which 
to generate elaborated enamide and dienamide structural units. Hence, reliable 
and effective methodology able to stereoselectively deliver (E)- and (Z)-β-halo-
enamides would allow their widespread use. To date, synthetic approaches 
towards the synthesis of β-halo-enamides have been very limited with scarce 
flexibility, and have been focused on the synthesis of the (E)-isomers largely 
due to the availability of starting materials. Access to the corresponding (Z)-β-
halo-enamides has proved to be highly challenging as there are no 
stereoselective synthetic methods currently available for their synthesis.  
In the past few years, the Marquez group studies on the synthesis of enamides 
and dienamides have focused on the exploitation of N-formyl imides as reactive 
intermediates capable of undergoing Wittig-type olefination reactions for the 
generation of the desired products. On this basis, previous members of the group 
have developed reliable methodologies for the synthesis of (E)-enamides and 
(Z,E)-dienamides.[1a-c,26] However, despite the efficiency of such methods, in some 
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cases the stereocontrol of the double bond geometry was unsatisfactory, obtaining 
mixtures of double bond isomers. 
Therefore, in order to address these issues, our project focused on the 
stereoselective synthesis of β-halo-enamides as reliable synthetic platforms from 
which to generate more elaborated moieties without problems related to 
stereocontrol (Figure 14). 
 
 
 
Figure 14. Marquez exploitation of N-formyl imides. 
 
The project began with the generation of N-formyl imides, which can be readily 
prepared via simple formylation reactions starting from the corresponding lactams 
or acyclic amides (Figure 15). 
 
 
 
 
Figure 15. N-formyl imides as reactive intermediates. 
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2.2 N-Formyl imides from cyclic lactams 
 
 
In order to explore the scope and limitations of our methodology, we took into 
consideration the use of both cyclic and acyclic amides. Lactams were chosen as 
the cyclic model units due to their affordability and availability in varying ring sizes. 
For the acyclic systems, a selection of aliphatic and aromatic, primary and 
secondary amides was considered. The formylation of the lactams was 
straightforward with the use of acetic formic anhydride as formylating agent. The 
anhydride was easily prepared by acetylating sodium formate (Scheme 48).[1a-c] 
 
 
 
Scheme 48. Preparation of acetic formic anhydride. 
 
Direct treatment of the lactam with the freshly prepared anhydride, afforded the 
desired N-formylimide. The formylation was straightforward and efficient, required 
minimum purification effort and provided the desired cyclic N-formyl imides, ready 
to be utilised in the subsequent halo-olefination reactions (Table 1). 
 
 
 
Table 1. Preparation of N-formyl imides from lactams. 
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2.3 Formylation 
 
 
In contrast to the cyclic amides, which were easily formylated by treatment with 
acetic formic anhydride, the acyclic amides, due to their non nucleophilic 
character, required the use of stronger formylating conditions. For this reason, a 
series of formylating agents and experimental conditions were evaluated.  
The formyl group itself has deep roots in organic chemistry and the term “formyl” 
derives from the Latin “formica”, meaning “ant”, as formic acid is one of the major 
components of ant fluids and tissues. The formyl carbonyl group shows a great 
polarisability due to its two components: a hard donor oxygen (hard base) and a 
reasonably hard acceptor carbon (hard acid). If the formyl group is attached to a 
heteroatom with a lone pair of electrons (like a nitrogen) the carbonyl carbon 
becomes softer. There has consistently been significant interest in the formyl 
moiety in organic synthesis with the aim to improve one carbon extension 
reactions. For such reasons, formylation is an integral part of organic, medicinal 
and biological chemistry both in industrial and academic settings.  A reflection of 
this importance is the number of approaches and reagents that have been 
developed to achieve it (Figure 16).[58] 
However, most of the formylating reagents developed to date suffer from a number 
of severe disadvantages which has drastically curtailed their use.  
 
 
 
Figure 16. Traditional formylating agents. 
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The most common formylating agents, for example, formic halides and formic 
anhydrides tend to suffer from stability issues and degrade easily upon storage.  
Cyanomethyl formate is a very useful, however, difficult to prepare formylating 
agent.[59] Isopropenyl formate, on the other hand, is also a very fast and efficient 
reagent, but its synthesis requires a multi-step sequence. The ozonolysis of 
oxazoles also leads to formyl compounds but requires the use of ozone. 
Commercially available N-formylimidazole is a valuable formylating agent but is 
also very hygroscopic. Great instability also characterises N-formyl-4-pyridone and 
N-formyl-2-pyridone.[60a-d] Finally, coupling agents have also been used in 
conjunction with formic acid to achieve N- and O- formylation, however, the 
removal of the resultant side products is often labour intensive.[61] Among the 
others, Katrizky’s N-formylbenzotriazole has proven to be a valuable, efficient, 
stable and easy to handle formylating agent.[62]  
 
2.4 N-Formylbenzotriazole 
 
 
In 1994, Katrizky developed N-formylbenzotriazole 186 (Figure 17) as a stable 
and convenient formylating agent to achieve N- and O- formylation quickly and 
efficiently. 
 
 
Figure 17. N-Formylbenzotriazole 186. 
 
N-Formylbenzotriazole has become, in a large number of cases, the reagent of 
choice to achieve the mild and selective formylation of alcohols, amines and even 
amides. Katrizky’s method for the synthesis of N-formylbenzotriazole starts with 
benzotriazole which is coupled with formic acid in the presence of N,N’-
dicyclohexylcarbodiimide (DCC) in anhydrous dichloromethane (Scheme 49).  
 
 
Scheme 49. Katrizky’s preparation of N-Formylbenzotriazole 186. 
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Unfortunately, while the coupling proceeds quickly and efficiently, the separation of 
the desired N-formylbenzotriazole from the urea side product is non-trivial and 
requires repeated and lengthy purification by recrystallisation which severely 
decreases the isolated yield. Furthermore, even after repeated recrystallisation 
and trituration, the N-formylbenzotriazole obtained is often contaminated with urea 
by-products making the yields highly variable and often irreproducible. Efforts in 
our group to reduce the amount of urea side products by switching to N,N’-
diisopropylcarbodiimide (DIC) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDCi) failed to yield pure N-formylbenzotriazole in significant amounts and with 
the necessary purity. To solve such issues, a fast, efficient and environmentally 
friendly method for the synthesis of N-formylbenzotriazole had to be developed for 
the successful completion of this project.    
It was hypothesised that acetic formic anhydride 162 might effectively formylate 
benzotriazole 187 under mild conditions without the need for coupling agents 
and/or reaction additives. Thus, acetic formic anhydride was formed efficiently 
from acetic anhydride and formic acid, both under normal heating at 55 °C or at 80 
°C under microwave conditions.  The newly formed mixed anhydride was then 
treated with neat benzotriazole 187 at 55 °C. In our initial studies, the reaction 
mixture was dissolved in ethyl acetate, and the organic layer washed with water.  
Removal of the solvent under reduced pressure gave a white solid in 60% yield 
which consisted of N-formylbenzotriazole 186 and N-acetylbenzotriazole 189 in a 
6:1 ratio, but most importantly, without any other side products (Scheme 50). 
 
 
 
Scheme 50. Preliminary synthesis of N-formylbenzotriazole. 
 
Optimisation of the transformation by lowering the temperature of formylation to 0 
°C shifted the ratio to 44:1 in favour of the formylated adduct 186.  Further 
lowering of the temperature to -10 °C increased the selectivity and specificity of 
the reaction to afford N-formylbenzotriazole in a 160:1 ratio and with no detectable 
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side products. The lower reaction temperatures favour the preferential 
benzotriazole attack on the formyl as opposed to the more hindered acetyl 
carbonyl unit. This results in the selective ejection of acetate over a formate 
leaving group. Additionally, the yield was significantly improved (94%) by 
eliminating the workup procedure and simply removing the acetic acid by-product 
under reduced pressure (Table 2). 
 
 
Table 2. Optimisation of the synthesis. 
 
Faced with such a dramatic improvement, the optimised mixed anhydride 
formylation conditions were also applied to a number of differently substituted 
benzotriazoles. In all cases, the formylation took place in excellent yield (Table 3).   
 
 
Table 3. Synthesis of substituted N-formylbenzotriazoles. 
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As expected, formylation of unsymmetrical, 5-substituted benzotriazoles results in 
the formation of various ratios of formylated regioisomers depending on the 
electronic nature of the substituent group. The structure of the major regioisomer 
was established through selective NOESY studies (Figure 18).  
 
 
 
Figure 18. Selective NOE confirmation of the regioselectivity of the reaction. 
 
Interestingly, the presence of electron withdrawing substituents on the 
benzotriazole unit resulted in a decrease in the formylation selectivity, presumably 
due to the lower reactivity of the benzotriazole core unit. 
Acetic formic anhydride also formylated effectively the azo-analogue 197 (entry 4) 
in excellent yield and with good selectivity relative to the acetylated product.    
Interestingly, a 12:1 ratio of N-formylated regioisomers was obtained (Scheme 
51).   
 
 
Scheme 51. Synthesis of the azo-analogue 197. 
 
NOE studies show that formylation takes place preferentially on the same side as 
the pyridine ring’s nitrogen.  Indeed, no NOE interaction was observed between 
the formyl proton and any ring protons, indicating the presence of the formyl group 
adjacent to the heteroatom (Figure 19). The observed regioselectivity can be 
explained through a zwitterionic intermediate analogous to that proposed by 
Carpino for 1-hydroxy-7-azabenzotriazole (HOAt)[63] (Figure 20).  
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Figure 19. NOE confirmation of the regioselectivity of the reaction. 
 
 
 
Figure 20. Carpino’s zwitterionic intermediate. 
 
Having explored the scope of the reaction conditions to formylate other 
benzotriazole systems, the feasibility for scaling the process up was then 
assessed (Table 4).  We were pleased to see that increasing the scale of the 
reaction had minimal effect on the yield and the purity of the N-formylbenzotriazole 
186 obtained.  Most importantly, there was no product purification required 
regardless of the reaction scale. The volume of THF used was also significantly 
decreased by increasing the concentration of benzotriazole in THF up to 1.8 M 
without any significant drop in yield, purity or selectivity. Furthermore, preliminary 
results suggest that it might be possible to use non-anhydrous conditions during 
the formylation. 
 
 
Table 4. Scale-up of the reaction. 
A. E. Pasqua 2013 Chapter I Results and Discussion 
 
44 
 
In summary, a fast, efficient, and environmentally friendly procedure for the 
synthesis of N-formylated benzotriazoles was developed. This method required 
very small amounts of organic solvent and produced acetic acid as the only 
significant side product.  The THF used in the reaction mixture can be recovered 
during the evaporation step, thus causing minimal environmental impact and 
minimising costs. As a whole, this procedure represents a great improvement 
compared to other methods currently available for the synthesis of N-
formylbenzotriazole in terms of cost, yield and overall efficiency.   
Attention was then focused on the synthesis of the tetrabromo-derivative 204 and 
the dinitro-derivative 202. It was expected that the symmetry of their structure 
would avoid the formation of mixtures of regioisomers and of special interest was 
the inductive and electronic nature of their substituents which should increase the 
reactivity. Disappointingly, while the synthesis of the starting materials 201 and 
203 proceeded smoothly, their formylation was unsuccessful (Scheme 52). 
 
 
 
Scheme 52. Efforts towards the synthesis of new N-formylbenzotriazoles. 
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2.5 N-Formyl imides from acyclic amides 
 
 
Thanks to the development of this novel efficient procedure for the synthesis of 
highly pure N-formylbenzotriazole, it was possible to successfully subject a series 
of acyclic amides to our previously used formylation conditions.[1a-c]  
 
 
 
Table 5. Synthesis of acyclic N-formyl imides. 
 
Apart from a few exceptions, the transformation was satisfactory and afforded the 
desired N-formyl imides in high purity, ready to be used in the subsequent step of 
halo-olefination. 
 
A. E. Pasqua 2013 Chapter I Results and Discussion 
 
46 
 
2.6 Halo-enamides via Takai olefination 
 
 
With the N-formyl imides in hand, we focused our efforts towards the development 
of an efficient approach to the regioselective synthesis of β-halo-enamides as well 
as a demonstration of their practical synthetic potential. 
The first attempt was based on the Takai olefination to afford the respective β-
iodo-enamides. This olefination reaction was introduced by Takai and Utimoto in 
1987 and describes the simple and stereoselective conversion of an aldehyde to 
the resulting (E)-alkenyl halide, after treatment with a haloform-chromium(II)-
chloride system. The organochromium species can be generated from iodoform, 
bromoform or chloroform and an excess of chromium(II) chloride (Scheme 
53).[64a,b]  
 
 
 
Scheme 53. Takai-Utimoto olefination. 
 
The E/Z ratio depends on the haloform used (Cl>Br>I), with best selectivity 
observed when X = Cl. The rate of the reaction is also correlated to the haloform 
used: I>Br>Cl. Iodoform reacts rapidly at low temperatures (0 °C) while the other 
haloforms require higher temperatures to react. 
The mechanistic details of this transformation are not yet completely known, 
however, a plausible hypothesis is that the reaction proceeds via geminal-
dichromium intermediates, that are nucleophilic and attack the carbonyl compound 
to form a β-oxychromium intermediate, which then evolves towards the desired 
(E)-alkene (Figure 21). 
 
 
 
Figure 21. Mechanism of the Takai-Utimoto reaction. 
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Our initial studies began with valerolactam 33, which was efficiently N-formylated 
using acetic formic anhydride 162 to generate the desired N-formyl imide 167 
under our previously reported conditions.[1a-c] Treatment of N-formyl imide 167 
under standard Takai conditions using commercially sourced chromium(II)chloride 
afforded the desired β-iodoenamide 219 in variable yields, and as inseparable 
mixtures of (E)- and (Z)- isomers. Unfortunately, the reaction proved to be highly 
dependent on the quality of the commercially sourced chromium(II)chloride 
employed. In a number of cases, the iodoolefination failed to yield any of the 
desired β-iodo-enamide adduct (Scheme 54). 
 
 
 
 
Scheme 54. Takai olefination of N-formylimide 167. 
 
Faced with such an erratic procedure, a more reproducible and reliable method 
was sought. Gratifyingly, treatment of N-formyl imide 167 according to Auge’s 
modification of the Takai reaction, in which chromium(III)chloride hydrate is 
reduced in situ using zinc, yielded the desired β-iodo-enamide 219 in moderate 
yield, and significantly, as a single (E)- double bond isomer (Scheme 55).[65] 
 
 
 
 
Scheme 55. Auge’s modification of Takai reaction. 
 
 
The assignment of the double bond geometry of the newly formed β-iodo-enamide 
219 was confirmed by both 1H NMR and crystallographic analysis (Figure 22). 
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Figure 22. Crystal structure of β-iodo-enamide 219. 
 
 
Using the optimised conditions, a library of lactams were formylated and the 
resulting N-formyl imides 166-169 were treated under Auge’s modified Takai 
conditions to generate the desired β-iodo-enamides 219-222 in moderate yield 
(Table 6). In all cases, only the (E)-isomer was detected both in the 1H NMR of the 
crude reaction mixture and after purification by column chromatography. 
 
 
 
Table 6. Synthesis of β-iodo-enamides from cyclic N-formyl imides. 
 
Having shown the ability of cyclic N-formyl imides to undergo iodoolefination, we 
became interested in exploring acyclic N-formyl imides as Takai olefination 
substrates. The idea of having an unprotected imide is very appealing as this 
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would avoid the need to subject the often unstable enamide derivatives to the 
generally incompatible conditions required for the removal of nitrogen protecting 
groups. 
Thus, acyclic amides 205, 206 and 209, were N-formylated using N-
formylbenzotriazole/nBuLi. The quality and the purity of N-formylbenzotriazole are 
essential for obtaining pure N-formyl imides in reproducible yields. 
Iodoolefination of acyclic imides 212, 213 and 216 under Auge’s conditions 
however, yielded some very interesting and intriguing results. N-Formylbenzimide 
216 and N-formylbutyrimide 216 yielded mixtures of (E)/(Z)-iodo-enamides 223 
and 224 in which the (E)-iodo olefin was the major isomer. In the case of the 
dioxolane substituted N-formyl imide 212, on the other hand, a nearly equal 
mixture of (E)/(Z) iodo-olefins 225 was obtained in which the (Z)-isomer was 
slightly predominant. Interestingly, the dioxolane derived (E)-iodoenamide 225E 
proved to be unstable to normal separation conditions and underwent 
decomposition during the purification procedure (Scheme 56). 
 
 
 
Scheme 56. Synthesis of β-iodo-enamides from acyclic N-formyl imides. 
 
We believe that the marked difference in behaviour during the iodo-olefination 
between the lactam derived imides and the acylic cases can be attributed to the 
geometry of the N-formyl imide. In the lactam cases, the cyclic nature of the imide 
unit severely restricts the conformational flexibility of the imide unit, which in turn 
translates into the generation of a single (E)-iodo-olefin isomer. 
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In the case of the acyclic N-formyl imides, the situation is more complicated. 
Crystallographic data for N-formyl imides 216 and 212 suggest that the N-formyl 
carbonyl adopts a similar conformation within the two imides[1c] (Figure 23). 
     
 
 
Figure 23. N-formylbenzimide 216 and dioxolane derived N-formylimide 212. 
 
 
This would imply that it is the rotational freedom of the imide unit along the bond 
between the internal carbonyl and the acyclic unit that determines the selectivity of 
the reaction. This would be consistent with the results observed in which the alkyl 
group in imide 212 exerts a slightly greater influence on the imide conformation 
than the flat aromatic substituent in imide 216.  
The geometry of N-formyl imide 212 on the other hand, is influenced by the 
conformation of the dioxolane ring as well as the potential interaction of the imide 
unit with the proximal oxygen of the ketal unit. 
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2.7 Sonogashira coupling 
 
 
Having generated the desired β-halo-enamides, we were interested in their utility 
in combination with other methodologies (for example, metal mediated couplings) 
to generate novel, and diverse building units. 
It was initially decided to evaluate the ability of β-iodo-enamides to undergo 
palladium-mediated Sonogashira couplings with the aim to generate novel β-yn-
enamide units. It was reasoned that structurally constrained β-yn-enamides could 
have applications as reactive intermediates in both synthetic and medicinal 
organic chemistry. Furthermore, their defined molecular shape makes them 
potential candidates for the development of molecular tweezers and other 
structurally defined units in materials and supramolecular chemistry.  
The Sonogashira coupling was introduced for the first time in 1975, when 
Sonogashira and co-workers reported the copper-palladium catalysed coupling of 
terminal alkynes with aryl and vinyl halides to give enynes (Scheme 57).  
 
 
 
Scheme 57. Sonogashira coupling. 
 
The copper(I) salt can be commercially available CuI or CuBr and is only needed 
in catalytic amounts (0.5-5 mol%) with respect to the halide or alkyne, often the 
base serves as the solvent, but occasionally a co-solvent is used. Crucially, the 
reaction does not require rigorous drying. The coupling is also stereospecific as it 
preserves the stereochemistry of the substrates in the products. The order of 
reactivity for aryl and vinyl halides is I~OTf>Br>>Cl. Although, almost all functional 
groups are tolerated, alkynes with conjugated EWG tend to rearrange to allenes. 
The large functional group tolerance has rendered the Sonogashira coupling 
extremely useful in the late stages of total synthesis. There are only few limitations 
to this methodology, such as the use of high temperatures for unreactive or bulky 
substrates and the potential side reactions of alkynes at high temperature. 
A. E. Pasqua 2013 Chapter I Results and Discussion 
 
52 
 
The mechanism of the Sonogashira coupling follows the traditional pathway of 
oxidative addition and reductive elimination, however, some mechanistic details 
such as the catalytically active species remain unknown. The sequence begins 
with the generation of the Pd(0) species from a Pd(II) complex by reduction with the 
alkyne or with a phosphine ligand. The Pd(0) species is then subjected to oxidative 
addition with the aryl or vinyl halide, followed by transmetallation by the copper(I)-
acetylide. Reductive elimination affords the desired coupled product and the cycle 
ends with the regeneration of the catalyst (Figure 24).[66] 
 
 
 
Figure 24. Sonogashira coupling’s mechanism. 
 
Initial Sonogashira coupling of β-iodo-enamide 219 with phenyl acetylene afforded 
the desired β-yn-enamide 226 in excellent yield and as a single isomer (Scheme 
58). The structural assignment of the β-yn-enamide 226 was corroborated by X-
ray crystallography (Figure 25).[67] 
 
 
 
 
Scheme 58. Sonogashira coupling. 
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Figure 25. Crystal structure of compound 226. 
 
The excellent yield observed in the Sonogashira cross-coupling of β-iodo-enamide 
226 and phenyl acetylene was then reproduced with a number of phenyl 
substituted acetylenes using both cyclic and acyclic β-iodo-enamides to generate 
the β-yn-enamides 227-232. However, when alkyl substitued alkynes were used in 
the cross-coupling, a significant drop in the yield of the β-yn-enamides 231 and 
232 obtained was observed. We believe that this difference in yield between the 
alkyl substituted and phenyl substituted alkyne β-yn-enamide products is due to 
the greater stability of the phenyl β-yn-enamide adducts obtained rather than due 
to the Sonogashira coupling itself (Table 7).  
 
 
 
 
Table 7. β-yn-enamides. 
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The custom alkynes 235 and 238 used for the Sonogashira coupling were easily 
prepared following the traditional Corey-Fuchs procedure, while the alkyne 240 
was prepared via TBDMS protection (Scheme 59). 
 
 
 
 
Scheme 59. Custom alkynes for Sonogashira coupling studies. 
 
 
Furthermore, preliminary evidence demonstrated that it is possible to selectively 
reduce the recently obtained β-yn-enamides to selectively generate (E,Z)-
dienamides in excellent yield through catalytic hydrogenation (Scheme 60). 
 
 
 
 
Scheme 60. Reduction of β-yn-enamides to (E,Z)-dienamides. 
 
 
The stereochemistry of the dienamides obtained was confirmed via 1H-NMR 
studies together with NOE studies. The observed J values of 14 Hz and 11 Hz are 
a clear indication of the geometry of the two double bonds in the (E,Z)-dienamides. 
In addition, NOE correlations were observed between the lactam ring and the 
aromatic ring, as well as between the protons of the dienamide moiety; those 
correlations are possible only in the presence of a cis double bond (Figure 26). 
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Figure 26. NMR observations. 
 
In conclusion, we have developed a fast and efficient method which takes 
advantage of the pseudo-aldehyde behaviour of N-formyl imides to access β-halo-
enamides in a single step, in moderate-good yields and without the need for 
nitrogen protecting groups. The β-halo-enamides can be easily functionalised into 
β-yn-enamides and dienamides in excellent yields and with complete selectivity.  
We believe that this route complements and expands the methodologies currently 
available for the synthesis of β-haloenamides, β-yn-enamides and dienamides, 
and can be easily modified for the generation of novel structural motifs with 
potential applications in synthetic, biological, medicinal, supramolecular and 
materials chemistry.[68] 
Despite these promising results, this route required the use of toxic chromium salts 
and was limited to the synthesis of (E)-halo-enamides. As a result, we next 
focused our attention on the development of a synthetic method for the (Z)-
selective generation of β-halo-enamides. 
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2.8 Stork-Zhao olefination 
 
 
Our initial approach to the synthesis of (Z)- β-halo-enamides was focused around 
the Stork-Zhao modification of the Wittig olefination.  
The reaction of a phosphorus ylide with a carbonyl unit was introduced by Wittig 
and Gessler in 1953, and is considered the most widely recognised method for 
carbonyl olefination. The Wittig reaction is a syn elimination, driven by the strength 
of an oxygen-phosporus bond. The elimination step occurs from an in situ 
generated intermediate, which decomposes spontaneously.  
Mechanistically, the reaction begins with a phosphonium salt that is deprotonated 
by a moderately strong base to form the corresponding ylide. The ylide is the 
nucleophilic species which attacks the carbonyl group to generate the intermediate 
betaine, which, in turn, evolves to the 4-membered ring oxaphosphetane 
intermediate. This species is very unstable and evolves spontaneously towards 
the desired alkene and the phosphine oxide as a by-product via elimination. The 
formation of the phosphorus-oxygen double bond is responsible for driving the 
reaction equilibrium towards product formation (Figure 27).[69a] 
 
 
 
Figure 27. The Wittig-type olefination reaction. 
 
The stereochemical outcome of the reaction depends on the nature of the ylide 
employed. In fact, the stabilised ylides (so called because the negative charge is 
stabilised by an adjacent EWG) evolve towards (E)-alkenes and the unstabilised 
ylides, on the other hand, towards (Z)-alkenes. The (Z)-selectivity in Wittig 
reactions of unstabilised ylides can be explained through the stereoselective 
formation of the syn oxaphosphetane intermediate, followed by a stereospecific 
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elimination. The syn oxaphosphetane is favoured because the large substituents 
tend to orientate themselves as far as possible in the transition state (Figure 
28).[69b] 
 
 
Figure 28. Stereoselectivity of the Stork-Zhao olefination reaction. 
 
Our Stork-Zhao olefination studies began with the caprolactam derived N-formyl 
imide 168 which was treated under classic Stork-Zhao’s olefination conditions[70] 
using bromomethylenetriphenylphosphorane
[71a,b]
 and NaHMDS. Unfortunately, 
the reaction failed to generate the desired (Z)-bromo-enamide. After extensive 
experimentation, with a number of different bases and varying amounts of  
phosphonium salt, the desired (Z)-bromo-enamide was detected only in poor 
yields. However, using a 10-fold excess of phosphonium salt and switching the 
base to tBuOK, cleanly converted the N-formyl imide 168 into the unexpected 
dibromo-enamide 243b in excellent yield (Table 8). 
 
 
 
Table 8. Synthesis of β,β-dibromo-enamide 243b. 
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Dibromo-enamides are well-known synthetic intermediates which have been 
previously accessed through the use of a Ramirez olefination. [55,56] 
Unfortunately, the Ramirez conditions are limited to the dibromo-olefination of 
tosyl-, Piv- and Boc- imides, and are not applicable to unprotected imide 
systems (Scheme 61). Indeed, Lautens reported that the gem-dibromination of 
formamides only works when an N-carbonyl protecting group (Boc or Piv) on 
the formamide is present.[57] 
 
 
 
Scheme 61. Previous syntheses of β,β-dibromo-enamides. 
 
Hence, the unexpected and high yielding imide dibromo-olefination reaction 
could provide a viable synthetic alternative for the synthesis of structurally 
diverse β,β-dibromo-enamide units. Significantly, consistently, excellent results 
were obtained when the same bromo-olefination conditions were applied to a 
wide variety of N-formyl imides (Table 9).  
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i)All reactions were conducted using 1 eq of N-formyl imide, 10 eq of salt and 10 eq of base in dry THF (0.33 M) at 
RT for 12 hours. 
 
Table 9. Effect of imide substitution on dibromo-olefination. 
 
Faced with such satisfying yields and scope for the synthesis of dibromo-
enamides, we were curious to discover whether similar results could be 
obtained using iodomethylenetriphenylphosphorane. Initial iodo-olefination of 
N-formyl imide 168 matched the results obtained during the bromo-olefination, 
yielding diiodo-enamide 253 in excellent yield (Scheme 62).  
The structure of the diiodoenamide 253 was corroborated by crystallographic 
analysis (Figure 29). 
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Scheme 62. Synthesis of β,β-diiodo-enamide 253. 
 
 
 
 
Figure 29. Crystal structure of diiodo-enamide 253. 
 
Currently, the only other report in the literature for the synthesis of β,β-diiodo-
enamides is that of Ferreira and co-workers, who reported the generation of 
β,β-diiodo-enamides in highly variable yields by treatment of amino acid 
derived enamides with I2 at 80 °C (Scheme 63).
[72a,b] 
 
 
 
Scheme 63. Ferreira’s synthesis of β,β-diiodo-enamides. 
 
Application of identical iodo-olefination conditions to the model group of N-
formyl imides previously used demonstrated that the iodo-olefination is 
substrate dependent (Table 9), a fact previously noted by Ferreira in his 
enamide iodination studies. For instance, iodo-olefination of N-formyl imide 169 
under the same conditions yielded the diiodo-enamide 254 together with traces 
of the unexpected (E)-iodo-enamide 221. The iodo-olefination of the N-formyl 
imides 166 and 167 on the other hand resulted in the exclusive formation of β-
iodo-enamides 220 and 219 respectively. In both instances, the reaction 
proceeded in good yield and with complete (E)-double bond selectivity. 
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Interestingly, aromatic N-formyl imides (216, 245) proved inert under the 
reaction conditions affording only starting materials, while the same N-formyl 
imides proceeded cleanly to generate the dibromo-enamide products. 
Furthermore, the steric environment surrounding the N-formyl group seems to 
influence the iodo-olefination significantly; for instance, whilst the butyramide 
derived imide 213 was diiodo-olefinated in working yields, N-methyl 
propionimide 244 failed to react under identical conditions. 
 
 
i)All reactions were conducted using 1 eq of N-formyl imide, 10 eq of salt and 10 eq of base in dry THF (0.33M) at RT 
for 12 hours. 
 
Table 9. Iodo-olefination of N-formyl imides.  
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This result was unexpected, as dihalo-olefins are seldom detected as side 
products during the olefination of ketones and aldehydes. The closest literature 
precedence for the formation of dibromo-enamide 243b is the dibromo-
olefination of lactones reported by Chapleur and co-workers (Scheme 64).[73] 
 
 
 
Scheme 64. Chapleur’s dibromo-olefination of lactones. 
 
Mechanistically, the formation of the β,β-dibromo-enamides using 
bromomethylenetriphenylphosphorane could follow two potentially competing 
reaction pathways as proposed by Chapleur in explaining the lactone 
dibromoolefination.  Initially, deprotonation of the phosphonium salt yields ylide 
A which then reacts with a second equivalent of the phosphonium salt to 
generate the dibromo-phosphonium unit B and methylene ylide C.  
Deprotonation of the dibromo phosphonium salt by either ylide C or tert-
butoxide then yields the dibromomethylenetriphenylphosphorane D that can 
subsequently react with the N-formyl group of imide 168 to generate the 
observed dibromo-enamide 243b (Figure 30). 
 
 
 
Figure 30. Chapleur’s mechanism for in-situ generation of 
dibromomethylenetriphenylphosphorane D. 
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Alternatively the initial olefination of N-formyl imide 168 with 
bromomethylenetriphenylphosphorane A would yield bromo-enamide 256, 
which then undergoes a second bromination to generate the observed dibromo-
enamide intermediate 243b (Scheme 65). 
 
 
 
Scheme 65. Stepwise mechanism for synthesis of dibromo-enamides. 
 
From a mechanistic point of view, the high yield isolation of iodo-enamides 219 
and 220, would suggest a different mechanism from that proposed by Chapleur, 
and would indicate that a step-wise process is taking place, and that the rate 
for the iodination step is highly dependent on the structural nature of the iodo-
enamide intermediate generated. Alternatively, it could imply that N-formyl 
imides with very closely related structures have very different rates of reaction 
with ylides A or D and that the iodo-enamide products obtained from the 
reaction with ylide A are not intermediates in the pathway for the synthesis of 
diiodo-enamides. Circumstantial evidence for a stepwise process was provided 
by control experiments in which valeraldehyde generated the expected mono-
halogenated olefin when subjected to the same reaction conditions, 
demonstrating the enamide nitrogen’s pivotal role during the bromination step.  
Further indication that a stepwise pathway is taking place was provided by the 
fact that none of the N-formyl imides reacted with the dibromo ylide D 
generated through Ramirez olefination conditions (Scheme 66).  
 
 
 
Scheme 66. Failed attempts of Ramirez olefination. 
 
Additional mechanistic evidence for a step-wise process was provided by 
treatment of the pantolactone derived N-formyl imide 212 under the same 
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iodoolefination conditions, which resulted in the formation of diiodo-enamide 
257 and oxazole 258 in good overall yield (Scheme 67).  The structures of both 
diiodo-enamide and oxazole units were corroborated by crystallographic 
analysis (Figure 31). 
 
Scheme 67. Iodo-olefination of pantolactone derived N-formyl imide 212. 
 
      
 
Figure 31. Crystal structures of diiodo-enamide 257 and oxazole 258. 
 
The oxazole unit was presumably generated through the intramolecular 
cyclisation of the iodo-enamide intermediate, in a process akin to that reported 
by Ferreira through the basic treatment of amino-acid derived β-iodo-enamides 
(Scheme 68).[72a,b]  
 
 
 
Scheme 68. Ferreira cyclisation of β-iodo-enamides. 
 
Further evidence that ylide A is the reactive species was provided by the 
bromo-olefination of pantolactone derived N-formyl imide 212, which yielded 
oxazole 258 in near quantitative yield under the same reaction conditions 
(Scheme 69). This would strongly suggest that the N-formyl imide 212 is first 
converted to a putative bromo-enamide intermediate which then undergoes 
cyclisation to generate oxazole 258. 
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Scheme 69. One-step synthesis of oxazole 258. 
 
These results imply that, at least in the case of di-halo-enamide formation, a 
different mechanism is taking place from that proposed by Chapleur for the 
dibromo-olefination of lactones. Having successfully achieved a high yielding, 
flexible and reliable synthesis of β,β-dihalo-enamides, the key steroselective 
dehalogenations were attempted.  Both for mechanistic reasons and for the 
stability displayed previously by (E)-β-iodo-enamides, it was decided to initially 
focus our attentions on the selective de-halogenation of the diiodo-enamide 
units. We were pleased to find that treatment of the diiodo-enamides with a Zn-
Cu couple[74] proceeded cleanly to stereoselectively generate the (E)-β-iodo-
enamides 221 and 222 in good yield (Table 10). Interestingly, in the case of the 
pantolactone derived iodo-enamide 257, the (Z)-product was the sole isomer 
obtained.  We believe that the opposite double bond geometry obtained in iodo-
enamide 225 is the result of electronic interactions between the tetramethyl 
dioxolane ring and the enamide unit affecting the reactive conformation of 
diiodo-enamide 225. 
 
i)All reactions were conducted using 1 eq of diiodoenamide,30 eq of Zn-Cu couple and 100 eq of AcOH at 0 °C for 
0.5 hours. 
 
Table 10. Selective de-iodination of diiodo-enamides. 
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Crucially, having access to both the diiodo-enamide 257 and (Z)-iodo-enamide 
225 provided the opportunity to further probe the mechanism of the halo-
olefination taking place. It was proposed that if the step-wise mechanistic 
hypothesis was valid, basic treatment of iodo-enamide 225 should result in 
oxazole formation. 
Gratifyingly, treatment of (Z)-iodo-enamide 225 under basic conditions yielded 
oxazole 258 together with traces of the de-halogenated enamide 259.  On the 
other hand, treatment of diiodo-enamide 257 under identical conditions gave 
only unreacted starting material (Scheme 70). This would support the theory 
that iodo-olefination of N-formyl imide 212 initially yields an iodo-enamide 
intermediate, which can then either undergo a second iodination to generate 
the diiodo-enamide 257 or a deprotonation-cyclisation to generate oxazole 258. 
 
 
 
Scheme 70. Synthesis of oxazole 258 from iodo-enamide 225. 
 
In addition to these mechanistic observations, there was also the support 
deriving from control experiments. The same reaction conditions were applied 
to simple aldehydes rather than N-formyl imides and the outcome of the 
reaction in these cases was, as expected, the generation of monohalo-olefins. 
This suggests that the nitrogen present in the N-formyl imides is involved in the 
mechanism of the dihalo-olefination reaction. Also the Ramirez olefination (in 
which it has been proven that the reactive species is D) was applied to the N-
formylimide substrates, however without success, suggesting again that is not 
species D but species A which participates in our novel dihalo-olefination 
reaction (Figure 32). 
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Figure 32. Suggested pathway of the dihalo-olefination reaction. 
 
Final mechanistic observations, that again supported our hypothesis of a step-
wise mechanism, derived from 31P-NMR experiments in THF, which showed the 
presence of species A (δ ~ 13 ppm) and C (δ ~ 19 ppm) in the reaction mixture, 
but not D. In view of this evidence acquired, we have tentatively excluded 
Chaupleur’s mechanistic proposal in favour of a step-wise mechanism. 
Having demonstrated the feasibility of carrying out selective dehalogenations 
on diiodo-enamides, analogous debromination, with the aim of accessing (Z)-β-
bromo-enamides, was investigated.  
Initial debromination attempts on dibromo-enamide 246 using Zn-Cu couple 
resulted in a 6:1 (E:Z) product ratio of β-bromo-enamides 260E/260Z in 
quantitative yield (Scheme 71).  Although this provides a highly efficient 
approach to the synthesis of (E)-halo-enamides, it did not provide us with the 
complete selectivity observed in the diiodo-enamide series.  Crucially, however, 
treatment of dibromoenamide 246 using tributyltin hydride/palladium tetrakis[75] 
afforded the highly desired (Z)-β-bromo-enamide 260Z in excellent yield and 
with complete diastereoselectivity (Scheme 71). 
 
 
 
Scheme 71.  Initial debromination attempts. 
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In order to ascertain the efficiency and selectivity for the synthesis of (Z)-
bromo-enamide units, the reproducibility of the debromination conditions was 
assessed. We were pleased to find that in all cases, the reduction resulted in 
the desired (Z)-bromo enamides 256Z and 260-264 in high yields and with 
complete stereocontrol (Table 11). 
 
 
 
i)The reactions were conducted using 1 eq of N-Formyl imide, 10 eq of salt and 10 eq of base in dry THF (0.33 M) at 
RT for 12 hours.
 
ii)The reactions were conducted using 1 eq of dibromo-enamide, 1.2 eq of Bu3SnH and 0.1 eq of 
catalyst in dry EtOAc (16 mM) at RT for 12 hours.  
 
Table 11. Stereoselective synthesis of (Z)-β-bromo-enamides. 
 
To complete our halo-enamide studies, β-chloro-enamides were also taken into 
consideration. In all cases, the methodology efficiently converted the N-formyl 
imides into halo-olefins, however, while in the case of the acyclic starting materials 
the only reaction products were the (Z)-β-chloro-enamides (Scheme 72), the 
A. E. Pasqua 2013 Chapter I Results and Discussion 
 
69 
 
lactam systems afforded mixtures of (Z)-β-chloro-enamides, (E)-β-chloro-
enamides and β,β-dichloro-enamides (scheme 73).  
Further studies are necessary for the optimisation of the methodology. 
 
 
 
Scheme 72. Synthesis of (Z)-β-chloro-enamides. 
 
 
 
 
 
Scheme 73. Synthesis of cyclic chloro-enamides. 
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2.9 Potential and limitations of β-halo-enamides 
 
 
Thus far, we have described two novel methods for the synthesis of β-halo-
enamides as stereodefined reactive intermediates to be exploited in cross-
coupling reactions for the generation of more elaborated enamide units. By using 
the Takai olefination reaction, we have shown the selective synthesis of (E)-β-
iodo-enamides, which are robust and useful substrates in Sonogashira cross-
couplings for the generation of β-yn-enamides and eventually (E,Z)-dienamides.  
On the other hand, by using the Stork-Zhao olefination reaction, we have explored 
the synthesis of gem-dihalo-enamides. Such species have the potential to be 
flexible substrates for the synthesis of branched or unbranched products via 
Suzuki-Miyaura cross-coupling reactions. Indeed, reaction of both cyclic and 
acyclic dibromo-enamides, under Cossy’s procedure,[56] yielded the desired cross-
coupled adducts. Significantly, there was no need for nitrogen protection in the 
acyclic substrate (Scheme 74). 
 
 
Scheme 74. Synthesis of branched and unbranched products. 
 
Additionally, β,β-dihalo-enamides can also be exploited for the generation of 
aminoketones, following Lautens’ protocol[57] (Scheme 75).  
 
 
 
Scheme 75. Synthesis of aminoketones. 
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Finally, we have also observed the potential for acyclic β-halo-enamides to be 
useful substrates for a novel generation of oxazole products (Scheme 76). 
 
 
 
Scheme 76. Synthesis of oxazoles. 
 
For such reasons, we can conclude that β-halo-enamides and β,β-dihalo-
enamides have great potential as key intermediates from which a series of 
important transformations can be developed. These substrates have shown a 
good reactivity in Csp2-Csp and Csp2-Csp2 cross-couplings, with retention of the 
double bond geometry. Importantly, this methodology represents a protecting 
group-free strategy, an attractive feature not present in the existing examples 
reported so far in the literature (Figure 33). 
 
 
 
Figure 33. Synthetic potential of β-halo-enamides. 
A. E. Pasqua 2013 Chapter I Results and Discussion 
 
72 
 
Thus far, we have explored the use of the β-halo-enamides in Csp2-Csp 
(Sonogashira) and Csp2-Csp2 (Suzuki) cross-couplings. The next step, was to 
consider the reactivity of our novel β-halo-enamides in the more challenging Csp2-
Csp3 cross-coupling reactions, which could be very useful in the total synthesis of 
natural products containing complex enamide moieties (for example, crocacin D as 
will be elucidated in the next chapter). To the best of our knowledge, there are no 
examples in the literature so far of Csp2-Csp3 cross-coupling reactions involving β-
halo-enamides. In our preliminary studies, we took into consideration the use of 
(Z)-β-bromovinyl-benzamide 281 as a model system and we attempted the Stille 
coupling with a custom lateral chain 282, initially following Echavarren’s 
protocol.[76] A series of catalysts, additives, solvents and temperatures were 
explored, however, disappointingly, the reaction was unsuccessful in all cases, 
giving decomposition or in some cases (entry 1 and 2) a collateral dehalogenation 
to afford the undesired terminal olefin by-product 280 (Table 12). 
 
 
 
Table 12. Efforts towards the Stille coupling. 
 
After the first unsuccessful attempts, Negishi coupling was also explored under 
Lipshutz’s conditions.[77a,b] Again, the cross-coupling was unsuccessful, yielding 
either unreacted or isomerised starting material. In an additional case formation of 
the by-product 280 was also observed (Table 13). 
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Table 13. Efforts towards the Negishi coupling. 
 
Finally, a preliminary attempt to apply Molander’s conditions of Suzuki cross-
coupling to our model system was, likewise, unsuccessful, as generating only the 
undesired by-product 280 (Scheme 77).[78] 
 
 
 
Scheme 77. Preliminary attempt of Suzuki coupling. 
 
Thus, we have shown that β-halo-enamides and β,β-dihalo-enamides are 
excellent substrates for Csp2-Csp2 and Csp2-Csp bond formation reactions to yield 
the desired enamides in good yield.  
Unfortunately, successful Csp2-Csp3 cross-coupling of β-halo-enamides has 
proven rather elusive and remains a significant challenge. 
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2.10 Synthesis of Lansiumamides and Alatamide 
 
 
Once our methodology for the synthesis of stereodefined β-halo-enamides was 
developed, a practical application of this novel procedure was explored. The 
methodology appeared to be particularly suitable for the total synthesis of three 
stereodefined enamide-containing natural products, namely lansiumamide A 288, 
lansiumamide B 289 and alatamide 290 (Figure 34).  
 
 
 
Figure 34. Lansiumamide A 288, B 289 and alatamide 290. 
 
Lansiumamide A 288 and B 289 are two cinnamamide derivatives isolated from 
the seeds of Clausena lansium, which is a plant native to China and Taiwan. 
Some parts of this plant have been used in traditional Chinese medicine as 
remedies against a variety of diseases and, in particular, the leaves are used for 
the treatment of asthma and gastro-intestinal diseases, while the seeds can also 
be used for the treatment of ulcers and acute or chronic gastro-intestinal 
inflamations (Figure 35).[79a-c]  
 
  
 
Figure 35. Clausena lansium fruits and seeds. 
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In our retrosynthetic analysis, we envisioned lansiumamide B as deriving directly 
from lansiumamide A by direct methylation. Lansiumamide A, in turn, could be 
derived from the (Z)-β-bromo-enamide 292, via Suzuki coupling with benzylboronic 
acid 293. Enamide 292 could be easily obtained via the Pd/Bu3SnH-mediated 
stereoselective debromination of β,β-dibromo-enamide 291. The latter could be 
accessed through our dibromo-olefination methodology starting from N-
formylimide 294, which, in turn, could originate from trans-cinnamamide 295 via N-
formylation (Figure 36). 
 
 
 
Figure 36. Retrosynthesis of lansiumamide A 288 and B 289. 
 
Our synthesis began with trans-cinnamamide 295 which was formylated with N-
formylbenzotriazole to afford the N-formylimide 294 in good yield.  
Treatment of imine 294 with (bromomethyl)triphenylphosphonium bromide and 
potassium tert-butoxide, cleanly afforded β,β-dibromo-enamide 291 in good yield. 
Stereoselective debromination of 291 yielded the (Z)-β-bromo-enamide 292 with 
complete stereocontrol. Coupling of halo-enamide 292 with phenylboronic acid 
293 under Suzuki-Miyaura conditions gave lansiumamide A 288 in good yield and 
more importantly as a single double bond isomer. Methylation of lansiumamide A 
288 afforded lansiumamide B 289 in quantitative yield (Scheme 78). 
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Scheme 78. Synthesis of lansiumamide A 288 and B 289. 
 
Alatamide 290 is a β-phenylethylamine-derived amide isolated from the aerial 
parts of the plant Piper guayranum, originating from both Trinidad and Tobago and 
Venezuela (Figure 37). Thus far, there have been no reports of medicinal uses of 
this plant.[80] 
 
 
 
Figure 37. Piper guayranum. 
 
The retrosynthetic analysis of alatamide 290 began with a Zn-Cu 
couple/CH3COOH-mediated debromination of intermediate 277. The latter, in turn, 
could be accessed via stereoselective Suzuki coupling of the β,β-dibromo-
enamide 251 with boronic acid 297. The gem-dihalo-enamide 251 could be 
derived from the corresponding N-formylimide 216 via dibromo-olefination.  
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N-Formylimide 216 could be accessed via formylation of benzamide 209 (Figure 
38). 
 
 
 
Figure 38. Retrosynthesis of alatamide. 
 
Following our synthetic approach, benzamide 209 was successfully formylated to 
afford N-formylbenzimide 216 in good yield. N-Formylimide 216 was then 
subjected to our optimised dibromo-olefination conditions to yield the desired β,β-
dibromo-enamide 251 in good yield. Suzuki cross-coupling of the dihalo-enamide 
251 with boronic acid 298 afforded the desired enamide 277 in 55% yield (75% 
brsm) together with the undesired by-product 278 in 12% yield. Dehalogenation of 
enamide 277 with Zn-Cu couple/acetic acid yielded alatamide 290 in 90% yield 
(Scheme 79). 
 
 
 
Scheme 79. Synthesis of alatamide 290. 
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In conclusion, our methodology for the stereoselective preparation of β-halo-
enamides, allowed the completion of the syntheses of three enamide-containing 
natural products in a simple and efficient fashion. The strategy compares 
favourably with the previous examples reported in the literature[2,21,24,25,81a,b] both 
for availability of the starting materials, costs, number of steps and overall yield. 
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2.11 Summary and future work 
 
 
In summary, an efficient and environmentally friendly procedure for the synthesis 
of N-formylbenzotriazole 186 and its derivatives has been developed. This method 
is considered green as it requires relatively small volumes of organic solvent and 
produces acetic acid as the only significant side product. The THF used in the 
reaction mixture can be recovered during the evaporation step, thus causing 
minimal environmental impact and minimising costs. The procedure represents a 
great improvement compared to other methods available currently for the 
synthesis of N-formylbenzotriazole in terms of cost, yield and overall efficiency 
(Scheme 80).   
 
 
 
Scheme 80. Synthesis of N-formylbenzotriazoles. 
 
Subsequently, the N-formylbenzotriazole so obtained has been exploited for the 
synthesis of N-formyl imides starting from acyclic commercial amides, while cyclic 
N-formyl imides have been prepared starting from commercial lactams and easily 
available acetic formic anhydride 162 (Scheme 81).   
 
 
 
Scheme 81. Synthesis of N-formyl imides. 
 
A. E. Pasqua 2013 Chapter I Results and Discussion 
 
80 
 
With the N-formyl imides in hand, we then developed a fast and efficient method, 
which takes advantage of the pseudo-aldehyde behaviour of N-formyl imides, to 
access β-halo-enamides in a single step, in moderate-good yields and without the 
need for nitrogen protecting groups. The approach hinges on the ability of N-formyl 
imides to undergo olefination reactions to generate enamides in good yield and 
most significantly without the need for nitrogen protection in acyclic cases. The β-
halo-enamides, in turn, can be easily functionalised into β-yn-enamides and (E,Z)-
dienamides in excellent yields and with complete stereoselectivity (Figure 39).  
 
 
 
Figure 39. Synthesis of β-yn-enamides and (E,Z)-dienamides. 
 
We have also developed a novel, protecting group-free, efficient and 
stereoselective approach to the generation of β-dihalo-enamides through the use 
of modified Stork-Zhao olefination conditions.  Our results have shown that this 
methodology provides a robust synthetic platform from which (Z)- or (E)-enamides 
can be generated in good yields and with complete stereocontrol (Figure 40). 
 
 
 
Figure 40. Proposed synthesis of β-halo-enamides from N-formyl imides. 
 
The synthetic utility of the methodology has been proven through the efficient and 
stereoselective syntheses of three simple enamide-containing natural products, 
lansiumamide A 288, B 289 and alatamide 290 (Figure 41). 
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Figure 41. Synthesis of lansiumamide A, B and alatamide.  
 
We have also obtained very promising results for the synthesis of oxazoles, 
however optimisation of these results is still necessary to expand the scope of this 
transformation (Figure 42). 
 
 
 
Figure 42. Conversion of β-halo-enamides into oxazoles. 
 
Finally, as all the attempts to couple the β-halo-enamides with alkylic substrates 
have proven unsuccessful thus far, hence, new efforts will be required to address 
and solve these issues (Figure 43). 
 
 
 
Figure 43. New efforts towards the Csp2-Csp3 cross-coupling. 
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3 Experimental 
 
All reactions were performed in oven-dried glassware under an inert argon 
atmosphere unless otherwise stated. Tetrahydrofuran (THF), diethyl ether, toluene 
and dichloromethane were purified through a Pure Solv 400-5MD solvent 
purification system (Innovative Technology, Inc). Anhydrous dimethylformamide, 
N-methylpyrrolidone, ethyl acetate, methanol and dioxane were purchased from 
Sigma-Aldrich. All reagents were used as received, unless otherwise stated. 
Solvents were evaporated under reduced pressure at 40 °C using a Büchi 
Rotavapor. IR spectra were recorded neat using a JASCO FT/IR410 Fourier 
Transform spectrometer. Only significant absorptions (νmax) are reported in 
wavenumbers (cm-1).  Proton magnetic resonance spectra (1H NMR) and carbon 
magnetic resonance spectra (13C NMR) were recorded using a Bruker DPX 
Avance400 instrument.  Chemical shifts (δ) are reported in parts per million (ppm) 
and are referenced to the residual solvent peak. The order of citation in 
parentheses is (1) number of equivalent nuclei (by integration), (2) multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, b = broad, dm = doublet 
of multiplet, dd = doublet of doublet, dt = doublet of triplet) and (3) coupling 
constant (J) quoted in Hertz to the nearest 0.1Hz. High resolution mass spectra 
were recorded on a JEOL JMS-700 spectrometer by electrospray (ESI), fast atom 
bombardment (FAB), electron impact (EI) and chemical ionisation (CI) mass 
spectrometer operating at a resolution of 15000 full widths at half height.  Where a 
100% peak was not observed in low resolution mass spectra the highest peak was 
taken to be 100%. Flash chromatography was performed using silica gel (Apollo 
Scientific Silica Gel 60, 40-63 mm) as the stationary phase. TLC was performed 
on aluminium sheets pre-coated with silica (Merck Silica Gel 60 F254). The plates 
were visualised by the quenching of UV fluorescence (λmax 254 nm) and/or by 
staining with either anisaldehyde or potassium permanganate followed by heating. 
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N-Formylbenzotriazole, 186 
 
 
 
A solution of commercial grade acetic anhydride (4.72 mL, 50.0 mmol) was treated 
with 100% formic acid (3.80 mL, 100 mmol) at 0 °C and the resulting mixture was 
stirred at 80 °C for 45 minutes under microwave irradiation.  The resulting crude 
anhydride mixture was then analysed by 1H NMR and the yield of mixed anhydride 
162 was obtained (42%, 21.0 mmol). The mixed anhydride was cooled down to -
10 °C and the benzotriazole 187 (0.9 eq based on the amount of anhydride 162 
generated, 2.25 g, 18.9 mmol) was added as a solution in anhydrous THF (25 
mL).  The resulting mixture was then stirred at -10 °C until complete as indicated 
by TLC analysis (45 minutes).  The solvent was removed under vacuum to yield 
the desired N-formyl benzotriazole 186 without the need of purification in 
quantitative yield (2.78 g, 18.9 mmol). IR νmax (film) 3105, 1723, 1604, 1595 cm
-1; 
1H NMR (400 MHz, CDCl3): δH 9.86 (1H, s, CHO), 8.26 (1H, d, J 8.0 Hz, CHAr), 
8.18 (1H, dd, J 1.0, 8.0 Hz, CHAr), 7.71 (1H, ddd, J 1.0, 7.2, 8.2 Hz, CHAr), 7.59 
(1H, ddd, J 1.0, 7.2, 8.2 Hz, CHAr); 
13C NMR (100 MHz, CDCl3): δC 159.7 (CO), 
146.5 (CAr), 130.7 (CHAr), 129.8 (CAr), 127.0 (CHAr), 120.4 (CHAr), 113.6 (CHAr); 
HRMS (CI+/ISO) calc. for C7H5N3O [M]
+: 147.0433. Found 147.0435; m.p. 78-80 
°C. 
 
The characterisation matches with the data reported in literature: 
Katrizky A. R.; Chang H. X.; Yang B. Synthesis 1995, 503. 
 
5-Methyl-N-formylbenzotriazole and 6-Methyl-N-formylbenzotriazole, 191    
    
                
 
A solution of commercial grade acetic anhydride (4.72 mL, 50.0 mmol) was treated 
with 100% formic acid (3.80 mL, 100 mmol) at 0 °C and the resulting mixture was 
stirred under argon at 55 °C for 3 hours. The resulting crude anhydride mixture 
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was analysed by 1H NMR and the yield of mixed anhydride 162 was obtained 
(47%, 23.3 mmol). The mixed anhydride was then cooled down to -10 °C and the 
5-methyl-1H-benzo[d][1,2,3]triazole 190 (0.9 eq based on the amount of anhydride 
162 generated, 2.80 g, 21.0 mmol) was then added as a solution in anhydrous 
THF (25 mL). The resulting mixture was stirred at -10 °C until complete as 
indicated by TLC analysis (45 minutes).  The solvent was removed under vacuum 
to yield the desired product without the need of purification. The methyl substituted 
N-formylbenzotriazole 191 was obtained as a 1.6.:1.0 mixture of regioisomers in 
99% yield (3.36 g, 20.8 mmol). IR νmax (film) 2959, 2924, 1699, 1617, 1491, 1440, 
1372, 1349, 1300, 1062 cm-1; HRMS (ESI+) calc. for C8H7N3O [M]
+: 161.0589. 
Found 161.0592; m.p. 70-71 °C. 
Major isomer (5-Methyl-N-formylbenzotriazole): 1H NMR (400 MHz, CDCl3): δH 
9.82 (1H, s, CHO), 8.04 (1H, s, CHAr), 7.99 (1H, dd, J 0.5, 8.5 Hz, CHAr), 7.38 (1H, 
dd, J 1.1, 8.4 Hz, CHAr), 2.58 (3H, s, CH3); 
13C NMR (100 MHz, CDCl3): δC 159.9 
(CO), 145.1 (CAr), 142.0 (CAr), 130.3 (CAr), 128.9 (CHAr), 119.7 (CHAr), 113.1 
(CHAr), 22.1 (CH3). 
Minor isomer (6-Methyl-N-formylbenzotriazole): 1H NMR (400 MHz, CDCl3): δH 
9.82 (1H, s, CHO), 8.10 (1H, dd, J 0.4, 8.4 Hz, CHAr), 7.91 (1H, s, CHAr), 7.52 (1H, 
dd, J 1.0, 8.3 Hz, CHAr), 2.56 (3H, s, CH3); 
13C NMR (100 MHz, CDCl3): δC 159.7 
(CO), 147.1 (CAr), 137.4 (CAr), 132.5 (CAr), 128.2 (CHAr), 119.5 (CHAr), 112.9 
(CHAr), 21.6 (CH3). 
 
5,6-Dimethyl-N-formylbenzotriazole, 193 
 
 
 
A solution of commercial grade acetic anhydride (4.72 mL, 50.0 mmol) was treated 
with 100% formic acid (3.80 mL, 100 mmol) at 0 °C and the resulting mixture was 
stirred at 80 °C for 45 minutes under microwave irradiation. The resulting crude 
anhydride mixture was analysed by 1H NMR and the yield of mixed anhydride was 
obtained (42%, 21.0 mmol). The mixed anhydride 162 was then cooled down to -
10 °C and the 5,6-dimethyl-1H-benzo[d][1,2,3]triazole 192 (0.9 eq based on the 
amount of anhydride 162 generated, 2.84 g, 18.9 mmol) was added as a solution 
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in anhydrous THF (25 mL). The resulting mixture was stirred at -10 °C until 
complete as indicated by TLC analysis (45 minutes). The solvent was removed 
under vacuum to yield the desired 5,6-dimethyl-N-formyl benzotriazole 193 without 
the need of purification in 94% yield (3.12 g, 17.8 mmol). IR νmax (film) 3294, 2946, 
2918, 2358, 1727, 1714, 1587, 1478, 1463, 1448, 1203, 1060 cm-1; 1H NMR (400 
MHz, CDCl3): δH 9.80 (1H, s, CHO), 8.01 (1H, s, CHAr), 7.88 (1H, s, CHAr), 2.47 
(3H, s, CH3), 2.45 (3H, s, CH3); 
13C NMR (100 MHz, CDCl3): δC 159.8 (CO), 145.6 
(CAr), 141.4 (CAr), 136.9 (CAr), 128.7 (CAr), 119.6 (CHAr), 113.2 (CHAr), 20.9 (CH3), 
20.5 (CH3); HRMS (ESI+):  calc. for C9H9N3O [M]
+: 175.0746. Found 175.0747; 
m.p. 110-111 °C. 
 
5-Chloro-N-formylbenzotriazole and 6-Chloro-N-formylbenzotriazole, 195 
 
               
A solution of commercial grade acetic anhydride (4.72 mL, 50.0 mmol) was treated 
with 100% formic acid (3.80 mL, 100 mmol) at 0 °C and the resulting mixture was 
stirred under argon at 55 °C for 3 hours. The crude anhydride mixture was 
analysed by 1H NMR and the yield of mixed anhydride 162 was obtained (42%, 
21.0 mmol). The mixed anhydride was cooled down to -10 °C and the 6-chloro-1H-
benzo[d][1,2,3]triazole 194 (0.9 eq based on the amount of anhydride 162 
generated, 2.88 g, 18.8 mmol) was added as a THF solution (25 mL). The 
resulting mixture was stirred at -10 °C for 45 minutes. The solvent was removed 
under vacuum to yield the desired product without the need of purification. The 
chloro substituted N-formylbenzotriazole 195 was obtained as a 2.5:1.0 mixture of 
regioisomers in 99% yield (3.38 g, 18.6 mmol). IR νmax (film) 3101, 3010, 2956, 
2834, 1910, 1759, 1732, 1608, 1586, 1460, 1367, 1220 cm-1; HRMS (ESI+):  calc. 
for C7H4N3O
35Cl [M]+: 181.0043. Found 181.0036; m.p. 88-90 °C. 
Major isomer (5-Chloro-N-formylbenzotriazole): 1H NMR (400 MHz, CDCl3): δH 
9.82 (1H, s, CHO), 8.28 (1H, d, J 1.8 Hz, CHAr), 8.08 (1H, dd, J 0.5, 8.8 Hz, CHAr), 
7.55 (1H, dd, J 1.9, 8.8 Hz, CHAr);
 13C NMR (100 MHz, CDCl3): δC 159.5 (CO), 
145.0 (CAr), 137.5 (CAr), 130.5 (CAr), 128.1 (CHAr), 121.2 (CHAr), 113.7 (CHAr).
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Minor isomer (6-Chloro-N-formylbenzotriazole): 1H NMR (400 MHz, CDCl3): δH 
9.83 (1H, s, CHO), 8.20 (1H, d, J 1.8 Hz, CHAr), 8.15 (1H, dd, J 0.6, 8.7 Hz, CHAr), 
7.68 (1H, dd, J 1.8, 8.6 Hz, CHAr); 
13C NMR (100 MHz, CDCl3): δC 159.4 (CO), 
143.5 (CAr), 132.8 (CAr), 131.5 (CAr), 128.6 (CHAr), 120.0 (CHAr), 114.3 (CHAr). 
 
N-Formyl-4-azabenzotriazole and N-Formyl-7-azabenzotriazole, 197 
 
           
 
A solution of commercial grade acetic anhydride (4.72 mL, 50.0 mmol) was treated 
with 100% formic acid (3.80 mL, 100 mmol) at 0 °C and the resulting mixture was 
stirred at 80 °C for 45 minutes under microwave irradiation. The resulting crude 
anhydride mixture was analysed by 1H NMR and the yield of mixed anhydride 162 
was obtained (50%, 25.0 mmol). The mixed anhydride was then cooled down to -
10 °C and the 1H-[1,2,3]triazolo[4,5-b]pyridine 196 (0.9 eq based on the amount of 
anhydride 162 generated, 1.85 g, 22.5 mmol) was added as a solution in THF (25 
mL). The resulting mixture was stirred at -10 °C until complete as indicated by TLC 
analysis (45 minutes). The solvent was removed under vacuum to yield the 
desired product without the need of purification. The N-formyl-aza-benzotriazole 
197 was obtained as a 12.0:1.0 mixture of regioisomers in 96% yield (3.20 g, 21.6 
mmol). IR νmax (film) 2680, 1728, 1594, 1584, 1399, 1376, 1259, 1060 cm
-1; HRMS 
(CI+/ISO):  calc. for C6H5N4O [M+H]
+: 149.0463. Found 149.0472; m.p. 103-105 
°C. 
Major isomer (N-Formyl-7-azabenzotriazole): 1H NMR (400 MHz; DMSO-d6): δH 
10.03 (1H, s, CHO), 8.91 (1H, dd, J 1.5, 4.5 Hz, CHAr); 8.65 (1H, dd, J 1.4, 8.2 Hz, 
CHAr), 7.86 (1H, dd, J 4.5, 8.3 Hz, CHAr); 
13C-NMR (100 MHz; DMSO-d6): δC 172.1 
(CO), 163.1 (CAr), 149.7 (CAr), 144.8 (CHAr), 125.4 (CHAr), 123.3 (CHAr). 
Minor isomer (N-Formyl-4-azabenzotriazole): 1H-NMR (400 MHz; DMSO-d6): δH 
9.98 (1H, s, CHO), 8.87 (1H, dd, J 1.6, 4.4 Hz, CHAr); 8.64 (1H, dd, J 1.5, 8.3 Hz, 
CHAr), 7.81 (1H, dd, J 4.5, 8.3 Hz, CHAr); 
13C-NMR (100 MHz; DMSO-d6): δC 172.0 
(CO), 163.0 (CAr), 149.5 (CAr), 144.7 (CHAr), 125.4 (CHAr), 122.9 (CHAr). 
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5-nitro-1H-benzo[d][1,2,3]triazole, 198 
 
 
 
To a suspension of 4-nitro-1,2-phenylendiamine 200 (10.0 g, 65.0 mmol) in 15.7 
mL of glacial acetic acid and 650 mL of cold distilled water, it was added dropwise 
and slowly a solution of sodium nitrite (4.50 g, 65.0 mmol) while stirring. The hot 
mixture was neutralised with a 5% solution of ammonia (117 mL) and cooled to 
allow the precipitation of the product. The product was filtered, washed with cold 
water and dried under vacuum at 80 °C overnight to afford the pure product 198 as 
a yellow solid in 88% yield (9.38 g, 57.2 mmol). 1H-NMR (400 MHz; CDCl3): δH 
8.95 (1H, bd, J 1.2 Hz, CHAr), 8.39 (1H, dd, J 2.4, 9.2 Hz, CHAr), 7.92 (1H, d, J 8.8 
Hz, CHAr); 
1H-NMR (400 MHz; DMSO-d6): δH 8.95 (1H, dd, J 0.6, 1.7 Hz, CHAr), 
8.33 (1H, dd, J 1.7, 9.1 Hz, CHAr), 8.12 (1H, dd, J 0.6, 9.1 Hz, CHAr); HRMS (EI+):  
calc. for C6H4N4O2 [M]
+: 164.0334. Found 164.0337. 
 
The characterisation matches with the data reported in literature: 
Larina L. I.; Milata V. Magn. Reson. Chem. 2009, 47, 142. 
 
5-Nitro-N-formylbenzotriazole and 6-Nitro-N-formylbenzotriazole, 199 
 
                      
 
A solution of commercial grade acetic anhydride (4.72 mL, 50.0 mmol) was treated 
with 100% formic acid (3.80 mL, 100 mmol) at 0 °C and the resulting mixture was 
stirred under argon at 55 °C for 3 hours. The resulting crude anhydride mixture 
was analysed by 1H NMR and the yield of mixed anhydride 162 was obtained 
(44%, 21.7 mmol). The mixed anhydride 162 was cooled down to -10 °C and the 
6-nitro-1H-benzo[d][1,2,3]triazole 198 (0.9 eq based on the amount of anhydride 
162 generated, 3.20 g, 19.5 mmol) was added as a solution in anhydrous THF (25 
mL). The resulting mixture was stirred at -10 °C until complete as indicated by TLC 
analysis (45 minutes). The solvent was removed under vacuum to yield the 
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desired product without the need of purification. The nitro substituted N-
formylbenzotriazoles 199 was obtained as a 5.7:1.0 mixture of regioisomers in 
90% yield (3.37 g, 17.6 mmol). IR νmax (film) 3173, 3098, 1751, 1742, 1618, 1520, 
1339, 1205 cm-1; HRMS (ESI+):  calc. for C7H4N4O3 [M]
+: 192.0283. Found 
192.0284; m.p. 210-211 °C. 
Major isomer (5-Nitro-N-formylbenzotriazole): 1H-NMR (400 MHz; CDCl3): δH 
9.90 (1H, s, CHO), 9.09 (1H, d, J 1.7 Hz, CHAr), 8.64 (1H, dd, J 2.0, 9.0 Hz, CHAr), 
8.42 (1H, d, J 8.9 Hz, CHAr);
 13C-NMR (100 MHz; CDCl3): δC 159.2 (CO), 146.0 
(CAr), 132.8 (CAr), 125.7 (CHAr), 117.2 (CHAr), 116.9 (CAr), 114.2 (CHAr).
 
Minor isomer (6-Nitro-N-formylbenzotriazole): 1H-NMR (400 MHz; CDCl3): δH 
9.91 (1H, s, CHO), 9.05 (1H, d, J 1.8 Hz, CHAr), 8.56 (1H, dd, J 2.0, 9.0 Hz, CHAr), 
8.45 (1H, d, J 9.5 Hz, CHAr); 
13C-NMR (100 MHz; CDCl3): δC 159.0 (CO), 146.5 
(CAr), 125.3 (CAr), 122.1 (CAr), 121.4 (CHAr), 117.2 (CHAr), 110.3 (CHAr). 
 
5,6-Dinitro-1H-benzo[d][1,2,3]triazole, 201 
 
 
 
To a solution of 5-nitro-1H-benzo[d][1,2,3]triazole 198 (2.50 g, 15.0 mmol) in 30 
mL of concentrated H2SO4 at 0 °C, 30 mL of HNO3 (70%) were added dropwise in 
a period of 20 minutes. Stirring was continued for a further 15 minutes at 0 °C and 
then the resulting mixture was stirred at 115 °C overnight. The solution was cooled 
to room temperature and poured over ice to give a precipitate that was washed 
with distilled water and dried under vacuum at 80 °C overnight to afford the pure 
product 201 as a pale yellow solid in 56% yield (1.76 g, 8.40 mmol). 1H-NMR (400 
MHz; DMSO-d6): δH 9.00 (2H, s, 2 x CHAr); HRMS (EI+):  calc. for C6H3N5O4 [M]
+: 
209.0185. Found 209.0182. 
 
The characterisation matches with the data reported in literature: 
McHugh C. J.; Tackley D. R.; Graham D. Heterocycles 2002, 57, 1461. 
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4,5,6,7-Tetrabromo-1H-benzo[d][1,2,3]triazole, 203 
 
 
 
To a solution of benzotriazole 187 (1.20 g, 10.0 mmol) in concentrated HNO3 (20 
mL), bromine (3.33 mL, 65.0 mmol) was added dropwise and the resulting mixture 
was allowed to stir at reflux for 12 hours. The solution was allowed to cool to room 
temperature and the precipitate was washed with petroleum ether (20 mL), filtered 
and dried to afford a light yellow solid as pure product 203 in 80% yield (3.50 g, 
8.00 mmol). 13C-NMR (125 MHz; DMSO-d6): δC 143.1 (CAr), 138.8 (CAr), 124.7 
(CAr), 113.4 (CAr), 111.0 (CAr); HRMS (EI+):  calc. for C6HN3
79Br4 [M]
+: 430.6904. 
Found 430.6887. 
 
The characterisation matches with the data reported in literature: 
Borowski P.; Deinert J.; Schalinski S.; Bretner M.; Ginalski K.; Kulikowski T.; Sugar 
D. Eur. J. Biochem. 2003, 270, 1645. 
 
2-Oxo-pyrrolidine-1-carbaldehyde, 166 
 
 
Sodium formate (30.0 g, 0.44 mol) was dried under vacuum at 130 °C for 24 
hours. The dry sodium formate was suspended in dry diethyl ether (30 mL), and 
acetyl chloride (31.4 mL, 0.44 mol) was added quickly. The resulting solution was 
then stirred at room temperature under argon overnight. The reaction mixture was 
treated with the neat lactam 2-pyrrolidinone 163 (3.74 g, 44.0 mmol) and the 
solution was stirred at 60 °C overnight. The reaction mixture was cooled down to 
room temperature and concentrated under reduced pressure to give a white solid 
which was taken up into dichloromethane (150 mL) and filtered to remove the 
insoluble salt by-product. The filtrate was washed with water (100 mL) and the 
aqueous phase was extracted into dichloromethane (50 mL). The combined 
organic phases were dried over anhydrous sodium sulfate and concentrated under 
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reduced pressure to give a crude brown oil. Purification of the crude oil by flash 
column chromatography on silica gel (20% ethyl acetate in petroleum ether) gave 
the imide 166 as a colourless oil in 72% yield (3.58 g, 31.7 mmol). IR νmax (film) 
2969, 2903, 1744, 1686, 1395, 1350, 1321, 1292, 1240, 1219, 1194, 1018, 789, 
731 and 650 cm-1; 1H NMR (400 MHz, CDCl3): δH 9.07 (1H, s, CHO), 3.71 (2H, td, 
J 0.8, 7.2 Hz, CH2N), 2.58 (2H, t, J 7.2 Hz, CH2CO), 2.08 (2H, qn, J 7.2 Hz, CH2); 
13C-NMR (100 MHz; CDCl3): δC 176.9 (CO), 160.3 (CHO), 42.1 (CH2N), 33.2 
(CH2CO), 17.9 (CH2); HRMS (EI+):  calc. for C5H7NO2 [M]
+: 113.0477. Found 
113.0480. 
 
The characterisation matches with the data reported in literature: 
Villa M. V. J.; Targett S. M.; Barnes J. C.; Whittingham W. G.; Marquez R. Org. 
Lett. 2007, 9, 1631. 
 
2-Oxo-piperidine-1-carbaldehyde, 167 
 
 
Sodium formate (30.0 g, 0.44 mol) was dried under vacuum at 130 °C for 24 
hours. The dry sodium formate was suspended in dry diethyl ether (30 mL), and 
acetyl chloride (31.4 mL, 0.44 mol) was added quickly. The resulting solution was 
then stirred at room temperature under argon overnight. The reaction mixture was 
treated with the neat lactam δ-valerolactam 33 (4.36 g, 44.0 mmol) and the 
solution was stirred at 60 °C overnight. The reaction mixture was cooled down to 
room temperature and concentrated under reduced pressure to give a white solid 
which was taken up in dichloromethane (150 mL) and filtered to remove the 
insoluble salt by-product. The filtrate was washed with water (100 mL) and the 
aqueous phase was extracted into dichloromethane (50 mL). The combined 
organic phases were dried over anhydrous sodium sulfate and concentrated under 
reduced pressure to give a crude brown oil. Purification of the crude oil by flash 
column chromatography on silica gel (20% ethyl acetate in petroleum ether) gave 
the imide 167 as a colourless oil in 75% yield (4.19 g, 33.0 mmol). IR νmax (film) 
2953, 2880, 1713, 1684, 1479, 1460, 1396, 1368, 1342, 1331, 1290, 1281, 1231, 
1155, 1090, 984 and 766 cm-1; 1H NMR (400 MHz, CDCl3): δH 9.31 (1H, s, CHO), 
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3.50-3.47 (2H, bm, CH2N), 2.47-2.42 (2H, m, CH2CO), 1.78-1.68 (4H, bm, 2 x 
CH2); 
13C-NMR (100 MHz; CDCl3): δC 170.9 (CO), 162.2 (CHO), 41.5 (CH2N), 33.1 
(CH2CO), 22.3 (CH2CH2CO), 19.7 (CH2CH2N); HRMS (CI+/ISO):  calc. for 
C6H10NO2 [M+H]
+: 128.0712. Found 128.0709. 
 
The characterisation matches with the data reported in literature: 
Villa M. V. J.; Targett S. M.; Barnes J. C.; Whittingham W. G.; Marquez R. Org. 
Lett. 2007, 9, 1631. 
 
2-Oxo-azepane-1-carbaldehyde, 168 
 
 
Sodium formate (30.0 g, 0.44 mol) was dried under vacuum at 130 °C for 24 
hours. The dry sodium formate was suspended in dry diethyl ether (30 mL), and 
acetyl chloride (31.4 mL, 0.44 mol) was added quickly. The resulting solution was 
then stirred at room temperature under argon overnight. The reaction mixture was 
treated with the neat lactam ε-caprolactam 164 (4.98 g, 44.0 mmol) and the 
solution was stirred at 60 °C overnight. The reaction mixture was cooled down to 
room temperature and concentrated under reduced pressure to give a white solid 
which was taken up in dichloromethane (150 mL) and filtered to remove the 
insoluble salt by-product. The filtrate was washed with water (100 mL) and the 
aqueous phase was extracted into dichloromethane (50 mL). The combined 
organic phases were dried over anhydrous sodium sulfate and concentrated under 
reduced pressure to give a crude brown oil. Purification of the crude oil by flash 
column chromatography on silica gel (20% ethyl acetate in petroleum ether) gave 
the imide 168 as a colourless oil in 81% yield (5.03 g, 35.6 mmol). IR νmax (film) 
2932, 2861, 1718, 1682, 1462, 1437, 1348, 1331, 1261, 1213, 1179, 1153, 1082, 
964, 905 and 849 cm-1; 1H NMR (400 MHz, CDCl3): δH 9.40 (1H, s, CHO), 3.78 
(2H, t, J 4.8 Hz, CH2N), 2.70 (2H, t, J 4.8 Hz, CH2CO), 1.83-1.68 (6H, m, 3 x CH2); 
13C-NMR (100 MHz; CDCl3): δC 178.0 (CO), 162.2 (CHO), 40.2 (CH2N), 38.3 
(CH2CO), 29.6 (CH2CH2CO), 28.6 (CH2CH2N), 23.6 (CH2); HRMS (CI+/ISO):  calc. 
for C7H12NO2 [M+H]
+: 142.0868. Found 142.0864. 
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The characterisation matches with the data reported in literature: 
Villa M. V. J.; Targett S. M.; Barnes J. C.; Whittingham W. G.; Marquez R. Org. 
Lett. 2007, 9, 1631. 
 
2-Oxo-azocane-1-carbaldehyde, 169 
 
 
Sodium formate (30.0 g, 0.44 mol) was dried under vacuum at 130 °C for 24 
hours. The dry sodium formate was suspended in dry diethyl ether (30 mL), and 
acetyl chloride (31.4 mL, 0.44 mol) was added quickly. The resulting solution was 
then stirred at room temperature under argon overnight. The reaction mixture was 
treated with the neat lactam 2-azacyclooctanone 165 (2.00 g, 16.0 mmol) and the 
solution was stirred at 60 °C overnight. The reaction mixture was cooled down to 
room temperature and concentrated under reduced pressure to give a white solid 
which was taken up in dichloromethane (150 mL) and filtered to remove the 
insoluble salt by-product. The filtrate was washed with water (100 mL) and the 
aqueous phase was extracted into dichloromethane (50 mL). The combined 
organic phases were dried over anhydrous sodium sulfate and concentrated under 
reduced pressure to give a crude brown oil. Purification of the crude oil by flash 
column chromatography on silica gel (20% ethyl acetate in petroleum ether) gave 
the imide 169 as a colourless oil in 85% yield (2.11 g, 13.6 mmol). IR νmax (film) 
2932, 2861, 1713, 1682, 1447, 1331, 1242, 1213, 1128, 1090, 914, 727 and 708 
cm-1; 1H NMR (400 MHz, CDCl3): δH 9.46 (1H, s, CHO), 3.85 (2H, t, J 6.0 Hz, 
CH2N), 2.67 (2H, t, J 6.0 Hz, CH2CO), 1.92 (2H, qn, J 6.0 Hz, CH2CH2CO), 1.72 
(2H, qn, J 6.0 Hz, CH2CH2N), 1.63 (2H, qn, J 6.0 Hz, CH2), 1.51 (2H, qn, J 6.0 Hz, 
CH2); 
13C-NMR (100 MHz; CDCl3): δC 178.3 (CO), 162.6 (CHO), 40.5 (CH2N), 35.1 
(CH2CO), 29.1 (CH2CH2CO), 28.6 (CH2CH2N), 25.9 (CH2), 24.4 (CH2); HRMS 
(CI+/ISO): calc. for C8H14NO2 [M+H]
+: 156.1025. Found 156.1021. 
 
The characterisation matches with the data reported in literature: 
Villa M. V. J.; Targett S. M.; Barnes J. C.; Whittingham W. G.; Marquez R. Org. 
Lett. 2007, 9, 1631. 
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2,4-Dihydroxy-3,3-dimethylbutanamide 
 
 
 
A 500-mL three-necked round bottom flask was loaded with pantolactone (20.0 g, 
154 mmol) and liquid ammonia (200 mL) was allowed to drip through a condenser 
connected to a cylinder in the vessel. The reaction mixture was allowed to stir at 
room temperature overnight, and then it was allowed to dry under vacuum for 12 
hours to afford the pure product as a white solid in 98% yield (22.1 g, 150 mmol). 
IR νmax (film) 3433, 3295, 3169, 3165, 2975, 2966, 1683, 1604, 1413, 1310, 1072, 
1048, 1019, 979 and 693 cm-1; 1H NMR (400 MHz, DMSO-d6): δH 7.11 (2H, s, 
NH2), 5.22 (1H, d, J 5.6 Hz, OH), 4.49 (1H, t, J 5.6 Hz, OH), 3.62 (1H, d, J 5.6 Hz, 
CHOH), 3.36 (1H, dd, J 5.6, 10.4 Hz, CHHOH), 3.18 (1H, dd, J 5.6, 10.4 Hz, 
CHHOH), 0.82 (3H, s, CH3), 0.81 (3H, s, CH3); 
13C-NMR (100 MHz; DMSO-d6): δC 
175.5 (CO), 75.1 (CHOH), 68.0 (CH2OH), 40.1 (C), 20.9 (CH3), 20.4 (CH3); HRMS 
(CI+/ISO):  calc. for C6H14NO3 [M+H]
+: 148.0974. Found 148.0972; m.p. 120-122 
°C. 
 
The characterisation matches with the data reported in literature: 
Aquino F.; Pauling H.; Walter W.; Plattner D. A.; Bonrath W. Synthesis  2000, 5, 
731. 
 
2,2,5,5-Tetramethyl-1,3-dioxane-4-carboxamide, 205 
 
 
The 2,4-dihydroxy-3,3-dimethylbutanamide  (2.94 g, 20.0 mmol) was suspended in 
a 1:1 mixture of acetone (45 mL) and dichloromethane (45 mL). Meanwhile, p-
toluenesulfonic acid (100 mg, 0.60 mmol) and 2-methoxypropene (3.83 mL, 40.0 
mmol) were dissolved in acetone (10 mL) and the resulting solution was cooled at 
10 °C. The previously prepared amide suspension was added to give a dark red 
solution, which was allowed to stir at room temperature for 1 hour and then filtered 
to remove the resulting white precipitate. The filtrate was neutralised with NH4Cl 
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saturated aqueous solution (100 mL) giving a transparent light green solution, 
which was separated, dried over Na2SO4, filtered and concentrated under vacuum 
to give a yellow oil as crude product. The crude product was purified through flash 
column chromatography on silica gel (2% methanol in dichloromethane) to afford a 
yellow solid as pure product 205 in 80% yield (3.00 g, 16.0 mmol). IR νmax (film) 
3475, 3276, 3143, 2988, 2971, 2867, 1695, 1406, 1375, 1370 and 1125 cm-1; 1H 
NMR (400 MHz, DMSO-d6): δH 7.22 (1H, bs, NHH), 6.85 (1H, bs, NHH), 3.99 (1H, 
s, CH), 3.65 (1H, d, J 11.6 Hz, CHH), 3.18 (1H, d, J 11.6 Hz, CHH), 1.39 (3H, s, 
CH3), 1.38 (3H, s, CH3), 0.95 (3H, s, CH3), 0.93 (3H, s, CH3); 
13C-NMR (100 MHz; 
DMSO-d6): δC 173.1 (CO), 98.7 (C), 76.5 (CH), 70.2 (CH2O), 31.9 (C), 28.8 (CH3), 
21.3 (CH3), 18.6 (CH3), 18.3 (CH3); LRMS (CI+/ISO):  calc. for C9H18NO3 [M+H]
+: 
188.3. 
 
The characterisation matches with the data reported in literature: 
Aquino F.; Pauling H.; Walter W.; Plattner D. A.; Bonrath W. Synthesis  2000, 5, 
731. 
 
N-Formyl-2,2,5,5-tetramethyl-[1,3]dioxane-4-carboxylic acid amide, 212 
 
 
 
A solution of 2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide 205 (187 mg, 1.00 
mmol) in anhydrous THF (10 mL) was cooled to 0 °C before being treated with n-
BuLi (0.69 mL, 1.10 mmol, 1.6 M solution in hexanes). The reaction was then 
stirred at 0 °C for 5 minutes before being treated with N-formylbenzotriazole 186 
(177 mg, 1.20 mmol). The resulting mixture was then allowed to warm up to room 
temperature and then stirred for a further 12 hours. The reaction was diluted with t-
butylmethyl ether (10 mL), and quenched with a saturated aqueous NaHCO3 
solution (10 mL). The aqueous phase was then extracted with diethyl ether (3 × 20 
mL) and the combined organic layers dried over Na2SO4. The solvent was 
removed under vacuum to afford the crude product, which was then purified by 
flash column chromatography on silica gel (from 10 to 20% ethyl acetate in 
petroleum ether) to afford the desired N-formyl imide 212 in 73% yield (157 mg, 
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0.73 mmol). 1H NMR (400 MHz, CDCl3): δH 9.10 (1H, d, J 10.5 Hz, CHO), 8.81 
(1H, bd, J 10.5 Hz, NH), 4.13 (1H, s, CHO), 3.68 (1H, d, J 11.8 Hz, CHHO), 3.28 
(1H, d, J 11.8 Hz, CHHO), 1.40 (3H, s, OCCH3), 1.38 (3H, s, OCCH3), 0.99 (3H, s, 
CCH3), 0.98 (3H, s, CCH3).  
 
The characterisation matches with the data reported in literature: 
Villa M. V. J.; Targett S. M.; Barnes J. C.; Whittingham W. G.; Marquez R. Org. 
Lett. 2007, 9, 1631. 
 
N-Formylbenzamide, 216 
 
 
 
A solution of benzamide 209 (0.50 g, 4.13 mmol) in anhydrous THF (40 mL) was 
cooled to 0 °C before being treated with n-BuLi (3.1 mL, 4.96 mmol, 1.6 M solution 
in hexanes). The reaction was then stirred at 0 °C for 5 minutes before being 
treated with N-formylbenzotriazole 186 (0.91 g, 6.19 mmol). The resulting mixture 
was then allowed to warm up to room temperature and stir for a further 12 hours. 
The reaction was diluted with t-butylmethyl ether (20 mL), and quenched with a 
saturated aq. NaHCO3 solution (40 mL). The aqueous phase was extracted with 
diethyl ether (3 × 40 mL) and the organic layers dried over Na2SO4. The solvent 
was removed under vacuum to afford the crude product, then purified by flash 
column chromatography on silica gel (from 10 to 20% ethyl acetate in petroleum 
ether) to afford the desired N-formyl imide 216 as a white solid in 75% yield (462 
mg, 3.10 mmol). IR νmax (film) 3414, 1728, 1683, 1463, 1364, 1252, 1208 cm
-1; 1H 
NMR (500 MHz, CDCl3): δH 9.38 (1H, d, J 9.8 Hz, CHO), 9.21 (1H, bd, J 9.8 Hz, 
NH), 7.92 (2H, dd, J 1.5, 6.6 Hz, 2 x ortho CHAr), 7.67 (1H, tt, J 1.2, 7.5 Hz, para 
CHAr), 7.55 (2H, td, J 1.5, 5.7 Hz, 2 x meta CHAr); 
13C NMR (125 MHz, CDCl3): δC 
166.8 (CO), 164.9 (CHO), 134.1 (CAr), 131.2 (CHAr), 129.2 (CHAr), 128.2 (CHAr); 
HRMS (CI+/ISO) calc. for C8H7NO2 [M]
+: 149.0477. Found: 149.0474. 
 
The characterisation matches with the data reported in literature: 
Villa M. V. J.; Targett S. M.; Barnes J. C.; Whittingham W. G.; Marquez R. Org. 
Lett. 2007, 9, 1631. 
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N-Formylbutyramide, 213 
 
 
 
A solution of butyramide 206 (87.0 mg, 1.00 mmol) in anhydrous THF (10 mL) was 
cooled to 0 °C before being treated with n-BuLi (0.69 mL, 1.10 mmol, 1.6 M 
solution in hexanes). The reaction was then stirred at 0 °C for 5 minutes before 
being treated with N-formylbenzotriazole 186 (177 mg, 1.20 mmol). The resulting 
mixture was then allowed to warm up to room temperature and then stirred for a 
further 12 hours. The reaction was diluted with t-butylmethyl ether (10 mL), and 
quenched with a saturated aqueous NaHCO3 solution (10 mL). The aqueous 
phase was then extracted with diethyl ether (3 × 20 mL) and the combined organic 
layers dried over Na2SO4. The solvent was removed under vacuum to afford the 
crude product, which was then purified by flash column chromatography on silica 
gel (from 10 to 20% ethyl acetate in petroleum ether) to afford the desired N-formyl 
imide 213 in 60% yield (69.0 mg, 0.60 mmol). 1H NMR (400 MHz, CDCl3): δH 9.73 
(1H, bs, NH), 9.15 (1H, s, CHO), 2.40 (2H, t, J 7.3 Hz, CH2CO), 1.80–1.70 (2H, m, 
CH2), 1.03 (3H, t, J 7.3 Hz, CH3).  
 
The characterisation matches with the data reported in literature: 
Mathieson J. E.; Crawford J. J.; Schmidtmann M.; Marquez R. Org. Biomol. Chem. 
2009, 7, 2170. 
 
N-Formylpicolinamide, 218 
 
 
A solution of picolinamide 211 (122 mg, 1.00 mmol) in anhydrous THF (10 mL) 
was cooled to 0 °C before being treated with n-BuLi (0.69 mL, 1.10 mmol, 1.6 M 
solution in hexanes). The reaction was then stirred at 0 °C for 5 minutes before 
being treated with N-formylbenzotriazole 186 (177 mg, 1.20 mmol). The resulting 
mixture was then allowed to warm up to room temperature and then stirred for a 
further 12 hours. The reaction was diluted with t-butylmethyl ether (10 mL), and 
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quenched with a saturated aqueous NaHCO3 solution (10 mL). The aqueous 
phase was then extracted with diethyl ether (3 × 20 mL) and the combined organic 
layers dried over Na2SO4. The solvent was removed under vacuum to afford the 
crude product, which was then purified by flash column chromatography on silica 
gel (from 10 to 20% ethyl acetate in petroleum ether) to afford the desired N-formyl 
imide 218 in 22% yield (33.0 mg, 0.22 mmol). 1H NMR (400 MHz, CDCl3): δH 
10.32 (1H, bs, NH), 9.30 (1H, d, J 10.8 Hz, CHO), 8.51 (1H, d, J 5.0 Hz, CHAr), 
8.23 (1H, d, J 7.8 Hz, CHAr), 7.90 (1H, td, J 1.7, 7.8 Hz, CHAr), 7.47 (1H, ddd, J 
1.7, 5.0, 7.8 Hz, CHAr); 
13C-NMR (100 MHz; CDCl3): δC 164.5 (CO), 161.8 (CHO), 
148.8 (CHAr), 147.2 (CAr), 137.8 (CHAr), 128.1 (CHAr), 123.3 (CHAr); HRMS 
(CI+/ISO):  calc. for C7H7N2O2 [M+H]
+: 151.0508. Found 151.0510. 
 
The characterisation matches with the data reported in literature: 
Villa M. V. J.; Targett S. M.; Barnes J. C.; Whittingham W. G.; Marquez R. Org. 
Lett. 2007, 9, 1631. 
 
N-Formylisobutyramide, 214 
 
 
A solution of isobutyramide 207 (87.0 mg, 1.00 mmol) in anhydrous THF (10 mL) 
was cooled to 0 °C before being treated with n-BuLi (0.69 mL, 1.10 mmol, 1.6 M 
solution in hexanes). The reaction was then stirred at 0 °C for 5 minutes before 
being treated with N-formylbenzotriazole 186 (177 mg, 1.20 mmol). The resulting 
mixture was then allowed to warm up to room temperature and then stirred for a 
further 12 hours. The reaction was diluted with t-butylmethyl ether (10 mL), and 
quenched with a saturated aqueous NaHCO3 solution (10 mL). The aqueous 
phase was then extracted with diethyl ether (3 × 20 mL) and the combined organic 
layers dried over Na2SO4. The solvent was removed under vacuum to afford the 
crude product, which was then purified by flash column chromatography on silica 
gel (from 10 to 20% ethyl acetate in petroleum ether) to afford the desired N-formyl 
imide 214 in 44% yield (51.0 mg, 0.44 mmol). 1H NMR (400 MHz, CDCl3): δH 9.16 
(1H, d, J 10.0 Hz, CHO), 8.58 (1H, bd, J 10.0 Hz, NH), 2.51-2.43 (1H, m, CHMe2), 
1.28 (6H, d, J 6.0 Hz, 2 × CH3). 
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The characterisation matches with the data reported in literature: 
Mathieson J. E.; Crawford J. J.; Schmidtmann M.; Marquez R. Org. Biomol. Chem. 
2009, 7, 2170. 
 
N-Formyl-N-methylbenzamide, 217 
 
 
 
A 0 °C solution of N-methylbenzamide 210 (5.00 g, 37.0 mmol) in dry THF (100 
mL) was treated by the dropwise addition of n-butyllithium (2.5 M in hexanes, 16.3 
mL, 40.7 mmol). The resulting mixture was stirred at 0 °C for 1 hour and then 
treated with a solution of N-formylbenzotriazole 186 (6.53 g, 44.4 mmol) in THF 
(50 mL). The reaction mixture was then allowed to warm to room temperature and 
stirred for a further 12 hours. The mixture was diluted with tert-butyl methyl ether 
(100 mL) and quenched with saturated aqueous NaHCO3 (100 mL). The layers 
were separated and the aqueous phase was extracted with diethyl ether (3 × 100 
mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated under vacuum to afford a crude brown oil. Purification of the crude 
residue by flash column chromatography on silica gel (from 0 to 20% ethyl acetate 
in hexane) gave the N-formylimide 217 as a yellow oil in 81% yield (4.80 g, 30.0 
mmol). IR νmax (film) 2935, 1722, 1654, 1600, 1413, 1338, 1274, 1043, 1022 cm
−1; 
1H NMR (500 MHz, CDCl3): δH 8.90 (1H, s, CHO), 7.49−7.40 (5H, m, 5 × CHAr), 
3.19 (3H, s, CH3); 
13C-NMR (125 MHz, CDCl3): δC 172.4 (CO), 164.3 (CHO), 133.4 
(CAr), 132.0 (CHAr), 128.8 (CHAr), 128.7 (CHAr), 27.4 (CH3); HRMS (CI+/ISO) calc. 
for C9H10NO2 [M+H]
+: 164.0712. Found: 164.0714.  
 
N-Formyl-N-methylpropionamide, 215 
 
 
 
A 0 °C solution of N-methylpropionamide 208 (5.00 g, 57.5 mmol) in dry THF (100 
mL) was treated by the dropwise addition of n-butyllithium (2.5 M in hexanes, 25.3 
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mL, 63.2 mmol). The resulting mixture was stirred at 0 °C for 1 hour and then 
treated with a solution of N-formylbenzotriazole 186 (10.2 g, 69.0 mmol) in THF 
(50 mL). The reaction mixture was then allowed to warm to room temperature and 
stirred for a further 12 hours. The mixture was diluted with tert-butyl methyl ether 
(100 mL) and quenched with saturated aqueous NaHCO3 (100 mL). The layers 
were separated, and the aqueous phase was extracted with diethyl ether (3 × 100 
mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated under vacuum to afford a crude brown oil. Purification of the crude 
residue by flash column chromatography on silica gel (from 0 to 20% ethyl acetate 
in hexane) gave the N-formylimide 215 as a yellow oil in 48% yield (3.20 g, 27.6 
mmol). IR νmax (film) 2985, 1722, 1668, 1452, 1417, 1365, 1265, 1051 cm
−1; 1H 
NMR (500 MHz, CDCl3): δH 9.14 (1H, s, CHO), 2.97 (3H, s, CH3), 2.56 (2H, q, J 
7.4 Hz, CH2), 1.09 (3H, t, J 7.4 Hz, CH3); 
13C-NMR (125 MHz, CDCl3): δC 175.1 
(CO), 162.4 (CHO), 28.1 (CH2), 26.3 (NCH3), 8.3 (CH3); HRMS (CI+/ISO) calc. for 
C5H10NO2 [M+H]
+: 116.0712. Found: 116.0707. 
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(E)-1-(2-Iodovinyl)pyrrolidin-2-one, 220 
 
 
 
Method A: Chromium(III)chloride hexahydrate (2.85 g, 18.0 mmol) was placed in 
a two neck round bottom flask and was heated using a bunsen burner until the 
colour of the chromium(III)chloride changed from dark green to light green and 
then to purple. The purple chromium(III)chloride was then treated with zinc (0.59 g, 
9.00 mmol) and NaI (2.25 g, 15.0 mmol), and the resulting mixture was stirred and 
heated under vacuum and for 15 minutes. The reaction mixture was then allowed 
to cool down to room temperature whilst still under vacuum and then placed under 
argon. The dry mixture was then suspended in anhydrous THF (30 mL) and the 
reaction mixture was stirred at room temperature for 10 minutes. A solution of N-
formyl imide 166 (147 mg, 1.30 mmol) and iodoform (1.02 g, 2.60 mmol) in THF 
(15 mL) was then cannulated into the chromium mixture and the resulting brown 
suspension was stirred overnight at room temperature. The reaction was then 
quenched with saturated aqueous NaCl (30 mL), followed by saturated aqueous 
IDRANAL III® (30 mL) and the solution was allowed to stir at room temperature for 
30 minutes before being extracted with diethyl ether (3 × 20 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure. The crude oil was then purified by flash column chromatography on 
silica gel eluting with 10% ethyl acetate in petroleum ether to afford the desired 
product 220 as a yellow solid in 51% yield (156 mg, 0.66 mmol). 
Method B: A suspension of (iodomethyl)triphenylphosphonium iodide (2.65 g, 
5.00 mmol) in anhydrous THF (10 mL) was treated with potassium tert-butoxide 
(600 mg, 5.00 mmol), and the resulting bright orange suspension was allowed to 
stir at room temperature until it turned brown, indicating the ylide formation (6 
hours). The resulting brown suspension was then treated dropwise with a solution 
of 2-oxopyrrolidin-1-carbaldehyde 166 (56.5 mg, 0.50 mmol) in THF (5 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
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diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford 
the iodo-enamide 220 as a yellow solid in 78% yield (92.0 mg, 0.39 mmol). IR νmax 
(film) 3057, 2957, 2917, 2889, 1685, 1607, 1480, 1457, 1263, 1174 cm-1; 1H NMR 
(400 MHz, CDCl3): δH 7.59 (1H, d, J 15.0 Hz, NCH=), 5.37 (1H, d, J 15.0 Hz, 
=CHI), 3.51 (2H, t, J 7.1 Hz, CH2N), 2.46 (2H, t, J 7.8 Hz, CH2CO), 2.12 (2H, qn, J 
7.5 Hz, CH2); 
13C-NMR (100 MHz, CDCl3): δC 172.3 (CO), 134.7 (NCH=), 55.0 
(=CHI), 44.6 (CH2N), 30.6 (CH2CO), 17.4 (CH2); HRMS (EI+) calc. for C6H8INO 
[M]+ 236.9655. Found: 236.9651; m.p. 27-28 °C. 
 
(E)-1-(2-Iodovinyl)piperidin-2-one, 219 
 
 
 
Method A: Chromium(III)chloride hexahydrate (1.70 g, 10.8 mmol) was placed in 
a two neck round bottom flask and was heated using a bunsen burner until the 
colour of the chromium(III)chloride changed from dark green to light green and 
then to purple. The purple chromium(III)chloride was then treated with zinc (352 
mg, 5.38 mmol) and NaI (1.34 g, 8.97 mmol), and the resulting mixture was stirred 
and heated under vacuum and for 15 minutes. The reaction was then allowed to 
cool down to room temperature whilst still under vacuum and then placed under 
argon. The dry mixture was then suspended in anhydrous THF (30 mL) and the 
reaction mixture was stirred at room temperature for 10 minutes. A solution of N-
formyl imide 167 (100 mg, 0.78 mmol) and iodoform (614 mg, 1.56 mmol) in THF 
(15 mL) was then cannulated into the chromium mixture and the resulting brown 
suspension was stirred overnight at room temperature.The reaction was then 
quenched with saturated aqueous NaCl (30 mL), followed by saturated aqueous 
IDRANAL III® (30 mL) and the solution was allowed to stir at room temperature for 
30 minutes before being extracted with diethyl ether (3 × 20 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure. The crude oil was then purified by flash column chromatography on 
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silica gel eluting with 10% ethyl acetate in petroleum ether to afford the desired 
product 219 as a yellow solid in 46% yield (90.0 mg, 0.36 mmol). 
Method B: A suspension of (iodomethyl)triphenylphosphonium iodide (2.65 g, 
5.00 mmol) in anhydrous THF (10 mL) was treated with potassium tert-butoxide 
(600 mg, 5.00 mmol), and the resulting bright orange suspension was allowed to 
stir at room temperature until it turned brown, indicating the ylide formation (6 
hours). The resulting brown suspension was then treated dropwise with a solution 
of 2-oxopiperidin-1-carbaldehyde 167 (63.5 mg, 0.50 mmol) in THF (5 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford 
the iodo-enamide 219 as a yellow solid in 80% yield (100 mg, 0.40 mmol). IR νmax 
(film) 2924, 2854, 1651, 1599, 1458, 1404, 1296, 1257 cm-1; 1H NMR (400 MHz, 
CDCl3): δH 8.11 (1H, d, J 14.0 Hz, NCH=), 5.44 (1H, d, J 14.0 Hz, =CHI), 3.41 (2H, 
t, J 6.0 Hz, CH2N), 2.48 (2H, t, J 6.4 Hz, CH2CO), 1.88-1.81 (2H, m, CH2CH2CO), 
1.79-1.70 (2H, m, CH2CH2N); 
13C-NMR (100 MHz, CDCl3): δC 167.8 (CO), 137.7 
(NCH=), 55.0 (=CHI), 45.0 (CH2N), 32.8 (CH2CO), 22.4 (CH2CH2CO), 20.6 
(CH2CH2N); HRMS (CI+/ISO) calc. for C7H11INO [M+H]
+:251.9886. Found: 
251.9885; m.p. 31-33 °C. 
 
(E)-1-(2-Iodovinyl)azepan-2-one, 221 
 
 
 
Method A: Chromium(III)chloride hexahydrate (2.85 g, 18.0 mmol) was placed in 
a two neck round bottom flask and was heated using a bunsen burner until the 
colour of the chromium(III)chloride changed from dark green to light green and 
then to purple. The purple chromium(III)chloride was then treated with zinc (588 
mg, 9.00 mmol) and NaI (2.25 g, 15.0 mmol), and the resulting mixture was stirred 
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and heated under vacuum and for 15 minutes. The reaction was then allowed to 
cool down to room temperature whilst still under vacuum and then placed under 
argon. The dry mixture was then suspended in anhydrous THF (30 mL) and the 
reaction mixture was stirred at room temperature for 10 minutes. A solution of N-
formyl imide 168 (184 mg, 1.30 mmol) and iodoform (1.02 g, 2.60 mmol) in THF 
(15 mL) was then cannulated into the chromium mixture and the resulting brown 
suspension was stirred overnight at room temperature.The reaction was then 
quenched with saturated aqueous NaCl (30 mL), followed by saturated aqueous 
IDRANAL III® (30 mL) and the solution was allowed to stir at room temperature for 
30 minutes before being extracted with diethyl ether (3 × 20 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure. The crude oil was then purified by flash column chromatography on 
silica gel eluting with 10% ethyl acetate in petroleum ether to afford the desired 
product 221 as a yellow solid in 40% yield (137 mg, 0.52 mmol). 
Method B: The dihaloenamide 1-(2,2-diiodovinyl)azepan-2-one 253 (380 mg, 0.97 
mmol) was dissolved in an anhydrous MeOH/THF mixture (1:1, 20 mL total 
volume), and the resulting solution was cooled to 0 °C. The solution was treated 
with Zn−Cu couple (3.70 g, 29.1 mmol) and glacial acetic acid (5.9 mL, 97.0 
mmol), and the resulting reaction mixture was stirred at 0 °C until completion by 
TLC analysis (30 minutes). The reaction was quenched with NaHCO3 saturated 
aqueous solution (10 mL) and extracted with diethyl ether (3 × 10 mL). The 
combined organic phases were dried over Na2SO4 and concentrated under 
vacuum to afford the iodo enamides 221E and 221Z (10:1 ratio) as an inseparable 
mixture in 94% yield (240 mg, 0.91 mmol). 
(E)-1-(2-Iodovinyl)azepan-2-one 221E: IR (neat) νmax 2930, 1658, 1602, 1476, 
1389, 1325, 1191 cm−1; 1H NMR (400 MHz; CDCl3) δH 7.84 (1H, d, J 13.7 Hz, 
NCH=), 5.51 (1H, d, J 14.2 Hz, =CHI), 3.57−3.52 (2H, m, CH2N), 2.63−2.58 (2H, 
m, CH2CO), 1.75−1.67 (6H, m, 3 × CH2); 
13C NMR (100 MHz, CDCl3) δC 173.5 
(CO), 137.3 (NCH=), 55.0 (=CHI), 45.1 (CH2N), 36.9 (CH2CO), 29.4 (CH2CH2CO), 
27.5 (CH2CH2N), 23.4 (CH2); HRMS (CI/ISO) found [M + H]
+ 266.0042, C8H13INO 
requires 266.0041; m.p. 35-36 °C. 
(Z)-1-(2-Iodovinyl)azepan-2-one 221Z: 1H NMR (400 MHz; CDCl3) δH 7.45 (1H, 
d, J 6.3 Hz, NCH=), 5.83 (1H, d, J 6.9 Hz, =CHI), 3.76−3.73 (2H, m, CH2N), 
2.63−2.58 (2H, m, CH2CO), 1.75−1.67 (6H, m, 3 × CH2); 
13C NMR (100 MHz, 
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CDCl3) δC 176.2 (CO), 138.6 (NCH=), 66.9 (=CHI), 49.5 (CH2N), 37.4 (CH2CO), 
30.4 (CH2CH2CO), 29.8 (CH2CH2N), 23.3 (CH2). 
 
(E)-1-(2-Iodovinyl)azocan-2-one, 222 
 
 
 
Method A: Chromium(III)chloride hexahydrate (2.85 g, 18.0 mmol) was placed in 
a two neck round bottom flask and was heated using a bunsen burner until the 
colour of the chromium(III)chloride changed from dark green to light green and 
then to purple. The purple chromium(III)chloride was treated with zinc (588 mg, 
9.00 mmol) and NaI (2.25 g, 15.0 mmol), and the resulting mixture was stirred and 
heated under vacuum and for 15 minutes. The reaction was allowed to cool down 
to room temperature and was then suspended in anhydrous THF (30 mL) under 
argon and the reaction mixture was stirred at room temperature for 10 minutes. A 
solution of N-formyl imide 169 (201 mg, 1.30 mmol) and iodoform (1.02 g, 2.60 
mmol) in THF (15 mL) was cannulated into the mixture and the resulting brown 
suspension was stirred overnight at room temperature. The reaction was 
quenched with saturated aqueous NaCl (30 mL), followed by saturated aqueous 
IDRANAL III® (30 mL) and the solution was allowed to stir at room temperature for 
30 minutes before being extracted with diethyl ether (3 × 20 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure. The crude oil was then purified by flash column chromatography on 
silica gel eluting with 10% ethyl acetate in petroleum ether to afford the desired 
product 222 as a yellow solid in 42% yield (150 mg, 0.54 mmol). 
Method B: The dihaloenamide 1-(2,2-diiodovinyl)azocan-2-one 254 (405 mg, 1.00 
mmol) was dissolved in an anhydrous MeOH/THF mixture (1:1, 20 mL total 
volume), and the resulting solution was cooled to 0 °C. The solution was treated 
with Zn−Cu couple (3.81 g, 30.0 mmol) and glacial acetic acid (6.1 mL, 100 mmol), 
and the resulting reaction mixture was stirred at 0 °C until completion by TLC 
analysis (30 minutes). The reaction was quenched with NaHCO3 saturated 
aqueous solution (10 mL) and extracted with diethyl ether (3 × 10 mL). The 
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combined organic phases were dried over Na2SO4 and concentrated under 
vacuum to afford the iodo enamide 222 as a white solid, which did not require any 
further purification, in 77% yield (215 mg, 0.771 mmol). IR νmax (film) 3083, 2938, 
2929, 2915, 1647, 1603, 1484, 1453, 1388, 1312 cm-1; 1H NMR (400 MHz, 
CDCl3): δH 7.95 (1H, d, J 14.1 Hz, NCH=), 5.51 (1H, d, J 14.1 Hz, =CHI), 3.72 (2H, 
dd, J 5.8, 5.9 Hz, CH2N), 2.63-2.56 (2H, m, CH2CO), 1.88-1.78 (2H, m, 
CH2CH2CO), 1.73-1.68 (2H, m, CH2CH2N), 1.62-1.58 (2H, m, CH2), 1.50-1.42 (2H, 
m, CH2); 
13C-NMR (100 MHz, CDCl3): δC 173.1 (CO), 136.2 (NCH=), 55.5 (=CHI), 
43.6 (CH2N), 34.3 (CH2CO), 29.1 (CH2CH2CO), 27.9 (CH2CH2N), 26.4 (CH2), 24.2 
(CH2); HRMS (CI+/ISO) calc. for C9H15INO [M+H]
+: 280.0203. Found: 280.0198; 
m.p. 54-56 °C. 
 
(Z)-N-(2-Iodovinyl)-2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide, 225 
 
 
 
Method A: Chromium(III)chloride hexahydrate (2.85 g, 18.0 mmol) was heated 
using a bunsen burner until the colour of the chromium(III)chloride changed from 
dark green to light green and then to purple. The purple chromium(III)chloride was 
treated with zinc (588 mg, 9.00 mmol) and NaI (2.25 g, 15.0 mmol), and the 
resulting mixture was stirred and heated under vacuum and for 15 minutes. The 
reaction was allowed to cool down to room temperature and was then suspended 
in anhydrous THF (30 mL) under argon and the reaction mixture was stirred at 
room temperature for 10 minutes. A solution of N-formyl imide 212 (280 mg, 1.30 
mmol) and iodoform (1.02 g, 2.60 mmol) in THF (15 mL) was cannulated into the 
mixture and the resulting brown suspension was stirred overnight at room 
temperature. The reaction was quenched with saturated aqueous NaCl (30 mL), 
followed by saturated aqueous IDRANAL III® (30 mL) and the solution was allowed 
to stir at room temperature for 30 minutes before being extracted with diethyl ether 
(3 × 20 mL). The combined organic extracts were dried over Na2SO4 and 
concentrated under reduced pressure to afford a crude 1.0/1.1 mixture of E/Z 
isomers. The crude oil was then purified by flash column chromatography on silica 
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gel eluting with 10% ethyl acetate in petroleum ether to afford the desired product 
225 as a light yellow solid in 32% yield (140 mg, 0.41 mmol). 
Method B: The dihaloenamide N-(2,2-diiodovinyl)-2,2,5,5-tetramethyl-1,3-
dioxane-4-carboxamide 257 (160 mg, 0.34 mmol) was dissolved in an anhydrous 
MeOH/THF mixture (1:1, 10 mL total volume), and the resulting solution was 
cooled to 0 °C. The solution was treated with Zn−Cu couple (1.33 g, 10.3 mmol) 
and glacial acetic acid (2.1 mL, 34.4 mmol), and the resulting reaction mixture was 
stirred at 0 °C until completion by TLC analysis (30 minutes). The reaction was 
quenched with NaHCO3 saturated aqueous solution (10 mL) and extracted with 
diethyl ether (3 × 10 mL). The combined organic phases were dried over Na2SO4 
and concentrated under vacuum to afford the iodo enamide 225 as a yellow solid, 
which did not require any further purification, in 71% yield (0.08 g, 0.24 mmol). IR 
νmax (film) 2988, 2956, 2872, 1699, 1626, 1464, 1375, 1285, 1235 cm
-1; 1H NMR 
(400 MHz, CDCl3): δH 8.55 (1H, bd, J 11.0 Hz, NH), 7.28 (1H, dd, J 6.4, 11.2 Hz, 
NCH=), 5.42 (1H, d, J 6.4 Hz, =CHI), 4.17 (1H, s, CH), 3.72 (1H, d, J 11.8 Hz, 
CHHO), 3.32 (1H, d, J 11.8 Hz, CHHO), 1.54 (3H, s, CH3), 1.47 (3H, s, CH3), 1.05 
(3H, s, CH3), 1.04 (3H, s, CH3); 
13C-NMR (100 MHz, CDCl3): δC 167.6 (CO), 129.4 
(NCH=), 99.4 (C), 77.2 (CH), 71.4 (CH2), 61.4 (=CHI), 33.3 (C), 29.5 (CH3), 21.9 
(CH3), 19.1 (CH3), 18.8 (CH3); HRMS (EI+) calc. for C11H18INO3 [M]
+: 339.0331. 
Found: 339.0332; m.p. 109-110 °C. 
 
(E)-N-(2-Iodovinyl)benzamide and (Z)-N-(2-Iodovinyl)benzamide, 223 
 
 
 
Chromium(III)chloride hexahydrate (2.20 g, 13.8 mmol) was placed in a two neck 
round bottom flask and was heated using a bunsen burner until the colour of the 
chromium(III)chloride changed from dark green to light green and then to purple. 
The purple chromium(III)chloride was then treated with zinc (452 mg, 6.90 mmol) 
and NaI (1.73 g, 11.5 mmol), and the resulting mixture was stirred and heated 
under vacuum and for 15 minutes. The reaction was then allowed to cool down to 
room temperature whilst still under vacuum and then placed under argon. The dry 
mixture was then suspended in anhydrous THF (30 mL) and the reaction mixture 
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was stirred at room temperature for 10 minutes. A solution of N-formyl imide 216 
(149 mg, 1.00 mmol) and iodoform (0.78 g, 2.00 mmol) in THF (15 mL) was then 
cannulated into the chromium mixture and the resulting brown suspension was 
stirred overnight at room temperature.The reaction was then quenched with 
saturated aqueous NaCl (30 mL), followed by saturated aqueous IDRANAL III® (30 
mL) and the solution was allowed to stir at room temperature for 30 minutes before 
being extracted with diethyl ether (3 × 20 mL). The combined organic extracts 
were dried over Na2SO4 and concentrated under reduced pressure. The crude oil 
was then purified by flash column chromatography on silica gel eluting with 10% 
ethyl acetate in petroleum ether to afford the product as a yellow solid in 41% yield 
(113 mg, 0.42 mmol) in 3.0/1.0 mixture of E/Z isomers 223E and 223Z from which 
an analytical clean fraction of the isomer 223E could be obtained.  
Z isomer: 1H NMR (400 MHz, CDCl3): δH 8.06 (1H, bs, NH), 7.89-7.84 (2H, m, 2 × 
CHAr), 7.62-7.48 (3H, m, 3 × CHAr), 7.40 (1H, d, J 6.7 Hz, NCH=), 5.49 (1H, d, J 
6.7 Hz, =CHI). 
E isomer: IR νmax (film) 3299, 2929, 1687, 1652, 1620, 1508, 1464, 1283 cm
-1; 1H 
NMR (400 MHz, CDCl3): δH 7.96 (1H, app bd, J 8.9 Hz, NH), 7.79 (2H, app dd, J 
1.4, 7.3 Hz, 2 × CHAr), 7.65 (1H, dd, J 10.1, 13.7 Hz, NCH=), 7.55 (1H, appt, J 7.3 
Hz, 1 × CHAr), 7.46 (2H, appt, J 8.1 Hz, 2 × CHAr), 5.84 (1H, d, J 13.8 Hz, =CHI); 
13C-NMR (100 MHz, CDCl3): δC 164.3 (CO), 132.8 (NCH=), 132.7 (CAr), 130.7 
(CHAr), 129.1 (CHAr), 127.4 (CHAr), 61.2 (=CHI); HRMS (EI+) calc. for C9H8INO 
[M]
+
: 272.9651. Found: 272.9654; m.p. 115-130 °C. 
 
(E)-N-(2-Iodovinyl)butyramide, 224 
 
 
 
Chromium(III)chloride hexahydrate (2.85 g, 18.0 mmol) was placed in a two neck 
round bottom flask and was heated using a bunsen burner until the colour of the 
chromium(III)chloride changed from dark green to light green and then to purple. 
The purple chromium(III)chloride was then treated with zinc (588 mg, 9.00 mmol) 
and NaI (2.25 g, 15.0 mmol), and the resulting mixture was stirred and heated 
under vacuum and for 15 minutes. The reaction was then allowed to cool down to 
room temperature whilst still under vacuum and then placed under argon. The dry 
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mixture was then suspended in anhydrous THF (30 mL) and the reaction mixture 
was stirred at room temperature for 10 minutes. A solution of N-formyl imide 213 
(149 mg, 1.30 mmol) and iodoform (1.02 g, 2.60 mmol) in THF (15 mL) was then 
cannulated into the chromium mixture and the resulting brown suspension was 
stirred overnight at room temperature.The reaction was then quenched with 
saturated aqueous NaCl (30 mL), followed by saturated aqueous IDRANAL III® (30 
mL) and the solution was allowed to stir at room temperature for 30 minutes before 
being extracted with diethyl ether (3 × 20 mL). The combined organic extracts 
were dried over Na2SO4 and concentrated under reduced pressure to afford a 
crude 5.0/1.0 mixture of E/Z isomers. The crude oil was then purified by flash 
column chromatography on silica gel eluting with 10% ethyl acetate in petroleum 
ether to afford the E isomer 224 as a yellow solid in 21% yield (65.0 mg, 0.27 
mmol). IR νmax (film) 3265, 2960, 1664, 1624, 1492, 1462, 1222 cm
-1; 1H NMR 
(400 MHz, CDCl3): δH 7.45 (1H, dd, J 10.6, 13.9 Hz, NCH=), 7.28 (1H, bs, NH), 
5.64 (1H, d, J 13.9 Hz, =CHI), 2.20 (2H, t, J 7.3 Hz, CH2CO), 1.68 (2H, sext, J 7.5 
Hz, CH2), 0.96 (3H, t, J  7.4 Hz, CH3); 
13C-NMR (100 MHz, CDCl3): δC 169.8 (CO), 
133.7 (NCH=), 56.6 (=CHI), 38.3 (CH2CO), 18.9 (CH2), 13.8 (CH3); HRMS 
(CI+/ISO) calc. for C6H11INO [M+H]
+: 239.9885. Found: 239.9880; m.p. 85-90 °C. 
 
(E)-1-(4-Phenylbut-1-en-3-ynyl)piperidin-2-one, 226 
 
 
 
A 0.3 M solution of β-iodo-enamide 219 (0.06 g, 0.24 mmol) in DMF was treated 
with Pd(PPh3)4 (28.0 mg, 24.0 μmol) and the suspension was stirred at room 
temperature for 10 minutes. Then phenyl acetylene (132 μL, 1.20 mmol), CuI (10.0 
mg, 48.0 μmol) and TEA (72.0 μL, 0.48 mmol) were sequentially added, and the 
resulting mixture was stirred at room temperature for 72 hours. The reaction 
mixture was quenched with distilled water (20 mL) and extracted with diethyl ether 
(3 × 20 mL). The combined organic extracts were then washed with water (10 × 20 
mL), dried over Na2SO4 and concentrated under vacuum to afford a brown 
residue. The crude product was purified by flash column chromatography on silica 
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gel eluting with 50/50 petroleum ether/dichloromethane + 5% diethyl ether to afford 
the pure β-yn-enamide product 226 as a yellow-brown solid in 93% yield (50.0 mg, 
0.22 mmol). IR νmax (film) 3086, 2939, 2877, 2198, 1728, 1658, 1612, 1458 cm
-1; 
1H NMR (500 MHz, CDCl3): δH 8.02 (1H, d, J 14.8 Hz, NCH=), 7.37-7.32 (2H, m, 2 
× CHAr), 7.26-7.17 (3H, m, 3 × CHAr), 5.21 (1H, d, J 14.8 Hz, =CHI), 3.43 (2H, t, J 
6.0 Hz, CH2N), 2.54 (2H, t, J 6.5 Hz, CH2CO), 1.87 (2H, qn, J 6.2 Hz, CH2CH2CO), 
1.75 (2H, qn, J 6.2 Hz, CH2CH2N); 
13C-NMR (125 MHz, CDCl3): δC 168.2 (CO), 
137.3 (NCH=), 131.3 (2 × ortho CHAr), 128.4 (2 × meta CHAr), 127.7 (para CHAr), 
123.7 (CAr), 89.8 (=CH), 88.9 (=CH-Calkyne), 87.4 (Calkyne-Ar), 45.0 (CH2N), 32.9 
(CH2CO), 22.4 (CH2CH2CO), 20.3 (CH2CH2N); HRMS (CI+/ISO) calc. for 
C15H16NO [M+H]
+: 226.1233. Found: 226.1232; m.p. 91-92 °C. 
 
(E)-1-(4-(4-Methoxyphenyl)but-1-en-3-ynyl)piperidin-2-one, 227 
 
 
 
A 0.3 M solution of β-iodo-enamide 219 (0.05 g, 199 μmol) in DMF was treated 
with Pd(PPh3)4 (23.0 mg, 19.0 μmol) and the suspension was stirred at room 
temperature for 10 minutes. Then 4-ethylanisole (132 mg, 995 μmol), CuI (7.00 
mg, 38.0 μmol) and TEA (60.0 μL, 39.8 μmol) were sequentially added, and the 
resulting mixture was stirred at room temperature for 72 hours. The reaction 
mixture was quenched with distilled water (20 mL) and extracted with diethyl ether 
(3 × 20 mL). The combined organic extracts were then washed with water (10 × 20 
mL), dried over Na2SO4 and concentrated under vacuum to afford a brown 
residue. The crude product was purified by flash column chromatography on silica 
gel eluting with 50/50 petroleum ether/dichloromethane + 5% diethyl ether to afford 
the pure β-yn-enamide product 227 as a yellow-brown solid in 92% yield (47.0 mg, 
0.18 mmol). IR νmax (film) 3080, 2949, 2837, 2191, 1660, 1616, 1565, 1506, 1473 
cm-1; 1H NMR (500 MHz, CDCl3): δH 7.99 (1H, d, J 14.8 Hz, NCH=), 7.35 (2H, m, 2 
× ortho CHAr), 6.83 (2H, m, 2 × meta CHAr), 5.20 (1H, d, J 14.8 Hz, =CH), 3.81 
(3H, s, OCH3), 3.43 (2H, t, J 6.0 Hz, CH2N), 2.54 (2H, t, J 6.5 Hz, CH2CO), 1.92 
(2H, qn, J 6.2 Hz, CH2CH2CO), 1.80 (2H, qn, J 6.2 Hz, CH2CH2N); 
13C-NMR (125 
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MHz, CDCl3): δC 168.1 (CO), 159.2 (CAr-OMe), 136.7 (NCH=), 132.7 (2 × ortho 
CHAr), 115.9 (CAr), 114.0 (2 × meta CHAr), 90.2 (=CH), 88.8 (=CH-Calkyne), 85.9 
(Calkyne-Ar), 55.3 (OCH3), 45.0 (CH2N), 33.0 (CH2CO), 22.5 (CH2CH2CO), 20.4 
(CH2CH2N); HRMS (EI+) calc. for C16H17NO2 [M]
+: 255.1260. Found: 255.1259; 
m.p. 130-132 °C. 
 
(E)-1-(4-p-Tolylbut-1-en-3-ynyl)piperidin-2-one, 230 
 
 
A 0.3 M solution of β-iodo-enamide 219 (0.05 g, 0.20 mmol) in DMF was treated 
with Pd(PPh3)4 (23.2 mg, 20.0 μmol) and the suspension was stirred at room 
temperature for 10 minutes. Then p-toluyl acetylene 235 (116 mg, 1.00 mmol), CuI 
(8.00 mg, 40.0 μmol) and TEA (61.0 μL, 40.0 μmol) were sequentially added, and 
the resulting mixture was stirred at room temperature for 72 hours. The reaction 
mixture was quenched with distilled water (20 mL) and extracted with diethyl ether 
(3 × 20 mL). The combined organic extracts were then washed with water (10 × 20 
mL), dried over Na2SO4 and concentrated under vacuum to afford a brown 
residue. The crude product was purified by flash column chromatography on silica 
gel eluting with 50/50 petroleum ether/dichloromethane + 5% diethyl ether to afford 
the pure β-yn-enamide product 230 as a yellow-brown solid in 99% yield (48.0 mg, 
0.20 mmol). IR νmax (film) 3086, 2955, 2924, 2877, 2191, 1666, 1620, 1504, 1458 
cm-1; 1H NMR (500MHz, CDCl3): δH 8.00 (1H, d, J 14.8 Hz, NCH=), 7.30 (2H, d, J 
8.0 Hz, 2 × ortho CHAr), 7.10 (2H, d, J 7.6 Hz, 2 × meta CHAr), 5.20 (1H, d, J 14.8 
Hz, =CH), 3.43 (2H, t, J 6.2 Hz, CH2N), 2.54 (2H, t, J 6.6 Hz, CH2CO), 2.34 (3H, s, 
CH3), 1.94 (2H, qn, J 6.2 Hz, CH2CH2CO), 1.83 (2H, qn, J 6.2 Hz, CH2CH2N); 
13C-
NMR (125 MHz, CDCl3): δC 168.2 (CO), 137.8 (CAr-Me), 137.0 (NCH=), 131.1 (2 × 
ortho CHAr), 129.1 (2 × meta CHAr), 120.7 (CAr), 90.1 (CH=), 89.1 (CH-Calkyne), 86.7 
(Calkyne-Ar), 45.0 (CH2N), 33.0 (CH2CO), 22.4 (CH2CH2CO), 21.5 (CH3), 20.4 
(CH2CH2N); HRMS (EI+) calc. for C16H17NO [M]
+: 239.1311. Found: 239.1310; 
m.p. 147-148 °C. 
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(E)-1-(4-(4-Pentanoylphenyl)but-1-en-3-ynyl)piperidin-2-one, 228 
 
 
A 0.3 M solution of β-iodo-enamide 219 (35.0 mg, 139 μmol) in DMF was treated 
with Pd(PPh3)4 (16.0 mg, 14.0 μmol) and the suspension was stirred at room 
temperature for 10 minutes. Then 1-(4- ethynylphenyl)pentan-1-one 238 (130 mg, 
0.70 mmol), CuI (5.00 mg, 28.0 μmol) and TEA (40.0 μL, 0.30 mmol) were 
sequentially added, and the resulting mixture was stirred at room temperature for 
72 hours. The reaction mixture was quenched with distilled water (20 mL) and 
extracted with diethyl ether (3 × 20 mL). The combined organic extracts were then 
washed with water (10 × 20 mL), dried over Na2SO4 and concentrated under 
vacuum to afford a brown residue. The crude product was purified by flash column 
chromatography on silica gel eluting with 50/50 petroleum ether/dichloromethane + 
5% diethyl ether to afford the pure β-yn-enamide product 228 as a yellow-brown 
solid in 94% yield (40.0 mg, 0.13 mmol). IR νmax (film) 3078, 3045, 2955, 2193, 
1680, 1664, 1616, 1593, 1552, 1500 cm-1; 1H NMR (400MHz, CDCl3): δH 8.07 (1H, 
d, J 14.9 Hz, NCH=), 7.89 (2H, d, J 8.7 Hz, 2 × meta CHAr), 7.47 (2H, d, J 8.7 Hz, 
2 × ortho CHAr), 5.22 (1H, d, J 14.8 Hz, =CH), 3.45 (2H, t, J 6.0 Hz, CH2N), 2.95 
(2H, t, J 7.4 Hz, CH2CO), 2.57 (2H, t, J 6.4 Hz, CH2CO), 1.99-1.91 (2H, m, 
CH2CH2N), 1.89-1.82 (2H, m, CH2CH2CO), 1.71 (2H, app qn, J 7.1 Hz, 
CH2CH2CO), 1.41 (2H, app sextet, J 7.5 Hz, CH2CH3), 0.88 (3H, t, J 7.3 Hz, CH3).  
13C-NMR (100 MHz, CDCl3): δC 197.5 (CO), 168.5 (CON), 138.3 (CCO), 134.7 
(NCH=), 131.2 (2 × ortho CHAr), 128.6 (CAr), 128.0 (2 × meta CHAr), 100.0 (Calkyne-
Ar), 95.4 (=CH), 89.3 (Calkyne-CH=), 45.1 (CH2N), 38.4 (CH2CO), 33.0 (CH2CO), 
26.5 (CH2CH2N), 22.5 (CH2CH2CO), 22.4 (CH2CH3), 20.4 (CH2CH2CO), 14.0 
(CH3); HRMS (EI+) calc. for C20H23NO2 [M]+: 309.1727. Found: 309.1729; m.p. 
169-170 °C. 
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(E)-1-(6-(tert-Butyldimethylsilyloxy)hex-1-en-3-ynyl)piperidin-2-one, 231 
 
 
 
A 0.3 M solution of β-iodo-enamide 219 (25.0 mg, 100 μmol) in DMF was treated 
with Pd(PPh3)4 (12.0 mg, 10.0 μmol) and the suspension was stirred at room 
temperature for 10 minutes. Then 1-(tert-butyldimethylsilyloxy)-3-butyne 240 (92.0 
mg, 0.50 mmol), CuI (4.00 mg, 20.0 μmol) and TEA (30.0 μL, 0.20 mmol) were 
sequentially added, and the resulting mixture was stirred at room temperature for 
72 hours. The reaction mixture was quenched with distilled water (20 mL) and 
extracted with diethyl ether (3 × 20 mL). The combined organic extracts were then 
washed with water (10 × 20 mL), dried over Na2SO4 and concentrated under 
vacuum to afford a brown residue. The crude product was purified by flash column 
chromatography on silica gel eluting with 50/50 petroleum ether/dichloromethane + 
5% diethyl ether to afford the pure β-yn-enamide product 231 as a yellow oil in 
33% yield (10.2 mg, 33.0 µmol). IR νmax (film) 2931, 2854, 2337, 1736, 1666, 1620 
cm-1; 1H NMR (500 MHz, CDCl3): δH 7.78 (1H, d, J 14.8 Hz, NCH=), 4.88 (1H, dm, 
J 14.8 Hz, =CH), 3.64 (2H, t, J 7.3 Hz, CH2N), 3.28 (2H, t, J 6.3 Hz, CH2CO), 2.43 
(4H, m = 2 × t, 2 × CH2), 1.81 (2H, qn, J 6.2 Hz, CH2CH2CO), 1.73 (2H, qn, J 6.2 
Hz, CH2CH2N), 1.46 (6H, s, 2 × CH3), 0.81 (9H, s, 3 × CH3); 
13C-NMR (125 MHz, 
CDCl3): δC 168.5 (CO), 136.7 (NCH=), 90.2 (=CH), 90.0 (=CH-Calkyne), 77.6 
(Calkyne), 62.1 (CH2O), 44.9 (CH2N), 32.9 (CH2CO), 25.9 (3 × CH3), 23.9 
(CH2CH2O), 22.5 (CH2CH2CO), 20.4 (CH2CH2N), 18.4 (CMe3), -5.2 (2 × CH3); 
HRMS (CI+/ISO) calc. for C17H30NO2Si [M+H]
+: 308.2046. Found: 308.2051. 
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N-((E)-4-Phenyl-but-1-en-3-ynyl)-benzamide and N-((Z)-4-Phenyl-but-1-en-3-
ynyl)-benzamide, 229 
 
 
A 0.3 M solution of a 2:1 mixture of E/Z β-iodo-enamides 223 (55.0 mg, 201 μmol) 
in DMF was treated with Pd(PPh3)4 (23.0 mg, 21.0 μmol) and the suspension was 
stirred at room temperature for 10 minutes. Then phenyl acetylene (120 μL, 1.00 
mmol), CuI (8.00 mg, 40.2 μmol) and TEA (60.0 μL, 0.40 mmol) were sequentially 
added, and the resulting mixture was stirred at room temperature for 72 hours. 
The reaction mixture was quenched with distilled water (20 mL) and extracted with 
diethyl ether (3 × 20 mL). The combined organic extracts were then washed with 
water (10 × 20 mL), dried over Na2SO4 and concentrated under vacuum to afford a 
brown residue. The crude product was purified by flash column chromatography 
on silica gel eluting with 50/50 petroleum ether/dichloromethane + 5% diethyl ether 
to afford a 2:1 mixture of double bond isomers 229E and 229Z as a yellow oil in 
85% yield (42.0 mg, 0.17 mmol) from which an analytical clean fraction of the 
isomer 229E could be obtained.  
Z isomer: 1H NMR (400 MHz, CDCl3): δH 7.97 (1H, bd, J 9.8 Hz, NH), 7.82 (1H, d, 
J 8.8 Hz, NCH=), 7.65 – 7.28 (10H, m, 10 × CHAr), 5.11 (1H, d, J 8.8 Hz, =CH). 
E isomer: 1H NMR (400 MHz, CDCl3): δH 7.98 (1H, bd, J 9.8 Hz, NH), 7.84 (2H, 
m, 2 × CHAr), 7.65-7.28 (9H, m, 8 × CHAr and NCH=), 5.56 (1H, d, J 14.5 Hz, 
=CH); 13C-NMR (100 MHz, CDCl3): δC 163.8 (CO), 133.1 (CAr), 132.5 (CHAr), 
132.2 (CHAr), 131.3 (NCH=), 128.8 (CHAr), 128.5 (CHAr), 128.3 (CHAr), 127.2 
(CHAr), 122.9 (CAr), 97.5 (Calkyne), 89.9 (=CH), 83.5 (=CH-Calkyne); IR νmax (film) 
3302, 2930, 2854, 2360, 1699, 1657, 1626, 1597, 1518, 1491 cm-1; HRMS 
(CI+/ISO) calc. for C17H14NO [M+H]
+: 248.1075. Found: 248.1074. 
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N-[(E)-6-(tert-Butyl-dimethyl-silanyloxy)-hex-1-en-3-ynyl]-benzamide, 232 
 
 
A 0.3 M solution of (E)-β-iodo-enamide 223 (55.0 mg, 201 μmol) in DMF was 
treated with Pd(PPh3)4 (20.0 mg, 17.0 μmol) and the suspension was stirred at 
room temperature for 10 minutes. Then 1-(tert-butyldimethylsilyloxy)-3-butyne 240 
(153 mg, 325 μmol), CuI (7.00 mg, 33.0 μmol) and TEA (50.0 μL, 0.33 mmol) were 
sequentially added, and the resulting mixture was stirred at room temperature for 
72 hours. The reaction mixture was quenched with distilled water (20 mL) and 
extracted with diethyl ether (3 × 20 mL). The combined organic extracts were then 
washed with water (10 × 20 mL), dried over Na2SO4 and concentrated under 
vacuum to afford a brown residue. The crude product was purified by flash column 
chromatography on silica gel eluting with 50/50 petroleum ether/dichloromethane + 
5% diethyl ether to afford the product 232 as a single isomer in 40% yield (153 mg, 
0.47 mmol). IR νmax (film) 3292, 2929, 2855, 2359, 1707, 1627, 1519, 1488, 1252, 
1090 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.91 (1H, bd, J 10.6 Hz, NH), 7.79 (2H, 
d, J  6.8 Hz, 2 × CHAr), 7.58-7.39 (4H, m, NCH= and 3 × CHAr), 5.33 (1H, app dt, J 
2.2, 14.4 Hz, =CH), 3.75 (2H, t, J  6.9 Hz, CH2O), 2.54 (2H, app td, J 2.2, 7.1 Hz, 
CH2), 0.91 (9H, s, 3 × CH3), 0.09 (6H, s, 2 × CH3); 
13C-NMR (100 MHz, CDCl3): δC 
164.9 (CO), 133.4 (CAr), 132.4 (CHAr), 131.2 (NCH=), 128.9 (2 × CHAr), 127.3 (2 × 
CHAr), 93.2 (=CH), 88.2 (Calkyne), 78.1 (Calkyne), 62.6 (CH2O), 26.8 (3 × CH3), 24.2 
(CH2), 18.4 (C), -4.8 (2 × CH3); HRMS (CI+/ISO) calc. for C19H28NO2Si [M+H]
+ 
330.1889. Found: 330.1893. 
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1-((1E,3Z)-4-Phenylbuta-1,3-dienyl)piperidin-2-one, 241 
 
 
 
A solution of en-yne 226 (10.0 mg, 44.4 µmol) in anhydrous ethyl acetate (1 mL) 
containing 2% quinoline (v/v) was treated with Lindlar’s catalyst® (10.0 mg) and 
the resulting mixture was placed under a hydrogen atmosphere. The reaction was 
then stirred at room temperature until completion by TLC analysis (1.5 hour). The 
solution was then filtered through Celite®, and washed several times with brine (10 
× 10 mL) followed by and 10% aqueous HCl (1N, 10 mL). The aqueous layer was 
extracted with diethyl ether (3 × 10 mL) and the combined organic layers were 
dried over Na2SO4. The solution was filtered and concentrated under vacuum to 
afford the desired E,Z-dienamide 241 as a yellow oil, which required no further 
purification, in 99% yield (10.0 mg, 44.0 µmol). IR νmax (film)  2950, 2929, 1726, 
1665, 1629, 1595, 1402 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.78 (1H, d, J 13.6 
Hz, NCH=), 7.37-7.30 (5H, m, 5 × CHAr), 6.46 (1H, d, J 10.0 Hz, =CH), 6.33 (1H, 
dd, J 10.0, 16.0 Hz, CH=), 6.25 (1H, dd, J 13.6, 16.0 Hz, =CH), 3.44 (2H, t, J 6.1 
Hz, CH2N), 2.53 (2H, t, J 6.6 Hz, CH2CO), 1.93-1.87 (2H, m, CH2CH2CO), 1.85-
1.78 (2H, m, CH2CH2N); 
1H NMR (400 MHz, C6D6): δH 8.29 (1H, d, J 13.5 Hz, 
NCH=), 7.50-7.16 (5H, m, 5 × CHAr), 6.40-6.26 (3H, m, =CH and CH=CH), 2.70 
(2H, t, J 6.1 Hz, CH2N), 2.20 (2H, t, J 6.6 Hz, CH2CO), 1.50-1.47 (2H, m, 
CH2CH2CO), 1.03-0.95 (2H, m, CH2CH2N); 
13C-NMR (100 MHz, CDCl3): δC 168.7 
(CO), 132.2 (NCH=), 128.7 (CH=), 128.6 (CAr), 128.5 (CHAr), 128.3 (CHAr), 127.4 
(CHAr), 126.6 (CH=), 107.8 (CH=), 45.5 (CH2N), 33.1 (CH2CO), 22.9 (CH2CH2CO), 
20.7 (CH2CH2N); HRMS (EI+) calc. for C15H17NO [M]+: 227.1310. Found: 
227.1306. 
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1-((1E,3Z)-4-p-Tolylbuta-1,3-dienyl)piperidin-2-one, 242 
 
 
 
A solution of en-yne 230 (11.2 mg, 46.9 µmol) in anhydrous ethyl acetate (1 mL) 
containing 2% quinoline (v/v) was treated with Lindlar’s catalyst® (12.0 mg) and 
the resulting mixture was placed under a hydrogen atmosphere. The reaction was 
then stirred at room temperature until completion by TLC analysis (1.5 hour). The 
solution was then filtered through Celite®, and washed several times with brine (10 
× 10 mL) followed by and 10% aqueous HCl (1N, 10 mL). The aqueous layer was 
extracted with diethyl ether (3 × 10 mL) and the combined organic layers were 
dried over Na2SO4. The solution was filtered and concentrated under vacuum to 
afford the desired E,Z-dienamide 242 as a yellow oil, which required no further 
purification, in 79% yield (8.90 mg, 37.0 µmol). IR νmax (film)  2951, 2937, 2919, 
2895, 2875, 1654, 1625, 1595, 1510, 1477, 1458, 1402, 1345, 1329, 1305, 1287, 
1267, 1252, 1178 and 1164 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.71 (1H, d, J 
13.6 Hz, NCH=), 7.15 (2H, d, J 8.0 Hz, 2 × ortho CHAr), 7.08 (2H, d, J 7.6 Hz, 2 × 
meta CHAr), 6.23 (1H, d, J 10.4 Hz, =CH), 6.20 (1H, dd, J 10.4, 16.8 Hz, CH=), 
6.17 (1H, dd, J 14.0, 16.8 Hz, CH=), 3.37 (2H, t, J 6.0 Hz, CH2N), 2.45 (2H, t, J 6.0 
Hz, CH2CO), 2.27 (3H, s, CH3), 1.85-1.82 (2H, m, CH2CH2CO), 1.76-1.73 (2H, m, 
CH2CH2N); 
13C-NMR (100 MHz, CDCl3): δC 168.6 (CO), 136.3 (NCH=), 135.2 
(CAr), 131.9 (CAr), 131.7 (CHAr), 130.1 (CH=), 129.1 (CHAr), 128.6 (CH=), 115.2 
(CH=), 45.4 (CH2N), 33.0 (CH2CO), 22.5 (CH2CH2CO), 21.2 (CH2CH2N), 20.5 
(CH3); HRMS (EI+) calc. for C16H19NO [M]+: 241.1467. Found: 241.1466. 
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1-Ethynyl-4-methylbenzene, 235 
 
 
 
To a suspension of triphenylphosphine (7.90 g, 30.0 mmol) and zinc dust (1.96 g, 
30.0 mmol) in anhydrous dichloromethane (34 mL), under argon at 0 °C, a solution 
of carbon tetrabromide (9.95 g, 30.0 mmol) in anhydrous dichloromethane (7 mL) 
was added dropwise and the resulting mixture was allowed to stir at 0 °C for 20 
minutes. p-Tolylaldehyde 233 (1.20 g, 10.0 mmol) in 7 mL of dry dichloromethane 
was added dropwise and the resulting mixture was allowed to warm to room 
temperature and to stir for 5 hours. Then the reaction mixture was poured into 
hexane, filtered to remove the precipitate, concentrated under reduced pressure 
and dissolved in anhydrous THF (20 mL). The solution was cooled to -78 °C and 
nBuLi (10.4 mL, 26.0 mmol, 2.5 M solution in hexanes) was added dropwise and 
the resulting mixture was allowed to stir until completion as indicated by TLC. The 
reaction was quenched with NaHCO3 saturated aqueous solution (20 mL), 
extracted with diethyl ether (3 × 10 mL), dried over Na2SO4, filtered and 
concentrated under vacuum to afford a yellow oil as crude product. The crude 
product was purified by flash column chromatography on silica gel (petroleum 
ether) to afford the pure product 235 as a yellow oil in 60% yield (696 mg, 5.98 
mmol). IR νmax (film) 3295, 3049, 3025, 2956, 2917, 2857, 1594, 1508, 1448, 1373, 
964, 808, 748, 707 and 690 cm
-1
; 
1
H NMR (400 MHz, CDCl3): δH 7.31 (2H, d, J 8.0 
Hz, 2 × ortho CHAr), 7.03 (2H, d, J 8.0 Hz, 2 × meta CHAr), 2.94 (1H, s, CH), 2.26 
(3H, s, CH3); 
13C-NMR (100 MHz, CDCl3): δC 138.9 (CAr), 134.6 (CHAr), 129.4 
(CHAr), 119.1 (CAr), 83.9 (CH), 76.5 (C), 21.5 (CH3); HRMS (EI+) calc. for C9H8 
[M]+: 116.0626. Found: 116.0627. 
 
The characterisation matches with the data reported in literature: 
Zhao M.; Kuang C.; Yang Q.; Cheng X. Tetrahedron Lett. 2011, 52, 992. 
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1-(4-Ethynylphenyl)pentan-1-one, 238 
 
 
 
To a suspension of triphenylphosphine (7.90 g, 30.0 mmol) and zinc dust (1.96 g, 
30.0 mmol) in anhydrous dichloromethane (34 mL), under argon at 0 °C, a solution 
of carbon tetrabromide (9.95 g, 30.0 mmol) in anhydrous dichloromethane (7 mL) 
was added dropwise and the resulting mixture was allowed to stir at 0 °C for 20 
minutes. 4-Cyanobenzaldehyde 236 (1.31 g, 10.0 mmol) in 7 mL of dry 
dichloromethane was added dropwise and the resulting mixture was allowed to 
warm to room temperature and to stir for 5 hours. Then the reaction mixture was 
poured into hexane, filtered to remove the precipitate, concentrated under reduced 
pressure and dissolved in anhydrous THF (20 mL). The solution was cooled to -78 
°C and nBuLi (10.4 mL, 26.0 mmol, 2.5 M solution in hexanes) was added 
dropwise and the resulting mixture was allowed to stir until completion as indicated 
by TLC. The reaction was quenched with NaHCO3 saturated aqueous solution (20 
mL), extracted with diethyl ether (3 × 10 mL), dried over Na2SO4, filtered and 
concentrated under vacuum to afford a brown oil as crude product. The crude 
product was purified by flash column chromatography on silica gel (petroleum 
ether) to afford the pure product 238 as a yellow solid in 50% yield (930 mg, 5.00 
mmol). IR νmax (film) 3233, 2955, 2901, 2870, 1674, 1597, 1551, 1458, 1404, 1373, 
1343, 1273, 1204, 1180, 972, 856, 833, 795, 710 and 687 cm-1; 1H NMR (400 
MHz, CDCl3): δH 7.84 (2H, dd, J 1.6, 8.0 Hz, 2 × meta CHAr), 7.50 (2H, dd, J 1.6, 
8.0 Hz, 2 × ortho CHAr), 3.17 (1H, s, CH), 2.88 (2H, t, J 7.2 Hz, CH2), 1.65 (2H, qn, 
J 7.2 Hz, CH2), 1.33 (2H, sextet, J 7.2 Hz, CH2), 0.88 (3H, t, J 7.2 Hz, CH3); 
13C-
NMR (100 MHz, CDCl3): δC 199.8 (CO), 136.8 (CAr), 132.3 (CHAr), 127.9 (CHAr), 
126.7 (CAr), 82.8 (C), 80.2 (CH), 38.4 (CH2CO), 26.4 (CH2), 22.5 (CH2CH3), 13.9 
(CH3); HRMS (CI+/ISO) calc. for C13H15O [M+H]+: 187.1123. Found: 187.1124. 
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(But-3-ynyloxy)(tert-butyl)dimethylsilane, 240 
 
 
 
To a solution of 3-butyn-1-ol 239 (2.50 g, 35.5 mmol) in anhydrous 
dichloromethane (36 mL), triethylamine (12.9 mL, 92.3 mmol) was added dropwise 
followed by TBDMSCl (5.89 g, 39.1 mmol) and the resulting mixture was allowed 
to stir at room temperature for 12 hours. The reaction was quenched with NaHCO3 
saturated aqueous solution (20 mL), extracted with diethyl ether (3 × 20 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford a yellow 
oil as crude product. The product was purified by distillation under vacuum (95 °C/ 
130 mmHg) to afford the pure product as a pale yellow oil in 25% yield (1.62 g, 
8.80 mmol). IR νmax (film) 3310, 2955, 2932, 2862, 1466, 1389, 1258, 1103, 1003, 
918, 833, 779 and 633 cm-1; 1H NMR (400 MHz, CDCl3): δH 3.66 (2H, t, J 7.2 Hz, 
CH2O), 2.32 (2H, td, J 2.4, 6.8 Hz, CH2), 1.87 (1H, t, J 2.4 Hz, CH), 0.83 (9H, s, 3 
× CH3), 0.01 (6H, s, 2 × CH3); 
13C-NMR (100 MHz, CDCl3): δC 80.4 (C), 68.3 (CH), 
60.7 (CH2O), 24.9 (3 × CH3), 21.8 (CH2), 17.4 (C), -5.0 (2 × CH3); HRMS 
(CI+/ISO) calc. for C10H21OSi [M+H]+: 185.1362. Found: 185.1363. 
 
The characterisation matches with the data reported in literature: 
Sneddon H. F.; Gaunt M. J.; Ley S. V. Org. Lett. 2003, 5, 1147. 
 
(Bromomethyl)triphenylphosphonium bromide 
 
 
 
A solution of triphenylphosphine (60.0 g, 230 mmol) in dry toluene (100 mL) was 
treated with the dropwise addition of methylene bromide (21.0 mL, 300 mmol), and 
the resulting solution was stirred at 60 °C for 72 hours. The precipitate obtained 
was filtered, washed with toluene (5 × 100 mL), and dried under vacuum for 12 
hours to yield 80.2 g, 184 mmol (80%) of bromomethyl)triphenylphosphonium 
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bromide as a white solid. IR (neat) νmax 3047, 2987, 1589, 1481, 1437, 1340, 1116 
cm−1; 1HNMR (400 MHz; DMSO-d6) δH 7.99−7.93 (6H, m, 6 × meta CHAr), 
7.84−7.79 (3H, m, 3 × para CHAr), 7.73−7.68 (6H, m, 6 × ortho CHAr), 5.88 (2H, d, 
J 5.4 Hz, CH2); 
13C NMR (100 MHz; DMSO-d6) δC 135.5, 134.4, 130.5, 116.6, 
18.3; HRMS (FAB+) found [M – Br]+ 355.0247, C19H17P
79Br requires 355.0251; mp 
220-222 °C (with decomposition). 
 
The characterisation matches with the data reported in literature: 
Seyferth D.; Heeren J. K.; Singh D.; Grim S. O.; Hughes W. B. J. Organometal. 
Chem.  1966, 5, 267. 
 
1-(2,2-Dibromovinyl)pyrrolidin-2-one, 246 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (2.20 g, 5.00 
mmol) in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 
mg, 5.00 mmol), and the resulting bright orange suspension was allowed to stir at 
room temperature until it turned brown, indicating the ylide formation (6 hours). 
The resulting brown suspension was then treated dropwise with a solution of 2-
oxopyrrolidine-1-carbaldehyde 166 (56.5 mg, 0.50 mmol) in THF (5 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford 
the dibromo-enamide 246 as a yellow oil in 94% (125 mg, 465 µmol). IR (neat) 
νmax 3039, 2962, 2901, 1697, 1620, 1481, 1373 cm
−1; 1HNMR (500 MHz; CDCl3) 
δH 7.59 (1H, s, NCH=), 4.01 (2H, t, J 7.4 Hz, CH2N), 2.39 (2H, t, J 8.2 Hz, CH2CO), 
2.09 (2H, qn, J 7.4 Hz, CH2); 
13C NMR (125 MHz; CDCl3) δC 174.7 (CO), 129.6 
(NCH=), 74.0 (=CBr2), 46.9 (CH2N), 29.9 (CH2CO), 18.9 (CH2); HRMS (CI+) found 
[M + H]+ 269.8957, C6H8NO
79Br81Br requires 269.8952. 
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1-(2,2-Dibromovinyl)piperidin-2-one, 247 
 
 
 
 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (4.40 g, 10.0 
mmol) in anhydrous THF (20 mL) was treated with potassium tert-butoxide (1.12 g, 
10.0 mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of 2-
oxopiperidine-1-carbaldehyde 167 (127 mg, 1.00 mmol) in THF (10 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum. The crude brown oil residue was purified 
by flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to 
afford the dibromo-enamide 247 as a yellow oil in 91% (258 mg, 912 µmol). IR 
(neat) νmax 3047, 2947, 1658, 1612, 1473, 1404, 1260, 1255, 1219, 1157 cm
−1; 
1
HNMR (500 MHz; CDCl3) δH 7.40 (1H, s, NCH=), 3.64 (2H, t, J 4.8 Hz, CH2N), 
2.45 (2H, t, J 6.6 Hz, CH2CO), 1.83 (4H, m, 2 × CH2); 
13C NMR (125 MHz; CDCl3) 
δC 169.9 (CO), 134.8 (NCH=), 85.9 (=CBr2), 48.8 (CH2N), 32.4 (CH2CO), 23.1 
(CH2CH2CO), 20.8 (CH2CH2N); HRMS (CI+) found [M + H]
+ 283.9102, 
C7H10NO
79Br81Br requires 283.9109. 
 
1-(2,2-Dibromovinyl)azepan-2-one, 243b 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (2.20 g, 5.00 
mmol) in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 
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mg, 5.00 mmol), and the resulting bright orange suspension was allowed to stir at 
room temperature until it turned brown, indicating the ylide formation (6 hours). 
The resulting brown suspension was then treated dropwise with a solution of 2-
oxoazepan-1-carbaldehyde 168 (70.5 mg, 0.50 mmol) in THF (5 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum. The crude brown oil was purified by flash 
column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford the 
dibromo-enamide 243b as a yellow oil in 93% (139 mg, 468 µmol). IR (neat) νmax 
3039, 2928, 1658, 1435, 1392, 1257, 1207, 1188 cm−1; 1H NMR (500 MHz; CDCl3) 
δH 7.41 (1H, s, NCH=), 3.66 (2H, t, J 4.7 Hz, CH2N), 2.58 (2H, t, J 6.4 Hz, CH2CO), 
1.84−1.80 (2H, m, CH2CH2CO), 1.77−1.73 (4H, m, 2 × CH2); 
13C NMR (125 MHz; 
CDCl3) δC 175.8 (CO), 135.8 (NCH=), 85.2 (=CBr2), 50.2 (CH2N), 37.3 (CH2CO), 
29.9 (CH2CH2CO), 29.4 (CH2CH2N), 23.2 (CH2); HRMS (CI+) found [M + H]
+ 
297.9261, C8H12NO
79Br81Br required 297.9265. 
 
1-(2,2-Dibromovinyl)azocan-2-one, 248 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (2.20 g, 5.00 
mmol) in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 
mg, 5.00 mmol), and the resulting bright orange suspension was allowed to stir at 
room temperature until it turned brown, indicating the ylide formation (6 hours). 
The resulting brown suspension was then treated dropwise with a solution of 2-
oxoazocan-1-carbaldehyde 169 (77.5 mg, 0.50 mmol) in THF (5 mL). The resulting 
mixture was stirred at room temperature until TLC analysis showed reaction 
completion (12 hours). The reaction mixture was quenched with distilled water (10 
mL) and poured into hexanes (25 mL), and the precipitate formed was filtered off. 
The phases were separated, and the aqueous layer was extracted with diethyl 
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ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated under vacuum. The crude brown oil was purified by flash column 
chromatography on silica gel (80:20 hexane/ethyl acetate) to afford the dibromo-
enamide 248 as a yellow oil in 90% (140 mg, 0.45 mmol). IR (neat) νmax 3039, 
2928, 1712, 1658, 1454, 1396, 1361, 1207, 1192 cm−1; 1H NMR (500 MHz; CDCl3) 
δH 7.42 (1H, s, NCH=), 3.67 (2H, t, J 5.1 Hz, CH2N), 2.59 (2H, t, J 6.4 Hz, 
CH2CO), 1.85−1.80 (2H, m, CH2CH2CO), 1.78−1.68 (6H, m, 3 × CH2); 
13C NMR 
(125 MHz; CDCl3) δC 175.9 (CO), 135.8 (NCH=), 77.7 (=CBr2), 50.2 (CH2N), 37.3 
(CH2CO), 29.9 (CH2CH2CO), 29.4 (CH2CH2N), 26.3 (CH2), 23.3 (CH2); HRMS 
(CI+) found [M + H]+ 311.9413, C9H14NO
79Br81Br required 311.9422. 
 
N-(2,2-Dibromovinyl)butyramide, 249 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (2.20 g, 5.00 
mmol) in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 
mg, 5.00 mmol), and the resulting bright orange suspension was allowed to stir at 
room temperature until it turned brown, indicating the ylide formation (6 hours). 
The resulting brown suspension was then treated dropwise with a solution of N-
formylbutyramide 213 (57.5 mg, 0.50 mmol) in THF (5 mL). The resulting mixture 
was stirred at room temperature until TLC analysis showed reaction completion 
(12 hours). The reaction mixture was quenched with distilled water (10 mL) and 
poured into hexanes (25 mL), and the precipitate formed was filtered off. The 
phases were separated, and the aqueous layer was extracted with diethyl ether (3 
× 10 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under vacuum. The crude brown oil was purified by flash column 
chromatography on silica gel (80:20 hexane/ethyl acetate) to afford the dibromo-
enamide 249 as a yellow solid in 99% (140 mg, 0.52 mmol). IR (neat) νmax 3053, 
2961, 1663, 1631, 1480, 1376, 1268, 1194 cm−1; 1H NMR (500 MHz; CDCl3) δH 
7.61 (1H, d, J 11.6 Hz, NCH=), 7.13 (1H, bs, NH), 2.27 (2H, t, J 7.4 Hz, CH2CO), 
1.67 (2H, sextet, J 7.4 Hz, CH2), 0.97 (3H, t, J 7.4 Hz, CH3); 
13
C NMR (125 MHz; 
CDCl3) δC 169.5 (CO), 127.5 (NCH=), 73.7 (=CBr2), 38.3 (CH2CO), 18.7 (CH2), 
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13.8 (CH3); HRMS (CI+) found [M + H]
+ 271.9110, C6H10NO
79Br81Br required 
271.9129; mp 66-67 °C. 
 
N-(2,2-Dibromovinyl)-N-methylpropionamide, 250 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (4.40 g, 10.0 
mmol) in anhydrous THF (20 mL) was treated with potassium tert-butoxide (1.12 g, 
10.0 mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-formyl-
N-methylpropionamide 244 (115 mg, 1.00 mmol) in THF (10 mL). The resulting 
mixture was stirred at room temperature until TLC analysis showed reaction 
completion (12 hours). The reaction mixture was quenched with distilled water (10 
mL) and poured into hexanes (25 mL), and the precipitate formed was filtered off. 
The phases were separated, and the aqueous layer was extracted with diethyl 
ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated under vacuum. The crude brown oil was purified by flash column 
chromatography on silica gel (80:20 hexane/ethyl acetate) to afford the dibromo-
enamide 250 as a yellow oil in quantitative yield (310 mg, 1.15 mmol). IR (neat) 
νmax 2980, 2939, 1666, 1595, 1462, 1373, 1265, 1062 cm
−1; 1H NMR (500 MHz; 
CDCl3) δH 7.06 (1H, s, NCH=), 3.01 (3H, s, N-CH3), 2.24 (2H, q, J 7.6 Hz, CH2), 
1.07 (3H, t, J 7.4 Hz, CH3); 
13C NMR (125 MHz; CDCl3) δC 173.0 (CO), 135.5 
(NCH=), 94.5 (=CBr2), 33.7 (N-CH3), 27.8 (CH2), 9.1 (CH3); HRMS (CI+) found [M 
+ H]+ 269.9130, C6H10NO
79Br2 requires 269.9129. 
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N-(2,2-Dibromovinyl)benzamide, 251 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (4.40 g, 10.0 
mmol) in anhydrous THF (20 mL) was treated with potassium tert-butoxide (1.12 g, 
10.0 mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-
formylbenzamide 216 (149 mg, 1.00 mmol) in THF (10 mL). The resulting mixture 
was stirred at room temperature until TLC analysis showed reaction completion 
(12 hours). The reaction mixture was quenched with distilled water (10 mL) and 
poured into hexanes (25 mL), and the precipitate formed was filtered off. The 
phases were separated, and the aqueous layer was extracted with diethyl ether (3 
× 10 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under vacuum. The crude brown oil was purified by flash column 
chromatography on silica gel (80:20 hexane/ethyl acetate) to afford the dibromo-
enamide 251 as a yellow solid in 79% (241 mg, 0.79 mmol). IR (neat) νmax 3396, 
3066, 1660, 1629, 1504, 1467, 1249, 848 cm−1; 1H NMR (500 MHz; CDCl3) δH 
7.85−7.82 (4H, m, NCH=, NH, 2 × ortho CHAr), 7.59 (1H, tt, J 1.2, 6.8 Hz, para 
CHAr), 7.50 (2H, tm, J 7.6 Hz, 2 × meta CHAr); 
13
C NMR (125 MHz; CDCl3) δC 
163.4 (CO), 132.9 (NCH=), 132.5 (CAr), 129.2 (CHAr), 127.8 (CHAr), 127.4 (CHAr), 
75.0 (=CBr2); HRMS (EI+) found [M]
+ 304.8883, C9H7NO
79Br81Br requires 
304.8874; mp 60-61 °C. 
 
N-(2,2-Dibromovinyl)-N-methylbenzamide, 252 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (4.40 g, 10.0 
mmol) in anhydrous THF (20 mL) was treated with potassium tert-butoxide (1.12 g, 
10.0 mmol), and the resulting bright orange suspension was allowed to stir at room 
A. E. Pasqua 2013 Chapter I Experimental 
 
126 
 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-formyl-
N-methylbenzamide 245 (163 mg, 1.00 mmol) in THF (10 mL). The resulting 
mixture was stirred at room temperature until TLC analysis showed reaction 
completion (12 hours). The reaction mixture was quenched with distilled water (10 
mL) and poured into hexanes (25 mL), and the precipitate formed was filtered off. 
The phases were separated, and the aqueous layer was extracted with diethyl 
ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated under vacuum. The crude brown oil was purified by flash column 
chromatography on silica gel (80:20 hexane/ethyl acetate) to afford the dibromo-
enamide 252 as a yellow solid in 85% (270 mg, 852 µmol). IR (neat) νmax 3020, 
2933, 1716, 1647, 1597, 1346, 1323 cm−1; 1H NMR (500 MHz; CDCl3) δH 
7.52−7.47 (2H, m, 2 × ortho CHAr), 7.46−7.41 (1H, m, para CHAr), 7.40−7.36 (2H, 
m, 2 × meta CHAr), 7.09 (1H, bs, NCH=), 3.26 (3H, s, N-CH3); 
13C NMR (125 MHz; 
CDCl3) δC 170.5 (CO), 136.8 (NCH), 135.0 (CAr), 131.0 (CHAr), 128.3 (CHAr), 128.2 
(CHAr), 90.0 (=CBr2), 34.9 (N-CH3); HRMS (CI+) found [M]
+ 316.9045, 
C10H9NO
79Br2 requires 316.9051; mp 79-80 °C. 
 
2-(2,2,5,5-Tetramethyl-1,3-dioxan-4-yl)oxazole, 258 
 
 
 
A suspension of (bromomethyl)-triphenylphosphonium bromide (4.40 g, 10.0 
mmol) in anhydrous THF (20 mL) was treated with potassium tert-butoxide (1.12 g, 
10.0 mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-formyl-
2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide 212 (108 mg, 0.50 mmol) in THF 
(5 mL). The resulting mixture was stirred at room temperature until TLC analysis 
showed reaction completion (12 hours). The reaction mixture was quenched with 
distilled water (10 mL) and poured into hexanes (25 mL), and the precipitate 
formed was filtered off. The phases were separated, and the aqueous layer was 
extracted with diethyl ether (3 × 10 mL). The combined organic layers were dried 
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over Na2SO4, filtered, and concentrated under vacuum. The crude brown oil was 
purified by flash column chromatography on silica gel (80:20 hexane/ethyl acetate) 
to afford the dibromo-enamide 258 as a yellow solid in 99% (105 mg, 0.49 mmol). 
IR (neat) νmax 3119, 2994, 2969, 1574, 1523, 1459, 1392, 1383, 1370, 1193, 1157 
cm−1; 1H NMR (400 MHz; CDCl3) δH 7.64 (1H, s, NCH), 7.09 (1H, s, OCH), 4.90 
(1H, s, CH), 3.78 (1H, d, J 11.4 Hz, CHHO), 3.41 (1H, d, J 11.4 Hz, CHHO), 1.53 
(3H, s, CH3CO), 1.50 (3H, s, CH3CO), 1.06 (3H, s, CH3), 0.86 (3H, s, CH3); 
13C 
NMR (100 MHz; CDCl3) δC 161.2 (C), 138.9 (OCH), 127.0 (NCH), 99.7 (C), 74.8 
(CH), 71.6 (CH2O), 34.2 (C), 29.5 (CH3CO), 21.8 (CH3), 19.3 (CH3), 18.7 
(CH3CO); HRMS (CI+) found [M + H]
+ 212.1282, C11H18NO3 requires 212.1287; 
mp 68−70 °C. 
 
(Iodomethyl)triphenylphosphonium iodide 
 
 
 
A solution of triphenylphosphine (30.0 g, 114 mmol) in dry toluene (50 mL) was 
treated dropwise with methylene iodide (12 mL, 149 mmol). The reaction mixture 
was allowed to stir at 60 °C for 72 hours, which caused a white precipitate to form. 
The suspension was then cooled down to room temperature, filtered and the white 
solid residue was washed several times with toluene (5 × 200 mL). The crude 
product was dried under vacuum for 12 hours to afford in 91% yield (55.0 g, 104 
mmol) the phosphonium iodide as a pure white solid. IR (neat) νmax 2994, 2970, 
1575, 1459, 1392, 1383 cm−1; 1H NMR (400 MHz; DMSO-d6) δH 7.98−7.81 (15H, 
m, 15 × CHAr), 5.10 (2H, d, J 8.5 Hz, CH2); 
13C NMR (100 MHz; DMSO-d6) δC 
136.1, 134.7, 131.0, 118.8, −15.4; HRMS (FAB+) found [M - I]+ 403.0110, 
C19H17PI requires 403.0113; mp 235-237 °C. 
 
The characterisation matches with the data reported in literature: 
Aquino F.; Pauling H.; Walter W.; Plattner D. A.; Bonrath W. Synthesis  2000, 5, 
731. 
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1-(2,2-Diiodovinyl)azepan-2-one, 253 
 
 
 
A suspension of (iodomethyl)triphenylphosphonium iodide (5.30 g, 10.0 mmol) in 
anhydrous THF (20 mL) was treated with potassium tert-butoxide (1.12 g, 10.0 
mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of 2-
oxoazepane-1-carbaldehyde 168 (141 mg, 1.00 mmol) in THF (10 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane:ethyl acetate) to afford 
the diiodo-enamide 253 as a yellow solid in 99% yield (390 mg, 0.99 mmol). IR 
(neat) νmax 3010, 2930, 2910, 1646, 1587, 1464, 1443, cm
−1; 1H NMR (400 MHz; 
CDCl3) δH 7.73 (1H, s, NCH=), 3.64 (2H, t, J 4.4 Hz, CH2N), 2.58−2.55 (2H, m, 
CH2CO), 1.83−1.74 (6H, m, 3 × CH2); 
13C NMR (100 MHz; CDCl3) δC 175.4 (CO), 
147.3 (NCH=), 50.6 (CH2N), 37.4 (CH2CO), 31.7 (CH2CH2CO), 29.9 (CH2CH2N), 
22.8 (CH2), 14.0 (=CI2); HRMS (CI+) found [M +H]
+ 391.9003, C8H12NOI2 requires 
391.9008; mp 74-75 °C. 
 
1-(2,2-Diiodovinyl)azocan-2-one, 254 
 
 
 
A suspension of (iodomethyl)triphenylphosphonium iodide (5.30 g, 10.0 mmol) in 
anhydrous THF (20 mL) was treated with potassium tert-butoxide (1.12 g, 10.0 
mmol), and the resulting bright orange suspension was allowed to stir at room 
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temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of 2-
oxoazocane-1-carbaldehyde 169 (155 mg, 1.00 mmol) in THF (10 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane:ethyl acetate) to afford 
386 mg of an inseparable 13:1 mixture of diiodo-enamide 254 (89%, 361 mg, 0.89 
mmol) and (E)-iodoenamide 221 (10%, 28.0 mg, 0.10 mmol). 
1-(2,2-Diiodovinyl)azocan-2-one, 254: IR (neat) νmax 2916, 2852, 1628, 1617, 
1588, 1472, 1444 cm−1; 1H NMR (400 MHz; CDCl3) δH 7.56 (1H, s, NCH=), 3.78 
(2H, t, J 5.6 Hz, CH2N), 2.53 (2H, t, J 6.3 Hz, CH2CO), 1.88−1.82 (2H, m, 
CH2CH2CO), 1.69−1.58 (4H, m, 2 × CH2), 1.53−1.47 (2H, m, CH2); 
13C NMR (100 
MHz; CDCl3) δC 175.6 (CO), 145.2 (NCH=), 47.0 (CH2N), 34.3 (CH2CO), 30.1 
(CH2CH2CO), 28.8 (CH2CH2N), 26.3 (CH2), 24.3 (CH2), 13.1 (=CI2); HRMS (CI+) 
found [M + H]+ 405.9169, C9H14NOI2 requires 405.9165.  
 
(E)-1-(2-Iodovinyl)azocan-2-one, 221: 1H NMR (400 MHz; CDCl3) δH 7.95 (1H, d, 
J 14.0 Hz, NCH=), 5.52 (1H, d, J 14.0 Hz, =CHI). 
 
N-(2,2-Diiodovinyl)-2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide, 257 
 
 
 
 
 
A suspension of (iodomethyl)triphenylphosphonium iodide (1.20 g, 2.25 mmol) in 
anhydrous THF (10 mL) was treated with potassium tert-butoxide (252 mg, 2.25 
mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-formyl-
2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide 212 (108 mg, 0.50 mmol) in THF 
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(5 mL). The resulting mixture was stirred at room temperature until TLC analysis 
showed reaction completion (12 hours). The reaction mixture was quenched with 
distilled water (10 mL) and poured into hexanes (25 mL), and the precipitate 
formed was filtered off. The phases were separated, and the aqueous layer was 
extracted with diethyl ether (3 × 10 mL). The combined organic layers were dried 
over Na2SO4, filtered, and concentrated under vacuum, and the crude residue was 
purified by flash column chromatography on silica gel (80:20 hexane:ethyl acetate) 
to afford the diiodo-enamide 257 in 32% yield (74.0 mg, 0.16 mmol) and the 
oxazole 258 in 16% yield (17.0 mg, 0.08 mmol) as yellow solids. 
 
N-(2,2-Diiodovinyl)-2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide 257: IR 
(neat) νmax 3351, 2836, 1686, 1612, 1465, 1384, 1379, 1094, 1050 cm
−1; 1H NMR 
(400 MHz; CDCl3) δH 8.34 (1H, bd, J 10.8 Hz, NH), 7.76 (1H, d, J 11.4 Hz, NCH=), 
4.14 (1H, s, CH), 3.71 (1H, d, J 11.7 Hz, CHHO), 3.32 (1H, d, J 11.7 Hz, CHHO), 
1.51 (3H, s, CH3CO), 1.45 (3H, s, CH3CO), 1.03 (3H, s, CH3), 1.02 (3H, s, CH3); 
13C NMR (100 MHz; CDCl3) δC 166.1 (CO), 136.4 (NCH=), 99.4 (C), 77.1 (CH), 
71.4 (CH2), 33.3 (C), 29.5 (CH3), 22.9 (CH3), 18.8 (CH3), 19.1 (CH3), −6.8 (=CI2); 
HRMS (CI+) found [M + H]+ 465.9372, C11H18NO3I2 requires 465.9376; mp 135-
136 °C. 
2-(2,2,5,5-Tetramethyl-1,3-dioxan-4-yl)oxazole 258: 1H NMR (400 MHz; CDCl3) 
δH 7.64 (1H, s, CH), 7.09 (1H, s, CH), 4.90 (1H, s, CH), 3.78 (1H, d, J 11.4 Hz, 
CHHO), 3.41 (1H, d, J 11.4 Hz, CHHO), 1.53 (3H, s, CH3CO), 1.50 (3H, s, 
CH3CO), 1.06 (3H, s, CH3), 0.86 (3H, s, CH3). 
 
N-(2,2-Diiodovinyl)butyramide, 255 and N-Butyrylbutyramide 
 
 
 
A suspension of (iodomethyl)triphenylphosphonium iodide (1.06 g, 2.00 mmol) in 
anhydrous THF (10 mL) was treated with potassium tert-butoxide (225 mg, 2.00 
mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-formyl-
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butyramide 213 (57.5 mg, 0.50 mmol) in THF (5 mL). The resulting mixture was 
stirred at room temperature until TLC analysis showed reaction completion (12 
hours). The reaction mixture was quenched with distilled water (10 mL) and 
poured into hexanes (25 mL), and the precipitate formed was filtered off. The 
phases were separated, and the aqueous layer was extracted with diethyl ether (3 
× 10 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under vacuum, and the crude residue was purified by flash column 
chromatography on silica gel (80:20 hexane:ethyl acetate) to afford the diiodo-
enamide 255 in 40% yield (73.0 mg, 0.20 mmol) and the N-butyrylbutyramide in 
20% yield (15.7 mg, 0.10 mmol) as yellow solids. 
 
N-(2,2-Diiodovinyl)butyramide 255: IR (neat) νmax 3264, 3179, 2963, 2878, 
1728, 1505, 1373 and 1165 cm−1; 1H NMR (400 MHz; CDCl3) δH 8.06 (1H, bd, J 
10.8 Hz, NCH=), 7.03 (1H, bd, J 8.4 Hz, NH), 2.29 (2H, t, J 7.2 Hz, CH2), 1.70 (2H, 
app qn, J 7.2 Hz, CH2), 1.00 (3H, t, J 7.2 Hz, CH3); 
13C NMR (100 MHz; CDCl3) δC 
168.9 (CO), 137.3 (NCH=), 39.3 (CH2), 17.8 (CH2), 13.6 (CH3), −9.1 (=CI2); HRMS 
(EI+) found [M]+ 364.8777, C6H9NOI2 requires 364.8774; mp 59-60 °C. 
N-Butyrylbutyramide: 1H NMR (400 MHz; CDCl3) δH 8.04 (1H, bs, NH), 2.57 (4H, 
t, J 7.3 Hz, 2 × CH2), 1.70 (4H, app qn, J 7.3 Hz, 2 × CH2), 0.98 (6H, t, J 7.3 Hz, 2 
× CH3). 
 
The characterisation matches with the data reported in literature: 
Mohammadpoor-baltork I.; Tangestaninejad S.; Moghadam M.; Mirkhani V.; Nasr-
Esfahani M.  J. Iran. Chem. Soc. 2011, 8, 401. 
 
(Z)-1-(2-Bromovinyl)pyrrolidin-2-one, 260 
 
 
 
A solution of 1-(2,2-dibromovinyl)pyrrolidin-2-one 246 (90.0 mg, 0.34 mmol) in 
anhydrous EtOAc (5 mL) was treated with Pd(PPh3)4 (39.0 mg, 0.03 mmol) and 
Bu3SnH (0.11 mL, 0.40 mmol). The resulting reaction mixture was stirred at room 
temperature until completion as indicated by TLC analysis (12 hours). The reaction 
was diluted with hexane (15 mL), filtered through Celite®, and concentrated under 
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vacuum to afford a yellow oil as crude residue. The crude product was purified by 
flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford 
the bromo-enamide 260 as a colourless oil in 88% yield (56.0 mg, 0.296 mmol).  
IR (neat) νmax 2953, 1703, 1640, 1484, 1381, 1313, 1251 cm
−1; 1H NMR (500 MHz; 
CDCl3) δH 7.29 (1H, d, J 7.0 Hz, NCH=), 5.41 (1H, d, J 7.0 Hz, =CHBr), 4.14 (2H, 
t, J 7.2 Hz, CH2N), 2.41 (2H, t, J 7.8 Hz, CH2CO), 2.09 (2H, qn, J 7.4 Hz, CH2); 
13C 
NMR (125 MHz; CDCl3) δC 175.3 (CO), 126.2 (NCH=), 86.6 (=CHBr), 47.5 (CH2N), 
30.1 (CH2CO), 18.8 (CH2); HRMS (CI+) found [M + H]
+ 189.9865, C6H9NO
79Br 
requires 189.9868. 
 
(Z)-1-(2-Bromovinyl)piperidin-2-one, 261 
 
 
 
A solution of 1-(2,2-dibromovinyl)piperidin-2-one 247 (90.0 mg, 0.34 mmol) in 
anhydrous EtOAc (32 mL) was treated with Pd(PPh3)4 (70.0 mg, 0.06 mmol) and 
Bu3SnH (0.2 mL, 0.71 mmol). The resulting reaction mixture was stirred at room 
temperature until completion as indicated by TLC analysis (12 hours). The reaction 
was diluted with hexane (30 mL), filtered through Celite®, and concentrated under 
vacuum to afford a yellow oil as crude residue. The crude product was purified by 
flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford 
the bromo-enamide 261 as a colourless oil in 70% yield (86.0 mg, 424 µmol). IR 
(neat) νmax 2953, 2877, 1656, 1626, 1477, 1460, 1427, 1406, 1269, 1172 cm
−1; 1H 
NMR (400 MHz; CDCl3) δH 7.37 (1H, d, J 6.5 Hz, NCH=), 5.74 (1H, d, J 6.5 Hz, 
=CHBr), 3.83−3.78 (2H, m, CH2N), 2.51−2.46 (2H, m, CH2CO), 1.89−1.79 (4H, m, 
2 × CH2); 
13C NMR (100 MHz; CDCl3) δC 170.3 (CO), 131.6 (NCH=), 94.8 
(=CHBr), 48.9 (CH2N), 32.4 (CH2CO), 23.1 (CH2CH2CO), 20.8 (CH2CH2N); HRMS 
(CI+) found [M + H]+ 204.0026, C7H11NO
79Br requires 204.0024. 
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(Z)-1-(2-Bromovinyl)azepan-2-one, 256Z 
 
 
 
A solution of 1-(2,2-dibromovinyl)azepan-2-one 243b (118 mg, 0.40 mmol) in 
anhydrous EtOAc (30 mL) was treated with Pd(PPh3)4 (46.0 mg, 0.04 mmol) and 
Bu3SnH (0.13 mL, 0.48 mmol). The resulting reaction mixture was stirred at room 
temperature until completion as indicated by TLC analysis (12 hours). The reaction 
was diluted with hexane (30 mL), filtered through Celite®, and concentrated under 
vacuum to afford a yellow oil as crude residue. The crude product was purified by 
flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford 
the bromo-enamide 256Z as a colourless oil in 75% yield (65.0 mg, 0.30 mmol). IR 
(neat) νmax 2929, 2856, 1739, 1666, 1627, 1394, 1332, 1321, 1190 cm
−1; 1H NMR 
(400 MHz; CDCl3) δH 7.29 (1H, d, J 6.3 Hz, NCH=), 5.73 (1H, d, J 6.3 Hz, =CHBr), 
3.80−3.76 (2H, m, CH2N), 2.63−2.61 (2H, m, CH2CO), 1.90−1.81 (2H, m, 
CH2CH2CO), 1.79−1.71 (4H, m, 2 × CH2); 
13C NMR (100 MHz; CDCl3) δC 176.4 
(CO), 132.6 (NCH=), 94.8 (=CHBr), 49.4 (CH2N), 37.3 (CH2CO), 29.9 
(CH2CH2CO), 29.3 (CH2CH2N), 23.4 (CH2); HRMS (CI+) found [M + H]
+ 218.0181, 
C8H13NO
79Br requires 218.0181. 
 
(Z)-N-(2-Bromovinyl)butyramide, 262 and 2-Propyloxazole 
 
 
 
A solution of N-(2,2-dibromovinyl)-butyramide 249 (63.0 mg, 0.23 mmol) in 
anhydrous EtOAc (3 mL) was treated with Pd(PPh3)4 (27.0 mg, 0.02 mmol) and 
Bu3SnH (0.10 mL, 0.28 mmol). The resulting reaction mixture was stirred at room 
temperature until completion as indicated by TLC analysis (12 hours). The reaction 
mixture was diluted with hexane (30 mL), filtered through Celite®, and 
concentrated under vacuum to afford a yellow oil as crude residue. The crude 
product was purified by flash column chromatography on silica gel (80:20 
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hexane/ethyl acetate) to afford the bromo-enamide 262 in 63% yield (28.0 mg, 147 
µmol) and 2-propyloxazole in 37% yield (9.60 mg, 87.0 µmol) as colourless oils. 
 
(Z)-N-(2-Bromovinyl)butyramide 262: IR (neat) νmax 2961, 1677, 1642, 1239, 
1195, 678 cm−1; 1H NMR (400 MHz; CDCl3) δH 7.40 (1H, dd, J 5.9, 10.9 Hz, 
NCH=), 7.32 (1H, bs, NH), 5.47 (1H, d, J 5.3 Hz, =CHBr), 2.30 (2H, t, J 7.3 Hz, 
CH2CO), 1.71 (2H, sextet, J 7.4 Hz, CH2), 0.99 (3H, t, J 7.4 Hz, CH3); 
13C NMR 
(100 MHz; CDCl3) δC 169.5 (CO), 127.5 (NCH=), 88.3 (=CHBr), 38.4 (CH2CO), 
18.8 (CH2), 13.8 (CH3); HRMS (CI+) found [M + H]
+ 192.0018, C6H11NO
79Br 
requires 192.0024. 
2-Propyloxazole: 1H NMR (400 MHz; CDCl3) δH 7.63 (1 H, d, J 10.9 Hz, CH), 
7.08 (1 H, d, J 10.9 Hz, CH), 2.28 (2H, t, J 7.6 Hz, CH2), 1.72 (2H, sextet, J 7.4 Hz, 
CH2), 0.98 (3H, t, J 7.4 Hz, CH3); 
13C NMR (100 MHz; CDCl3) δC 131.0 (C), 128.9 
(CH), 125.4 (CH), 29.1 (CH2), 23.1 (CH2), 11.1 (CH3); HRMS (CI+) found [M + H]
+ 
112.0769, C6H10NO requires 112.0762. 
 
(Z)-N-(2-Bromovinyl)-N-methylpropionamide, 263 
 
 
 
A solution of N-(2,2-dibromovinyl)-N-methylpropionamide 250 (117 mg, 0.43 
mmol) in anhydrous EtOAc (10 mL) was treated with Pd(PPh3)4 (50.0 mg, 0.04 
mmol) and Bu3SnH (0.14 mL, 0.52 mmol). The resulting reaction mixture was 
stirred at room temperature until completion as indicated by TLC analysis (12 
hours). The reaction was diluted with hexane (30 mL), filtered through Celite®, and 
concentrated under vacuum to afford a yellow oil as crude residue. The crude 
product was purified by flash column chromatography on silica gel (80:20 
hexane/ethyl acetate) to afford the bromo-enamide 263 as a colourless oil in 72% 
yield (60.0 mg, 313 µmol). IR (neat) νmax 3086, 3063, 2920, 1654, 1624, 1577, 
1446, 1346, 1300, 1057 cm−1; 1H NMR (500 MHz; CDCl3) δH 6.95 (1H, bs, NCH=), 
6.00 (1H, bs, =CHBr), 3.16 (3H, s, N-CH3), 2.31−2.30 (2H, m, CH2), 1.15−1.12 
(3H, m, CH3); 
13C NMR (125 MHz; CDCl3) δC 173.6 (CO), 133.3 (NCH=), 102.3 
(=CH), 34.0 (CH2CO), 27.8 (CH3), 9.2 (CH3); HRMS (CI+) found [M + H]
+ 
192.0015, C6H11NO
79Br requires 192.0024. 
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(Z)-N-(2-Bromovinyl)-N-methylbenzamide, 264 
 
 
 
A solution of N-(2,2-dibromovinyl)-N-methylbenzamide 252 (98.0 mg, 0.31 mmol) 
in anhydrous EtOAc (5 mL) was treated with Pd(PPh3)4 (36.0 mg, 0.03 mmol) and 
Bu3SnH (0.10 mL, 0.37 mmol). The resulting reaction mixture was stirred at room 
temperature until completion as indicated by TLC analysis (12 hours). The reaction 
was diluted with hexane (30 mL), filtered through Celite®, and concentrated under 
vacuum to afford a yellow oil as crude residue. The crude product was purified by 
flash column chromatography on silica gel (80:20 hexane/ethyl acetate) to afford 
the bromo-enamide 264 as a colourless oil in 86% yield (63.0 mg, 264 µmol). IR 
(neat) νmax 3086, 2982, 1666, 1631, 1612, 1462, 1423, 1377, 1276, 1057 cm
−1; 1H 
NMR (500 MHz; CDCl3) δH 7.51−7.49 (2H, m, 2 × ortho CHAr), 7.46−7.43 (1H, m, 
para CHAr), 7.39−7.37 (2H, m, 2 × meta CHAr), 6.96 (1H, bs, NCH=), 5.73 (1H, d, J 
6.0 Hz, =CHBr), 3.40 (3H, s, N-CH3); 
13C NMR (125 MHz; CDCl3) δC 171.4 (CO), 
135.4 (CAr), 134.6 (NCH=), 130.9 (CHAr), 128.4 (CHAr), 128.5 (CHAr), 97.3 
(=CHBr), 35.2 (N-CH3); HRMS (CI+) found [M + H]
+ 240.0026, C10H11NO
79Br 
requires 240.0024. 
 
1-(2,2-Dichlorovinyl)pyrrolidin-2-one, 267 and (E)/(Z)-1-(2-Chlorovinyl) 
pyrrolidin-2-one, 268/269 
 
 
 
A suspension of (chloromethyl)triphenylphosphonium chloride (1.74 g, 5.00 mmol) 
in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 mg, 5.00 
mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of 2-
oxopyrrolidine-1-carbaldehyde 166 (56.5 mg, 0.50 mmol) in THF (5 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
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reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane:ethyl acetate) to afford a 
first fraction consisting of a 1.0:1.7 mixture of the dichloro-enamide 267 and the 
(Z)-monochloro-enamide 268 (traces amounts) and a second clean fraction of the 
(E)-monochloro-enamide 269 in 98% yield (71.0 mg, 0.49 mmol) as a white solid. 
 
1-(2,2-Dichlorovinyl)pyrrolidin-2-one 267: IR (neat) νmax 3094, 3057, 2965, 
1705, 1645, 1379, 1333, 1277, 1256, 1225, 1165, 1026, 941, 918, 808 and 727 
cm−1; 1H NMR (500 MHz; CDCl3) δH 7.15 (1H, s, NCH=), 3.97 (2H, t, J 6.7 Hz, 
CH2N), 2.44-2.40 (2H, m, CH2CO), 2.14-2.07 (2H, m, CH2); 
13C NMR (125 MHz; 
CDCl3) δC 174.7 (CO), 123.2 (NCH=), 108.3 (=CCl2), 47.0 (CH2N), 29.9 (CH2CO), 
18.8 (CH2); HRMS (CI+) found [M + H]
+ 179.9980, C6H8NO
35Cl2 requires 
179.9983. 
 
(E)-1-(2-Chlorovinyl)pyrrolidin-2-one 268: IR (neat) νmax 3071, 2969, 2897, 
1692, 1628, 1481, 1458, 1398, 1329, 1292, 1217 and 939 cm−1; 1H NMR (500 
MHz; CDCl3) δH 6.91 (1H, d, J 6.7 Hz, NCH=), 5.39 (1H, d, J 6.7 Hz, =CH), 4.10 
(2H, t, J 6.7 Hz, CH2N), 2.44-2.40 (2H, m, CH2CO), 2.14-2.07 (2H, m, CH2); 
13C 
NMR (125 MHz; CDCl3) δC 175.1 (CO), 123.5 (NCH=), 100.1 (=CHCl), 47.7 
(CH2N), 29.9 (CH2CO), 18.8 (CH2); HRMS (CI+) found [M + H]
+ 146.0380, 
C6H9NO
35Cl requires 146.0373; m.p. 45-46 °C. 
 
(E)-1-(2-Chlorovinyl)piperidin-2-one, 270, (Z)-1-(2-Chlorovinyl)piperidin-2-
one, 271 and 1-(2,2-Dichlorovinyl)piperidin-2-one, 272  
 
 
 
A suspension of (chloromethyl)triphenylphosphonium chloride (1.74 g, 5.00 mmol) 
in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 mg, 5.00 
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mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of 2-
oxopiperidine-1-carbaldehyde 167 (63.5 mg, 0.50 mmol) in THF (5 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane:ethyl acetate) to afford a 
14.0:1.0:1.0 mixture of the (E)-monochloro-enamide 270 (74%, 58.8 mg, 0.37 
mmol), (Z)-monochloro-enamide 271 (5.3%, 4.20 mg, 26.0 µmol) and the dichloro-
enamide 272 (4.4%, 4.20 mg, 22.0 µmol) as a white solid (67.0 mg in total, 84% 
total yield). 
(E)-1-(2-Chlorovinyl)piperidin-2-one 270: IR (neat) νmax 3090, 2957, 2866, 1655, 
1618, 1472, 1456, 1431, 1410, 1346, 1331, 1287, 1271, 1231, 1177, 1167, 1090, 
985, 953, 920, 891, 851, 827, 787 and 719 cm−1; 1H NMR (500 MHz; CDCl3) δH 
7.77 (1H, d, J 13.4 Hz, NCH=), 5.67 (1H, d, J 12.7 Hz, =CH), 3.35 (2H, t, J 6.4 Hz, 
CH2N), 2.48 (2H, t, J 6.4 Hz, CH2CO), 1.92-1.78 (4H, m, 2 × CH2); 
13C NMR (125 
MHz; CDCl3) δC 167.9 (CO), 130.2 (NCH=), 102.7 (=CHCl), 45.7 (CH2N), 32.8 
(CH2CO), 22.5 (CH2CH2CO), 20.5 (CH2CH2N); HRMS (CI+) found [M + H]
+ 
160.0523, C7H11NO
35Cl requires 160.0529; m.p. 89-90 °C. 
 
(Z)-1-(2-Chlorovinyl)piperidin-2-one 271: 1H NMR (500 MHz; CDCl3) δH 7.02 
(1H, d, J 6.5 Hz, NCH=), 5.61 (1H, d, J 6.6 Hz, =CH), 3.65-3.62 (2H, m, CH2N), 
2.50-2.46 (2H, m, CH2CO), 1.92-1.78 (4H, m, 2 × CH2).  
 
1-(2,2-Dichlorovinyl)piperidin-2-one 272: 1H NMR (500 MHz; CDCl3) δH 7.04 
(1H, s, NCH=), 3.81-3.79 (2H, m, CH2N), 2.50-2.46 (2H, m, CH2CO), 1.92-1.78 
(4H, m, 2 × CH2).  
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(E)-1-(2-Chlorovinyl)azepan-2-one, 273, 1-(2,2-Dichlorovinyl)azepan-2-one, 
274 and (Z)-1-(2-Chlorovinyl)azepan-2-one, 275 
 
 
 
A suspension of (chloromethyl)triphenylphosphonium chloride (1.74 g, 5.00 mmol) 
in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 mg, 5.00 
mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of 2-
oxoazepane-1-carbaldehyde 168 (70.6 mg, 0.50 mmol) in THF (5 mL). The 
resulting mixture was stirred at room temperature until TLC analysis showed 
reaction completion (12 hours). The reaction mixture was quenched with distilled 
water (10 mL) and poured into hexanes (25 mL), and the precipitate formed was 
filtered off. The phases were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under vacuum, and the crude residue was purified by 
flash column chromatography on silica gel (80:20 hexane:ethyl acetate) to afford a 
14.0:1.0:1.0 mixture of the (E)-monochloro-enamide 273 (52%, 44.8 mg, 0.26 
mmol), dichloro-enamide 274 (11%, 11.2 mg, 54.0 µmol) and the (Z)-monochloro-
enamide 275 (10%, 8.90 mg, 0.05 mmol) as a white solid (65.0 mg in total, 73% 
total yield). 
 
(E)-1-(2-Chlorovinyl)azepan-2-one 273: IR (neat) νmax 3094, 2932, 2859, 1661, 
1624, 1439, 1395, 1350, 1335, 1310, 1260, 1209, 1184, 1152, 1082, 1034, 972, 
934 and 858 cm−1; 1H NMR (500 MHz; CDCl3) δH 7.45 (1H, d, J 12.7 Hz, NCH=), 
5.79 (1H, d, J 12.7 Hz, =CH), 3.50-3.48 (2H, m, CH2N), 2.59-2.55 (2H, m, 
CH2CO), 1.74-1.64 (6H, m, 3 × CH2); 
13C NMR (125 MHz; CDCl3) δC 173.8 (CO), 
130.3 (NCH=), 103.1 (=CHCl), 46.7 (CH2N), 36.9 (CH2CO), 29.4 (CH2CH2CO), 
27.4 (CH2CH2N), 23.4 (CH2); HRMS (CI+) found [M + H]
+ 174.0690, C8H13NO
35Cl 
requires 174.0686; m.p. 90-92 °C. 
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(Z)-1-(2-Chlorovinyl)azepan-2-one 274: 1H NMR (500 MHz; CDCl3) δH 6.91 (1H, 
d, J 6.3 Hz, NCH=), 5.59 (1H, d, J 6.3 Hz, =CH), 3.75-3.73 (2H, m, CH2N), 2.59-
2.55 (2H, m, CH2CO), 1.74-1.64 (6H, m, 3 × CH2).  
 
1-(2,2-Dichlorovinyl)azepan-2-one 275: 1H NMR (500 MHz; CDCl3) δH 6.98 (1H, 
s, NCH=), 3.63-3.61 (2H, m, CH2N), 2.50-2.46 (2H, m, CH2CO), 1.74-1.64 (6H, m, 
3 × CH2); HRMS (CI+) found [M + H]
+ 208.0293, C8H12NO
35Cl2 requires 208.0296. 
 
(Z)-N-(2-Chlorovinyl)-2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide, 265 
 
 
 
A suspension of (chloromethyl)triphenylphosphonium chloride (1.74 g, 5.00 mmol) 
in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 mg, 5.00 
mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-formyl-
2,2,5,5-tetramethyl-1,3-dioxane-4-carboxamide 212 (108 mg, 0.50 mmol) in THF 
(5 mL). The resulting mixture was stirred at room temperature until TLC analysis 
showed reaction completion (12 hours). The reaction mixture was quenched with 
distilled water (10 mL) and poured into hexanes (25 mL), and the precipitate 
formed was filtered off. The phases were separated, and the aqueous layer was 
extracted with diethyl ether (3 × 10 mL). The combined organic layers were dried 
over Na2SO4, filtered, and concentrated under vacuum, and the crude residue was 
purified by flash column chromatography on silica gel (80:20 hexane:ethyl acetate) 
to afford the (Z)-monochloro-enamide 265 as a white gel in 93% yield (115 mg, 
0.47 mmol). IR (neat) νmax 3401, 2993, 2958, 2870, 1699, 1652, 1473, 1376, 1316, 
1241, 1196, 1158, 1093, 1050, 1019, 903, 873, 768 and 757 cm−1; 1H NMR (500 
MHz; CDCl3) δH 8.53 (1H, bd, J 9.0 Hz, NH), 7.11 (1H, dd, J 5.8, 11.2 Hz, NCH=), 
5.50 (1H, d, J 5.8 Hz, =CH), 4.17 (1H, s, CH), 3.70 (1H, d, J 11.9 Hz, CHHO), 3.31 
(1H, d, J 11.9 Hz, CHHO), 1.51 (3H, s, CH3CO), 1.45 (3H, s, CH3CO), 1.04 (3H, s, 
CH3), 1.02 (3H, s, CH3); 
13C NMR (125 MHz; CDCl3) δC 167.2 (CO), 121.8 
(NCH=), 101.3 (=CHCl), 99.3 (C), 76.8 (CH), 71.3 (CH2), 33.2 (C), 29.3 (CH3), 
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21.9 (CH3), 18.9 (CH3), 18.6 (CH3); HRMS (CI+) found [M + H]
+ 248.1061, 
C11H19NO3
35Cl requires 248.1053. 
 
(Z)-N-(2-Chlorovinyl)butyramide, 266 
 
 
 
A suspension of (chloromethyl)triphenylphosphonium chloride (1.74 g, 5.00 mmol) 
in anhydrous THF (10 mL) was treated with potassium tert-butoxide (600 mg, 5.00 
mmol), and the resulting bright orange suspension was allowed to stir at room 
temperature until it turned brown, indicating the ylide formation (6 hours). The 
resulting brown suspension was then treated dropwise with a solution of N-formyl-
butyramide 213 (57.5 mg, 0.50 mmol) in THF (5 mL). The resulting mixture was 
stirred at room temperature until TLC analysis showed reaction completion (12 
hours). The reaction mixture was quenched with distilled water (10 mL) and 
poured into hexanes (25 mL), and the precipitate formed was filtered off. The 
phases were separated, and the aqueous layer was extracted with diethyl ether (3 
× 10 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under vacuum, and the crude residue was purified by flash column 
chromatography on silica gel (80:20 hexane:ethyl acetate) to afford the (Z)-
monochloro-enamide 266 as a white gel in quantitative yield (74.0 mg, 0.50 mmol). 
IR (neat) νmax 3284, 2966, 1675, 1649, 1483, 1316, 1241, 1191, 1115, 907, 763 
and 702  cm−1; 1H NMR (500 MHz; CDCl3) δH 7.47-7.33 (1H, bs, NH), 7.16 (1H, 
dd, J 6.1, 11.1 Hz, NCH=), 5.42 (1H, d, J 5.7 Hz, =CHCl), 2.29 (2H, t, J 7.4 Hz, 
CH2), 1.69 (2H, sextet, J 7.4 Hz, CH2), 0.96 (3H, t, J 7.3 Hz, CH3); 
13C NMR (125 
MHz; CDCl3) δC 170.3 (CO), 122.9 (NCH=), 99.7 (=CHCl), 38.4 (CH2), 18.8 (CH2), 
13.8 (CH3); HRMS (CI+) found [M + H]
+ 148.0528, C6H11NO
35Cl required 
148.0529. 
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N-Formylcinnamamide, 294 
 
 
 
A solution of trans-cinnamamide 295 (147 mg, 1.00 mmol) in anhydrous THF (10 
mL) was cooled to 0 °C before being treated with n-BuLi (0.75 mL, 1.20 mmol, 1.6 
M solution in hexanes). The reaction was then stirred at 0 °C for 5 minutes before 
being treated with N-formylbenzotriazole 186 (221 mg, 1.50 mmol). The resulting 
mixture was then allowed to warm up to room temperature and stir for a further 12 
hours. The reaction was diluted with t-butylmethyl ether (10 mL), and quenched 
with a saturated aq. NaHCO3 solution (20 mL). The aqueous phase was then 
extracted with diethyl ether (3 × 20 mL) and the combined organic layers dried 
over Na2SO4. The solvent was removed under vacuum to afford the crude product, 
which was then purified by flash column chromatography on silica gel (from 10 to 
20% ethyl acetate in petroleum ether) to afford the desired N-formyl imide 294 as 
a white solid in 70% yield (122 mg, 0.70 mmol). IR νmax (film) 3167, 2940, 2347, 
1730, 1670, 1624, 1491, 1479, 1449, 1366, 1319, 1209, 1134, 984, 812, 768, 756, 
743, 710 and 679 cm-1; 1H NMR (500 MHz, CDCl3): δH 9.52 (1H, bs, NH), 9.29 
(1H, d, J 9.9 Hz, CHO), 7.84 (1H, d, J 16.6 Hz, CH=), 7.60-7.57 (2H, m, 2 × ortho 
CHAr), 7.44-7.42 (3H, m, 3 × para and meta CHAr), 6.54 (1H, d, J 16.1 Hz, =CH); 
13C NMR (125 MHz, CDCl3): δC 165.5 (CO), 164.3 (CHO), 146.7 (CH=), 133.8 
(CAr), 131.4 (CHAr), 129.2 (CHAr), 128.7 (CHAr), 118.0 (=CH); HRMS (EI+) calc. for 
C10H9NO2 [M]
+: 175.0633. Found: 175.0636; m.p. 127-128 °C. 
 
N-(2,2-Dibromovinyl)cinnamamide, 291 
 
 
 
To a suspension of (bromomethyl)triphenylphosphonium bromide (573 mg, 1.31 
mmol) in 2.5 mL of dry THF,under argon and at room temperature, the base 
potassium tert-butoxide (147 mg, 1.31 mmol) was added and the resulting bright 
yellow suspension was allowed to stir for 6 hours, till the appearance of a brown 
mixture that indicates the formation of the ylide. At this point, the N-
formylcinnamamide 294 (23.0 mg, 0.13 mmol) in dry THF (1 mL) was added 
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dropwise and the resulting mixture was allowed to stir at room temperature for 12 
hours. The reaction mixture was quenched with 2 mL of distilled water, then 
poured in hexane (5 mL) and filtered to eliminate the precipitate. The organic layer 
was so separated, while the aqueous phase was extracted with diethyl ether (3 × 
10 mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated under vacuum to afford a brown oil as crude product, which was 
purified through flash column chromatography on silica gel (from 10 to 20% ethyl 
acetate in petroleum ether) to afford N-(2,2-dibromovinyl)cinnamamide 291 as a 
light yellow oil in 71% yield (31.0 mg, 94.0 µmol). IR νmax (film) 3297, 3069, 2959, 
2917, 2849, 1669, 1627, 1578, 1496, 1473, 1450, 1335, 1207, 977 and 764 cm-1; 
1H NMR (500 MHz, CDCl3) δH 7.71 (1H, d, J 15.5 Hz, CH=), 7.70 (1H, s, NCH=), 
7.56-7.53 (2H, m, 2 × ortho CHAr), 7.41-7.39 (3H, m, 3 × para and meta CHAr), 
7.24 (1H, bs, NH), 6.39 (1H, d, J 15.6 Hz, =CH); 13C NMR (125 MHz, CDCl3) δC 
162.1 (CO), 144.7 (CH=), 134.3 (CAr), 130.7 (NCH=), 129.1 (CHAr), 128.3 (CHAr), 
127.8 (CHAr), 118.4 (=CH), 74.5 (=CBr2); HRMS (CI+/ISO) calc. for 
C11H9NO
79Br81Br [M]+: 330.9031. Found: 330.9032. 
 
N-((Z)-2-Bromovinyl)cinnamamide, 292 
 
 
 
To a solution of N-(2,2-dibromovinyl)cinnamamide 291 (31.0 mg, 94.0 µmol), in 
anhydrous ethyl acetate (1 mL), Bu3SnH (27.5 mg, 95.0 µmol) was added in 
presence of the catalyst Pd(PPh3)4 (11.0 mg, 9.00 µmol). The reaction mixture 
was allowed to stir at room temperature for 18 hours, then it was diluted with 
hexane (5 mL), filtered through Celite® and concentrated under vacuum to afford a 
yellow oil as crude product. The crude was purified through flash column 
chromatography on silica gel (from 0 to 5% ethyl acetate in petroleum ether) to 
afford a colourless oil as pure product 292 in 64% yield (15.0 mg, 59.5 µmol). IR 
νmax (film) 3271, 2975, 2927, 2854, 1674, 1642, 1629, 1498, 1480, 1449, 1382, 
1337, 1298, 1236, 1181, 1169, 1115, 1073, 978, 915, 765, 758, 733, 716 and 679 
cm-1; 1H NMR (500 MHz, CDCl3): δH 7.77 (1H, d, J 15.3 Hz, CH=), 7.57-7.54 (4H, 
m, 2 × ortho CHAr and NH and NCH=), 7.41-7.39 (3H, m, 3 ×  meta and para 
CHAr), 6.49 (1H, d, J 16.1 Hz, =CH), 5.58 (1H, d, J 5.1 Hz, =CHBr); 
13C NMR (125 
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MHz, CDCl3): δC 162.9 (CO), 144.2 (CH=), 134.6 (CAr), 130.5 (NCH=), 129.1 
(CHAr), 127.4 (CHAr), 125.8 (CHAr), 119.2 (=CH), 89.1 (=CHBr); HRMS (CI+/ISO) 
calc. for C11H11NO
79Br [M+H]+: 252.0024. Found: 252.0023. 
 
N-Styrylcinnamamide (LANSIUMAMIDE A), 288 
 
 
 
To a solution of N-((Z)-2-bromovinyl)cinnamamide 292 (7.80 mg, 0.03 mmol) in 
anhydrous THF (1 mL), at room temperature and under argon, Pd(PPh3)4 (2.00 
mg, 1.50 µmol), K2CO3 (25.5 mg, 0.19 mmol) and phenylboronic acid 293 (12.0 
mg, 93.0 µmol) were added in one pot and the resulting mixture was allowed to stir 
for 12 hours at 70 °C. Then the reaction mixture was allowed to cool to room 
temperature, diluted with ethyl acetate (5 mL) and filtered through Celite® to afford 
a dark red oil as crude product. The crude was purified through flash column 
chromatography on silica gel (10% ethyl acetate in hexane) to afford a yellow solid 
as pure product 288 in 62% yield (4.80 mg, 19.2 µmol). IR νmax (film) 3300, 2955, 
2923, 2852, 1737, 1669, 1647, 1628, 1506, 1480, 1467, 1450, 1443, 1260, 1204, 
1172, 1028, 976, 763 and 697 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.79 (1H, bd, J 
10.5 Hz, NH), 7.73 (1H, d, J 15.5 Hz, CH=), 7.53-7.44 (2H, m, 2 × CHAr), 7.42-7.25 
(8H, m, 8 × CHAr), 7.13 (1H, dd, J 9.6 Hz, 11.3 Hz, CH=), 6.39 (1H, d, J 15.5 Hz, 
=CH), 5.84 (1H, d, J 9.6 Hz, =CH); 13C NMR (125 MHz, CDCl3): δC 163.2 (CO), 
143.2 (CH=), 136.0 (CAr), 134.8 (CAr), 130.3 (CHAr), 129.3 (CHAr), 129.0 (CHAr), 
128.2 (CHAr), 127.2 (CHAr), 122.6 (NCH=), 119.9 (=CHPh), 110.8 (=CHCO); 
HRMS (EI+) calc. for C17H15NO [M]
+: 249.1154. Found: 249.1149. 
 
The characterisation matches with the data reported in literature: 
Bayer A.; Maier M. E. Tetrahedron 2004, 60, 6665. 
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N-Methyl-N-styrylcinnamamide (LANSIUMAMIDE B), 289 
 
 
 
To a solution of lansiumamide A 288 (17.0 mg, 0.07 mmol) in dry THF (1 mL), 
under argon and at 0 °C, NaH (3.00 mg, 71.0 µmol) was added and the resulting 
suspension was allowed to stir for 30 minutes. Then, iodomethane (5 µL, 0.08 
mmol) was added and the resulting mixture was allowed to stir for 3 hours at 70 
°C. The reaction was quenched with H2O (1 mL) and extracted with diethyl ether 
(3 × 1 mL). The organic layers were combined, dried over Na2SO4 and 
concentrated under vacuum to afford a yellow oil as crude product, which was 
purified through flash column chromatography on silica gel (from 0 to 10% ethyl 
acetate in petroleum ether) to afford the pure product 289 as a pale yellow oil in 
quantitative yield (18.0 mg, 0.07 mmol). IR νmax (film) 2956, 2923, 2853, 1742, 
1660, 1639, 1600, 1450, 1428, 1375, 1362, 1259, 1235, 1218, 1178, 1114, 1086, 
763 and 696 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.63 (1H, d, J 15.5 Hz, CH=), 
7.45-7.44 (2H, m, 2 × CHAr), 7.34-7.21 (8H, m, 8 × CHAr), 6.93 (1H, d, J 15.5 Hz, 
=CH), 6.50 (1H, d, J 8.7 Hz, NCH=), 6.24 (1H, d, J 8.7 Hz, =CH), 3.09 (3H, s, N-
CH3); 
13C NMR (125 MHz, CDCl3): δC 166.6 (CO), 142.8 (CH=), 135.5 (CAr), 134.8 
(CAr), 129.8 (CHAr), 129.2 (CHAr), 128.9 (CHAr), 128.8 (CHAr), 128.7 (NCH=), 128.2 
(CHAr), 128.1 (CHAr), 125.3 (=CHPh), 118.7 (=CHCO), 34.7 (N-CH3); HRMS (EI+) 
calc. for C18H17NO [M]
+: 263.1310. Found: 263.1314. 
 
The characterisation matches with the data reported in literature: 
Bayer A.; Maier M. E. Tetrahedron 2004, 60, 6665. 
 
(Z)-N-(2-Bromo-2-(4-methoxyphenyl)vinyl)benzamide, 277 
 
 
 
 
To a solution of N-(2,2-dibromovinyl)benzamide 251 (37.0 mg, 0.12 mmol) in 
anhydrous THF (2.5 mL), at room temperature and under argon, Pd(PPh3)4 (8.00 
mg, 7.00 µmol), K2CO3 (34.0 mg, 243 µmol) and 4-methoxyphenylboronic acid 297 
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(18.4 mg, 121 µmol) were added in one pot and the resulting mixture was allowed 
to stir for 12 hours at 70 °C. Then the reaction mixture was allowed to cool to room 
temperature, diluted with ethyl acetate (5 mL) and filtered through Celite®  to afford 
a dark yellow solid as crude product. The crude was purified through flash column 
chromatography on silica gel (from 0 to 30% ethyl acetate in hexane) to afford a 
yellow solid as pure product 277 in 55% yield (75% brsm) (22.0 mg, 66.3 µmol) in 
addition to the disubstituted by-product N-(2,2-bis(4-methoxyphenyl) vinyl) 
benzamide 278 (5.00 mg, 14.0 µmol) in 12% yield. IR νmax (film) 3414, 3068, 2956, 
2917, 2848, 2364, 1678, 1642, 1605, 1511, 1502, 1468, 1442, 1298, 1281, 1251, 
1178, 1113, 1100, 1028, 827 and 709 cm-1; 1H NMR (500 MHz, CDCl3): δH 8.22 
(1H, bd, J 9.0 Hz, NH), 7.90 (2H, dd, J 1.5, 7.2 Hz, 2 × CHAr), 7.73 (1H, d, J 7.3 
Hz, =CH), 7.59 (1H, tt, J 1.2, 7.5 Hz, CHAr), 7.54-7.48 (4H, m, 4 × CHAr), 6.90 (2H, 
d, J 8.7 Hz, CHAr), 3.84 (3H, s, OCH3); 
13C NMR (125 MHz, CDCl3): δC 164.2 
(CO), 160.1 (C-OMe), 133.4 (CAr), 132.6 (CHAr), 129.8 (CAr), 129.1 (CHAr), 128.6 
(CHAr), 127.4 (CHAr), 120.9 (NCH=), 114.3 (CHAr), 108.8 (=CBr), 55.6 (OCH3); 
HRMS (CI+/ISO) calc. for C16H15NO2
79Br  [M+H]+: 332.0286. Found: 332.0276. 
 
N-(2,2-bis(4-Methoxyphenyl)vinyl)benzamide (BY-PRODUCT), 278 
 
 
 
 
IR νmax (film) 3429, 2922, 2850, 2366, 2339, 1729, 1671, 1635, 1605, 1576, 1511, 
1503, 1472, 1435, 1363, 1208, 831 and 804 cm-1; 1H NMR (500 MHz, CDCl3): δH 
7.66-7.61 (2H, m, CHAr), 7.52-7.45 (2H, m, NH and CHAr), 7.42-7.39 (3H, m, CH= 
and CHAr), 7.27-7.25 (2H, m, CHAr), 7.21 (2H, d, J 8.7 Hz, CHAr), 7.03 (2H, d, J 8.7 
Hz, CHAr), 6.84 (2H, d, J 8.9 Hz, CHAr), 3.88 (3H, s, OCH3), 3.81 (3H, s, OCH3); 
13C NMR (125 MHz, CDCl3): δC 159.6 (CO), 159.2 (2 × C-OMe), 133.9 (CAr), 133.2 
(CAr), 132.7 (CAr), 132.4 (CHAr), 132.0 (CHAr), 131.2 (CHAr), 128.9 (CHAr), 128.2 
(CHAr), 127.1 (C), 118.8 (CH=), 115.1 (CHAr), 114.1 (CHAr), 55.3 (OCH3), 55.2 
(OCH3); HRMS (CI+/ISO) calc. for C23H22NO3 [M+H]
+: 360.1600. Found: 
360.1597. 
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(E)-N-(4-Methoxystyryl)benzamide (ALATAMIDE), 290 
 
 
 
 
 
The (Z)-N-(2-bromo-2-(4-methoxyphenyl)vinyl)benzamide 277 (22.0 mg, 66.3 
µmol) was dissolved in a mixture 1:1 of THF/MeOH (1 mL : 1 mL) and cooled to 
0oC. After 10 minutes Zn-Cu couple (253 mg, 1.99 mmol) was added together with 
glacial acetic acid (398 mg, 6.63 mmol). The mixture was allowed to stir for 24 
hours and then washed with NH4Cl aqueous saturated solution (2 mL) and 
extracted with diethyl ether (3 × 1 mL). The organic layers were combined, dried 
over Na2SO4 and concentrated under vacuum to afford the desired product 290 as 
a pale yellow solid without necessity of any further purification in 90% yield (15.0 
mg, 59.7 µmol). IR νmax (film) 3322, 2969, 2955, 2924, 2853, 1658, 1506, 1456, 
1443, 1366, 1246, 1231, 1217, 1207, 1177, 1032 and 943 cm-1; 1H NMR (500 
MHz, Acetone-d6): δH 9.79 (1H, bd, J 7.9 Hz, NH), 8.02 (2H, dd, J 1.4, 7.2 Hz, 
CHAr), 7.66 (1H, dd, J 10.2, 15.0 Hz, NCH=), 7.61 (1H, tt, J 1.3, 7.3 Hz, CHAr), 7.54 
(2H, td, J 1.3, 7.7 Hz, CHAr), 7.38 (2H, dd, J 1.8, 6.8 Hz, CHAr), 6.93 (2H, dd, J 1.5, 
8.8 Hz, CHAr), 6.45 (1H, d, J 16.0 Hz, =CH), 3.83 (3H, s, CH3); 
13C NMR (125 
MHz, Acetone-d6): δC 165.5 (CO), 160.3 (C-OMe), 135.7 (CAr), 133.3 (CAr), 131.1 
(CHAr), 130.1(CHAr), 129.0 (CHAr), 128.1 (CHAr), 123.9 (NCH=), 115.8 (=CH), 
114.3 (CHAr), 56.3 (OCH3); HRMS (EI+) calc. for C16H15NO2 [M]
+: 253.1103. 
Found: 253.1106. 
 
The characterisation matches with the data reported in literature: 
Obrecht J.; Hellberg L.; Somanathan R. J. Chem. Soc., Chem. Commun. 1987, 
423, 1219. 
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1-(2,2-Diphenylvinyl)pyrrolidin-2-one, 276 
 
 
 
To a solution of 1-(2,2-dibromovinyl)pyrrolidin-2-one 246 (50.0 mg, 186 µmol) in 
anhydrous THF (4 mL), at room temperature and under argon, Pd(PPh3)4 (11.0 
mg, 9.00 µmol), NaOH (1 M, 0.56 mmol) and phenylboronic acid (46.0 mg, 372 
µmol) were added in one pot and the resulting mixture was allowed to stir for 3 
hours at 70 °C. Then the reaction mixture was allowed to cool to room 
temperature, diluted with ethyl acetate (5 mL) and filtered through Celite®  to afford 
a dark yellow solid as crude product. The crude was purified through flash column 
chromatography on silica gel (from 10 to 15% ethyl acetate in petroleum ether) to 
afford a white solid as pure product 276 in 93% yield (46.0 mg, 175 µmol). Rf: 0.12 
(20% EtOAc/PET); IR νmax (film) 1686, 1634, 1445, 1395, 1369, 1325, 1292, 1275, 
1225, 903, 723, 702 and 648 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.31-7.13 (11 H, 
m, NCH= and 10 × CHAr), 2.93 (2H, t, J 6.9 Hz, CH2N), 2.35 (2H, t, J 8.3 Hz, 
CH2CO), 1.81 (2H, qn, J 7.2 Hz, CH2); 
13C NMR (125 MHz, CDCl3): δC 175.7 (CO), 
141.6 (CAr), 138.9 (CAr), 130.9 (NCH=), 128.2 (CHAr), 128.1 (CHAr), 127.7 (CHAr), 
127.4 (CHAr), 127.1 (CHAr), 127.0 (CHAr), 122.6 (=C), 48.3 (CH2N), 30.6 (CH2CO), 
18.9 (CH2); HRMS (CI+/ISO) calc. for C18H18NO [M+H]
+: 264.1388. Found: 
264.1384; m.p. 106-107 °C. 
 
1-(2-Oxo-2-phenylethyl)azepan-2-one, 279 
 
 
 
To a solution of 1-(2,2-diiodovinyl)azepan-2-one 253 (110 mg, 281 µmol) in 
anhydrous THF (6 mL), at room temperature and under argon, Pd(PPh3)4 (33.0 
mg, 0.03 mmol), Cs2CO3 (458 mg, 1.41 mmol) and phenylboronic acid (103 mg, 
844 µmol) were added in one pot and the resulting mixture was allowed to stir for 
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12 hours at 70 °C. Then the reaction mixture was allowed to cool to room 
temperature, diluted with ethyl acetate (10 mL) and filtered through Celite® to 
afford a dark yellow solid as crude product. The crude was purified through flash 
column chromatography on silica gel (from 30 to 50% ethyl acetate in petroleum 
ether) to afford a colourless oil as pure product 279 in 51% yield (33.0 mg, 0.14 
mmol). IR νmax (film) 3486, 1707, 1638, 1439, 1421, 1360, 1221, 1121, 1092 and 
723 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.97-7.95 (2H, m, 2 × ortho CHAr), 7.61 
(1H, tt, J 1.4, 7.5 Hz, para CHAr), 7.47 (2H, tt, J 1.7, 8.0 Hz, 2 × meta CHAr), 4.87 
(2H, s, CH2), 3.44-3.42 (2H, m, CH2), 2.64-2.61 (2H, m, CH2), 1.75-1.73 (6H, m, 3 
× CH2); 
13C NMR (125 MHz, CDCl3): δ 195.2 (CO), 176.5 (CO), 135.4 (CAr), 133.7 
(CHAr), 128.9 (CHAr), 128.2 (CHAr), 55.2 (CH2), 51.1 (CH2), 37.1 (CH2CO), 30.2 
(CH2), 28.2 (CH2), 23.5 (CH2); LRMS (CI+/ISO): C14H18NO2 [M + H]
+. Found: 
232.3. 
 
The characterisation matches with the data reported in literature: 
Malmusi L.; Franchini S.; Mucci A.; Angeli P.; Gulini U.; Marucci G.; Brasili L. Med. 
Chem. Res. 1998, 8, 499. 
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Appendix 24: X-ray crystallography of compound 219 
 
Table 1.  Crystal data and structure refinement for compound 219. 
  
      Empirical formula                    C7 H10 I N O 
  
       Formula weight                        251.06 
  
       _cell_length_a                      10.2578(9) 
 _cell_length_b                       15.9675(16) 
 _cell_length_c                      9.9684(10) 
 _cell_angle_alpha                 90 
 _cell_angle_beta                   93.715(3) 
 _cell_angle_gamma             90 
 _cell_volume                         1629.3(3) 
 _cell_formula_units_Z          8 
 _cell_measurement_temperature     100(2) 
 _cell_measurement_reflns_used       8841 
 _cell_measurement_theta_min         6.08 
 _cell_measurement_theta_max         55.17 
 
 _exptl_crystal_description         block 
 _exptl_crystal_colour                  colourless 
 _exptl_crystal_size_max             0.3 
 _exptl_crystal_size_mid              0.2 
 _exptl_crystal_size_min              0.1 
 _exptl_crystal_density_diffrn     2.047 
 _exptl_crystal_density_method     'not measured' 
 _exptl_crystal_F_000                960 
 _exptl_absorpt_coefficient_mu     3.864 
 _exptl_absorpt_correction_type     multi-scan 
 _exptl_absorpt_correction_T_min    0.7004 
 _exptl_absorpt_correction_T_max    1.000 
 _exptl_absorpt_process_details     'CrystalClear 1.4.0 (Rigaku, 2008)' 
_diffrn_ambient_temperature         100(2) 
_diffrn_radiation_type               MoK\a 
_diffrn_radiation_wavelength        0.71075 
_diffrn_radiation_monochromator     graphite 
_diffrn_reflns_number                10183 
_diffrn_reflns_av_R_equivalents     0.035 
_diffrn_reflns_av_unetI/netI        0.0271 
_diffrn_reflns_theta_min             3.04 
_diffrn_reflns_theta_max            27.47 
_diffrn_reflns_theta_full             27.47 
_diffrn_measured_fraction_theta_max   0.997 
_diffrn_measured_fraction_theta_full    0.997 
_diffrn_reflns_limit_h_min          -13 
_diffrn_reflns_limit_h_max          13 
_diffrn_reflns_limit_k_min          -20 
_diffrn_reflns_limit_k_max          20 
_diffrn_reflns_limit_l_min          -12 
_diffrn_reflns_limit_l_max           12 
 _reflns_number_total                 1873 
_reflns_number_gt                   1635 
_reflns_threshold_expression        >2\s(I) 
_refine_ls_structure_factor_coef    Fsqd 
_refine_ls_matrix_type               full 
_refine_ls_R_factor_all             0.0277 
_refine_ls_R_factor_gt               0.0238 
_refine_ls_wR_factor_ref            0.058 
_refine_ls_goodness_of_fit_ref     1.231 
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_refine_ls_restrained_S_all         1.231 
_refine_ls_number_reflns           1873 
_refine_ls_number_parameters       131 
_refine_ls_number_restraints     0 
_refine_ls_hydrogen_treatment      refall 
_refine_ls_weighting_scheme        calc 
_refine_ls_weighting_details      
'calc w=1/[\s^2^(Fo^2^)+(0.0252P)^2^+1.7860P] where P=(Fo^2^+2Fc^2^)/3' 
_refine_ls_shift/su_max            0.001 
_refine_ls_shift/su_mean           0 
_refine_diff_density_max           0.828 
_refine_diff_density_min           -0.832 
_refine_diff_density_rms           0.141 
_refine_ls_extinction_method       none 
 
 
 
 
         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for compound 219. 
         U(eq) is defined as one third of the trace of the orthogonalised 
         Uij tensor. 
 
 
       ________________________________________________________________ 
  
                              x                           y                      z                     U(eq) 
         ________________________________________________________________ 
  
I1   0.698582(18)  -0.022335(11)  0.313183(18)  0.01739(8)  
O1  0.6963(2)  0.31368(14)  0.2913(2)  0.0201(5)  
N1  0.5777(2)  0.22957(15)  0.4200(2)  0.0151(5)  
C4  0.4102(3)  0.29393(19)  0.5576(3)  0.0193(6)  
C1  0.6178(3)  0.30692(18)  0.3780(3)  0.0156(6)  
C3  0.4990(3)  0.37021(19)  0.5729(3)  0.0187(6)  
C2  0.5598(3)  0.38404(18)  0.4392(3)  0.0181(6)  
C6  0.6307(3)  0.15784(18)  0.3630(3)  0.0166(6)  
C5  0.4886(3)  0.21642(18)  0.5294(3)  0.0188(6)  
C7  0.6178(3)  0.08012(19)  0.4082(3)  0.0186(6)  
H1  0.495(3)  0.402(2)  0.375(3)  0.013(8)  
H5  0.342(3)  0.306(2)  0.490(3)  0.013(8)  
H3  0.569(3)  0.360(2)  0.644(3)  0.017(8)  
H8  0.543(3)  0.197(2)  0.609(3)  0.019(9)  
H10  0.580(4)  0.066(3)  0.485(4)  0.029(10)  
H6  0.368(3)  0.287(2)  0.631(4)  0.018(9)  
H7  0.429(3)  0.171(2)  0.496(3)  0.020(9)  
H9  0.677(3)  0.168(2)  0.295(3)  0.018(9)  
H4  0.456(4)  0.420(3)  0.602(4)  0.030(10)  
H2  0.631(3)  0.428(2)  0.446(3)  0.026(9)  
 
         ________________________________________________________________ 
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Table 3.  Bond lengths [A] and angles [deg] for compound 219. 
_____________________________________________________________ 
I1 C7   2.089(3)  
O1 C1    1.224(4)  
N1 C1   1.376(4)  
N1 C6    1.404(4)  
N1 C5    1.482(4)  
C4 C5    1.512(4)  
C4 C3    1.523(4)  
C4 H5    0.96(3)  
C4 H6   0.88(4)  
C1 C2    1.513(4)  
C3 C2    1.524(4)  
C3 H3  0.99(3)  
C3 H4    0.96(4)  
C2 H1   0.94(3)  
C2 H2   1.01(4)  
C6 C7    1.330(4)  
C6 H9    0.87(3)  
C5 H8    0.99(3)  
C5 H7    0.99(4)  
C7 H10  0.91(4)            
C1 N1 C6  118.5(2)  
C1 N1 C5  124.2(3)  
C6 N1 C5  117.1(2)  
C5 C4 C3  110.6(3)  
C5 C4 H5  114(2)  
C3 C4 H5  109(2)  
C5 C4 H6  110(2)  
C3 C4 H6  110(2)  
H5 C4 H6  104(3)  
O1 C1 N1  121.2(3)  
O1 C1 C2  120.5(3)  
N1 C1 C2  118.3(3)  
C4 C3 C2  107.7(3)  
C4 C3 H3  110.5(19)  
C2 C3 H3  108.9(19)  
C4 C3 H4  114(2)  
C2 C3 H4  111(2)  
H3 C3 H4  104(3)  
C1 C2 C3  115.4(2)  
C1 C2 H1  105(2)  
C3 C2 H1  110(2)  
C1 C2 H2  107(2)  
C3 C2 H2  112(2)  
H1 C2 H2  108(3)  
C7 C6 N1  125.0(3)  
C7 C6 H9  121(2)  
N1 C6 H9  114(3)  
N1 C5 C4  112.4(3)  
N1 C5 H8  106.9(19)  
C4 C5 H8  113(2)  
N1 C5 H7  105(2)  
C4 C5 H7  109(2)  
H8 C5 H7  110(3)  
C6 C7 I1  121.7(2)  
C6 C7 H10  125(3)  
I1 C7 H10  113(3)  
_____________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms: 
  Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for compound 
219. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
___________________________________________________________________________ 
  
           U11             U22                  U33                   U12                    U13                   U23 
___________________________________________________________________________ 
  
I1 0.01807(13)  0.01316(11)  0.02106(13)  0.00090(7)  0.00204(8)  -0.00199(7) 
O1 0.0213(11)  0.0172(10)  0.0226(11)  -0.0004(8)  0.0083(9)  0.0015(8) 
N1 0.0151(12)  0.0127(11)  0.0180(12)  0.0007(9)  0.0058(10)  0.0023(9) 
C4 0.0208(16)  0.0185(14)  0.0194(15)  0.0008(12)  0.0068(13)  -0.0018(12) 
C1 0.0156(14)  0.0156(13)  0.0153(14)        -0.0005(11)  -0.0009(11)  0.0023(11) 
C3 0.0214(15)  0.0155(13)  0.0196(15)  0.0010(12)  0.0044(13)  -0.0023(11) 
C2 0.0211(15)  0.0138(13)  0.0191(15)        -0.0001(12)  0.0002(13)  0.0009(12) 
C6 0.0169(15)  0.0173(14)  0.0158(14)  -0.0009(12)  0.0032(12)  -0.0031(11) 
C5 0.0226(16)  0.0147(13)  0.0199(15)  -0.0011(12)  0.0075(13)  0.0018(11) 
C7 0.0200(15)  0.0171(14)  0.0188(15)  0.0015(12)  0.0027(12)  -0.0006(11) 
 
___________________________________________________________________________ 
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 Appendix 25: X-ray crystallography of compound 226 
 
Table 1.  Crystal data and structure refinement for compound 226. 
  
      Empirical formula                    C15 H15 N O 
  
       Formula weight                        225.28 
   
       _cell_length_a                      11.5713(3) 
       _cell_length_b                      8.1426(2) 
_cell_length_c                      12.6750(3) 
_cell_angle_alpha                   90 
_cell_angle_beta                    92.5340(10) 
_cell_angle_gamma                   90 
_cell_volume                        1193.08(5) 
_cell_formula_units_Z               4 
_cell_measurement_temperature      100(2) 
_exptl_crystal_density_diffrn      1.254 
_exptl_crystal_density_method      'not measured' 
_exptl_crystal_F_000                480 
_exptl_absorpt_coefficient_mu      0.078 
_exptl_absorpt_correction_type     multi-scan 
_exptl_absorpt_process_details    'SADABS, Bruker(2001)' 
_exptl_absorpt_correction_T_min    0.4303 
_exptl_absorpt_correction_T_max    0.7454 
 _diffrn_ambient_temperature        100(2) 
_diffrn_radiation_type              MoK\a 
_diffrn_radiation_wavelength       0.71073 
_diffrn_radiation_monochromator    graphite 
_diffrn_measurement_device_type    KappaCCD 
_diffrn_measurement_method         'CCD; rotation images' 
_diffrn_reflns_number               9801 
_diffrn_reflns_av_R_equivalents    0.0816 
_diffrn_reflns_av_unetI/netI       0.085 
_diffrn_reflns_theta_min           1.76 
_diffrn_reflns_theta_max           27.47 
_diffrn_reflns_theta_full           27.47 
_diffrn_measured_fraction_theta_max  0.998 
_diffrn_measured_fraction_theta_full   0.998 
_diffrn_reflns_limit_h_min         -15 
_diffrn_reflns_limit_h_max         15 
_diffrn_reflns_limit_k_min         -10 
_diffrn_reflns_limit_k_max         10 
_diffrn_reflns_limit_l_min          -16 
_diffrn_reflns_limit_l_max         16 
_reflns_number_total                2735 
_reflns_number_gt                  1590 
_reflns_threshold_expression       >2\s(I) 
_refine_ls_structure_factor_coef   Fsqd 
_refine_ls_matrix_type              full 
_refine_ls_R_factor_all             0.0991 
_refine_ls_R_factor_gt              0.0416 
_refine_ls_wR_factor_ref           0.0809 
_refine_ls_goodness_of_fit_ref     0.917 
_refine_ls_restrained_S_all        0.917 
_refine_ls_number_reflns           2735 
_refine_ls_number_parameters       214 
_refine_ls_number_restraints       0 
_refine_ls_hydrogen_treatment      refall 
_refine_ls_weighting_scheme        calc 
_refine_ls_weighting_details      
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'calc w=1/[\s^2^(Fo^2^)+(0.0297P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3' 
_refine_ls_shift/su_max             0 
_refine_ls_shift/su_mean           0 
_refine_diff_density_max           0.183 
_refine_diff_density_min           -0.207 
_refine_diff_density_rms           0.039 
_refine_ls_extinction_method       none 
 
 
 
 
         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for compound 226. 
         U(eq) is defined as one third of the trace of the orthogonalised 
         Uij tensor. 
 
 
       ________________________________________________________________ 
  
                              x                           y                      z                     U(eq) 
         ________________________________________________________________ 
  
H9  0.6315(11)  0.1549(16)  0.5031(10)  0.022(4)  
H1  0.3001(11)  0.3149(16) 0.6055(10)  0.028(4)  
H14  1.1654(11)  -0.1034(16)  0.1760(11)  0.032(4)  
H6  0.2080(12)  0.2277(15)  0.3294(10)  0.025(4)  
H15  0.9714(12)  -0.0134(17)  0.1841(11)  0.030(4)  
H8  0.4062(11)  0.2750(16)  0.3022(10)  0.026(4)  
H10  0.5758(11)  0.0902(16)  0.2788(10)  0.028(4)  
H11  0.9640(12)  -0.1754(17)  0.4890(10)  0.030(4)  
H2  0.3495(11)  0.4894(17)  0.5817(10)  0.023(4)  
H12  1.1614(12)  -0.2595(16)  0.4828(10)  0.026(4)  
H4  0.2824(11)  0.4828(17)  0.4035(10)  0.029(4)  
H13  1.2609(13)  -0.2209(17)  0.3252(10)  0.033(4)  
H5  0.2408(11)  0.1347(17)  0.4415(10)  0.029(4)  
H7  0.3977(11)  0.0829(17)  0.3300(10)  0.032(4)  
H3  0.1767(12)  0.4175(16)  0.4700(9)  0.028(4)  
N1  0.47280(10)  0.21927(13)  0.44771(8)  0.0220(3)  
O1  0.53122(9)  0.32723(13)  0.60609(7)  0.0341(3)  
C8  0.73551(13)  0.02119(17)  0.34543(10)  0.0239(4)  
 C9  0.83189(13)  -0.03234(18)  0.34102(10)  0.0249(4)   
C12  1.12010(13)  -0.20986(17)  0.41955(12)  0.0270(4)  
C1  0.45395(13)  0.30957(17)  0.53732(11)  0.0243(4)  
C7  0.62187(12)  0.08902(18)  0.34784(11)  0.0245(4)  
C5  0.38622(12)  0.1996(2)  0.35957(11)  0.0255(4)  
C6  0.58223(13)  0.15113(18)  0.43706(11)  0.0237(4)  
C13  1.17984(14)  -0.18802(18)  0.32840(12)  0.0281(4)  
C11  1.00601(13)  -0.16192(18)  0.42405(12)  0.0260(4)  
C2  0.33670(13)  0.3837(2)  0.55005(12)  0.0268(4)  
C10  0.94954(12)  -0.08861(17)  0.33648(11)  0.0241(3)  
C14  1.12404(13)  -0.11603(18)  0.24125(12)  0.0290(4)  
C4  0.26460(13)  0.22897(19)  0.39344(12)  0.0273(4)  
C15  1.01050(13)  -0.06593(19)  0.24468(12)  0.0282(4)  
C3  0.25821(14)  0.39125(19)  0.45136(12)  0.0288(4)  
 
 
         ________________________________________________________________ 
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Table 3.  Bond lengths [A] and angles [deg] for compound 226. 
_____________________________________________________________ 
N1 C1    1.3784(17)  
N1 C6    1.3944(17)  
N1 C5    1.4760(17)  
O1 C1    1.2292(16)  
C8 C9    1.2010(19)  
C8 C7    1.4278(19)  
C9 C10   1.4399(19)  
C12 C11   1.380(2)  
C12 C13   1.384(2)  
C12 H12   1.000(13)  
C1 C2    1.500(2)  
C7 C6    1.3383(19)  
C7 H10   1.004(13)  
C5 C4    1.508(2)  
C5 H8    0.987(13)  
C5 H7    1.033(14)  
C6 H9    0.993(12)  
C13 C14   1.385(2)  
C13 H13   0.978(14)  
C11 C10   1.3968(19)  
C11 H11   0.980(13)  
C2 C3    1.514(2)  
C2 H1    1.007(13)  
C2 H2    0.958(13)  
C10 C15   1.3994(19)  
C14 C15   1.378(2)  
C14 H14   0.979(13)  
C4 C3    1.515(2)  
C4 H6    1.020(14)  
C4 H5    1.025(13)  
C15 H15   0.973(14)  
C3 H4    1.008(14)  
C3 H3    1.006(13)  
C1 N1 C6  118.00(12)  
C1 N1 C5  123.68(12)  
C6 N1 C5  118.20(11)  
C9 C8 C7  177.96(15)  
C8 C9 C10  177.24(16)  
C11 C12 C13  120.81(15)  
C11 C12 H12  120.3(7)  
C13 C12 H12  118.8(7)  
O1 C1 N1  120.66(13)  
O1 C1 C2  120.63(13)  
N1 C1 C2  118.69(13)  
C6 C7 C8  120.98(14)  
C6 C7 H10  122.9(7)  
C8 C7 H10  116.1(7)  
N1 C5 C4  112.21(12)  
N1 C5 H8  108.5(8)  
C4 C5 H8  111.3(8)  
N1 C5 H7  106.3(7)  
C4 C5 H7  112.7(7)  
H8 C5 H7  105.4(10)  
C7 C6 N1  125.37(14)  
C7 C6 H9  121.3(7)  
N1 C6 H9  113.3(7)  
C12 C13 C14  119.20(14)  
C12 C13 H13  121.0(8)  
C14 C13 H13  119.8(8)  
C12 C11 C10  120.18(14)  
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C12 C11 H11  120.9(8)  
C10 C11 H11  118.9(8)  
C1 C2 C3  116.09(13)  
C1 C2 H1  105.2(8)  
C3 C2 H1  110.1(8)  
C1 C2 H2  106.4(8)  
C3 C2 H2  112.6(8)  
H1 C2 H2  105.7(10)  
C11 C10 C15  118.80(14)  
C11 C10 C9  120.94(13)  
C15 C10 C9  120.23(13)  
C15 C14 C13  120.78(15)  
C15 C14 H14  119.9(8)  
C13 C14 H14  119.3(8)  
C5 C4 C3  110.01(13)  
C5 C4 H6  110.2(7)  
C3 C4 H6  110.5(7)  
C5 C4 H5  109.2(7)  
C3 C4 H5  110.2(7)  
H6 C4 H5  106.6(10)  
C14 C15 C10  120.23(15)  
C14 C15 H15  121.1(8)  
C10 C15 H15  118.7(8)  
C2 C3 C4  108.94(13)  
C2 C3 H4  110.8(8)  
C4 C3 H4  109.4(8)  
C2 C3 H3  110.4(7)  
C4 C3 H3  111.4(8)  
H4 C3 H3  105.8(11)  
_____________________________________________________________ 
 
 
Symmetry transformations used to generate equivalent atoms: 
  Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for compound 
226. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
___________________________________________________________________________ 
  
           U11             U22                  U33                   U12                    U13                   U23 
___________________________________________________________________________ 
  
N1 0.0215(7)  0.0241(7)  0.0203(6)  0.0005(6)  0.0001(5)  0.0003(5) 
O1 0.0302(6)  0.0445(7)  0.0274(6)  0.0003(5)  -0.0028(5)  -0.0083(5) 
C8 0.0274(9)  0.0234(9)  0.0209(8)  -0.0004(7)  0.0015(6)  0.0018(6) 
C9 0.0307(9)  0.0230(9)  0.0209(8)  -0.0016(7)  0.0007(7)  0.0006(6) 
C12 0.0295(9)  0.0211(9)  0.0300(9)  0.0029(7)  -0.0041(7)  -0.0029(7) 
C1 0.0266(9)  0.0236(9)  0.0231(8)  -0.0044(7)  0.0031(7)  0.0008(7) 
C7 0.0241(9)  0.0252(9)  0.0241(8)  0.0012(7)  0.0002(7)  0.0031(7) 
C5 0.0235(9)  0.0285(10)  0.0243(8)  0.0011(7)  -0.0015(7)  0.0006(7) 
C6 0.0240(9)  0.0226(9)  0.0243(8)  -0.0003(7)  -0.0007(7)  0.0031(7) 
C13 0.0231(9)  0.0249(9)  0.0360(9)  0.0020(7)  0.0003(7)  -0.0079(7) 
C11 0.0287(9)  0.0224(9)  0.0269(8)  -0.0002(7)  0.0022(7)  -0.0027(7) 
C2 0.0276(9)  0.0226(10)  0.0306(9)  -0.0006(7)  0.0057(7)  -0.0030(7) 
C10 0.0236(9)  0.0204(8)  0.0281(8)  0.0005(7)  0.0008(6)  -0.0033(7) 
C14 0.0274(9)  0.0314(10)  0.0288(9)  -0.0009(7)  0.0063(7)  -0.0034(7) 
C4 0.0248(9)  0.0283(10)  0.0285(9)  0.0018(8)  -0.0022(7)  0.0004(7) 
C15 0.0294(9)  0.0267(9)  0.0285(9)  0.0012(8)  -0.0007(7)  -0.0001(7) 
C3 0.0238(9)  0.0270(9)  0.0358(9)  0.0009(7)  0.0026(7)  0.0012(8) 
___________________________________________________________________________ 
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Appendix 26: X-ray crystallography of compound 253 
 
Table 1.  Crystal data and structure refinement for compound 253 
 
      Empirical formula                   C8 H11 I2 N O 
  
      Formula weight                      390.98 
  
      Temperature                          150(2) K 
  
      Wavelength                           0.71073 A 
  
      Crystal system, space group         Monoclinic,  P2(1)/c 
  
      Unit cell dimensions                a = 6.9197(2) A    alpha = 90 deg. 
                                                        b = 14.4321(4) A     beta = 100.536(3) deg. 
                                                         c = 10.8204(4) A    gamma = 90 deg. 
  
      Volume                               1062.37(6) A^3 
  
      Z, Calculated density               4,  2.444 Mg/m^3 
  
      Absorption coefficient              5.88 mm^-1 
  
      F(000)                               720 
  
      Crystal size                         0.21 x 0.07 x 0.03 mm 
  
      Theta range for data collection     2.99 to 26.00 deg. 
  
      Limiting indices                    -8<=h<=8, -17<=k<=17, -12<=l<=13 
  
      Reflections collected / unique      8621 / 2085 [R(int) = 0.0456] 
  
      Completeness to theta = 26.00       99.6 % 
  
      Absorption correction               Analytical 
  
      Max. and min. transmission          0.828 and 0.513 
  
      Refinement method                   Full-matrix least-squares on F^2 
  
      Data / restraints / parameters      2085 / 0 / 109 
  
      Goodness-of-fit on F^2              1.046 
  
      Final R indices [I>2sigma(I)]       R1 = 0.0248, wR2 = 0.0407 
   
      R indices (all data)                R1 = 0.0345, wR2 = 0.0440 
  
      Extinction coefficient              none 
  
      Largest diff. peak and hole         0.62 and -0.60 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for compound 253. 
         U(eq) is defined as one third of the trace of the orthogonalised 
         Uij tensor. 
  
       ________________________________________________________________ 
  
                             x                y                  z             U(eq) 
         ________________________________________________________________ 
  
          I(1)         4014(1)       5775(1)       8249(1)       23(1) 
          I(2)         7529(1)       4022(1)       7894(1)       24(1) 
          O(1)        10647(4)       7217(2)       8360(3)       24(1) 
          N(1)         8369(4)       6791(2)       9500(3)       17(1) 
          C(1)         9728(5)       7401(3)       9193(4)       19(1) 
          C(2)         9973(6)       8304(3)       9888(4)       24(1) 
          C(3)         8148(6)       8931(3)       9578(4)       26(1) 
          C(4)         6633(6)       8727(3)      10399(4)       27(1) 
          C(5)         5772(5)       7757(3)      10235(4)       25(1) 
          C(6)         7252(6)       6969(3)      10516(4)       22(1) 
          C(7)         8442(5)       5885(3)       9008(4)       17(1) 
          C(8)         6941(5)       5344(3)       8529(4)       18(1) 
         ________________________________________________________________ 
  
 
 
 
           Table 3.  Bond lengths [A] and angles [deg] for compound 253. 
           _____________________________________________________________ 
            I(1)-C(8)                       2.087(4) 
            I(2)-C(8)                       2.093(4) 
            O(1)-C(1)                     1.223(5) 
            N(1)-C(1)                     1.372(5) 
            N(1)-C(7)                     1.416(5) 
            N(1)-C(6)                     1.477(5) 
            C(1)-C(2)                     1.499(5) 
            C(2)-C(3)                     1.540(5) 
            C(3)-C(4)                     1.522(6) 
            C(4)-C(5)                     1.518(5) 
            C(5)-C(6)                     1.524(5) 
            C(7)-C(8)                     1.327(5) 
            C(1)-N(1)-C(7)             115.4(3) 
            C(1)-N(1)-C(6)             122.9(3) 
            C(7)-N(1)-C(6)             120.0(3) 
            O(1)-C(1)-N(1)             120.7(4) 
            O(1)-C(1)-C(2)             122.1(4) 
            N(1)-C(1)-C(2)             117.1(4) 
            C(1)-C(2)-C(3)             112.8(3) 
            C(4)-C(3)-C(2)             112.6(3) 
            C(5)-C(4)-C(3)             114.1(4) 
            C(4)-C(5)-C(6)             115.5(3) 
            N(1)-C(6)-C(5)             113.9(3) 
            C(8)-C(7)-N(1)             127.7(3) 
            C(7)-C(8)-I(1)              123.4(3) 
            C(7)-C(8)-I(2)              118.7(3) 
            I(1)-C(8)-I(2)               117.76(18) 
           _____________________________________________________________ 
 
 
  
A. E. Pasqua 2013 Chapter I Appendices 
 
187 
 
Symmetry transformations used to generate equivalent atoms: 
  Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for compound 
253. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
_______________________________________________________________________ 
  
                U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    I(1)       17(1)      26(1)      26(1)      -1(1)       4(1)       1(1) 
    I(2)       27(1)      18(1)      26(1)      -3(1)       3(1)       3(1) 
    O(1)     21(1)      26(2)      28(2)       2(1)      11(1)       1(1) 
    N(1)     18(2)      16(2)      18(2)       1(2)        5(1)       2(1) 
    C(1)     16(2)      19(2)      20(3)       7(2)        0(2)       6(2) 
    C(2)     27(2)      21(2)      26(3)      -2(2)        7(2)      -7(2) 
    C(3)     34(2)      17(2)      27(3)       1(2)        5(2)       2(2) 
    C(4)     32(2)      20(2)      29(3)      -1(2)        8(2)       1(2) 
    C(5)     25(2)      25(2)      27(3)       1(2)        9(2)       3(2) 
    C(6)     26(2)      24(2)      19(2)      -2(2)        8(2)      -2(2) 
    C(7)     18(2)      18(2)      17(2)       2(2)        5(2)       4(2) 
    C(8)     19(2)      16(2)      19(2)       1(2)        7(2)       5(2) 
    _______________________________________________________________________ 
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 Appendix 27: X-ray crystallography of compound 257 
 
 Table 1.  Crystal data and structure refinement for compound 257. 
  
     Empirical formula                   C11 H17 I2 N O3 
  
      Formula weight                      465.06 
  
      Temperature                         150(2) K 
  
      Wavelength                          0.71073 A 
  
      Crystal system, space group         Orthorhombic, P2(1)2(1)2(1) 
  
      Unit cell dimensions                a = 7.9762(2) A    alpha = 90 deg. 
                                                      b = 13.5692(5) A     beta = 90 deg. 
                                                      c = 14.1525(5) A    gamma = 90 deg. 
  
      Volume                               1531.73(9) A^3 
  
      Z, Calculated density               4,  2.017 Mg/m^3 
  
      Absorption coefficient             4.104 mm^-1 
  
      F(000)                               880 
  
      Crystal size                         0.24 x 0.24 x 0.07 mm 
  
      Theta range for data collection     2.88 to 26.00 deg. 
  
      Limiting indices                    -9<=h<=9, -16<=k<=16, -17<=l<=17 
  
      Reflections collected / unique      13046 / 2996 [R(int) = 0.0428] 
  
      Completeness to theta = 26.00       99.8 % 
  
      Absorption correction               Analytical 
  
      Max. and min. transmission         0.770 and 0.466 
  
      Refinement method                   Full-matrix least-squares on F^2 
  
      Data / restraints / parameters      2996 / 1 / 161 
  
      Goodness-of-fit on F^2              1.027 
  
      Final R indices [I>2sigma(I)]       R1 = 0.0227, wR2 = 0.0452 
  
      R indices (all data)                R1 = 0.0257, wR2 = 0.0463 
  
      Absolute structure parameter        -0.01(3) 
  
      Extinction coefficient              none 
  
      Largest diff. peak and hole         0.37 and -0.58 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for compound 257. 
         U(eq) is defined as one third of the trace of the orthogonalised 
         Uij tensor. 
  
       ________________________________________________________________ 
  
                             x                 y                  z           U(eq) 
         ________________________________________________________________ 
  
          I(1)          7373(1)        2863(1)      4421(1)        24(1) 
          I(2)          7326(1)        254(1)        4291(1)        23(1) 
          O(1)         7454(4)       3909(2)       7427(2)       22(1) 
          O(2)         8280(3)       5159(2)       8461(2)       24(1) 
          O(3)         8095(4)       1411(2)       8010(2)       38(1) 
          C(1)         7650(5)       3150(3)       8123(2)       20(1) 
          C(2)         9047(4)       3448(3)       8824(3)       19(1) 
          C(3)         8533(5)       4456(3)       9194(3)       24(1) 
          C(4)         7056(5)       4863(3)       7786(3)       24(1) 
          C(5)         9130(5)       2742(4)       9665(3)       28(1) 
          C(6)       10736(5)      3505(4)        8323(3)       28(1) 
          C(7)         7234(6)       5560(3)       6956(3)       31(1) 
          C(8)         5290(5)       4893(4)       8197(3)       33(1) 
          C(9)         7923(5)       2192(3)       7596(3)       24(1) 
          C(10)       7873(4)      1458(3)        6041(2)       18(1) 
          C(11)       7617(5)      1510(3)        5117(2)       19(1) 
          N(1)         7919(4)       2264(3)       6640(2)       21(1) 
         ________________________________________________________________ 
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           Table 3.  Bond lengths [A] and angles [deg] for compound 257 
           _____________________________________________________________ 
  
            I(1)-C(11)                     2.093(4) 
            I(2)-C(11)                     2.080(4) 
            O(1)-C(4)                     1.426(5) 
            O(1)-C(1)                     1.434(4) 
            O(2)-C(3)                     1.423(5) 
            O(2)-C(4)                     1.424(4) 
            O(3)-C(9)                     1.219(5) 
            C(1)-C(9)                     1.515(5) 
            C(1)-C(2)                     1.546(5) 
            C(1)-H(1)                     1.0000 
            C(2)-C(3)                     1.522(6) 
            C(2)-C(6)                     1.524(5) 
            C(2)-C(5)                     1.530(5) 
            C(3)-H(3A)                   0.9900 
            C(3)-H(3B)                   0.9900 
            C(4)-C(7)                     1.514(6) 
            C(4)-C(8)                     1.524(5) 
            C(5)-H(5A)                   0.9800 
            C(5)-H(5B)                   0.9800 
            C(5)-H(5C)                   0.9800 
            C(6)-H(6A)                   0.9800 
            C(6)-H(6B)                   0.9800 
            C(6)-H(6C)                   0.9800 
            C(7)-H(7A)                   0.9800 
            C(7)-H(7B)                   0.9800 
            C(7)-H(7C)                   0.9800 
            C(8)-H(8A)                   0.9800 
            C(8)-H(8B)                   0.9800 
            C(8)-H(8C)                   0.9800 
            C(9)-N(1)                      1.356(5) 
            C(10)-C(11)                  1.326(5) 
            C(10)-N(1)                    1.384(5) 
            C(10)-H(10)                  0.9500 
            N(1)-H(1A)                   0.850(18) 
            C(4)-O(1)-C(1)             115.6(2) 
            C(3)-O(2)-C(4)             113.4(3) 
            O(1)-C(1)-C(9)             107.1(3) 
            O(1)-C(1)-C(2)             109.3(3) 
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            C(9)-C(1)-C(2)             115.9(3) 
            O(1)-C(1)-H(1)              108.1 
            C(9)-C(1)-H(1)              108.1 
            C(2)-C(1)-H(1)              108.1 
            C(3)-C(2)-C(6)              110.7(4) 
            C(3)-C(2)-C(5)              107.9(3) 
            C(6)-C(2)-C(5)              110.8(3) 
            C(3)-C(2)-C(1)              105.2(3) 
            C(6)-C(2)-C(1)              110.6(3) 
            C(5)-C(2)-C(1)              111.5(3) 
            O(2)-C(3)-C(2)              112.9(3) 
            O(2)-C(3)-H(3A)            109.0 
            C(2)-C(3)-H(3A)            109.0 
            O(2)-C(3)-H(3B)            109.0 
            C(2)-C(3)-H(3B)            109.0 
            H(3A)-C(3)-H(3B)         107.8 
            O(2)-C(4)-O(1)              110.0(3) 
            O(2)-C(4)-C(7)              106.3(3) 
            O(1)-C(4)-C(7)              105.6(3) 
            O(2)-C(4)-C(8)              111.7(3) 
            O(1)-C(4)-C(8)              111.4(3) 
            C(7)-C(4)-C(8)              111.5(4) 
            C(2)-C(5)-H(5A)            109.5 
            C(2)-C(5)-H(5B)            109.5 
            H(5A)-C(5)-H(5B)         109.5 
            C(2)-C(5)-H(5C)            109.5 
            H(5A)-C(5)-H(5C)         109.5 
            H(5B)-C(5)-H(5C)         109.5 
            C(2)-C(6)-H(6A)            109.5 
            C(2)-C(6)-H(6B)            109.5 
            H(6A)-C(6)-H(6B)         109.5 
            C(2)-C(6)-H(6C)            109.5 
            H(6A)-C(6)-H(6C)         109.5 
            H(6B)-C(6)-H(6C)         109.5 
            C(4)-C(7)-H(7A)            109.5 
            C(4)-C(7)-H(7B)            109.5 
            H(7A)-C(7)-H(7B)         109.5 
            C(4)-C(7)-H(7C)            109.5 
            H(7A)-C(7)-H(7C)         109.5 
            H(7B)-C(7)-H(7C)         109.5 
            C(4)-C(8)-H(8A)            109.5 
A. E. Pasqua 2013 Chapter I Appendices 
 
192 
 
            C(4)-C(8)-H(8B)            109.5 
            H(8A)-C(8)-H(8B)         109.5 
            C(4)-C(8)-H(8C)             109.5 
            H(8A)-C(8)-H(8C)          109.5 
            H(8B)-C(8)-H(8C)          109.5 
            O(3)-C(9)-N(1)               122.9(4) 
            O(3)-C(9)-C(1)               121.7(3) 
            N(1)-C(9)-C(1)               115.4(4) 
            C(11)-C(10)-N(1)           124.5(4) 
            C(11)-C(10)-H(10)          117.8 
            N(1)-C(10)-H(10)            117.8 
            C(10)-C(11)-I(2)             121.9(3) 
            C(10)-C(11)-I(1)             121.7(3) 
            I(2)-C(11)-I(1)                 116.39(15) 
            C(9)-N(1)-C(10)              123.6(4) 
            C(9)-N(1)-H(1A)             116(3) 
            C(10)-N(1)-H(1A)           118(3) 
           _____________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms: 
  Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for compound 
257. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
   _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    I(1)       33(1)      19(1)      21(1)       4(1)      -2(1)       1(1) 
    I(2)       31(1)      19(1)      19(1)      -3(1)      -3(1)       1(1) 
    O(1)     32(2)      18(1)      17(1)       0(1)      -2(2)      -1(2) 
    O(2)     28(1)      19(2)      24(2)      -7(1)      -6(1)       1(1) 
    O(3)     78(2)      20(2)      17(2)       3(1)      -7(2)      -5(2) 
    C(1)     24(2)      23(2)      12(2)       0(2)       4(2)      -4(2) 
    C(2)     22(2)      19(2)      17(2)       0(2)      -1(2)      -1(2) 
    C(3)     28(2)      29(3)      15(2)      -4(2)      -7(2)      -2(2) 
    C(4)     27(2)      22(3)      22(2)      -5(2)      -5(2)       3(2) 
    C(5)     37(2)      31(3)      17(2)       4(2)      -7(2)      -3(2) 
    C(6)     27(2)      31(3)      26(2)      -3(2)       0(2)       1(2) 
    C(7)     48(3)      20(2)      26(2)       2(2)      -7(2)       4(2) 
    C(8)     26(2)      45(3)      28(2)      -8(2)      -4(2)       8(2) 
    C(9)     29(2)      24(3)      18(2)      -2(2)       0(2)      -4(2) 
    C(10)   22(2)      12(2)      20(2)       1(2)       0(2)      -2(2) 
    C(11)   23(2)      14(2)      19(2)      -2(1)       0(2)       1(3) 
    N(1)     32(2)      14(2)      15(2)       1(1)       0(1)       0(2) 
    _______________________________________________________________________ 
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Appendix 28: X-ray crystallography of compound 258 
 
Table 1.  Crystal data and structure refinement for compound 258. 
  
      Empirical formula                   C11 H17 N O3 
  
      Formula weight                      211.26 
  
      Temperature                          150(2) K 
  
      Wavelength                           0.71073 A 
  
      Crystal system, space group         Triclinic,  P-1 
  
      Unit cell dimensions                a = 5.8915(4) A    alpha = 107.971(6) deg. 
                                                      b = 6.4911(4) A    beta = 101.168(6) deg. 
                                                      c = 8.4228(5) A    gamma =105.691(6)deg. 
  
      Volume                               281.14(3) A^3 
  
      Z, Calculated density               1,  1.248 Mg/m^3 
  
      Absorption coefficient              0.090 mm^-1 
  
      F(000)                               114 
  
      Crystal size                         0.33 x 0.17 x 0.13 mm 
  
      Theta range for data collection     3.52 to 25.69 deg. 
  
      Limiting indices                     -7<=h<=7, -7<=k<=7, -10<=l<=10 
  
      Reflections collected / unique      4450 / 2052 [R(int) = 0.0397] 
  
      Completeness to theta = 25.69       99.6 % 
  
      Absorption correction               Analytical 
  
      Max. and min. transmission          0.990 and 0.978 
  
      Refinement method                   Full-matrix least-squares on F^2 
  
      Data / restraints / parameters      2052 / 3 / 141 
  
      Goodness-of-fit on F^2              1.026 
  
      Final R indices [I>2sigma(I)]       R1 = 0.0473, wR2 = 0.0920 
  
      R indices (all data)                R1 = 0.0680, wR2 = 0.1022 
  
      Absolute structure parameter        0.4(13) 
  
      Extinction coefficient              none 
  
      Largest diff. peak and hole         0.15 and -0.21 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for compound 258. 
         U(eq) is defined as one third of the trace of the orthogonalised 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                               x                  y                  z            U(eq) 
         ________________________________________________________________ 
  
          O(1)         6372(3)        6651(3)       7835(2)       27(1) 
          C(1)         6426(4)        8293(4)       9433(3)       25(1) 
          C(5)         6476(5)      12309(5)     10936(3)       34(1) 
          C(3)         4682(5)      10217(5)       7725(3)       33(1) 
          O(2)         4661(3)        8464(3)       6182(2)       34(1) 
          C(2)         6757(4)      10668(4)       9302(3)       24(1) 
          C(4)         4435(5)        6318(4)       6343(3)       29(1) 
          O(3)         8051(3)        8614(3)     12411(2)       40(1) 
          C(8)         4983(6)        4887(5)       4771(4)       37(1) 
          C(7)         1906(5)        5118(5)       6436(4)       36(1) 
          C(6)         9245(5)      11736(5)       9054(4)       34(1) 
          C(9)         8412(5)        8323(4)     10850(3)       32(1) 
          C(10)     11669(6)        8334(5)     12453(4)       37(1) 
          C(11)     10166(5)        8612(5)     13425(4)       38(1) 
          N(1)       10516(4)        8136(4)     10783(3)       30(1) 
         ________________________________________________________________ 
   
A. E. Pasqua 2013 Chapter I Appendices 
 
196 
 
           Table 3.  Bond lengths [A] and angles [deg] for compound 258. 
         _____________________________________________________________ 
  
            O(1)-C(1)                     1.424(3) 
            O(1)-C(4)                     1.439(3) 
            C(1)-C(9)                     1.492(4) 
            C(1)-C(2)                     1.542(3) 
            C(1)-H(1)                     1.0000 
            C(5)-C(2)                     1.528(4) 
            C(5)-H(5A)                   0.9800 
            C(5)-H(5B)                   0.9800 
            C(5)-H(5C)                   0.9800 
            C(3)-O(2)                     1.434(3) 
            C(3)-C(2)                     1.511(3) 
            C(3)-H(3A)                   0.9900 
            C(3)-H(3B)                   0.9900 
            O(2)-C(4)                     1.414(3) 
            C(2)-C(6)                     1.527(4) 
            C(4)-C(7)                     1.512(4) 
            C(4)-C(8)                     1.513(4) 
            O(3)-C(9)                     1.336(3) 
            O(3)-C(11)                   1.368(3) 
            C(8)-H(8A)                   0.9800 
            C(8)-H(8B)                   0.9800 
            C(8)-H(8C)                   0.9800 
            C(7)-H(7A)                   0.9800 
            C(7)-H(7B)                   0.9800 
            C(7)-H(7C)                   0.9800 
            C(6)-H(6A)                   0.9800 
            C(6)-H(6B)                   0.9800 
            C(6)-H(6C)                   0.9800 
            C(9)-N(1)                     1.288(3) 
            C(10)-C(11)                 1.328(4) 
            C(10)-N(1)                   1.389(3) 
            C(10)-H(10)                  0.9500 
            C(11)-H(11)                  0.9500 
            C(1)-O(1)-C(4)             113.56(19) 
            O(1)-C(1)-C(9)             106.8(2) 
            O(1)-C(1)-C(2)             110.7(2) 
            C(9)-C(1)-C(2)             114.39(19) 
            O(1)-C(1)-H(1)             108.3 
            C(9)-C(1)-H(1)             108.3 
            C(2)-C(1)-H(1)             108.3 
            C(2)-C(5)-H(5A)           109.5 
            C(2)-C(5)-H(5B)           109.5 
            H(5A)-C(5)-H(5B)         109.5 
            C(2)-C(5)-H(5C)           109.5 
            H(5A)-C(5)-H(5C)         109.5 
            H(5B)-C(5)-H(5C)         109.5 
            O(2)-C(3)-C(2)              111.8(2) 
            O(2)-C(3)-H(3A)            109.3 
            C(2)-C(3)-H(3A)            109.3 
            O(2)-C(3)-H(3B)            109.3 
            C(2)-C(3)-H(3B)            109.3 
            H(3A)-C(3)-H(3B)         107.9 
            C(4)-O(2)-C(3)              113.85(19) 
            C(3)-C(2)-C(6)              109.7(2) 
            C(3)-C(2)-C(5)              109.1(2) 
            C(6)-C(2)-C(5)              110.2(2) 
            C(3)-C(2)-C(1)              105.64(19) 
            C(6)-C(2)-C(1)              112.3(2) 
            C(5)-C(2)-C(1)              109.8(2) 
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            O(2)-C(4)-O(1)              109.77(19) 
            O(2)-C(4)-C(7)               112.3(2) 
            O(1)-C(4)-C(7)               111.6(2) 
            O(2)-C(4)-C(8)               105.9(2) 
            O(1)-C(4)-C(8)               105.1(2) 
            C(7)-C(4)-C(8)               111.8(2) 
            C(9)-O(3)-C(11)             104.6(2) 
            C(4)-C(8)-H(8A)             109.5 
            C(4)-C(8)-H(8B)             109.5 
            H(8A)-C(8)-H(8B)           109.5 
            C(4)-C(8)-H(8C)             109.5 
            H(8A)-C(8)-H(8C)           109.5 
            H(8B)-C(8)-H(8C)           109.5 
            C(4)-C(7)-H(7A)             109.5 
            C(4)-C(7)-H(7B)             109.5 
            H(7A)-C(7)-H(7B)           109.5 
            C(4)-C(7)-H(7C)              109.5 
            H(7A)-C(7)-H(7C)           109.5 
            H(7B)-C(7)-H(7C)           109.5 
            C(2)-C(6)-H(6A)              109.5 
            C(2)-C(6)-H(6B)              109.5 
            H(6A)-C(6)-H(6B)           109.5 
            C(2)-C(6)-H(6C)              109.5 
            H(6A)-C(6)-H(6C)            109.5 
            H(6B)-C(6)-H(6C)            109.5 
            N(1)-C(9)-O(3)                 113.9(2) 
            N(1)-C(9)-C(1)                 128.0(2) 
            O(3)-C(9)-C(1)                 118.1(2) 
            C(11)-C(10)-N(1)             108.8(3) 
            C(11)-C(10)-H(10)           125.6 
            N(1)-C(10)-H(10)             125.6 
            C(10)-C(11)-O(3)             108.1(3) 
            C(10)-C(11)-H(11)           125.9 
            O(3)-C(11)-H(11)             125.9 
            C(9)-N(1)-C(10)               104.6(2) 
           _____________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms: 
Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for compound 
258. 
The anisotropic displacement factor exponent takes the form: 
-2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
                 U11       U22        U33        U23        U13       U12 
    _______________________________________________________________________ 
  
    O(1)     32(1)      26(1)      22(1)        7(1)       5(1)      13(1) 
    C(1)     30(1)      23(1)      22(1)        8(1)       8(1)        9(1) 
    C(5)     38(2)      29(2)      36(2)      12(1)     13(1)      13(1) 
    C(3)     39(2)      30(2)      31(2)      13(1)       8(1)      17(1) 
    O(2)     47(1)      32(1)      24(1)      14(1)       6(1)      17(1) 
    C(2)     29(1)      23(1)      26(2)      11(1)     12(1)      13(1) 
    C(4)     32(1)      30(2)      21(1)      10(1)       2(1)      11(1) 
    O(3)     47(1)      40(1)      30(1)      15(1)       5(1)      12(1) 
    C(8)     45(2)      39(2)      25(1)      10(1)     13(1)      14(1) 
    C(7)     31(2)      38(2)      30(2)        9(1)       3(1)        9(1) 
    C(6)     33(2)      29(2)      42(2)      17(1)     14(1)      11(1) 
    C(9)     42(2)      22(2)      28(2)      12(1)       4(1)        6(1) 
    C(10)   38(2)      30(2)      37(2)      16(1)      -2(2)        7(1) 
    C(11)   37(2)      37(2)      32(2)      17(1)      -3(2)        8(1) 
    N(1)     31(1)      31(1)      28(1)      16(1)       2(1)      10(1) 
    _______________________________________________________________________ 
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1 Introduction 
 
1.1 The family of the crocacins 
 
Isolation and structural elucidation  
 
The crocacins are a family of four antifungal and highly cytotoxic metabolites 
extracted from myxobacteria of the genus Chondromyces. The first isolation was 
performed in 1994 from the strain Cm c3 of Chondromyces crocatus by Jansen, 
Höfle and Reichenbach[1] at GBF in Braunschweig and yielded the compound now 
known as crocacin A, initially named simply as crocacin. In 1999, Jansen and co-
workers identified the presence of three different members of the family in the 
original extract from the strains Cm c1, Cm c2, Cm c3, Cm c4, Cm c5 and Cm c7 
of Chondromyces crocatus, together with the isolation of a fourth crocacin from the 
strain Cm p17 of Chondromyces pediculatus. To date there are four members of 
the crocacin family: 
                          - crocacin A, B, C (Chondromyces crocatus); 
                          - crocacin D (Chondromyces pediculatus). 
 
 
 
Figure 1. The family of the crocacins. 
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The extraction yield from the shaken cultures was quite low, in fact the major 
component, crocacin A, was produced in yields of only 20 mg/L.  
The crocacins A, B and C were isolated from the acetone extract of wet cell mass 
of C. crocatus using both Sephadex LH-20 and RP-18 silica gel. Considering the 
significant destruction of important co-metabolites upon silica-gel chromatography, 
this step was avoided in the new separation procedure.  
Crocacin D, on the other hand, was isolated from shaken cultures of C. 
pediculatus, strain Cm p17, by extraction from both cell mass and amberlite XAD 
16 adsorbent resin and purification via RP-MPLC.  
All four crocacins were obtained as pure colourless amorphous solids. 
 
 
 
Figure 2. Typical RP-HPLC of an extract of Chondromyces crocatus. 
 
Structurally, crocacins A, B and D are unusual dipeptides consisting of glycine and 
a 6-aminohexenoic or –hexadienoic acid, N-substituted by a complex polyketide-
derived acyl residue, while crocacin C is the primary amide.  
In 1999, Jansen and co-workers, together with the isolation and identification also 
provided the structural elucidation of the crocacins.[2] The most abundant 
compound, (+)-crocacin A 1, was considered for the elucidation of the basic 
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structure of the crocacin family. The EI-HRMS analysis furnished a molecular ion 
of m/z 538 from which it was possible to obtain the elemental composition 
C31H42N2O6. This formula implies the presence of 12 double bonds equivalents. 
After UV analysis, which showed broad absorption bands at 254 nm and 291 nm, 
the DBEs were assigned to different chromophores. The IR analysis put in 
evidence the presence of ester and amide moieties, due to the intense carbonyl 
absorptions at 1747 and 1649 cm-1 respectively, together with NH broad bands at 
3392 and 3252 cm-1. The carbon backbone of the molecule was established by 1H-
NMR, 13C-NMR and 2D-NMR experiments (COSY, HMQC). In addition, the 
relative positions of the secondary amide bonds, the methyl ester and the ether 
residues were established by long-range correlation spectra (HMBC). On the other 
hand, NOE correlations between the methyl group at C-13 and 15-H and between 
12-H and 14-H, were exploited to establish the (E) configuration of the Δ12 double 
bond, while for all the other double bonds (Δ5, Δ8, Δ14, Δ20) the simple analysis of 
the vicinal coupling constants was sufficient. The values of the other observed 1H 
vicinal coupling constants in the C-15 to C-20 segment, together with the 
calculated torsion angles obtained via MM+ calculations, and further NOE studies, 
clarified the relative configuration of the asymmetric centres in (+)-crocacin A 
(Figure 3).  
 
Figure 3. Structural elucidation of the (+)-crocacin A 1. 
 
Through NMR analysis it was possible to identify the free carboxylic acid moiety of 
crocacin B 2 by the lack of the methoxyl group signal, as was corroborated by EI-
HRMS analysis, which provided a molecular ion of m/z 524 and elemental 
composition C30H40N2O6.  
The structure of crocacin C 3 was identified via NMR analysis due to the lack of 
signals corresponding to the entire lateral chain, and due to the presence of the 
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primary amide moiety, confirmed by IR (1655 and 1600 cm-1). In addition, these 
data were corroborated by HRMS analysis which provided a molecular ion of m/z 
357 and elemental composition C22H31NO3.  
Finally, the structure of crocacin D 4 was established by evident comparison with 
the NMR spectra of crocacin A 1. The crocacin D spectra indicated the lack of the 
Δ5 double bond. The structure analysis was corroborated by EI-HRMS studies, 
which gave the molecular ion of m/z 540 and the elemental composition 
C31H44N2O6.  
 
 
Biological properties 
 
Jansen and co-workers disclosed the biological properties of the crocacin family in 
1994. In their studies it was observed that S. cerevisiae became less sensitive to 
the crocacins if grown in the presence of glucose. Since S. cerevisiae can 
metabolise sugars by fermentation, the antagonistic effect of glucose suggested 
that the crocacins might interfere with the respirative energy metabolism. This is 
the order of activity against yeasts: 
 
- crocacin A (MIC 10 mg/L) 
- crocacin B (MIC 12.5 µgm/L) 
- crocacin C (MIC 100 mg/L) 
- crocacin D (MIC 1.4 ng/L) 
 
The crocacins have also shown toxicity in L929 mouse fibroblast cell culture. A 
different order of activity is observed in this case: 
 
- crocacin A (IC50 0.2 mg/L) 
- crocacin B (IC50  40 mg/L) 
- crocacin C (IC50 140 mg/L) 
- crocacin D (IC50 0.06 mg/L) 
 
In all cases, crocacin D proved to be the most active and promising compound of 
the family, while crocacin C is essentially inactive. This observation led to the 
hypothesis that the (Z)-enamide moiety present in the lateral chain of the 
crocacins may be responsible for the biological activity.  
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Speculative proposals on the mode of action have been made suggesting that 
protonation occurs at the enamide moiety, followed by nucleophilic attack onto the 
resulting N-acyliminium ion to form a conjugate with the enzyme. The biological 
activity of the crocacins was confirmed in 2008 by Crowley who showed that the 
activity of the crocacins was due to the inhibition of the electron flow within the 
cytochrome bc1 segment (complex III) of the respiratory chain. The cytochrome 
bc1 complex is a fundamental element of the respiratory chain, responsible for 
electron transfer from quinol to cytochrome c and the movement of protons across 
the inner mitochondrial membrane. Crowley’s group published a series of 
molecular modelling studies[3a-d] based on crystallographic data which showed that 
the capability of crocacin A to inhibit the electron flow was related to the interaction 
with complex III through the following specific bonds (Figure 4): 
- the (Z)-enamide carbonyl accepts a hydrogen bond from the Nε of the 
residue His161 in the enzyme; 
- the (Z)-enamide linking group adopts a hair-pin conformation due to 
intramolecular hydrogen bonding between the two amide groups; 
- the glycine nitrogen donates a hydrogen bond to the carbonyl group of the 
residue Met138; 
- the glycine ester oxygen accepts a hydrogen bond from the backbone 
nitrogen of the residue Glu271. 
 
Figure 4. Binding moieties in crocacin A 1 structure. 
 
Inhibitors of the cytochrome bc1 complex are of great interest, both as potential 
biologically active molecules for the control of fungal diseases, and also as tools 
for probing the structure and function of the proteins involved in the respiratory 
electron transport chain. The aim of Crowley and co-workers was to design 
synthetic analogues of the natural fungicidal crocacins for potential exploitation as 
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agricultural fungicidal agents. The rationale behind this was that important 
fungicidals such as stigmatellin 5 and azoxystrobin 6 are also inhibitors of 
cytochrome bc1 complex (Figure 5). Since the crocacins are good inhibitors of the 
electron transport chain at the same level and have shown fungicidal activity, they 
could potentially be leads for new agricultural fungicides.  
 
 
 
Figure 5. Other mitochondrial respiration inhibitors. 
 
The crocacins display fungicidal activity against a number of plant pathogens 
including Blumeria graminis, Mycosphaerella graminicola, Phytophthora infestans, 
Palsmopara viticola and Puccinia triticina, Puccinia recondita and Septoria 
nodorum. Unfortunately, despite this interesting biological profile, the naturally 
occurring crocacins are characterised by great fragility which forbids their 
exploitation for agricultural purposes due to their instability to the field conditions. 
In simulated sunlight tests both crocacins A and D showed very poor photostability 
with 50% of parent compound being lost within 7 and 37 minutes, respectively.  
Hence it is no surprise that unnatural analogues have been designed as potential 
crop protection agents. The first class of analogues were designed with simplified 
liphophilic side chains. These regions were considered to be unrelated to the 
biological activity of the molecule. The second class of analogues was based on 
modification of the linker segment, which is characterised by rigid and sterically 
undemanding nature (Figure 6). Disappointingly, despite slight improvements in 
terms of stability and activity with respect to the natural products (for example 
entry 4 and 5), it was not deemed, by Syngenta, to be sufficient to allow 
industrialisation of the compounds (Table 1).  
 
 
Figure 6. Classification of molecule functions in (+)-crocacin D 4. 
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Table 1. Biological efficacy of analogues of (+)-crocacin D 4. 
 
However, despite the lack of current industrial interest, the crocacins remain a 
source of significant synthetic interest both due to their biological potential and 
interesting structural features. 
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1.2 Previous syntheses of (+)-crocacin C 
 
Rizzacasa’s approaches (2000) 
 
Rizzacasa reported the first enantioselective total synthesis of (+)-crocacin C 3 in 
2000.[4] Retrosynthetically, Rizzacasa proposed the first disconnection at the C1-
C5 (E,E)-dienamide moiety, which was envisioned as originating through the Stille 
coupling between the custom lateral chain 7 and the vinyl stannane intermediate 
8. The vinyl stannane 8 could be obtained via Hodgson’s chromium-mediated 
vinylstannylation, while the C8-C9 bond could be obtained using Paterson’s 
asymmetric syn-aldol reaction starting from cinnamaldehyde 9 and the 
dipropionate synthon 10. Finally, ketone 10 could be obtained in 3 steps from the 
commercial Roche ester 11 (Figure 7). 
 
 
 
Figure 7. Retrosynthetic analysis of (+)-crocacin C by Rizzacasa. 
 
Rizzacasa’s synthesis began with commercially available (S)-Roche ester 11 
which was converted into the corresponding Weinreb amide 12 and then protected 
to afford the PMB-ether 14. The latter was treated with ethyl magnesium bromide 
to afford the intermediate 10 which then underwent a Sn(II)-mediated syn-aldol 
reaction following Paterson’s protocol. This step involved the formation of the (Z)-
Sn(II)-enolate from the intermediate 10 and its addition to the commercial trans-
cinnamaldehyde 9 to afford the syn-syn adduct 15 in very good yield and with 
excellent diastereomeric excess. β-hydroxyketone 15 was then subjected to 
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reagent controlled reductive conditions to provide the anti-diol 16 in excellent yield 
and with complete diastereocontrol. The stereochemistry of diol 16 was confirmed 
via 13C-NMR studies on the corresponding acetonide following Rychnovsky’s 
protocol. At this point, due to issues involving PMB group removal in the latter 
stages of the synthesis, an unfortunate protecting group interconversion was 
necessary. Thus, diol 16 was acetylated and the PMB group removed via DDQ 
treatment to afford the primary alcohol 18, which was then reprotected with a 
TBDPS group. Reductive removal of the acetates, followed by methylation of the 
resultant diol 20, afforded the dimethyl ether 21, which was desilylated to give the 
free alcohol 22. The latter was subjected to careful oxidation and subsequent 
chromium-mediated vinylstannylation following Hodgson’s procedure to afford the 
(E)-stannane 8. The final step involved a Stille coupling between stannane 
intermediate 8 and the custom lateral chain 7 (Scheme 2). The iodide lateral chain 
7 was obtained in four steps from tetrolic acid 23. Initial addition of HI to the alkyne 
unit generated the (Z)-acid which was subjected to thermal isomerisation to give a 
70:30 mixture of E:Z isomers. Methylation using diazomethane then gave the pure 
(E)-ester 24 which was finally converted into the amide 7 with an overall yield of 
27% (Scheme 1). 
 
 
 
Scheme 1. Rizzacasa’s synthesis of the lateral chain 7. 
 
Finally the key Stille coupling was carried out to afford, after purification by flash 
column chromatography and HPLC, (+)-crocacin C 3.  
Rizzacasa’s synthesis was crucial in establishing the absolute stereochemistry of 
the natural product. 
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Scheme 2. Rizzacasa’s first generation synthesis of (+)-crocacin C, 3. 
 
Due to the unforeseen issues related to the PMB protecting group stability, and the 
necessity for interconversion which elongated the total synthesis of (+)-crocacin C, 
Rizzacasa developed an optimised approach.[4,5] As part of this second generation 
synthesis, a more convenient TIPS protecting group was used in place of the PMB 
group. Rizzacasa’s second generation synthesis began with ketone 25 which 
underwent a Sn(II)-mediated syn-aldol reaction, followed by stereoselective anti-
reduction, to yield diol 27. Bismethylation of diol 27 followed by TBAF removal of 
the silyl protecting group yielded free alcohol 22. This new synthetic sequence 
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effectively saved four steps with respect to the first generation synthesis. 
Successively, DMP oxidation of alcohol 22 followed by chromium-mediated 
vinylstannylation afforded stannane 8. The final Stille coupling was also optimised, 
which resulted in the replacement of the trifurylphosphine ligand with 
triphenylarsine in order to obtain the final target in a much improved 66% yield. 
In conclusion, Rizzacasa’s improved second generation synthesis yielded (+)-
crocacin C 3 in 10 steps and 17% overall yield from commercially available 
starting materials. 
 
 
 
 
Scheme 3. Rizzacasa’s second generation synthesis of (+)-crocacin C, 3. 
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Chakraborty’s approach (2001) 
 
Shortly after the publication of Rizzacasa’s initial total synthesis of (+)-crocacin C 
3, Chakraborty reported a new independent approach.[6] In his retrosynthetic 
analysis, Chakraborty envisioned (+)-crocacin C as originating through a HWE 
olefination between aldehyde 28 and the custom lateral chain 29 to incorporate the 
C4-C5 double bond. Aldehyde 28, in turn, could be obtained from allylic alcohol 30 
via Sharpless asymmetric epoxidation followed by a regioselective cuprate-
mediated epoxide opening. Alcohol 30 could be accessed through a Crimmins’ 
syn-aldol Ti(IV)-mediated reaction between N-acylthiazolidinethione 31 and 
cinnamaldehyde 9 (Figure 8). 
 
 
 
Figure 8. Retrosynthetic analysis of (+)-crocacin C by Chakraborty. 
 
Chakraborty’s synthesis began with the chiral oxazolidinethione 32 which was N-
acylated to give propanoyl oxazolidinethione 31. The latter was converted into the 
titanium enolate and was condensed with trans-cinnamaldehyde 9 via Crimmins’ 
syn-aldol Ti(IV)-mediated conditions to afford alcohol 33. Removal of the chiral 
auxiliary by DIBAL-H reduction afforded the corresponding aldehyde 34 which was 
then subjected to a Wittig olefination to afford the α,β-unsaturated ester 35 as a 
single (E)-isomer. DIBAL-H reduction of enoate 35 yielded alcohol 36 (Scheme 4). 
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Scheme 4. Chakraborty’s synthesis of intermediate 36. 
 
Selective silylation of the primary alcohol followed by methylation of the secondary 
alcohol afforded the differentially protected diol 37. Selective silyl group removal 
afforded (E)-allylic alcohol 30 which was subjected to Sharpless asymmetric 
epoxidation to give the desired epoxy alcohol 38 in excellent yield and as a single 
diastereoisomer. The C6-C7 stereocentres were then accessed via regioselective 
opening of the epoxide using lithium dimethylcuprate. The selectivity was 
attributed to the presence of a more bulky substituent which directed the attack to 
the less hindered position to give the desired 1,3-diol 39. Regioselective silylation 
of the primary alcohol afforded the TBS-ether 40, which upon methylation afforded 
differentially protected triol 41. Desilylation by CSA afforded primary alcohol 22 
(Scheme 5).  
Alcohol 22, upon Parikh-Doering oxidation, yielded aldehyde 28. Horner-
Wadsworth-Emmons olefination of aldehyde 28 gave the (E)-conjugated ethyl 
ester 42. Finally, saponification with lithium hydroxide, followed by activation of the 
resulting carboxylic acid and amidation afforded (+)-crocacin C 3 (Scheme 6). 
In a nutshell, Chakraborty’s synthesis of (+)-crocacin C was achieved in 17 steps 
with an overall yield of ~ 4% from commercially available starting materials. 
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Scheme 5. Chakraborty’s synthesis of intermediate 22. 
 
 
 
 
 
Scheme 6. Chakraborty’s completion of the synthesis of (+)-crocacin C, 3. 
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Dias’s approach (2001) 
 
Several months after Chakraborty’s synthesis was published, Dias’ and co-
workers also published their total synthesis of (+)-crocacin C 3.[7] Dias’ 
retrosynthetic analysis was influenced by Rizzacasa’s work and started with the 
Stille coupling between the vinyl iodide 43 and the custom lateral chain 44 to 
generate the C3-C4 bond. In order to generate the vinyl iodide 43, two 
disconnections were considered; the first involved a Takai olefination while the 
second involved a mCPBA epoxidation/cuprate-mediated epoxide opening 
sequence, starting from allylic alcohol 36. The latter was thought as being 
accessed via Evans aldol reaction between the N-propionyl oxazolidinone 45 and 
trans-cinnamaldehyde 9 (Figure 9). 
 
 
Figure 9. Retrosynthetic analysis of (+)-crocacin C by Dias. 
 
Dias’ synthesis began with commercially available (+)-(R)-oxazolidinone 46 which 
was N-acylated to afford the known (-)-acyloxazolidinone 45. The N-propionyl 
oxazolidinone 45 was then converted into the corresponding boron enolate and 
was coupled with trans-cinnamaldehyde 9, to yield the aldol adduct 47 in good 
yield and high diastereomeric ratio. TBS protection of the secondary alcohol 
followed by removal of the chiral auxiliary accessed the free primary alcohol 49, 
which was subsequently oxidised under Swern conditions to afford the aldehyde 
50 (Scheme 7).  
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Scheme 7. Dias’s synthesis of intermediate 50. 
 
HWE olefination of aldehyde 50 with phosphonate 51 afforded the α,β-unsaturated 
ester which was directly reduced to the corresponding trans-allylic alcohol 52 in 
high yield and good stereocontrol. Allylic alcohol 52 was subjected to a substrate 
controlled epoxidation to afford the epoxy alcohol 53 in good yield. Interestingly, 
the epoxidation proceeded with high regio- and diastereoselectivity from the 
opposite side of the TBS group to give the anti-epoxy alcohol 53 in high purity. 
Epoxide 53 was opened regioselectively with Me2CuCNLi2 to afford the anti-anti-
syn diol 54. Desilylation followed by regioselective TBDPS protection of the 
resulting primary alcohol, afforded the 1,3-diol 20. Permethylation followed by 
TBAF desilylation gave the free primary alcohol 22 (Scheme 8). 
 
 
 
Scheme 8. Dias’s synthesis of intermediate 22. 
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The stannane containing lateral chain 44 was prepared starting from the 
commercially available ethyl 2-butynoate 55 which was subjected to a cuprate-
mediated hydrostannylation to afford vinyl stannane 56. The latter was finally 
converted into the primary amide 44 via amidation by ammonium chloride 
(Scheme 9). 
 
 
 
Scheme 9. Dias’s synthesis of the lateral chain 44. 
 
DMP oxidation of alcohol 22 followed by Takai olefination afforded (E)-vinyl iodide 
43 in fair yield, however, with complete stereocontrol. The synthesis was 
completed with a Stille coupling between vinyl iodide 43 and stannane 44 using 
triphenyl arsine as the ligand, to access (+)-crocacin C 3 in 69% yield (Scheme 
10). Dias’ total synthesis of (+)-crocacin C 3 was completed in 16 steps from 
commercially available starting materials and in 8.5% overall yield. 
 
 
 
Scheme 10. Dias’s completion of the synthesis of (+)-crocacin C, 3. 
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Andrade’s approaches (2008-2010) 
 
Andrade’s approach to the synthesis of (+)-crocacin C was based on the 
chemoselective cross-metathesis between dienamide 58 and diene 57.[8] Diene 57 
was then dissected in two further places. The first proposed scission involved 
breaking the C6-C7 bond, which was proposed as originating through an 
asymmetric crotylboration via Brown’s or Roush’s reagent 60. The second 
disconnection involved the construction of the C8-C9 bond through the Crimmins 
aldol condensation of propionate synthon 59 with trans-cinnamaldehyde 9 (Figure 
10). 
 
 
 
Figure 10. First generation retrosynthesis of (+)-crocacin C by Andrade. 
 
As proposed, Andrade’s synthesis began with a Crimmins aldol reaction between 
the readily available thiazolidinethione propionimide 59 and trans-cinnamaldehyde 
9 to yield the syn-aldol adduct 60 in moderate yield and good diastereomeric 
excess. TBS protection of the primary alcohol followed by reductive removal of the 
chiral auxiliary, gave aldehyde 50 (Scheme 11).  
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Scheme 11. Andrade’s synthesis of intermediate 50. 
 
Aldehyde 50 was subjected to asymmetric crotylboration conditions, initially, under 
Brown’s and later under Roush’s protocols. In both cases disappointing 
diastereomeric mixtures were obtained in which the undesired product 64 was 
formed preferentially (Scheme 12).  
 
 
 
Scheme 12. Andrade’s attempts of double asymmetric crotylborations. 
 
Although Andrade’s initial approach was rich in originality, the disappointing results 
in the crotylboration step led to a revised synthetic strategy, strongly influenced by 
Chakraborty’s and Dias’ syntheses. In the revised synthetic plan, Andrade 
maintained a highly convergent approach in which C4-C5 bond formation was built 
through a HWE olefination between the lateral chain 29 and aldehyde 28. 
Aldehyde 28, in turn, could be accessed via Evans’ dipropionate aldol reaction 
between dipropionate synthon 66 and trans-cinnamaldehyde 9, followed by a 
diastereoselective 1,3-anti-reduction (Figure 11).[9a,b] 
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Figure 11. Andrade’s second generation retrosynthesis of (+)-crocacin C, 3. 
 
The revised synthesis showed a direct influence from both Rizzacasa’s and Dias’ 
approaches. It began with Evans’ reagent 46 which was N-acylated to afford the 
oxazolidinone 45. Oxazolidinone 45 was then subjected to aldol reaction with 
propionaldehyde, and the propionate intermediate subjected to a Parikh-Doering 
oxidation, to afford the dicarbonyl species 66. The latter underwent Evans’ 
asymmetric syn-aldol reaction with trans-cinnamaldehyde 9, to yield the aldol 
product 68. Stereoselective reagent controlled anti-reduction then completed the 
synthesis of the anti,anti,syn stereotetrad. Double methylation of the secondary 
alcohol moieties and reductive removal of the chiral auxiliary, yielded alcohol 22. 
Finally, careful oxidation of alcohol 22, afforded aldehyde 28 (Scheme 13).  
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Scheme 13. Andrade’s synthesis of intermediate 28. 
 
For his endgame strategy Andrade adopted Chakraborty’s procedure which 
involved HWE olefination between aldehyde 28 and phosphonate 29, to give ester 
42. Saponification of the ester, activation of the resulting acid and amidation, 
afforded (+)-crocacin C (Scheme 14). 
Andrade’s protecting-group-free approach was able to generate (+)-crocacin C in 
~ 4% overall yield over 11 steps. 
 
 
 
Scheme 14. Andrade’s completion of (+)-crocacin C, 3. 
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Burke’s approach (2008) 
 
Burke reported a novel and original approach to the synthesis of (+)-crocacin C, 
based on the use of N-methyliminodiacetic acid (MIDA) boronates.[10] Burke 
introduced the use of MIDA boronates as very stable vinylboronic acid surrogates 
and, in order to prove the utility of this new methodology in natural product 
synthesis, he chose (+)-crocacin C as a suitable target. In his retrosynthetic 
analysis, Burke considered the C11-C12 bond as his first disconnection, involving 
a Suzuki coupling to incorporate the aromatic ring. The second disconnection was 
at the C3-C4 bond involving a Stille coupling between vinyl iodide 71 and the 
known stannane 44, in a similar fashion to that reported by Dias. In the latter, two 
further disconnections were considered, one across the vinyl iodide moiety, 
involving a Takai olefination similar to Dias’ approach, and the other at the C8-C9 
bond involving a Paterson syn-aldol reaction following Rizzacasa’s protocol. This 
led back to two simple intermediates, the acrolein MIDA boronate 72 and the 
dipropionate synthon 10 (Figure 12). 
 
 
 
Figure 12. Retrosynthetic analysis of (+)-crocacin C by Burke. 
 
Burke’s synthesis began with acrolein MIDA boronate 72, which was subjected to 
a Sn(II)-mediated syn-aldol reaction to generate the propionate 73. 
Stereoselective anti-reduction of β-hydroxyketone afforded diol 74, which was 
permethylated to yield dimethyl ether 75. Removal of the PMB group, followed by 
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oxidation of the resulting primary alcohol 76, yielded aldehyde 77. Takai olefination 
of aldehyde 77 then yielded the key vinyl iodide unit 71. Iodide 71 was then 
subjected to CsF/CuI-promoted Stille coupling conditions with stannane 44 to 
afford dienamide 78. Finally, in situ boronic acid generation and Suzuki coupling 
between the MIDA boronate and bromobenzene, yielded (+)-crocacin C in 77% 
yield (Scheme 15). Burke’s synthesis was achieved in 9 steps and 13% overall 
yield. 
 
 
 
Scheme 15. Burke’s synthesis of (+)-crocacin C, 3. 
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Bressy and Pons’ approach (2010) 
 
In 2010, Bressy and Pons reported a convergent and protecting group-free 
synthesis of (+)-crocacin C.[11] Bressy ans Pons’ synthesis hinged on formation of 
the C3-C4 bond through a one-pot hydrostannylation/Stille coupling procedure 
between the alkyne intermediate 79 and the lateral chain 7. Alkyne 79, in turn, 
could be derived from pyran 80 via base-induced ring opening. Pyran 80 could be 
accessed from a Julia-type olefination between sulfone 81 and the meso-THP diol 
82. Diol 82, in turn, could be obtained from the oxabicycle via ozonolysis and 
reduction of the carbonyl moieties. Oxabicycle 83, on the other hand, could 
originate from furan 84 via a [4+3]-cycloaddition with custom ketone 85 (Figure 
13). 
 
 
 
Figure 13. Retrosynthetic analysis of (+)-crocacin C by Bressy-Pons. 
 
Bressy and Pons’ synthesis began with a [4+3]-cycloaddition between furan 84 
and 2-chloropentan-3-one 85 to afford oxabicycle 83. The newly formed 
oxabicycle 83 was stereoselectively reduced and the resulting alcohol 86 was 
methylated to give methylether 87. Methylether 87 was then subjected to an 
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ozonolysis-reduction sequence to afford meso-THP diol 82, which was then 
converted, via enzymatic desymmetrisation, to monoacetate 88 in high yield and 
with excellent stereocontrol. Monoacetate 88 was oxidised to the corresponding 
aldehyde 89 under Swern conditions, and then subjected to a Julia-type olefination 
with sulfone 81 to afford olefin 90. Acetate hydrolysis followed by chlorination of 
the resulting alcohol 91 gave chloride 80 which, upon base-induced THP ring 
opening and methylation, gave alkyne 79. Alkyne 79 was finally subjected to a 
one-pot hydrostannylation and in situ Stille coupling with the known lateral chain 7, 
to yield (+)-crocacin C 3. Bressy-Pons’ approach thus completed the synthesis in 
14 steps and 8% overall yield from commercially available starting materials 
(Scheme 16). 
 
 
 
Scheme 16. Bressy-Pons’s synthesis of (+)-crocacin C, 3. 
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Roush’s approach (2012) 
 
The most recent total synthesis of (+)-crocacin C was reported by Roush. The key 
step in Roush’s approach was a mismatched double asymmetric δ-
stannylcrotylboration to access the anti,anti-stereotriad in a stereoselective 
fashion.[12] Although attempts of mismatched double asymmetric crotylboration 
had previously been reported by Andrade with unsatisfactory results, Roush’s 
newly developed methodology was able to solve the issues related to the intrinsic 
diastereofacial preference of the aldehyde substrate. Thus, in his retrosynthetic 
analysis, Roush envisioned (+)-crocacin C as originating through the Stille 
coupling between the known iodide 7 and stannane 8. Stannane 8, in turn, could 
be obtained via δ-stannylcrotylboration starting from chiral crotylborane reagent 93 
and aldehyde 94. Finally, aldehyde 94 could be prepared through an Evans’ syn-
aldol reaction between the acyl oxazolidinone 95 and trans-cinnamaldehyde 9 
(Figure 14). 
 
 
 
Figure 14. Retrosynthetic analysis of (+)-crocacin C by Roush. 
 
Roush’s synthesis began with acyl oxazolidinone 95 which was deprotonated to 
give the corresponding (Z)-enolate, which was subjected to an Evans’ asymmetric 
syn-aldol addition with trans-cinnamaldehyde 9 to afford the aldol adduct 96. 
Transamidation of unit 96 then yielded Weinreb amide 97, which was methylated 
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and reduced to afford aldehyde 94. Hydrostannylation of aldehyde 94 using the 
crotylborane reagent, obtained from the enantioselective hydroboration of racemic 
allenylstannane (±)-99 with (dIpc)2BH, yielded vinyl stannane 100 in fair yield and 
good diastereomeric excess. Methylation and final Stille coupling under 
Rizzacasa’s conditions afforded the (+)-crocacin C in 71% yield (Scheme 17).  
Roush’s approach proved to be very efficient, yielding (+)-crocacin C in 20% 
overall yield over 7 steps on the longest linear sequence. 
 
 
 
Scheme 17. Roush’s synthesis of (+)-crocacin C, 3. 
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1.3 Previous syntheses of (+)-crocacin D 
 
Rizzacasa’s approach (2002) 
 
Rizzacasa and co-workers reported the first total synthesis of (+)-crocacin D 4.[5] 
As part of his approach, Rizzacasa envisioned (+)-crocacin D as originating from 
acyl chloride 101 and the carbamate lateral chain 102. Acyl chloride 101 was 
envisioned as originating using the same approach previously developed for (+)-
crocacin C, which was utilised as a synthetic precursor of (+)-crocacin D. The 
lateral chain 102, on the other hand, was envisioned as arising via addition of 
trimethylsilylethanol to isocyanate 103 (Figure 15). 
 
 
 
Figure 15. Retrosynthetic analysis of (+)-crocacin D by Rizzacasa. 
 
Rizzacasa’s synthesis of the left hand side of (+)-crocacin D paralleled his second 
generation approach for the total synthesis of (+)-crocacin C. However, upon 
accessing vinyl stannane 8, a modified Stille coupling was carried out in order to 
generate methyl ester 106 (Scheme 18). 
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Scheme 18. Rizzacasa’s synthesis of the intermediate 106. 
 
The synthesis of the (Z)-enamide containing right hand side of (+)-crocacin D 
began with the aldehyde 107, which was subjected to an Ando olefination in order 
to generate the sensitive (Z)-α,β-unsaturated ester. Ester saponification yielded 
carboxylic acid 108, which was then converted to acyl azide 109. Curtius 
rearrangement of acyl azide 109 afforded the (Z)-vinyl isocyanate intermediate 
103, which upon treatment with trimethylsilylethanol yielded the key carbamate 
102 (Scheme 19). 
 
 
 
Scheme 19. Rizzacasa’s synthesis of the intermediate 102. 
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Rizzacasa’s final steps towards the synthesis of (+)-crocacin D involved 
conversion of methyl ester 106 into acyl chloride 101, and subsequent coupling 
with the lateral chain 102 (Scheme 20). Removal of the silyl protecting group 
followed by oxidation of the resulting alcohol to the corresponding carboxylic acid 
and DPPA-mediated coupling with glycine methyl ester led to the protected 
enamide 112. Finally, Teoc deprotection afforded (+)-crocacin D in an overall yield 
of ~ 2% and in 18 steps on the longest linear sequence. 
 
 
 
Scheme 20. Rizzacasa’s synthesis of the (+)-crocacin D, 4. 
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Chakraborty’s approach (2002) 
 
Shortly after Rizzacasa’s synthesis, Chakraborty reported a total synthesis of (+)-
crocacin D.[13] Chakraborty envisioned (+)-crocacin D as originating through a 
double disconnection approach in which the N3-C4 bond was incorporated 
through an amide linkage involving glycine and the C8-C9 double bond  was 
generated through a Peterson elimination. The primary alcohol intermediate 113 
on the other hand was thought as having originated through the coupling of 
carboxylic acid 114 and TMS-amine 115. Carboxylic acid 114 could be 
synthesised following the same sequence previously developed by Chakraborty’s 
group for the synthesis of (+)-crocacin C. Fragment 115 could be accessed via 
regioselective epoxide opening from the TMS-epoxide 116. The latter could be 
obtained by alkene reduction and epoxidation from the known TMS-alkyne 117. 
 
 
 
Figure 16. Retrosynthesis of the (+)-crocacin D by Chakraborty. 
 
Chakraborty’s synthesis began with the oxidation of alcohol 118 under Swern 
conditions to give the corresponding aldehyde, which was directly subjected to 
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Corey-Fuchs alkynylation to afford the TMS acetylide 117 (Scheme 21). TBS 
removal followed by partial hydrogenation of the alkyne afforded (Z)-vinylsilane 
119. Epoxidation of vinylsilane 119 and regioselective opening of the epoxide 
intermediate 116 with sodium azide gave the α-azido-β-hydroxyalkylsilane 
intermediate 120. Reduction of the azide afforded the secondary amine 115.  
 
 
 
Scheme 21. Chakraborty’s synthesis of the intermediate 115. 
 
Acylation of amine 115 with the known carboxylic acid 114, yielded amide 113 
which was globally protected before the primary alcohol was selectively unmasked 
(Scheme 22). Alcohol 121 was oxidised to yield carboxylic acid 122, which was 
then coupled to glycine methyl ester via formation of the mixed anhydride.  
Finally, a TBAF-mediated one-pot desilylation/Peterson elimination afforded (+)-
crocacin D in 78% yield. 
As a whole, Chakraborty’s total synthesis of (+)-crocacin D was achieved in 24 
steps and ~ 1% overall yield. 
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Scheme 22. Chakraborty’s completion of the synthesis of (+)-crocacin D, 4. 
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Dias’s approach (2005) 
 
A few years later, Dias reported a novel and more convergent approach to the 
total synthesis of (+)-crocacin D, based on Buchwald’s copper-catalysed coupling 
of amides with vinyl halides.[14] Hence retrosynthetically, Dias envisioned (+)-
crocacin D as originating through the copper-mediated coupling between (+)-
crocacin C 3 and vinyl iodide 123. Vinyl iodide 123 could in turn be generated 
through the peptide coupling of the carboxylic acid intermediate with glycine 
methyl ester and functional group manipulation (Figure 17). 
 
 
 
Figure 17. Retrosynthesis of (+)-crocacin D by Dias. 
 
Dias’ synthesis began with the Swern oxidation of alcohol 126 to the 
corresponding aldehyde followed by HWE olefination to give the (E)-enoate 127 
(Scheme 23). Hydrogenation of the double bond followed by saponification 
afforded the carboxylic acid 125 which was then coupled with glycine methyl ester 
124 to yield amide 129. Boc protection of the secondary amide, desilylation and 
careful oxidation of the free alcohol, led to the aldehydic intermediate 131. The 
latter was subjected to a (Z)-selective Stork-Zhao olefination to afford vinyl iodide 
132, which after Boc-removal using TFA, afforded the desired lateral chain 123. 
The endgame strategy consisted of a copper-mediated cross-coupling between 
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(Z)-vinyl iodide 123 and (+)-crocacin C 3 under Buchwald’s conditions to afford 
(+)-crocacin D in ~ 6% overall yield and 17 steps on the longest linear sequence. 
 
 
 
Scheme 23. Dias’s synthesis of (+)-crocacin D, 4. 
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1.4 Previous syntheses of (+)-crocacin A 
 
Rizzacasa’s approach (2003) 
 
Rizzacasa’s group was, again, the first to report the total synthesis of (+)-crocacin 
A.[15] Rizzacasa’s retrosynthetic analysis was very similar to that previously 
proposed for (+)-crocacin D. Hence Rizzacasa envisioned (+)-crocacin A as 
originating through the coupling of the known acyl chloride 101 and to the (Z,Z)-
dienecarbamate 133. Carbamate 133 could in turn be accessed via addition of 
trimethylsilylethanol to vinyl isocyanate 134, which, on the orther hand, could be 
easily synthesised from the known 1,4-alkadiyne 135 (Figure 18).   
 
 
 
Figure 18. Retrosynthetic analysis of (+)-crocacin A by Rizzacasa. 
 
Rizzacasa’s synthesis began with the known alcohol 136 which was mesylated 
and subjected to a copper-mediated coupling to give the 1,4-alkadyine 135. The 
sensitive intermediate 135 was partially reduced to the corresponding (Z,Z)-diene 
138 using borohydride-reduced nickel catalyst (P-2Ni). The primary alcohol was 
then oxidised to carboxylic acid which, in turn, was converted to the corresponding 
azide 140 in moderate yield and with partial isomerisation of the double bonds 
(Z/E = 2:1). Azide 140 was then subjected to Curtius rearrangement conditions to 
give isocyanate 134 which was directly converted into carbamate 133 by treatment 
with trimethylsilylethanol (Scheme 24).  
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Scheme 24. Rizzacasa’s synthesis of the intermediate 133. 
 
Rizzacasa’s final steps towards the synthesis of (+)-crocacin A 1, began with 
dienoate 106 which was converted into the corresponding acyl chloride and 
directly coupled to carbamate 133 to afford the resulting enamide 141 in low yield 
(Scheme 25).  
Silyl group removal followed by oxidation of the primary alcohol yielded the 
corresponding carboxylic acid 142 which was TBAF deprotected and subsequently 
subjected to a DPPA-mediated coupling with glycine methyl ester 124 to afford  
(+)-crocacin A in 23% yield. 
Overall, Rizzacasa’s total synthesis of (+)-crocacin A 1 was completed in 1% yield 
and in 18 steps in the longest linear sequence. 
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Scheme 25. Rizzacasa’s completion of (+)-crocacin A, 1. 
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Chakraborty’s approach (2003) 
 
In the same year that Rizzacasa published his total synthesis of (+)-crocacin A 1, 
Chakraborty also reported his own independent approach.[16] Chakraborty’s 
retrosynthetic analysis hinged on an acylation reaction to generate the N3-C4 
bond, while a Peterson elimination would establish the C8-C9 double bond 
(Figure 19). The allylic alcohol precursor 143, on the other hand, was envisioned 
as being assembled through a new acylation reaction between carboxylic acid 114 
and amine 144. Amine 144 could be obtained by regioselective opening of epoxide 
145 which, in turn, could be prepared via partial reduction and epoxidation from 
the known bis-alkyne 146. 
 
 
 
Figure 19. Retrosynthetic analysis of (+)-crocacin A by Chakraborty. 
 
Chakraborty’s synthesis began with silylation of propargylic alcohol 147 which was 
converted into the TMS-intermediate 148. Tosylation of the primary alcohol 
position, followed by a copper-catalysed coupling with propargylic alcohol 147 
afforded the diynyl intermediate 146. Partial reduction of diynyl 146 gave (Z,Z)-
dienenol 150. Hydroxyl group tritylation and subsequent oxidation with mCPBA 
yielded the corresponding epoxide, which was regioselectively opened with 
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sodium azide to afford TMS-azide 152. Finally, reduction of the azide 152 
completed the synthesis of the lateral chain 144 (Scheme 26). 
 
 
 
Scheme 26. Chakraborty’s synthesis of the intermediate 144. 
 
The known carboxylic acid 114 was then subjected to an EDCI-mediated coupling 
with the amine lateral chain 144 to afford amide 153. Protecting group 
manipulation followed by oxidation of the primary alcohol yielded carboxylic acid 
154.  
EDCI-promoted peptide coupling with glycine methyl ester then afforded dipeptide 
155. Finally, a TBAF-mediated one-pot desilylation/Peterson olefination yielded 
(+)-crocacin A in 86% yield (Scheme 27).  
In conclusion, Chakraborty’s synthesis yielded (+)-crocacin A in ~1% yield and in 
23 steps in the longest linear sequence. 
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Scheme 27. Chakraborty’s completion of (+)-crocacin A, 1. 
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1.5 Previous syntheses of (+)-crocacin B 
 
To date, only one total synthesis of (+)-crocacin B 2 has been reported in literature 
by Rizzacasa and co-workers.[17] In 2003, Chakraborty’s group attempted the 
synthesis of crocacin B from crocacin A via hydrolysis of the ester moiety, 
however, disappointingly, the saponification resulted in the exclusive formation of 
undesired side products.[16]  
 
 
Rizzacasa’s approach (2008) 
 
Following Chakraborty’s attempts, in 2008 Rizzacasa also attempted the direct 
synthesis of crocacin B via hydrolysis of crocacin A, but once again, the result 
proved disappointing. In fact, the base-mediated saponification led to complete 
degradation of the natural product. Faced with this initial drawback, Rizzacasa 
proposed a new synthetic strategy very similar to his previous approach to (+)-
crocacin A. Crucially, however, Rizzacasa used the labile glycine TMSE ester 124 
in place of glycine methyl ester 156 in order to overcome the issues involved in the 
final hydrolytic step (Figure 20).[17] 
 
 
 
 
Figure 20. Retrosynthetic analysis of (+)-crocacin B by Rizzacasa. 
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Rizzacasa’s synthesis began with the DCC-promoted coupling between the known 
carboxylic acid 142 and glycine TMSE ester 156 to afford enamide 158. The 
coupling proceeded in low yield due to partial isomerisation of the C5-C6 double 
bond which resulted in formation of the undesired diene 157. Practically, the 
product mixture was carried through to the final step, where treatment with TBAF 
removed the Teoc protecting group, yielding (+)-crocacin B 2 in 68% yield 
(Scheme 28). 
Rizzacasa’s approach yielded (+)-crocacin B in ~1% overall yield and required 15 
steps in the longest linear sequence. 
 
 
 
Scheme 28. Rizzacasa’s synthesis of (+)-crocacin B, 2. 
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2 Results and discussion 
 
2.1 Formal synthesis of (+)-crocacin C 
 
anti,anti-Stereotriad: hydroboration-oxidation approach 
 
As part of our approach, several strategies were taken into consideration for the 
synthesis of (+)-crocacin C 3. Our principal aim in all of these efforts was the 
development of a synthetic route which could easily access the primary amide of 
(+)-crocacin C as simply and quickly as possible and from which more complex 
derivatives could be explored. In addition, of course, the proposed synthetic route 
needed to be enantioselective, amenable to scale up, economically viable and 
capable of bringing some important elements of novelty with respect to the 
numerous previous syntheses of (+)-crocacin C currently reported in literature.  
Our initial efforts towards the synthesis of (+)-crocacin C were based on a 
hydroboration-oxidation approach.[18] Thus, our retrosynthetic analysis began with 
a disconnection between the central core of the target, containing the four 
stereocentres, and the doubly conjugated lateral chain (Figure 21). This bond 
could be easily accessed through a HWE olefination between the corresponding 
aldehyde 28 and a diethylphosphonate intermediate 29,[19] followed by functional 
group interconversion of the ester moiety into primary amide. Diethyl phosphonate 
29 could be derived from a commercially available ethyl ester 159 in two 
straightforward steps of bromination and subsequent Michaelis-Arbuzov 
phosphonation following a well-known procedure.[20] The key aldehyde 28, bearing 
the four stereocentres present in (+)-crocacin C, could be achieved via an 
asymmetric aldol addition to chiral aldehyde 160. Aldehyde 160, on the other 
hand, could be accessed via the substrate controlled hydroboration-oxidation of 
the α,β-unsaturated ester 161, taking advantage of the indigenous chirality to 
introduce the two new stereocentres. Ester 161 could be accessed through Wittig 
olefination between aldehyde 163 and ylide 162. Aldehyde 163 can be easily 
prepared from the commercially available Roche ester, (S)-methyl 3-hydroxy-2-
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methylpropanoate 11, which provides us with the first stereocentre of the target 
from the outset. 
 
Figure 21. Retrosynthetic analysis of (+)-crocacin C via hydroboration approach. 
 
Our synthesis began with the TBDPS-protection of Roche ester 11, followed by 
reduction of the ester moiety to yield primary alcohol 165. Oxidation of the primary 
alcohol 165 under Swern conditions followed by Wittig olefination with ylide 162 
afforded the desired conjugated ester intermediate 161. These initial steps were 
extremely efficient and amenable to scale-up without problems of purity, 
epimerisation or drop in yields (>10 g scale) and accessed enoate 161 in excellent 
overall yield of 84% (Scheme 29).  
 
 
 
Scheme 29. Route from the commercial Roche ester to the intermediate 161. 
 
At this point, the hydroboration-oxidation strategy was ready to be tested on α,β-
unsaturated ester 161. The hydroboration step was performed in presence of a 
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catalytic amount of the Wilkinson’s catalyst, RhCl(PPh3)3.
[21] Literature reports 
have shown that small amounts of transition-metal complexes can accelerate the 
addition of boranes to alkenes under mild conditions and even at room 
temperature. In addition, the catalyst was expected to alter the chemoselectivity of 
the reaction in the case of multifunctional substrates. Studies made by Mannig and 
co-workers, have demonstrated that without Wilkinson’s catalyst the borane tends 
to add preferentially to the carbonyl group of the ester 161. However, in presence 
of 0.5 mol % of RhCl(PPh3)3, the hydroboration takes place preferentially at the 
double bond site.[22] 
 
Scheme 30. Prediction of chemoselectivity in hydroborations. 
 
The mechanism for the Rh-catalysed hydroboration reaction has not been fully 
established, but it is certainly fundamentally different from the corresponding 
uncatalysed processes. The most reasonable proposed mechanism is based on 
four phases (Scheme 31). The first step consists of the oxidative addition of the 
boron hydride to the metal, followed by ligand exchange in which the rhodium 
coordinates to the olefin. At this point, there is migratory insertion of the olefin into 
the rhodium hydride bond, followed by a final reductive elimination. 
 
 
 
Scheme 31. Proposed mechanism for Rh-catalysed hydroborations. 
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On initial analysis, the stereoselective outcome of the reaction was predicted to be 
controlled by the chiral centre already present in our substrate 161. This chiral 
centre was expected to direct preferential attack of the borane reagent from the Si 
face to avoid the steric hindrance of the methyl group (Figure 22).   
 
 
 
Figure 22. Predicted stereocontrol of the hydroboration reaction. 
 
Thus, the α,β-unsaturated ester 161 was treated with different hydroborating 
agents, such as 9-BBN 169, catecholborane 166 and pinacolborane 170 (Figure 
23), using a wide range of reaction conditions (temperature, reaction time, 
presence or absence of microwave irradiation). Unfortunately, all attempts were 
unsuccessful returning only starting material (Scheme 32, Table 2).  
 
 
Figure 23. 9-BBN 169, catecholborane 166, pinacolborane 170. 
 
 
 
 
Scheme 32. Efforts towards hydroboration-oxidation. 
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Entry Reagent Time Temperature MW mol % catalyst Result 
1 169 12 h -78 °C No 5 mol% No reaction 
2 169 24 h RT No 10 mol% No reaction 
3 169 48 h 100 °C Yes 10 mol% No reaction 
4 166 12 h -78 °C No 5 mol% No reaction 
5 166 24 h RT No 10 mol% No reaction 
6 166 48 h 100 °C Yes 10 mol% No reaction 
7 170 12 h -78 °C No 5 mol% No reaction 
8 170 24 h RT No 10 mol% No reaction 
9 170 48 h 100 °C Yes 10 mol% No reaction 
 
Table 2. Attempted conditions for the hydroboration-oxidation. 
 
It was reasoned that the double bond was too electron-poor due to conjugation 
with the ester moiety and it therefore seemed necessary, in order to increase the 
reactivity of the alkene, to reduce the ester unit. Reduction of the ester moiety 
proceeded cleanly to yield the corresponding alcohol which was then protected as 
a benzyl ether (Scheme 33). 
 
 
 
Scheme 33. Conversion to a more electron-rich system. 
 
However, as in the case of the hydroboration of ester 161, all attempts to achieve 
hydroboration proved unsuccessful, yielding only unreacted starting material 
(Scheme 34). 
 
 
 
Scheme 34. Attempted hydroboration-oxidation of benzyl ether 172. 
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On the other hand, when the hydroboration-oxidation sequence was performed 
using BH3
.THF, the reaction proceeded quickly and in fair yield. The observation 
that when bulky reagents such as 9-BBN, catecholborane and pinacolborane were 
used, the hydroboration did not take place at all, while with the use of the sterically 
undemanding reagent BH3
.THF the reaction was successful, suggested that steric 
factors exert more influence than electronic effects on the outcome of the reaction. 
Unfortunately, even if BH3
.THF improved the efficiency of the reaction, the 
stereoselectivity was very poor, as the hydroboration-oxidation gave 
diastereomeric mixtures. When the reaction was performed at room temperature, 
a ratio of 3.5:1.0 in favour of the undesired isomer 174 was obtained.  
Lowering the reaction temperature to -78 °C, resulted in a slight improvement in 
the ratio (1.8:1.0, 174:173). However, the result was clearly not satisfactory 
(Scheme 35). 
 
  
 
Scheme 35. BH3
.THF-mediated hydroboration-oxidation step. 
 
Entry Temperature 173/174 
1 RT 1.0/3.5 
2 -78 °C 1.0/1.8 
 
Table 3. Effect of temperature on the stereocontrol. 
 
The diastereoisomeric ratios obtained led us to reason that allylic strain (A1,3 
strain) might be controlling the facial selectivity of hydroboration.[23]  
In our hydroboration-oxidation system, in fact, the conformation is clearly 
controlled by a cis substituent. The low-energy conformer is that in which the 
hydrogen eclipses the double bond (A), while steric interactions between the chiral 
methyl and the alkene methyl (cis substituent) prevent the orientation in which the 
chiral methyl group would eclipse the double bond (B). This conformational bias 
influences the facial selectivity of the hydroboration and is responsible for the 
diastereoisomeric ratio obtained (Figure 24). 
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                                          (A)                               (B)                 
   
 
 
Figure 24. Allylic strain favours the undesired isomer 174. 
 
Taking into consideration the low selectivity associated with the hydroboration-
oxidation approach further investigation in this route was abandoned in favour of 
new strategies. 
 
 
anti,anti-Stereotriad: cuprate approach 
 
In order to overcome the difficulties met in the previous strategy, a new synthetic 
route toward (+)-crocacin C, based on the exploitation of cuprate chemistry, was 
explored. Retrosynthetically, the first disconnection of this second strategy mirrors 
the previous approach, and involves a HWE olefination between aldehyde 28 and 
diethylphosphonate 29. 
In this revised approach, aldehyde 28 could be accessed from epoxide 175 via 
organocuprate to generate the anti,anti stereotriad. Epoxide 175, in turn, could be 
obtained from α,β-unsaturated ester 176 via reduction to the corresponding allylic 
alcohol and subsequent Sharpless asymmetric epoxidation. Finally, the α,β-
unsaturated ester 176 could be easily synthesised through a Swern 
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oxidation/Wittig olefination sequence starting from commercially available Roche 
ester, (R)-methyl 3-hydroxy-2-methylpropanoate 177 (Figure 25). 
 
 
Figure 25. Second retrosynthetic analysis of crocacin C, 3. 
 
Synthetically, silyl protection of the (R)-Roche ester 177 yielded the TBDPS-ether 
178 in excellent yield. DIBAL-H reduction of ester 178 followed by oxidation of the 
resulting primary alcohol afforded aldehyde 179 in excellent yield. Wittig olefination 
of aldehyde 179 with ethyl triphenylphosphonoacetate yielded the desired (E)-ethyl 
enoate 176 in near quantitative yield and as a single double bond isomer. DIBAL-
H reduction of enoate 176 gave allylic alcohol 180.  
 
 
 
Scheme 36. Stereoselective synthesis of allylic alcohol 180. 
 
With the allylic alcohol 180 in hand, the epoxidation step was investigated.  
Epoxidation of this substrate under substrate controlled epoxidation conditions, 
using mCPBA and taking advantage of the chiral centre already present to direct 
the epoxidation, had been attempted previously within the Marquez group.[24] 
Disappointingly, the stereocontrol dictated by the methyl group was very poor, and 
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an unsatisfactory 1.6:1.0 mixture in favour of the desired diastereoisomer 175 was 
obtained (Scheme 37). 
 
 
Scheme 37. Substrate controlled mCPBA epoxidation. 
 
The rationale behind this result can be explained considering the work of Kishi and 
co-workers.[25] When cis-allylic alcohol 182 is the substrate of epoxidation using 
mCPBA, the desired isomer 183 is the only product of the reaction (Scheme 38). 
This is due to the fact that A is the preferred conformation assumed by the 
substrate as it minimises the steric compression present in the alternative eclipsed 
conformations B and C (Figure 26). 
 
 
 
Scheme 38. Kishi epoxidation of cis-allylic alcohol 182. 
 
 
 
Figure 26. Conformations of cis-allylic alcohol 182. 
 
On the other hand, when Kishi’s group performed the same reaction on the trans-
allylic alcohol 184, the stereocontrol was significantly reduced, and a 3:2 mixture 
of isomers was obtained (Scheme 39). 
 
A. E. Pasqua 2013  Chapter II  Results and Discussion 
  
252 
 
 
 
Scheme 39. Kishi epoxidation of trans-allylic alcohol 184. 
 
The lower stereoselectivity observed in the epoxidation of trans-allylic alcohol 184 
could be attributed to a lower degree of preference of one conformation with 
respect to the others, as the E geometry of the double bond causes less steric 
compression. 
Thus, trans-allylic alcohol 180 was deemed unsuitable to undergo substrate 
controlled epoxidation, and was instead subjected to a reagent controlled 
epoxidation under Sharpless conditions. Gratifyingly, the Sharpless asymmetric 
epoxidation of alkene 180 proceeded in excellent yield and with high 
diastereoselectivity to yield the syn-epoxy-alcohol 175 as an inseparable (95:5) 
mixture of diastereomers. This mixture of diastereoisomers was carried directly 
onto the next steps. 
  
 
 
Scheme 40. Stereocontrolled synthesis of the epoxide 175. 
 
 
 
Figure 27. Application of the SAE to our substrate 180. 
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In conclusion, the strategy led to the formation of the epoxide 175, with excellent 
yield in all steps. The synthetic sequence is amenable to scale up and was able to 
deliver significant amounts of epoxide (>10 g) in relatively short amounts of time.  
At this point, the regio- and stereoselective opening of 2,3-epoxy alcohol 175 with 
a methyl cuprate was attempted. It was reasoned that opening of epoxide would 
take place regioselectively at the C2 position due to both cuprate chelation with 
the free alcohol and steric hindrance exerted by the existing methyl group on the 
incoming nucleophile at the undesired position.  
In our initial attempt, the epoxy-alcohol mixture was treated with the lower order 
Gilmans’ reagent Me2CuLi, under Nakamura’s conditions, to yield the desired 1,3-
diol 187 together with trace amounts of the 1,2-diol side product 188.[26] The 
undesired diol was removed by treatment of the diastereomeric mixture with 
sodium periodate. This two step sequence yielded the desired 1,3-diol 187 in 
reasonable overall yield of 65% (Scheme 41). In later attempts, the two 
diastereoisomers were successfully separated by flash column chromatography. 
 
 
 
Scheme 41. Epoxide-opening via cuprate approach. 
 
In order to improve the reaction yield, a more reactive higher order Lipshutz’ 
cuprate, Me2Cu(CN)Li2 (in which the Cu-cluster contains an additional ligand),  
was utilised, following Dias’ experimental conditions.[7] Despite an increased 
reaction rate with respect to the first order cuprate conditions, the reaction yield 
obtained was slightly lower (56%). Considering these results, Nakamura’s 
procedure became the pivotal strategy for our synthesis. 
The diastereomerically pure 1,3-diol 187 was then selectively benzylated and the 
resulting secondary alcohol 189 methylated to afford the differentially protected 
triol 190.  Desilylation of ether 190 using TBAF yielded the free primary alcohol 
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191 which was oxidised under Swern conditions to produce the desired aldehyde 
192 in excellent yield.   
Until the arrival to aldehyde 192, the synthetic route proceeded well, with 
reasonably good yields, and as such was considered a satisfactory improvement 
with respect to the previous disappointing hydroboration-oxidation approach. 
 
 
 
Scheme 42. Conversion of 1,3-diol 187 to aldehyde 192. 
 
 
Strategies of coupling 
 
With the aldehyde intermediate 192 in hand, several coupling approaches were 
explored for the introduction of the styrene moiety. A preliminary coupling attempt 
was based on Carreira’s procedure which, if successful, would provide a one-pot 
stereoselective condensation of aldehyde 192 with the phenylacetylenic moiety. 
Carreira reported the enantioselective synthesis of propargylic alcohols by direct 
addition of terminal alkynes to aldehydes, under mild conditions and in the 
presence of either (+)- or (-)-N-methylephedrine as a chiral additive (Scheme 
43).[27] Carreira’s proposed mechanism involves the in situ generation of a zinc 
alkynylide as key step. The choice of chiral additive as a ligand for Zn(II) then 
determines the enantioselectivity of the reaction. 
 
 
Scheme 43. Carreira’s alkynylation of aldehydes. 
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Unfortunately, when Carreira’s conditions were applied to aldehyde 182, a 
disappointingly small percentage of aldehyde evolved toward the desired product 
193, the major product 194 being the result of collateral β-elimination. 
 
 
 
Scheme 44. Application of Carreira’s protocol to our substrate. 
 
Considering the unfortunate results, Carreira’s procedure was abandoned and 
subsequent efforts focused on a substrate controlled stereoselective coupling.  
 
 
 
Scheme 45. Substrate-dependent proposed coupling. 
 
The main concept in this new approach (Scheme 45) was to utilise a 
straightforward addition of the phenylacetylene moiety to the aldehyde 
intermediate 192, without the use of chiral reagents, through the exploitation of the 
intrinsic directing-effects exerted by the substrate. The aldehyde intermediate 192 
bears substituents at both the α and β positions and each of these stereocenters 
could potentially influence the stereochemistry of the nucleophilic addition.  
This is a typical example of an integrated α,β-stereoinduction model as proposed 
by Evans.[28a,b] In fact, this revised model integrates the Felkin-Ahn and 1,3-
asymmetric induction models and could be used to predict the stereoselective 
outcome of the reaction. Aldehyde 192 displays an anti relationship between the α-
methyl and the β-alkoxy substituents, and based on Evans’ model, the relative 
configurations of these substituents should mutually reinforce each other and 
result in preferential nucleophilic addition as to generate the syn,anti-adduct 
(Figure 28). This analysis leads to the conclusion that such a synergic effect 
should enhance the π-facial selectivity in the desired fashion. 
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Figure 28. Evans merged α,β-stereoinduction polar model. 
 
Alternatively, chelation control would afford a different result. In fact, as Evans 
shows in his studies, the chelate of the anti-substituted aldehyde reveals a non 
reinforcing nature of this stereochemical array. The chelate intermediate places 
the α and β substituents on opposite sides of the coordinated carbonyl. As the 
nucleophile approaches from the Felkin diastereoface, it encounters steric 
encumbrance from the α-methyl group (Figure 29), therefore addition to anti-
substituted aldehydes would result in diminished stereoselectivity under chelate 
control. 
 
Figure 29. Evans merged α,β-stereoinduction chelate model. 
 
However, it was reasoned that, even in case of unsatisfactory isomeric ratios in 
the products, an oxidation/stereoselective reduction sequence could be exploited 
following Midland’s protocol to afford the desired product (Scheme 46).[29] 
 
 
 
Scheme 46. Oxidation/stereoselective reduction proposed sequence. 
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The reduction of unhindered ketones, such as acetylenic ketones, using either 
enantiomer of B-3-pinanyl-9-borabicyclo[3.3.1]nonane (Alpine-Borane®), known as 
the Midland reduction, provides a simple means of forming chiral, non racemic 
alcohols of known absolute configuration in high enantiomeric purity.  
The reaction is widely applicable to ketones, however, on the basis of steric 
effects, in general, methyl ketones give the lowest selectivity. If the group adjacent 
to the ketone is a branched alkyl group or phenyl group, then the purity of the α-
pinene becomes the limiting factor in obtaining high enantioselectivities. The 
reaction’s selectivity is highly reliable and use of the same enantiomer of Alpine-
Borane® consistently gives the same absolute configuration of the resulting 
alcohol. The reaction conditions are very mild and the reagent is chemoselective 
easily discriminating the acetylenic group from other unsaturated functionalities.  
A major contributing factor to the degree of asymmetry observed in the alcohol 
products is the specificity of Alpine-Borane® for the substrate ketone. The ketone 
is postulated to approach the borane such that a boatlike transition state is formed. 
Two possible transition states are possible. The bulkier substituent could be 
accommodated in either an axial or an equatorial orientation. The preference for 
reduction by transition state A or transition state B would determine the absolute 
degree of asymmetry that could be introduced into the resulting alcohol (Figure 
30). Other competing modes of reduction, i.e. dehydroboration-reduction, or the 
use of α-pinene of less than 100% e.e., will lower the asymmetric induction 
observed. 
 
 
 
Figure 30. Transition-state model. 
 
Orientating the ketone substituents into the proposed model transition state such 
that the smallest group occupies the pseudoaxial position, it is possible to predict 
the configuration of the asymmetric carbinol center generated. In our specific case, 
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considering the nature of the substituents present on each side of the ketone, it 
was expected that the desired isomer would be obtained using (R)-Alpine-Borane® 
(Scheme 47). 
 
 
 
Scheme 47. Proposed use of (R)-Alpine-Borane®. 
 
The applicability of this strategy, was tested on a small scale. Disappointingly, all 
attempts to introduce the phenyl acetylene unit resulted in β-elimination. These 
results mirror those encountered during the application of the Carreira 
methodology, further corroborating the unsuitability of this particular approach. 
 
 
 
Scheme 48. New efforts toward the aldol addition. 
 
At this stage an alternative strategy based on a Stille coupling between an acid 
chloride intermediate and an organotin reagent was considered.[30]  
The palladium-catalysed coupling of acid chlorides with organotin reagents has 
been demonstrated as an efficient reaction to afford ketones in high yields. The 
reaction is quite general with respect to both coupling partners, the ketone product 
is formed rapidly under mild, neutral reaction conditions. Furthermore, a wide 
variety of functional groups can also be present on the acid chloride, including 
nitro, nitrile, haloaryl, methoxy, ester, and even aldehydes. In the proposed 
catalytic cycle for this reaction the active catalyst bis(triphenylphosphine) 
palladium(0) 2, generated from benzylchlorobis(triphenylphosphine)palladium(II), 
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undergoes oxidative addition of the acid chloride to give the acylchloropalladium 
complex 3. Transmetalation reaction between complex 3 and the organotin 
reagent yields the acylalkylpalladium(II) species 4, which undergoes reductive 
elimination of the ketone and regenerates 2. The transmetalation stage 3 - 4, in 
the palladium-catalysed ketone synthesis, has been proposed to occur by the 
electrophilic attack of acylchloropalladium(II) complex 3 on the carbon bonded to 
tin (Figure 31).  
 
 
 
Figure 31. Catalytic cycle for the coupling reaction of acylchlorides with 
organotins. 
 
Synthetically, this new approach began with the synthesis of the stannyl-fragment 
200 which was easily synthesised from phenylacetylene 199 through treatment 
with tributyltin hydride and AIBN (Scheme 49). 
 
 
 
Scheme 49. Synthesis of the stannyl-intermediate 200. 
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On the other hand, the acid chloride was generated starting from alcohol 191 via 
PDC oxidation to carboxylic acid, followed by conversion to chloride via treatment 
with SOCl2. Unfortunately, formation of the acid chloride proved highly problematic 
due to the same β-elimination observed previously, which affected the purity of the 
acid chloride obtained. Nevertheless, the Stille coupling was attempted on the 
crude acyl chloride, however the reaction disappointingly resulted in complete 
decomposition of starting material with no product being detected (Scheme 50). 
 
 
 
Scheme 50. Stille coupling attempt. 
 
Faced with the difficulties encountered during the nucleophilic addition to both the 
aldehyde and acid chloride, a new approach was subsequently taken into 
consideration. Our new strategy was based on a Wittig olefination/[3,3]-
sigmatropic rearrangement sequence. The first step required the synthesis of ylide 
204 which was afforded in good yield using a simple procedure reported in 
literature (Scheme 51).[31] 
 
 
 
Scheme 51. Preparation of ylide 204. 
 
Olefination of aldehyde 192 with the stabilised phosphorane 204, as expected, 
gave the desired (E)-enone 201 as a single double bond isomer, in moderate 
yield. The low yield could potentially be explained by the formation of the 
previously seen undesired β-elimination product 194, although no side products 
were isolated (Scheme 52). 
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Scheme 52. Synthesis of enone 201 via Wittig olefination. 
 
Stereoselective Corey-Bakshi-Shibata reduction of enone 201,[32] proceeded with 
an excellent yield of 99%, however a disappointing 1.1:1.0 mixture of 
diastereoisomers in favour of the desired product 205 was obtained. Fortunately, 
this mixture was easily separable by flash column chromatography and the desired 
isomer 205 was obtained cleanly in fair yield (Scheme 53). 
 
Scheme 53. Asymmetric reduction of enone 201. 
 
 
anti,anti,syn-Stereotetrad: [3,3]-sigmatropic rearrangement 
 
The desired allylic alcohol 205 was acetylated to afford the intermediate 207 from 
which the key [3,3]-sigmatropic rearrangement of allylic acetates was explored.[33a-
d] This transformation proceeds via a pericyclic reaction, characterised by the 
movement of a sigma bond from the 1 position to the relative 3 position. The 
reaction is so called because the newly formed σ bond has a 3,3 relationship to 
the former σ bond as shown below (Figure 32): 
 
 
 
Figure 32. Bond movement in the [3,3]-sigmatropic rearrangement. 
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The process occurs in a concerted manner and is characterised by suprafacial 
symmetry as the new bond is formed on the same face as was the former. There 
are three components involved in this transformation: two non-conjugated π 
bonds, which must overlap, with a σ bond connecting the two. All of these 
components participate with two electrons each, with the pericyclic process taking 
place through a chair-like six-membered transition state as shown below (Figure 
33): 
 
 
Figure 33. Orbital description in the [3,3]-sigmatropic rearrangement. 
 
In our case, we considered a Pd(II)-catalysed rearrangement. The metal-catalysed 
rearrangement proceeds through a cyclisation-induced mechanism starting with 
the coordination of the metal to the alkene, followed by nucleophilic attack of the 
oxygen to form a six-membered ring, which finally collapses to generate the 
desired product (Figure 34).  
 
 
 
Figure 34. [3,3]-sigmatropic rearrangement. 
 
Upon treatment with PdCl2(CH3CN)2 under Overman’s conditions, the acetate 
group of 207 was cleanly transposed to generate the anti:anti:syn adduct 208 in 
quantitative yield and as a single diastereomer.  As this palladium(II)-catalysed 
sigmatropic rearrangement of allylic acetates is characterised by a suprafacial 
stereochemistry, there was complete transfer of chirality. After the Overman [3,3]-
sigmatropic rearrangement, reduction of the acetate group was cleanly achieved 
using DIBAL-H in 99% yield. Subsequently, the resulting secondary alcohol 209 
was methylated to afford the fully protected intermediate 210 (Scheme 54).  
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Thus far, this new approach had successfully incorporated each of the four chiral 
centres present in (+)-crocacin C. 
 
 
Scheme 54. [3,3]-sigmatropic rearrangement approach. 
 
 
Incorporation of the lateral chain of (+)-crocacin C via HWE olefination  
 
Benzyl-deprotection of intermediate 210,[34] followed by careful DMP-oxidation[35] 
of the resulting primary alcohol and stereoselective Horner-Wadsworth-Emmons 
olefination with phosphonoacetate 29 successfully completed the formal synthesis 
of (+)-crocacin C (Scheme 55).  
 
 
 Scheme 55. Completion of the formal synthesis of (+)-crocacin C. 
 
Phosphonate 29 was prepared in two steps from the commercially available ester 
ethyl 3-methylbut-2-enoate 159. The initial bromination step afforded a 1.3:1.0 
mixture of two isomers in favour of the desired product 211. This mixture was 
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cleanly separated via column chromatography to afford the desired isomer 211 in 
28% yield (Scheme 56). 
 
 
 
Scheme 56. Bromination of the lateral chain. 
 
Phosphonation of bromide 211 was performed following a Michaelis-Arbuzov 
procedure (Figure 35).[36] Thus, (E)-ethyl 4-bromo-3-methylbut-2-enoate 211 was 
heated with triethyl phosphite to afford the desired lateral chain (E)-ethyl 4-
(diethoxyphosphoryl)-3-methylbut-2-enoate 29 in excellent yield (Scheme 57). 
 
 
 
Scheme 57. Phosphonation of the lateral chain. 
 
 
 
Figure 35. Michaelis-Arbuzov mechanism. 
 
The spectral data and optical rotation of dienoate ester 42 is concurrent with that 
reported by Chakraborty and co-workers for the same advanced intermediate 
during their synthesis of (+)-crocacin C.[6] Gratifyingly, the HWE olefination 
proceeded with complete stereocontrol of the double bond geometry.  
In summary, a novel formal synthesis of (+)-crocacin C was completed, taking 
advantage of a highly regio-selective cuprate addition to the epoxide and a 
diastereoselective [3,3]-sigmatropic rearrangement. The final steps to achieve a 
total synthesis of (+)-crocacin C required the functional group interconversion of 
ethyl ester 42, into the (+)-crocacin C 3 amide. Initial attempts were based on the 
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saponification of ester 42 to the corresponding carboxylic acid, followed by 
activation with ethylchloroformate and subsequent treatment with ammonium 
hydroxide, following Chakraborty’s procedure.[6] Unfortunately, this procedure was 
unsuccessful, likely due to issues encountered during the saponification step. 
Treatment of the ethyl ester 42 with NaOH, KOH or LiOH at room temperature 
failed to give satisfactory results, while carrying out the reaction in refluxing THF 
led to epimerisation and decomposition of the starting material (Scheme 58).  
 
 
 
Scheme 58. Final functional group interconversion via saponification. 
 
Application of Ley’s conditions using magnesium nitride in methanol as a source of 
ammonia, proceeded in fair yield on a simple model system (Scheme 59).[37] 
Disappointingly, this methodology was unsuccessful on the more complex 
substrate 42 (Scheme 60). 
 
 
Scheme 59. Magnesium nitride treatment in model system 213. 
 
 
 
 
Scheme 60. Final functional group interconversion via magnesium nitride. 
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2.2 Revised total synthesis of (+)-crocacin C  
 
anti,anti-Stereotriad: crotylboronation approach 
 
Despite the successful completion of a novel formal synthesis of (+)-crocacin C, 
the approach itself was deemed unsuitable for scale-up due to the number of 
steps required and its low overall efficiency. In addition, the final conversion of the 
ester moiety into the primary amide was unsuccessful under all attempted 
conditions. Challenged by this outcome, an alternative, more convergent route to 
(+)-crocacin C was devised. This led to the development of a second generation 
synthesis based on a crotylboronation/[3,3]-sigmatropic rearrangement approach. 
As shown in Figure 36, this revised strategy was much more concise with respect 
to the previous approaches. The foremost alteration considered was the 
introduction of the lateral chain directly as primary amide through a Stille coupling, 
thus avoiding the issues related to the final amide formation. The styrenyl moiety 
on the other hand was envisioned as originating through a cross-metathesis 
reaction followed by the highly successful [3,3]-sigmatropic rearrangement 
previously employed as part of our first generation synthesis. This led to the 
fragment 215 in which the iodo-olefin could be introduced via Takai olefination 
while the opposite terminal olefin could, in another significant alteration to the 
previous approach, be accessed by crotylboronation of aldehyde 163. 
 
 
 
Figure 36. Second generation retrosynthesis of (+)-crocacin C, 3. 
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Our revised synthesis of (+)-crocacin C 3 began with Roche ester 11 which, via 
silyl protection and reduction-oxidation of the resultant methyl ester 164, was 
converted to aldehyde 163. The key diastereoselective crotylboronation of 
aldehyde 163 under Roush’s conditions[38a,b] yielded the desired anti,anti-adduct 
217.  These initial steps in the synthesis were straightforward, quick and high-
yielding. It is noteworthy that the reaction sequence was amenable to scale-up (> 
10 g) without significant drop in the yield and purity of the sample and, 
significantly, alcohol 217 was the first intermediate in the synthesis that required 
purification (Scheme 61).   
 
 
 
Scheme 61. Synthesis of alcohol 217. 
 
 
Roush’s crotylboronation 
 
The key step in our new approach was the pivotal crotylboronation that allowed 
the one pot insertion of two stereocentres to generate the challenging anti,anti 
stereotriad in a single transformation. The chiral reagent (S,S)-diisopropyl tartrate-
modified (E)-crotylboronate 216 is well known in literature and can be prepared 
with high isomeric purity (> 98%) via metallation of trans-2-butene 218 with n-
butyllithium and potassium tert-butoxide in tetrahydrofuran. The resultant (E)-
crotylpotassium 219 can then be treated with triisopropylborate and esterified with 
(S,S)-DIPT.[38a] 
 
 
 
Scheme 62. Roush synthesis of asymmetric crotylboronate 216. 
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The first step involves n-butyllithium deprotonation of trans-2-butene while 
potassium tert-butoxide treatment subsequently affords a stabilised ion pair. In this 
phase, temperature control is extremely important. Schlosser’s studies have 
shown that at -48 °C the crotylpotassium species exists as a 99:1 equilibrium in 
favour of the (Z) isomer (Scheme 63).[39] 
 
 
 
Scheme 63. Importance of temperature control. 
 
The cis isomer is favoured due to the endo transition state in which the protons of 
the terminal methyl group can contribute hydrogen-bonding with the anion. For this 
reason the reaction must be strictly carried at -50 °C, never above. 
The choice of K+ as counter-ion is also very important as allylpotassium species 
are fairly stable, undergoing configurational changes only very slowly.  
With the chiral reagent (S,S)-DIPT 216 in hand, Roush’s crotylboration was 
explored using the (S)-aldehyde 163. This substrate pairing is an example of a 
mismatched double asymmetric combination. The desired diastereoisomer 217 is 
intrinsically disfavoured, displaying anti-Felkin relationship with respect to the 
aldehyde. However, through utilisation of the chiral auxiliary, it was possible to 
override the diastereofacial preference of the aldehyde (Figure 37).
[38b]
 
 
 
 
Figure 37. Mismatched double asymmetric crotylboration. 
 
Significantly, Roush’s crotylboronation did not only generate the desired anti,anti-
adduct, but it also provided an olefinic handle from which a cross-metathesis could 
be explored. 
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Insertion of styrene moiety via cross-metathesis 
 
In order to determine the maximum efficiency of our terminal olefin 217 in cross-
metathesis reactions, three potential coupling partners were prepared: enone 222, 
allylic alcohol 223 and allylic acetate 224. Enone 222 was accessed via Grignard 
addition to benzaldehyde 225, followed by oxidation of the resultant allylic alcohol 
with TEMPO/BAIB.[40] Enone 222 was stereoselectively reduced to the 
corresponding allylic alcohol 223 via Corey-Bakshi-Shibata reaction and finally, the 
allylic alcohol 223 was acetylated to afford the corresponding allylic acetate 224 
(Scheme 64). 
 
 
 
Scheme 64. Synthesis of the coupling partners 222, 223 and 224. 
 
With the desired coupling partners in hand, the cross-metathesis conditions were 
explored. Despite extensive experimentation, cross-metathesis of olefin 217 with 
either vinyl acetophenone 224 or its reduced form 223 proved to be extremely 
slow likely due to the low reactivity of both coupling partners. However, application 
of the cross-metathesis conditions recently reported by Donohoe using the Zhan-
1B catalyst 226 (figure 226) successfully coupled the two olefins 217 and 222 in 
good yield and with excellent stereocontrol to give the desired (E)-enone 227 
(Table 4 and Scheme 65).[41] 
 
 
 
Figure 38. Zhan 1B catalyst 226. 
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Table 4. Cross-metathesis studies for the synthesis of enone 227. 
 
 
 
Scheme 65. Optimised synthesis of the enone 227. 
 
It is well documented that the more hindered and electron-poor the olefin, the less 
reactive it will be to cross-metathesis. Therefore a categorisation of different olefin 
types was disclosed. Olefins are ranked into four classes ranging from type I, 
electron-rich/unhindered olefins, to type IV, electron-poor/sterically demanding 
olefins.[42] In our specific case, the vinyl ketone 222, deemed a type II olefin, and 
the secondary homoallylic alcohol 217, a particularly hindered type II olefin, is 
considered a difficult borderline case. Although the reaction proved to be fairly 
slow for both homo- and hetero-dimerisation, it was successful as a result of three 
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positive factors: the first factor was the presence of the free alcohol in the coupling 
partner 217. Such olefins bearing proximal alcohol groups have emerged as a 
special substrate class for cross-metathesis due to their enhanced levels of 
reactivity, likely due to hydrogen bonding with the chloride ligands on the 
metathesis catalyst.[43] The second positive factor was the use of the coupling 
partner 222; such electron-deficient olefins are well known for their capability to 
undergo slow dimerisation in the presence of metathesis catalysts, hence enone 
222 is an ideal coupling partner for cross-metathesis with terminal olefins. As a 
result, when this electron-poor substrate was used in excess (5 equivalents), the 
reaction proceeded efficiently and stereoselectively to generate the (E)-isomer.[44] 
Finally, the third factor was the choice of the modern and extremely powerful Zhan 
1B catalyst, which shows increased reactivity due to the presence of a 
dimethylsulfonamide stabilising group and has proven effective even in the 
metathesis of poorly reactive substrates. 
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Corey-Bakshi-Shibata reduction of the enone 227 
 
Subsequently, enone 227 was stereoselectively reduced via Corey-Bakshi-Shibata 
reduction to afford the desired allylic alcohol 228 in excellent yield and in >99% 
d.e. (Scheme 66). 
 
 
 
Scheme 66. CBS reduction of the enone 227. 
 
Interestingly, we observed a long-range influence exerted by the homoallylic 
alcohol on the outcome of this reduction.[45a-c] For example, in the case of 
acetylated intermediate 229, the alcohol 231 was observed as the major 
diastereomer in moderate yield.  However, when the allylic alcohol was methylated 
230, the yield was improved significantly, but no stereocontrol was observed 
during the reduction.  In the case of the unprotected alcohol 227, the reduction 
proceeded with complete stereocontrol to generate the desired diol 228 (Table 5).   
 
 
 
Table 5. Long-range neighbouring group effects observed during CBS reductions. 
 
Although the reasons for this remarkable change in behaviour are not completely 
clear, there are some observations that can be seen when considering the boat-
like transition state involved in the process. Through computational and modelling 
studies, such as those reported by Meyer,
[45c]
 it has become increasingly evident 
that the nonbonding interactions in the transition state of the process play a 
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complex role in the mediation of stereoselection. Computational studies proved 
that the cyclic arrangement of the transition state including the reductant borane 
and the carbonyl of the ketone to be reduced, (at least in the case of prochiral 
ketones bearing a small substituent with greater steric presence such as in our 
case) assumed a boat conformation, as was previously predicted by Evans.[45b] 
When the boat-like transition state is considered, it can be seen that the only 
neighbouring group of the CBS catalyst that is brought into close proximity with the 
substrate is the B-Me group. This suggests that this group may be involved in the 
stereoselectivity. Hence, it is possible that in the presence of the free alcohol, the 
co-ordination between the hydroxyl group and the oxazaborolidine is responsible 
for the enhancement in stereoselectivity observed, while when the methoxy or the 
acetyl moiety are present, the steric clash with the B-Me group creates an 
opposing effect on the stereocontrol (Figure 39). 
 
 
 
Figure 39. Long-range neighbouring group effects observed during CBS 
reductions. 
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[3,3]-Sigmatropic rearrangement 
 
The newly generated diol 228 was then acetylated to afford bis-acetate 233, 
allowing us to implement the key [3,3]-sigmatropic rearrangement.  Gratifyingly, 
when treated with PdCl2(CH3CN)2, the bis-acetate 233 gave the desired 
anti,anti,syn-product 19 as a single diastereomer in excellent yield. Hydrolysis of 
bis-acetate 19 generated the free diol 20 together with triol 234, which was 
selectively reprotected to afford the desired diol 20 in very good overall yield.  
Methylation of diol 20 followed by silyl-group removal gave the desired alcohol 22 
in near quantitative yield over the two steps. With alcohol 22 in hand, the final 
steps of the synthesis were explored. Careful oxidation of alcohol 22 generated 
aldehyde 28 (Scheme 67). 
 
 
 
Scheme 67. Synthesis of alcohol 22. 
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Lateral chain insertion via Stille coupling 
 
As a consequence of the initial setback encountered in the previous strategy 
based on an HWE olefination for the introduction of the lateral chain, an alternative 
end game was required for the total synthesis of (+)-crocacin C 3.  In order to 
introduce the amide functionality without necessitating a final functional group 
interconversion, a strategy involving a metal-mediated coupling with the amide unit 
already in place was pursued. Thus, treatment of aldehyde 28 under Takai 
conditions[46] afforded the desired (E)-vinyl iodide 43 in excellent yield and with 
complete stereocontrol. With the (E)-iodo-alkene 43 in hand, Stille coupling with 
the stannyl enamide 44 afforded (+)-crocacin C 3 in poor yield, however, an 
exciting mixture of products containing two novel isomeric crocacin analogues 235 
and 236 was also obtained (Scheme 68). 
 
 
Scheme 68. Preliminary attempt of Stille coupling. 
 
The structures of these novel analogues were assigned based on analysis of their 
1D and 2D NMR spectra, and the double bond geometries were confirmed by 
NOE studies (Figure 40). 
 
 
 
Figure 40. Observed NOEs. 
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The promising Stille coupling results prompted us to consider a reverse coupling 
strategy for the completion of the synthesis whereby the enamide unit would be 
introduced as the vinyl halide and the C4-C11 framework of (+)-crocacin C 3 would 
be brought forward as the vinyl stannane 8. Conveniently, the synthesis of the key 
(E)-vinyl stannane 8 was achieved in one step through the Hodgson olefination of 
aldehyde 28 in moderate yield (Scheme 69).[47a,b] 
 
 
 
Scheme 69. Hodgson olefination. 
 
Microwave assisted Stille coupling of vinyl stannane 8 with the vinyl iodide bearing 
amide 7 then yielded (+)-crocacin C 3.  Importantly, (+)-crocacin C was isolated as 
a single double bond isomer in much improved yield with respect to the initial end-
game strategy. 
 
 
Scheme 70. Reverse Stille coupling strategy. 
 
Although the Stille coupling of vinyl stannane 8 with vinyl iodide 7 yielded (+)-
crocacin C 3 as a single alkene isomer, the process was not amenable to scale-
up, often resulting in protodestannylation during purification of vinyl stannane 8. 
In a variant of the highly promising Stille coupling which would allow us to 
circumvent the protodestannylation issues, aldehyde 28 was envisioned as being 
converted into the corresponding alkyne 79, which could then potentially undergo 
a one-pot Pd-catalysed hydrostannylation/Stille coupling reaction, following 
Malezka’s protocol. 
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Scheme 71. Proposed one-pot procedure. 
 
Following this new synthetic strategy, aldehyde 28 was subjected to Ohira-
Bestmann homologation conditions to generate alkyne 79. The homologation 
proceeded in quantitative yield to afford alkyne 79 after minimal purification 
(Scheme 72).[48a,b] 
 
 
Scheme 72. Ohira-Bestmann homologation. 
 
Mechanistically, the Ohira-Bestmann homologation is believed to occur via 
deacylation of the Ohira-Bestmann reagent by methoxide. The resulting carbanion 
then attacks the aldehyde to form an oxaphosphetane-type intermediate, which 
subsequently decomposes to afford a thermally unstable diazoalkene. The 
diazoalkene loses dinitrogen through α-elimination and the resulting 
alkylidenecarbene undergoes a 1,2-shift to give rise to the desired alkyne (Figure 
41).  
 
 
Figure 41. Ohira-Bestmann homologation mechanism. 
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Having alkyne 79 in place, the one-pot hydrostannylation/Stille coupling sequence 
developed by Maleczka[49] was considered. This strategy has proven to be an 
extremely convenient method which avoids any issues related to the isolation and 
purification of the stannane intermediate. Stannane intermediates can be prone to 
silica gel-mediated protonolysis, resulting in destannylation and as a consequence 
dramatic drop in yield and purity of the product. Conveniently, the catalyst used for 
the sequence, Pd(II)Cl2(PPh3)2, is cheap, air stable and easily prepared, 
culminating in an extremely convenient overall process. The reactive species is 
formed in situ via reduction of Pd(II) to Pd(0) by tributyltin hydride (Equation A). 
 
 
 
The proposed mechanism of the reaction involves the oxidative addition of 
tributyltin hydride to the metal centre, followed by coordination of the alkyne which 
can undergo hydro-metallation. Final reductive elimination affords the desired 
organostannane; the process occurs with cis stereoselective addition leading to 
the desired (E)-isomer. As was shown by both Giubè[50] and Maleczka,[49] a good 
(E)-regioselectivity in this process depends on the presence of bulky propargylic 
substituents (Figure 42).[51] 
 
 
 
Figure 42. Mechanism of Pd-catalysed hydrostannation. 
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To our delight, in situ conversion of alkyne 79 into the (E)-vinyl stannane 8 with 
concomitant Stille coupling (with vinyl iodide 7) using Bressy and Pons’ 
conditions[11] afforded (+)-crocacin C 3 in high yield and as a single isomer. In our 
specific case the nature of the propargylic group provided enough steric hindrance 
to give complete (E)-stereocontrol. 
 
 
 
Scheme 73. End-game strategy to (+)-crocacin C 3. 
 
 
Completion of the total synthesis of (+)-crocacin C 
 
In conclusion, we have developed a reliable, flexible and highly efficient synthesis 
of (+)-crocacin C 3. Our approach is amenable to scale-up and is able to generate 
(+)-crocacin C 3 in 14 steps (8 isolated intermediates) and 20% overall yield (89% 
yield per step) from commercially available Roche ester 11. This represents a 
great improvement respect to our first approach in which a formal synthesis of our 
target up to the common intermediate 22 was completed in 16 isolated 
intermediates and with a modest 2.3% overall yield.  
Our new approach exploits some interesting key steps never used before for the 
synthesis of the crocacins, such as a (S,S)-diisopropyl tartrate-modified (E)-
crotylboronate mediated crotylboronation, a cross-metathesis coupling and a [3,3]-
sigmatropic rearrangement of allylic acetates. The total synthesis compares 
favourably with the previous syntheses reported in literature.   
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2.3 Total synthesis of (+)-crocacin D 
 
Imide/halo-olefination approach 
 
With (+)-crocacin C in hand, we next considered the generation of the more 
complex members of the crocacin family and, in particular, (+)-crocacin D, which 
has proven to exhibit the widest and strongest biological activity. The initial project 
was based on the exploitation of the recently developed methodology of 
imide/halo-enamide formation that has been deeply discussed in the first section 
of this dissertation. On the basis of this plan, the free carboxamide (+)-crocacin C 
3 could be considered as the starting point for the generation of the more complex 
(+)-crocacin A 1, B 2 and D 4. Formylation of the primary amide was envisioned 
using N-formylbenzotriazole as formylating agent. The resulting N-formylimide 
could be then stereoselectively converted into the (Z)-mono-halo-enamide 238. At 
this point, the sp2-sp3 coupling of the custom lateral chain 239 should deliver the 
desired crocacins.  
 
 
 
Figure 43. Retrosynthetic analysis of (+)-crocacin A 1, B 2, D 4. 
 
Despite the great potential of the project, this basic idea proved so far to be 
unsuccessful as a result of two main issues. Regardless of extensive 
experimentation, the first step of formylation via N-formylbenzotriazole (following 
the recently developed protocol) failed under several conditions. The use of n-
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butyllithium as base proved to be too harsh and created problems of β-elimination, 
due to the highly conjugated nature of the system. The choice of a weaker base 
such as sodium hydride, led to epimerisation and isomerisation issues affording 
complex mixtures of difficult interpretation. The use of milder conditions, such as 
potassium tert-butoxide and microwave irradiation returned the unreacted starting 
material (Table 6). 
 
 
 
Table 6. Attempts of formylation of (+)-crocacin C 3. 
 
In addition to the issues related to amide formylation, subsequent steps pose 
severe challenges also. As described in the first section of this dissertation, the 
sp2-sp3 coupling of halo-enamides proved problematic under a variety of 
conditions (Stille, Suzuki, Negishi, Molander, Lipshutz).[52a-e] Indeed, to the best of 
our knowledge, there are no examples so far in the literature of successful 
couplings between a β-halo-enamide and a sp3-alkyl chain. Therefore, even in the 
event of successful formylation and halo-olefination, the insertion of the lateral 
chain 239 on intermediate 238 would prove troublesome. In addition, it must be 
stressed that the crocacins are very fragile natural products, highly sensitive in 
particular to acidic conditions, light and moisture. As such, a stepwise approach 
does not seem conducive to their synthesis, as fragmentation issues may appear 
along the way. Thus, considering this initial setback, it was reasoned that the 
exploitation of an alternative approach based on the highly convergent insertion of 
the lateral chain on the precursor (+)-crocacin C would be optimal. 
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Ruthenium mediated coupling approach 
 
The ruthenium-catalysed anti-Markovnikov hydroamidation of terminal alkynes first 
introduced by Gooßen and co-workers in 2005 is an atom-economic 
transformation in which the stereochemistry of the product depends on the nature 
of the ligands chosen for the catalyst.[53] Hence, both (E)- and (Z)-enamides can 
be prepared in a stereocontrolled fashion from the corresponding primary amides 
and custom terminal alkynes. The catalytically active species in such 
transformations are the phosphine-stabilised ruthenium(II) amides generated from 
the catalyst precursor [(cod)Ru(met)2] after displacement of: a) the cyclooctadiene 
ligand (COD) with phosphine ligands; and b) the basic methallyl ligands with 
Yb(OTf)3-acidified amides (Figure 44). 
 
 
 
Figure 44. Activation of the catalyst. 
 
A strong Lewis acid co-catalyst is necessary for the preferential activation of the N-
H bond of the primary amide with respect to that of the resulting secondary amide 
product. Thus, the process terminates after a single vinylation even in presence of 
excess alkyne. The choice of DMF as solvent is almost compulsory as it is able to 
solubilise the co-catalyst without reducing its activity. In addition, the reaction 
conditions are very mild so that a variety of common functional groups are 
tolerated, including ester, ether, alkene, nitrile, nitro and halide moieties. 
From a stereoselective point of view, the thermodynamically unfavoured (Z)-
configured secondary enamides can be synthesised using a catalyst generated in 
situ from bis(2-methallyl)(cycloocta-1,5-diene)ruthenium(II), 1,4-bis(dicyclohexyl-
phosphino)butane and ytterbium triflate. The thermodynamically favoured (E)-
isomers, on the other hand, can be obtained by an in situ isomerisation of the (Z)-
double bond mediated by triethylamine and molecular sieves. The strong 
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dependence of the stereocontrol of the reaction on the choice of ligand for the 
catalyst can be explained if we consider that the preferred orientation of the 
vinylidene moiety relative to the amide will occur depending on the steric bulk of 
the phosphines, Figure 45. The use of electron-rich, sterically demanding and 
chelating ligands leads to the formation of an (E)-ruthenium-enamide complex B 
which will afford the (Z)-isomers, while the use of less demanding ligands is 
necessary to afford the (E)-configured products. 
 
 
 
Figure 45. Ligand-dependent stereoselectivity of the coupling. 
 
Although to date the mechanism of the process has not been completely proven, 
the most recent mechanistic investigation carried by Gooßen in 2011,[54] supports 
the presence of a ruthenium-hydride and ruthenium-vinylidene species as principal 
intermediates. Following this hypothesis, the first step can be considered the 
oxidative addition of the amide to an active Ru0 species, followed by alkyne 
insertion into the ruthenium-hydride bond and then the vinyl-vinylidene 
rearrangement. Finally, nucleophilic attack of the amide to the α-carbon of the 
adduct and subsequent reductive elimination affords the anti-Markovnikov product 
(Figure 46). 
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Figure 46. Mechanistic hypothesis. 
 
On the basis of this methodology, (+)-crocacin D could be envisioned as 
originating from (+)-crocacin C through a ruthenium(II)-mediated coupling with 
alkyne 241 (Figure 47). 
 
 
 
Figure 47. Retrosynthetic analysis of (+)-crocacin D via ruthenium-mediated 
coupling.  
 
Synthetically, the alkyne derived lateral chain 241 was accessed in excellent yield 
in a very straightforward manner by the HBTU-mediated peptide coupling between 
carboxylic acid 242 and the glycine methyl ester 124 (Scheme 74).  
 
 
 
Scheme 74. Synthesis of the alkyne lateral chain 241. 
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Once the desired lateral chain 241 was prepared, a preliminary coupling attempt 
was performed on a simple model system, the commercial benzamide 243 
(Scheme 75). 
Disappointingly, after 6 hours (according to the Gooßen protocol) no reaction had 
taken place at all. After 36 hours at 60 °C, the reaction afforded the desired 
product 244 in a very poor yield of 10%, while 90% of the starting material 
remained inert to these conditions and was recovered unreacted. Gooßen 
reported that the use of small amounts of water as a co-solvent proved decisive in 
the case of some very sluggish couplings. Therefore, the same reaction was 
repeated also in the presence of 6-8 equivalents of distilled water, relative to the 
amide substrate; however, even in this case the result was unsatisfactory as no 
product was isolated after 6, 12, 24 or 36 hours. 
 
 
 
Scheme 75. First attempt of coupling on a model system. 
 
Considering these initial, unsatisfactory results, a second coupling attempt was 
performed on a different amide, the trans-cinnamamide 245, using a simpler and 
more stable partner, phenylacetylene 199. This combination was chosen in order 
to establish if the difficulty of the coupling could be attributed to an intrinsic lower 
reactivity of the custom lateral chain 241 with respect to other simpler alkynes. 
Disappointingly, also in this case, the coupling efficiency was excessively low 
(Table 7). 
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Table 7. Attempted Gooßen coupling on a simple model system. 
 
Despite the unsatisfactory results when applied to the model systems, the Gooßen 
coupling was attempted on a very small scale between (+)-crocacin C 3 and 
alkyne 241. As expected, the reaction did not proceed and the starting amide was 
recovered (Scheme 76). 
 
 
 
Scheme 76. Attempted synthesis of (+)-crocacin D via Gooßen coupling.  
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Copper mediated coupling approach 
 
In response to the initial set-back in the endgame strategy for the completion of 
the (+)-crocacin D 4, another coupling approach was taken into consideration. In 
order to ensure as much convergence as possible, the revised synthetic strategy 
paralleled Dias’ approach[14] and envisioned (+)-crocacin D 4 as being directly 
derived from (+)-crocacin C 3 through a Buchwald’s copper(I)-mediated coupling 
with the (Z)-vinyl iodide 123 (Figure 48).[55] 
 
 
 
Figure 48. Retrosynthetic analysis of (+)-crocacin D via copper-mediated coupling.  
 
The copper(I)-mediated coupling can be considered one of the mildest method for 
the introduction of an enamide moiety in a complex natural product, due to the use 
of a weak base, non-polar solvent, fairly low temperatures and catalytic amounts 
of copper. Although the mechanistic details of the coupling are not well 
established, recent studies have offered more clarity. In particular, it has been 
established via kinetic studies the role of the ligand involved. It has been 
postulated that the diamine ligand facilitates the amidation reaction because it 
does not allow the formation of multiply-ligated cuprate structures which would be 
otherwise unreactive, and instead stabilises the active species copper-amide 
complex.[55]  
Synthesis of the key (Z)-vinyl iodide 123 began with 1,5-pentane-diol 247, which 
was mono-protected as a TBDPS-ether 248 and then oxidised to afford the 
corresponding carboxylic acid 249 which was coupled with glycine methyl ester 
124 to yield amide 250. In our initial studies, desilylation of ether 250 in the 
presence of the unprotected amide moiety yielded alcohol 251 in 11% yield. The 
disappointing efficiency of the deprotection step was due in part to the excessive 
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polarity of the product which was difficult to separate from TBAF impurities even 
after repeated flash column chromatography. Oxidation of alcohol 251 by DMP 
and pyridine, however failed to yield any of the desired aldehyde 252 (Scheme 
77).  
 
 
 
Scheme 77. Initial studies on the synthesis of the (+)-crocacin D lateral chain. 
 
Faced with this initial set-back, the previous strategy was modified slightly; amide 
250 was protected to afford the Boc-amide 253 (Scheme 78), which was then 
TBAF-desilylated to yield alcohol 254 without incident. The latter was oxidised to 
the corresponding aldehyde 131, via treatment with DMP and pyridine, and was 
immediately converted to the (Z)-iodo-olefin 132 following the Stork-Zhao 
olefination protocol. Finally, Boc-removal with TFA afforded the desired lateral 
chain 123 in a total of 8 steps and 48% overall yield from diol 247.  
 
 
 
Scheme 78. Completion of the lateral chain 123. 
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Despite the successful synthesis of the lateral chain 123, a further round of 
optimisation was carried out. In the revised approach, commercially available 
carboxylic acid 242 underwent an HBTU-mediated coupling with glycine methyl 
ester, to yield amide 241 (Scheme 79). Alkyne 241 was then quantitatively 
converted to iodo-alkyne 255 by simple treatment with iodine and morpholine. 
Hydroboration-protonolysis of iodo-alkyne 255, completed the synthesis of the 
iodo-alkene unit 123. This new approach accessed the lateral chain in 3 steps with 
an excellent 83% overall yield, representing a significant improvement with respect 
to the previous strategy.  
 
 
 
 
Scheme 79. Second generation synthesis of the lateral chain 123. 
 
With (+)-crocacin C 3 and (Z)-iodo-olefin 123 in hand, the final copper-mediated 
coupling was explored. The reaction was performed in the presence of caesium 
carbonate as the base, copper iodide as the catalyst, N,N’-dimethyl 
ethylenediamine as the ligand and THF as the solvent (Scheme 80). The reaction 
mixture was allowed to stir at 70 °C for 18 hours, and pleasantly afforded (+)-
crocacin D 4. Disappointingly, only a semi-crude yield (70%) could be established 
for the final step because the compound, due to its extremely low stability, 
decomposed during purification by HPLC. Nevertheless, NMR, IR and MS analysis 
of the semi-pure sample allowed the unequivocal identification of (+)-crocacin D 4.  
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Scheme 80. Total synthesis of (+)-crocacin D, 4. 
 
In conclusion, the total synthesis of (+)-crocacin D has been completed in 15 steps 
(9 isolated intermediates) on the longest linear sequence which represents the 
shortest synthesis of (+)-crocacin D 4 to date from commercially available starting 
materials. 
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2.4 Unnatural analogues of (+)-crocacin D 
 
Given the success of the copper-mediated coupling for the synthesis of (+)-
crocacin D, it was reasoned to use the same strategy for the preparation of a 
focused library of unnatural analogues of (+)-crocacin D. The rationale was that 
the lateral chain containing the (Z)-enamide moiety, which is believed to be 
responsible for the biological activity of the crocacins, remained unaltered, while 
the lipophilic section, was simplified.  
Following the library rationale, the first unnatural analogue to be prepared was the 
benzamide-derived 244. The copper-mediated coupling was successful and the 
compound displayed good stability, which allowed purification to afford the desired 
product in 75% yield (Scheme 81). 
 
 
 
Scheme 81. Synthesis of analogue 244. 
 
In addition, in order to prepare other stable and simplified analogues, naphthoic 
acid 256 was taken into consideration due to the stability of the lipophilic portion 
derived from the presence of two aromatic rings. Hence, carboxylic acid 256 was 
at first converted into amide 258 via a simple two-step sequence in a moderate 
overall yield of 66% (Scheme 82).  
 
 
 
Scheme 82. Synthesis of amide 258. 
 
Amide 258 was then coupled with the lateral chain 123 via the same copper-
mediated conditions to afford the desired analogue 259 (Scheme 83).  
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Scheme 83. Synthesis of analogue 259. 
 
Following the same basic principle, trans-cinnamic acid 260 was converted into 
the corresponding trans-cinnamamide 245 in working overall yield of 34% over the 
two steps (Scheme 84). 
 
 
 
Scheme 84. Synthesis of amide 245. 
 
In turn, trans-cinnamamide 245 was subjected to a copper-mediated coupling with 
lateral chain 123 to afford the desired analogue 262 in fair yield (Scheme 85).  
 
 
 
Scheme 85. Synthesis of analogue 262. 
 
In conclusion, the first three unnatural analogues 244, 259 and 262 were prepared 
via straightforward transformations in good to moderate yields. Although the 
efficiency of the copper-mediated coupling was not excellent, it guaranteed 
complete stereocontrol of the (Z)-enamide moiety, so that the Buchwald coupling, 
in this context, proved to be the elected strategy for the preparation of simple 
analogues of (+)-crocacin D 4. Following the same rationale, the library was 
expanded to incorporate various other analogues. For example, the commercial 
aromatic nicotinamide 263 and 4-aminobenzamide 264 were subjected to coupling 
with the custom lateral chain 123 to afford analogues 265 and 266 respectively. 
Disappointingly, these substrates proved to be almost completely unreactive 
towards the copper-mediated coupling, likely due to the presence of the nitrogen in 
the starting materials, which could contribute a deleterious effect on the outcome 
A. E. Pasqua 2013  Chapter II  Results and Discussion 
  
293 
 
of the reaction for electronic reasons (Schemes 86 and 87). Due to the extremely 
poor yields (calculated from the 1H NMR of the crude mixture), the isolation of 
clean products from large amounts of unreacted starting materials was not 
achieved.  
 
 
 
Scheme 86. Synthesis of analogue 265. 
 
 
 
 
Scheme 87. Synthesis of analogue 266. 
 
Additionally, a smaller non-aromatic substrate was also taken into consideration: 
3-methylbut-2-enamide 267. Successful coupling of amide 267 to the lateral chain 
123 would provide access to the entire C1-C14 fragment of (+)-crocacin D, and 
would determine the activity of the C15-C27 complex polypropionate fragment 
(Figure 49).  
 
 
 
Figure 49. Structural analogies between the natural (+)-crocacin D and the 
unnatural analogue 268. 
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In any event, the Cu(I)-mediated coupling afforded the desired enamide analogue 
268 in a moderate 41% yield, however, disappointingly, the product suffered from 
a significant intrinsic instability which led to complete decomposition during the 
characterisation process (Scheme 88). This result suggested that the C1-C14 
fragment of (+)-crocacin D, even if strictly involved in the biological activity of the 
molecule, does not exhibit the required characteristics of stability necessary to be 
considered an analogue of interest. 
 
 
 
Scheme 88. Synthesis of analogue 268. 
 
The next step focused on the exploration of an “hybrid analogue”. The hybrid 
species was envisioned as deriving from the coupling between the C1-C9 
fragment of (+)-crocacin D and the pantoyl moiety of CJ-15,801, an important 
pantothenic acid analogue involved in the inhibition of the CoA biosynthesis 
(Figure 50).[56] The rationale behind this idea was to explore the possibility of 
double, or enhanced, activity of the hybrid analogue due to its strong correlation to 
two important natural products. 
 
 
 
Figure 50. Structural features of the hybrid analogue 269. 
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In our initial effort towards the synthesis of the hybrid analogue, the easily 
accessed 2,4-dihydroxy-3,3-dimethylbutanamide 271 was subjected to Buchwald 
coupling with custom lateral chain 123. The coupling was unsuccessful and 
yielded a complex mixture, likely due to the presence of the two free alcohol 
moieties. 
 
 
 
Scheme 89. First attempt of synthesis of the hybrid analogue 269. 
 
Considering the unsatisfactory outcome of this coupling on the unprotected 
substrate 271, a similar reaction was carried out on the starting material 272 which 
has the 1,3-diol masked as an acetonide (Scheme 90). Interestingly, as shown by 
crude 1H NMR analysis, the reaction conditions led to the complete removal of the 
acetonide group and only to a very low efficiency of coupling, while a significant 
amount of free carboxamide remained uncoupled. In addition, the product did not 
satisfy the requisites of stability necessary for a successful analogue as it 
decomposed upon purification. Hence, in order to study the biological activity of 
this interesting hybrid analogue, both the coupling procedure and purification 
protocol would require significant optimisation. 
 
 
 
Scheme 90. Synthesis of the hybrid analogue 273. 
 
Finally, taking the satisfactory results of coupling and stability obtained with the 
analogues 259 and 262 into consideration, two further analogues based on the 
naphthyl- and trans-cinnamyl- frameworks were prepared. The variation in this 
case was concentrated to the lateral chain which maintained the biologically 
important (Z)-enamide moiety, but incorporated a simplified and more stable ester 
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functionality. The lateral chain 275 was prepared quantitatively in a single step 
from the commercial ethyl propionate 274 via hydroiodination (Scheme 91).[57] 
 
 
 
Scheme 91. Synthesis of iodo-enoate 275. 
 
With the (Z)-ethyl 3-iodoacrylate 275 in hand, coupling with 2-naphtamide 258 was 
carried out to afford the desired analogue 276 in reasonable yield (Scheme 92). 
Importantly, this analogue displayed good stability to the conditions of isolation 
and purification.  
 
 
 
Scheme 92. Synthesis of analogue 276. 
 
In the same fashion, trans-cinnamamide 245 was coupled to the new lateral chain 
275 in moderate yield and without problems of purification (Scheme 93). 
 
 
 
Scheme 93. Synthesis of analogue 277. 
 
In summary, a small library of 9 unnatural analogues of (+)-crocacin D was 
prepared, however among those, only 5 compounds (analogues 244, 259, 262, 
276, 277) displayed the characteristics of stability necessary to be taken onto the 
next step of rigorous biological testing. 
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In order to determine the potential of the 5 stable analogues, they were subjected 
to a screening on the Discovery Early Screen (DES) platform against a range of 
weed species, insect pests and fungal pathogens by Syngenta (Jealott’s Hill 
International Research Centre, Bracknell, UK). All testing was carried out in 96-
well plates. In herbicide assays the compounds were tested for activity against 
Arabidopsis thaliana at 10ppm and Poa annua at 32ppm (Table 8). Test plates 
were stored for seven days in a controlled environment cabinet. Scores were given 
as 0 or 99, where 99 is any herbicidal effect, and 0 is no effect.  
 
Test species Treatment timing  Rate (ppm) 
Arabidopsis thaliana Pre emergence 10 
Poa annua Pre emergence 32 
 
Table 8. Herbicide assays. 
 
In insecticide assays the compounds were tested for activity against the aphid 
species, Aphis gossypii, in a leaf-disc assay at 1000ppm. The compounds were 
also evaluated at a rate of 5000ppm on Plutella maculipennis in an artificial diet 
assay and against the nematode species Caenorhabditis elegans in liquid culture 
at 10ppm (Table 9). The analogues were applied to feeding aphids, prior to 
infestation with P. xylostella larvae, or diluted into the C. elegans culture. Mortality 
was assessed relative to control wells using a 2 band system (0 or 99 where 99 is 
significant mortality and 0 is no significant effect), 5-9 days after the treatment 
depending on the assay. C. elegans were also assessed for symptomology. 
 
Test species Treatment type Media Rate (ppm) 
Aphis gossypii Feeding/contact Leaf disc 1000 
Plutella maculipennis Feeding/contact Artificial diet 5000 
Caenorhabditis elegans Feeding/contact Liquid culture 10 
 
Table 9. Insecticide assays. 
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In fungicidal assays, the compounds were evaluated in mycelial growth tests in 
artificial media against Pythium dissimile, Alternaria solani, Botryotini cinerea and 
Gibberella zeae at rates of 20ppm and 2ppm (Table 10).  
 
Test species  Media Rate (ppm) 
Pythium dissimile Semi-solid 20 and 2 
Alternaria solani Semi-solid 20 and 2 
Botryotinia cinerea Semi-solid 20 and 2 
Gibberella zeae Semi-solid 20 and 2 
 
Table 10. Fungicide assays. 
 
Leaf-piece assays were also conducted. The compounds were evaluated at 
200ppm and 60ppm against Phytophthora infestans on tomato and 100ppm for 
Uromyces vicae-fabae on bean (Table 11). The analogues were applied prior to 
inoculation in the leaf-piece assays.  
 
Test species Host Rate (ppm) 
Pytophthora infestans Tomato 200 and 60 
Uromyces viciae-fabae Bean  100 
 
Table 11. Leaf-piece assays. 
 
Mycelial growth or disease inhibition was assessed visually and scored using a 3 
band system (0, 55 and 99 where 99 is total inhibition of hyphal growth/disease 
development, 55 is partial inhibition and 0 is no inhibition), 4-14 days after 
inoculation depending on the assay. Screening results are presented in Tables 12, 
13 and 14. 
- Herbicide: the compounds tested were inactive on the herbicide screens. 
- Insecticide: the majority of the analogues were inactive on the insecticide 
screens. However, interestingly, one compound, analogue 276, proved to 
be highly active against the species Nematode Caenorhabditis elegans, 
and therefore showed a good potential for further investigation.  
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- Fungicide: Most of the compounds were inactive on the fungicide screens. 
Only analogue 259 showed a moderate activity against the species 
Uromyces viciae-fabae. Analogue 262, on the other hand, showed low 
activity against Uromyces viciae-fabae and moderate activity against 
Phytophtora infestans. These results were not sufficient for further interest. 
 
Tested compounds Arabidopsis thaliana Poa annua 
Analogue 244 0, 0, 0 0, 0, 0 
Analogue 259 0, 0, 0 0, 0, 0 
Analogue 262 0, 0, 0 0, 0, 0 
Analogue 276 0, 0, 0 0, 0, 0 
Analogue 277 0, 0, 0 0, 0, 0 
 
Table 12. Herbicide effect. 
 
Tested 
compounds 
Aphis  
gossypii 
Plutella 
maculipennis 
Caenorhabditis 
elegans 
Analogue 244 0, 0, 0 0, 0, 0 0, 0, 0 
Analogue 259 0, 0, 0 0, 0, 0 0, 0, 0 
Analogue 262 0, 0, 0 0, 0, 0 0, 0, 0 
Analogue 276 0, 0, 0 0, 0, 0 99, 99, 99 
Analogue 277 0, 0, 0 0, 0, 0 0, 0, 0 
 
Table 13. Insecticide effect. 
 
Tested 
compounds 
Gibberella 
zeae 
Botryotinia 
cinerea 
Alternaria 
solani 
Pythium 
dissimile 
Uromyces 
viciae-fabae 
Phytophtora 
infestans 
Analogue 244 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 
Analogue 259 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 55, 55, 55 0, 0, 0 
Analogue 262 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 0, 55, 27 99, 0, 49 
Analogue 276 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 
Analogue 277 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 0, 0, 0 
 
Table 14. Fungicide effect. 
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Positive control compounds were included in each test as appropriate: 
Azoxystrobin 278 and/or Prochloraz 279 for fungicide assays, Thiamethoxam 280 
and Indoxacarb 281 for the insecticide assays and Norflurazon 282 for herbicide 
assays (Figure 51). 
 
 
 
Figure 51. Positive control compounds. 
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2.5 Studies towards the synthesis of (+)-crocacin A, B 
 
In parallel to the design of novel unnatural analogues, the total synthesis of (+)-
crocacin A 1 and B 2 was also investigated. The retrosynthesis is very similar to 
the one followed for the synthesis of (+)-crocacin D and is based on a Buchwald 
Cu(I)-mediated coupling between (+)-crocacin C 3 and the lateral chain 283, made 
more complex by the presence of a further (Z)-enamide moiety (Figure 52). 
 
 
 
Figure 52. Retrosynthesis of (+)-crocacin A and B via copper-mediated coupling.  
 
The synthesis of the (+)-crocacin A lateral chain 283 began with the TBDPS-
protection of but-3-yn-1-ol 284 (Scheme 94). Alkyne lithiation followed by 
alkylation with p-formaldehyde yielded propargylic alcohol 286. The alcohol moiety 
was then oxidised to the corresponding carboxylic acid 287 which was then 
subjected to an HBTU-mediated peptide coupling with glycine methyl ester 124 to 
afford dipeptide 288. Boc-protection of the secondary amide followed by TBAF-
mediated desilylation afforded the free homo-propargylic alcohol 290.  
 
 
Scheme 94. Efforts towards the synthesis of the crocacin A lateral chain 283. 
A. E. Pasqua 2013  Chapter II  Results and Discussion 
  
302 
 
Surprisingly, however, oxidation of the propargylic alcohol unit proved difficult to 
achieve. Initial efforts, using TEMPO and BAIB, returned only unreacted starting 
material. The use of Swern oxidation conditions, resulted in a complex mixture of 
unidentifiable products which by 1H NMR analysis of the crude product mixture 
appeared to show olefin migration. Due to the homo-propargylic alcohol’s apparent 
fragility, milder oxidation conditions such as Dess-Martin Periodinane were 
attempted.[58] Unfortunately, in all cases, the starting material remained largely 
unreacted without any trace of product being detected by crude 1H NMR (Table 
15).  
 
 
Table 15. Efforts towards the oxidation of propargylic alcohol 290. 
 
To combat the issues caused by the presence of the homo-propargylic moiety, 
partial reduction of the alkyne to (Z)-double bond via hydrogenation was 
performed to afford homoallylic alcohol 290, which was in turn subjected to 
oxidation conditions in an effort to access the corresponding aldehyde 
intermediate 291.[59] Unfortunately, the majority of the starting material remained 
unreacted, together with traces of by-product due to the migration of the double 
bond (Scheme 95).  
 
 
 
Scheme 95. Partial reduction of homo-propargylic alcohol 290. 
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To avoid issues of bond migration, it was decided to mask alkyne 290 by forming 
cobalt carbonyl complex 294 which then, in turn, was subjected to DMP 
oxidation.[60] Disappointingly, the oxidation of the dicobalt complex 294 was also 
unsuccessful (Scheme 96). 
 
 
 
Scheme 96. Efforts towards the synthesis of the lateral chain 297. 
 
Unfortunately, time constrains prevented us from completing the synthesis of the 
desired lateral chain for (+)-crocacins A and B.  
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2.6 Summary and future work 
 
In conclusion, a formal synthesis of (+)-crocacin C 3 was completed in 20 steps 
(16 isolated intermediates) and 2.3% overall yield (83% per step) from 
commercially available (R)-Roche ester 177. 
 
 
 
Figure 53. First generation formal synthesis of (+)-crocacin C, 3. 
 
After this initial result, which gave us the possibility to test the key steps of the 
process, such as the [3,3]-sigmatropic rearrangement, a second approach was 
developed which led to the completion of the total synthesis of (+)-crocacin C 3 in 
14 steps (8 isolated intermediates) with a 20% overall yield (89% per step) from 
commercially available starting materials. 
 
 
 
Figure 54. Second generation total synthesis of (+)-crocacin C, 3. 
 
Building on from the total synthesis of (+)-crocacin C 3, the total synthesis of the 
bioactive (+)-crocacin D 4 was completed in 15 steps (9 isolated intermediates) 
and ~14% overall yield. This synthesis, based on the key Buchwald copper-
mediated coupling between crocacin C 3 and vinyl iodide 123, is the shortest 
synthesis of (+)-crocacin D reported to date.  
 
 
Figure 55. Total synthesis of (+)-crocacin D, 4. 
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A mini-library of unnatural analogues of (+)-crocacin D was also developed, 
among which it is worthy to highlight analogue 276 for its high and promising anti-
nematodal potential displayed during preliminary biological tests. 
 
 
 
Figure 56. Analogues of (+)-crocacin D, 4. 
 
Besides, studies towards the synthesis of the lateral chain of the last two members 
of the crocacin family (crocacins A and B) are ongoing; 8 steps have been 
successfully completed, affording the intermediate 294.  
 
 
 
Figure 57. Studies towards the intermediate 294. 
 
Finally, (+)-crocacin D has shown a broad spectrum of biological activities, 
encompassing antibiotic, antifungal and cytotoxic properties in addition to its 
activity against plant pathogens. Hence, this natural product has been considered 
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a potential drug lead, not only for medicinal purposes but also for crop protection. 
However, despite this great potential, crocacin D has been deemed unsuitable for 
the harsh field conditions due to its intrinsic instability. Thus, the need for stable 
crocacin D analogues has become increasingly evident. Following on from the 
development of the dihalo-olefination methodology described in the first section of 
this dissertation, the design of stabilised and branched crocacin analogues, in an 
effort to overcome the stability issues is currently underway. 
 
 
 
Figure 58. Stabilised crocacin analogues 299. 
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3 Experimental 
 
All reactions were performed in oven-dried glassware under an inert argon 
atmosphere unless otherwise stated. Tetrahydrofuran (THF), diethyl ether, toluene 
and dichloromethane were purified through a Pure Solv 400-5MD solvent 
purification system (Innovative Technology, Inc). Anhydrous acetone, 
dimethylformamide, methanol, benzene and absolute ethanol were purchased 
from Sigma-Aldrich. All reagents were used as received, unless otherwise stated. 
Solvents were evaporated under reduced pressure at 40 °C using a Büchi 
Rotavapor. IR spectra were recorded neat using a JASCO FT/IR410 Fourier 
Transform spectrometer. Only significant absorptions (νmax) are reported in 
wavenumbers (cm-1). Proton magnetic resonance spectra (1H NMR) and carbon 
magnetic resonance spectra (13C NMR) were recorded using a Bruker DPX 
Avance400 instrument.  Chemical shifts (δ) are reported in parts per million (ppm) 
and are referenced to the residual solvent peak. The order of citation in 
parentheses is (1) number of equivalent nuclei (by integration), (2) multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, b = broad, dm = doublet 
of multiplet, dd = doublet of doublet, dt = doublet of triplet) and (3) coupling 
constant (J) quoted in Hertz to the nearest 0.1Hz. High resolution mass spectra 
were recorded on a JEOL JMS-700 spectrometer by electrospray (ESI), fast atom 
bombardment (FAB), electron impact (EI) and chemical ionisation (CI) mass 
spectrometer operating at a resolution of 15000 full widths at half height.  Where a 
100% peak was not observed in low resolution mass spectra the highest peak was 
taken to be 100%. Flash chromatography was performed using silica gel (Apollo 
Scientific Silica Gel 60, 40-63 mm) as the stationary phase. TLC was performed 
on aluminium sheets pre-coated with silica (Merck Silica Gel 60 F254). The plates 
were visualised by the quenching of UV fluorescence (λmax 254 nm) and/or by 
staining with either anisaldehyde or potassium permanganate followed by heating. 
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 (S)-Methyl 3-(tert-butyldiphenylsilyloxy)-2-methylpropanoate, 164 
 
 
 
To a solution of (S)-methyl 3-hydroxy-2-methylpropanoate 11 (7.00 g, 59.3 mmol) 
and imidazole (4.80 g, 71.1 mmol) in dichloromethane (300 mL), cooled at 0 °C, 
TBDPSCl (17.0 mL, 65.2 mmol) was added dropwise and the reaction mixture was 
allowed to warm to room temperature and to stir for 12 hours. Then the reaction 
was quenched with 200 mL of NaHCO3 saturated aqueous solution and extracted 
with dichloromethane (3 × 150 mL). The organic layers were collected, dried over 
Na2SO4, filtered and concentrated under vacuum to afford the product 164 as a 
colourless oil in a quantitative yield (21.2 g, 59.3 mmol). The crude product 
resulted clean without necessity of any further purification. Rf 0.44 (hexane:EtOAc, 
9:1); [α]22D +6.8 (c 1.0, CHCl3); IR νmax (film) 3073-2859, 1740, 1472, 1427, 1389, 
1362, 1258, 1198, 1177, 1106, 824, 739, 702 cm-1; 1H NMR (400 MHz, CDCl3): δH 
7.70-7.65 (4H, m, CHAr), 7.45-7.37 (6H, m, CHAr), 3.86 (1H, dd, J 6.9 Hz, 9.8 Hz, 
CHH), 3.76 (1H, dd, J 5.9 Hz, 9.8 Hz, CHH), 3.71 (3H, s, OCH3), 2.79-2.68 (1H, m, 
CH), 1.18 (3H, d, J 7.0 Hz, CH3), 1.06 (9H, s, 3 × CH3); 
13C NMR (100 MHz, 
CDCl3): δC 175.5 (CO), 135.7 (CHAr), 133.6 (CAr), 129.8 (CHAr), 127.8 (CHAr), 66.0 
(CH2), 51.7 (OCH3), 42.5 (CH), 26.8 (3 × CH3), 19.4 (C), 13.6 (CH3); HRMS 
(CI+/ISO) calc. for C21H29O3Si [M+H]
+
: 357.1886. Found: 357.1888. 
 
The characterisation matches with the data reported in literature: 
Cossy J.; Bauer D.; Bellosta V. Tetrahedron 2002, 58, 5909. 
 
(R)-3-(tert-Butyldiphenylsilyloxy)-2-methylpropan-1-ol, 165 
 
 
 
The (S)-methyl 3-(tert-butyldiphenylsilyloxy)-2-methylpropanoate 164 (22.0 g, 61.7 
mmol) was dissolved in dry dichloromethane (300 mL) and the solution was cooled 
at 0 °C. Then DIBAL-H (136 mL, 136 mmol, 1 M solution in hexane) was added 
dropwise and the reaction mixture was allowed to stir at 0 °C for 3 hours. The 
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reaction mixture was quenched carefully at 0 °C with 250 mL of a Rochelle’s salt 
saturated aqueous solution added dropwise and the biphasic system was allowed 
to stir at room temperature for 12 hours. Then the organic layer was saved and the 
aqueous layer was extracted with ethyl acetate (3 × 150 mL). All the organic layers 
were combined, washed with brine (300 mL) and dried over Na2SO4, filtered and 
concentrated under vacuum to afford a colourless oil as product 165 (20.1 g, 61.2 
mmol) in 99% yield . The crude product resulted clean enough, without necessity 
of any further purification and very stable. (The batch was kept at -20 °C for 
several months without any decomposition or silyl migration issues, as proved by 
1H NMR analysis and optical rotation). Rf 0.29 (hexane:EtOAc, 9:1); [α]
25
D +4.0 (c 
1.0, CHCl3); IR νmax (film) 3387, 3073-2859, 1472, 1427, 1391, 1362, 1111, 1086, 
1028, 939, 822, 802, 739, 698 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.71-7.66 (4H, 
m, CHAr), 7.47-7.37 (6H, m, CHAr), 3.74 (1H, dd, J 4.5 Hz, 9.9 Hz, CHH), 3.68 (2H, 
bd, J 4.5 Hz, CH2), 3.61 (1H, dd, J 7.7 Hz, 10.1 Hz, CHH), 2.56 (1H, bs, OH), 2.06-
1.95 (1H, m, CH), 1.07 (9H, s, 3 × CH3), 0.84 (3H, d, J 7.0 Hz, CH3); 
13C NMR 
(100 MHz, CDCl3): δC 135.7 (CHAr), 134.9 (CAr), 129.9 (CHAr), 127.9 (CHAr), 68.9 
(CH2), 67.8 (CH2), 37.4 (CH), 26.9 (3 × CH3), 19.3 (C), 13.3 (CH3); HRMS 
(CI+/ISO) calc. for C20H29O2Si [M+H]
+: 329.11937. Found: 329.1933. 
 
The characterisation matches with the data reported in literature: 
Cossy J.; Bauer D.; Bellosta V. Tetrahedron 2002, 58, 5909. 
 
(S)-3-(tert-Butyldiphenylsilyloxy)-2-methylpropanal, 163 
 
 
 
Oxalyl chloride (2.15 mL, 24.5 mmol) was dissolved in freshly distilled 
dichloromethane (195 mL) and the solution was cooled at -78 °C under argon. 
Then a solution of dimethylsulfoxide  (3.5 mL, 49.0 mmol) in dichloromethane (8 
mL) was added dropwise and stirred under argon at -78oC for 30 minutes. A 
solution of (R)-3-(tert-butyldiphenylsilyloxy)-2-methylpropan-1-ol 165 (4.02 g, 12.3 
mmol) in dichloromethane (8 mL), was added dropwise and the reaction mixture 
was allowed to stir at -78 °C for 1 hour. Then the reaction mixture was quenched at 
-78 °C by dropwise addition of triethylamine (13.7 mL, 98.0 mmol) with the use of a 
A. E. Pasqua 2013 Chapter II Experimental 
  
310 
 
bleach trap and the obtained solution was allowed to stir at -78 °C for 10 minutes 
and at room temperature for 30 minutes. The solution was washed with 100 mL of 
NaHCO3 aqueous saturated solution and extracted with dichloromethane (3 × 100 
mL). The organic layers were collected, washed with 100 mL of brine, dried over 
Na2SO4, filtered and concentrated under vacuum to afford the product 163 as a 
yellow oil in quantitative yield (4.02 g, 12.3 mmol). The crude product was taken 
straight onto the next step without any further purification. Rf 0.38 (hexane:Et2O, 
9:1); [α]26D +5.0 (c 2.0, CHCl3); IR νmax (film) 3073-2720, 2114, 1738-1713, 1472, 
1428, 1111, 1026, 1008, 808, 826, 739, 698, 689, 615 cm-1; 1H NMR (400 MHz, 
CDCl3): δH 9.77 (1H, d, J 1.7 Hz, CHO), 7.68-7.62 (4H, m, CHAr), 7.45-7.38 (6H, 
m, CHAr), 3.95-3.82 (2H, m, CH2), 2.65-2.50 (1H, m, CH), 1.10 (3H, d, J 6.8 Hz, 
CH3), 1.05 (9H, s, 3 × CH3); 
13C NMR (100 MHz, CDCl3): δC 204.6 (CO), 135.7 
(CHAr), 133.2 (CAr), 129.9 (CHAr), 127.9 (CHAr), 64.2 (CH2), 48.9 (CH), 26.9 (3 × 
CH3), 19.3 (C), 10.4 (CH3); HRMS (CI+/ISO) calc. for C20H27O2Si [M+H]
+: 
327.1780. Found: 327.1774. 
 
The characterisation matches with the data reported in literature: 
Cossy J.; Bauer D.; Bellosta V. Tetrahedron 2002, 58, 5909. 
 
(R,E)-Ethyl 5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpent-2-enoate, 161 
 
 
 
To a solution of (S)-3-(tert-butyldiphenylsilyloxy)-2-methylpropanal 163 (933 mg, 
2.86 mmol) in benzene (10 mL), under argon at room temperature, ethyl 2-
(triphenylphosphoranylidene) propanoate (2.60 g, 7.15 mmol) was added in one 
portion and the resulting mixture was heated at 80 °C and allowed to stir for 18 
hours. Then the reaction mixture was allowed to cool to room temperature and the 
solvent was removed under vacuum to afford a yellow oil as crude product. The 
crude product was purified through flash column chromatography on silica gel 
(from 0 to 5% ethyl acetate in hexane) to afford the pure product 161 as a 
colourless oil in 85% yield (939 mg, 2.27 mmol). Rf 0.43 (hexane:EtOAc, 9:1); 
[α]26D -3.6 (c 1.0, CHCl3); IR νmax (film) 3072, 2960, 2932, 2896, 2858, 1709, 1473, 
1427, 1233, 1110, 1080, 1029, 823, 802, 739, 699, 689 and 615 cm-1; 1H NMR 
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(500 MHz, CDCl3): δH 7.67-7.65 (4H, m, CHAr), 7.43-7.36 (6H, m, CHAr), 6.60 (1H, 
dq, J 1.4, 9.9 Hz, CH=), 4.20 (2H, q, J 7.6 Hz, CH2), 3.55 (2H, dd, J 2.7, 6.4 Hz, 
CH2), 2.77-2.73 (1H, m, CH), 1.81 (3H, d, J 1.4 Hz, CH3), 1.29 (3H, t, J 7.6 Hz, 
CH3), 1.05 (9H, s, 3 × CH3), 1.04 (3H, d, J 6.6 Hz, CH3); 
13C NMR (125 MHz, 
CDCl3): δC 168.4 (CO), 144.6 (CH=), 135.8 (CHAr), 133.8 (CAr), 129.8 (CHAr), 
128.1 (C=), 127.8 (CHAr), 67.9 (CH2), 60.6 (CH2), 36.3 (CH), 26.9 (3 × CH3), 19.4 
(C), 16.5 (CH3), 14.4 (CH3), 12.7 (CH3); HRMS (CI+/ISO) calc. for C25H35O3Si 
[M+H]+: 411.2355. Found: 411.2350. 
 
(R,E)-5-(tert-Butyldiphenylsilyloxy)-2,4-dimethylpent-2-en-1-ol 
 
 
 
To a solution of (R,E)-ethyl 5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpent-2-enoate 
163 (720 mg, 1.76 mmol) in dry diethyl ether (10 mL), under argon at 0 °C, DIBAL-
H (3.9 mL, 3.90 mmol, 1M solution in diethyl ether) was added slowly dropwise 
and the resulting mixture was allowed to stir for 2 hours at 0 °C. The reaction 
mixture was quenched carefully at 0 °C with 10 mL of a Rochelle’s salt saturated 
aqueous solution added dropwise and the biphasic system was allowed to stir at 
room temperature for 12 hours. Then the organic layer was saved and the 
aqueous layer was extracted with ethyl acetate (3 × 10 mL). All the organic layers 
were combined and washed with brine (20 mL), then dried over Na2SO4, filtered 
and concentrated under vacuum to afford a colourless oil as product (650 mg, 1.76 
mmol) in quantitative yield. The product resulted very clean without necessity of 
any further purification. Rf 0.6 (hexane:EtOAc, 6:4); [α]
26
D -16.80 (c 1.0, CHCl3); IR 
νmax (film) 3341, 3071, 2960, 2932, 2855, 1427, 1389, 1111, 1072, 1003, 825, 787, 
741, 702 and 610 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.66 (4H, dd, J 0.7, 7.3 Hz, 
CHAr), 7.44-7.36 (6H, m, CHAr), 5.16 (1H, dq, J 1.1, 9.4 Hz, CH=), 4.00 (2H, bs, 
CH2O), 3.53-3.46 (2H, m, CH2OSi), 2.69-2.59 (1H, m, CH), 1.62 (3H, d, J 1.1 Hz, 
CH3), 1.58 (1H, bs, OH), 1.06 (9H, s, 3 × CH3), 1.00 (3H, d, J 6.8 Hz, CH3); 
13C 
NMR (125 MHz, CDCl3): δC 135.8 (CHAr), 135.7 (CHAr), 135.3 (C), 134.1 (C), 134.2 
(C), 129.7 (CHAr), 129.6 (CHAr), 129.1 (CH=), 127.8 (CHAr), 127.7 (CHAr), 69.0 
(CH2), 68.6 (CH2), 35.2 (CH), 27.0 (3 × CH3), 19.4 (C), 17.4 (CH3), 14.0 (CH3); 
HRMS (CI+/ISO) calc. for C23H31OSi [M-OH]
+: 351.2144. Found: 351.2145. 
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The characterisation matches with the data reported in literature: 
Paterson I.; Tillyer R. D. J. Org. Chem. 1993, 58, 4182. 
 
(R,E)-(5-(Benzyloxy)-2,4-dimethylpent-3-enyloxy)(tert-butyl)diphenylsilane, 
172 
 
 
To a solution of (R,E)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpent-2-en-1-ol (170 
mg, 462 µmol) in dry THF (10 mL), under argon at 0 °C, sodium hydride (60% wt, 
37.0 mg, 942 µmol) was added and the resulting suspension was allowed to stir 
for 30 minutes, then benzyl bromide (0.07 mL, 554 µmol) was added dropwise and 
the resulting mixture was allowed to warm to room temperature and to stir for 12 
hours. The reaction was quenched with NH4Cl saturated aqueous solution (10 mL) 
and extracted with ethyl acetate (3 × 10 mL). The organic layers were combined, 
washed with brine (20 mL), dried over Na2SO4 and concentrated under vacuum to 
afford a yellow oil as crude product. The crude product was purified through flash 
column chromatography on silica gel (from 0 to 20% ethyl acetate in hexane) to 
afford a colourless oil as pure product 172 in 94% yield (199 mg, 434 µmol). Rf 
0.83 (hexane:EtOAc, 8:2); [α]25D -14.00 (c 1.0, CHCl3); IR νmax (film) 3071, 2932, 
2855, 2739, 1458, 1427, 1389, 1366, 1173, 1111, 1065, 826, 741, 694 and 610 
cm-1; 1H NMR (500 MHz, CDCl3): δH 7.69 (4H, dd, J 1.1, 7.6 Hz, CHAr), 7.46-7.27 
(11H, m, CHAr), 5.25 (1H, dq, J 1.1, 9.3 Hz, CH=), 4.46 (2H, bs, CH2Ph), 3.92-3.88 
(2H, m, CH2O), 3.56-3.44 (2H, m, CH2OSi), 2.75-2.62 (1H, m, CHCH3), 1.66 (3H, 
d, J 1.1 Hz, CH3), 1.07 (9H, s, 3 × CH3), 1.03 (3H, d, J 6.6 Hz, CH3CH); 
13C NMR 
(125 MHz, CDCl3): δC 138.8 (C), 135.8 (CHAr), 134.1 (CAr), 132.6 (=C), 131.3 
(CH=), 129.7 (CHAr), 128.4 (CHAr), 127.8 (CHAr), 127.7 (CHAr), 127.6 (CHAr), 76.4 
(CH2), 71.5 (CH2), 68.6 (CH2), 35.3 (CH), 27.0 (3 × CH3), 19.4 (C), 17.4 (CH3), 
14.3 (CH3); HRMS (CI+/ISO) calc. for C30H39O2Si [M+H]
+: 459.2719. Found: 
459.2720. 
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(2R,3R,4S)-1-(Benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpentan-3-
ol, 173 
 
and 
(2S,3S,4S)-1-(Benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpentan-3-
ol, 174 
 
 
To a solution of (R,E)-(5-(benzyloxy)-2,4-dimethylpent-3-enyloxy)(tert-
butyl)diphenylsilane 172 (38.0 mg, 83.0 µmol) in dry THF (1 mL), under argon at 
room temperature, BH3
.THF (0.25 mL, 0.25 mmol, 1 M solution in THF) was added 
dropwise and the resulting mixture was allowed to stir at room temperature for 12 
hours. Then the reaction was quenched at 0 °C with 0.4 mL of NaOH 3 N aqueous 
solution and 0.4 mL of H2O2 (30%) and it was allowed to warm to room 
temperature. After 30 minutes it was extracted with diethyl ether (3 × 3 mL) and 
the organic layers were combined, washed with brine, dried over Na2SO4 and 
concentrated under vacuum to afford a pale yellow oil as crude product in 50% 
yield (20.0 mg, 42.0 µmol). The crude product without any further purification was 
analysed via 1H NMR analysis and resulted in an inseparable mixture of 
(2R,3R,4S)-1-(benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpentan-3-ol 
173 and (2S,3S,4S)-1-(benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethyl 
pentan -3-ol 174 in a 1:3.5 ratio in favour of the undesired compound (174). When 
the same reaction was performed at -78 °C, an inseparable mixture of (2R,3R,4S)-
1-(benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpentan-3-ol 173 and 
(2S,3S,4S)-1-(benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethyl-pentan-3-ol 
174 in a 1:1.8 ratio in favour of the undesired compound (174) was obtained with 
an overall yield of 64% (25.2 mg, 53.0 µmol). 
Minor isomer (desired product 173): Rf 0.58 (hexane:EtOAc, 8:2); 
1H NMR (400 
MHz, CDCl3): δH 7.75-7.63 (15H, m, CHAr), 4.51 (2H, s, CH2Ph), 3.74 (2H, d, J 5.7 
Hz, CH2OBn), 3.60-3.45 (2H, m, CH2OSi), 3.45-3.35 (1H, m, CHCH3), 2.06-1.98 
(1H, m, CHOH), 1.95-1.80 (1H, m, CHCH3), 1.07 (9H, s, 3 × CH3), 0.99 (3H, d, J 
6.9 Hz, CH3), 0.97 (3H, d, J 6.9 Hz, CH3). 
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The characterisation matches with the data reported in literature: 
Chandrasekhar S.; Yaragorla S. R.; Sreelakshmi L.; Reddy C. H. R. Tetrahedron 
2008, 64, 5174. 
 
Major isomer (undesired product 174): Rf 0.58 (hexane:EtOAc, 8:2); 
1H NMR 
(400 MHz, CDCl3): δH 7.74-7.65 (5H, m, CHAr), 7.45-7.21 (10H, m, CHAr), 4.53 
(2H, s, CH2Ph), 3.76-3.62 (3H, m, CH2OSi and CHCH3), 3.57 (2H, d, J 5.8 Hz, 
CH2OBn), 1.99-1.88 (1H, m, CHOH), 1.85-1.75 (1H, m, CHCH3), 1.08 (9H, s, 3 × 
CH3), 0.92 (3H, d, J 6.9 Hz, CH3), 0.86 (3H, d, J 6.9 Hz, CH3). 
 
The characterisation matches with the data reported in literature: 
Yasui K.; Tamura Y.; Nakatani T.; Kawada K.; Ohtani M. J. Org. Chem. 1995, 60, 
7567. 
 
(R)-Methyl 3-(tert-butyldiphenylsilyloxy)-2-methylpropanoate, 178 
 
 
To a solution of (-)-methyl-D-β-hydroxyisobutyrate (2.50 g, 21.2 mmol) and 
imidazole (1.73 g, 25.4 mmol) in dichloromethane (120 mL), cooled at 0 °C, 
TBDPSCl (6.1 mL, 23.3 mmol) was added dropwise and the reaction mixture was 
allowed to warm to room temperature and to stir for 12 hours. Then the reaction 
was quenched with 100 mL of NaHCO3 saturated aqueous solution and extracted 
with dichloromethane (3 × 50 mL). The organic layers were collected, dried over 
Na2SO4, filtrated and concentrated under vacuum to afford in a quantitative yield 
7.60 g, 21.2 mmol of a colourless oil as product 178. The product resulted very 
clean without necessity of any further purification. Rf 0.44 (hexane:EtOAc, 9:1); 
[α]25D -19.60 (c 2.0, CHCl3); IR νmax (film) 3073-2859, 1740, 1472, 1427, 1389, 
1362, 1258, 1198, 1177, 1106, 824, 739 and 702 cm-1; 1H-NMR (400 MHz; 
CDCl3): δH  7.70-7.67 (4H, m, CHAr), 7.47-7.39 (6H, m, CHAr), 3.86 (1H, dd, J 6.9, 
9.8 Hz, CHH), 3.76 (1H, dd, J 5.9, 9.9 Hz, CHH), 3.71 (3H, s, OCH3), 2.79-2.71 
(1H, m, CH), 1.18 (3H, d, J 7.0 Hz, CH3), 1.06 (9H, s, 3 × CH3). 
13C-NMR (100 MHz; CDCl3): δC 175.7 (CO), 135.7 (CHAr), 133.6 (CAr), 129.8 
(CHAr), 127.8 (CHAr), 66.1 (CH2), 51.7 (OCH3), 42.6 (CH), 26.8 (3 × CH3), 19.3 (C), 
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13.6 (CH3); HRMS (CI+/ISO) calc. for C21H29O3Si [M+H]
+: 357.1886. Found: 
357.1888. 
 
The characterisation matches with the data reported in literature: 
Trost B. M.; Papillon J. P. N. J. Am. Chem. Soc. 2004, 126, 13618. 
 
 (S)-3-(tert-Butyldiphenylsilyloxy)-2-methylpropan-1-ol 
 
 
 
The (R)-methyl 3-(tert-butyldiphenylsilyloxy)-2-methylpropanoate 178 (7.60 g, 21.2 
mmol) was dissolved in dry dichloromethane (91 mL) and the solution was cooled 
at 0 °C. Then a DIBAL-H (46.6 mL, 46.6 mmol, 1 M solution in hexane) was added 
dropwise and the reaction mixture was allowed to stir at 0 °C for 2 hours. The 
reaction mixture was quenched carefully at 0 °C with 100 mL of a Rochelle’s salt 
saturated aqueous solution added dropwise and the biphasic system was allowed 
to stir at room temperature for 12 hours. Then the organic layer was saved and the 
aqueous layer was extracted with ethyl acetate (3 × 50 mL). All the organic layers 
were combined and washed with brine (100 mL), then dried over Na2SO4, filtered 
and concentrated under vacuum to afford a colourless oil as product (7.00 g, 21.0 
mmol) in 99% yield . The product resulted very clean without necessity of any 
further purification. Rf 0.29 (hexane:EtOAc, 9:1); [α]
25
D -8.00 (c 0.5, CHCl3); IR νmax 
(film) 3387, 3073-2859, 1472, 1427, 1391, 1362, 1111, 1086, 1028, 939, 822, 802, 
739 and 698 cm-1; 1H-NMR (400 MHz; CDCl3): δH 7.71-7.64 (4H, m, CHAr), 7.47-
7.33 (6H, m, CHAr), 3.77-3.54 (4H, m, 2 × CH2), 2.59 (1H, bs, OH), 2.05-1.95 (1H, 
m, CH), 1.07 (9H, s, 3 × CH3), 0.83 (3H, d, J 6.7 Hz, CH3); 
13C-NMR (100 MHz; 
CDCl3): δC 135.8 (CHAr), 133.3 (CAr), 129.9 (CHAr), 127.9 (CHAr), 68.9 (CH2), 67.9 
(CH2), 37.4 (CH), 26.9 (3 × CH3), 19.3 (C), 13.3 (CH3); HRMS (CI+/ISO) calc. for 
C20H29O2Si [M+H]
+: 329.11937. Found: 329.1933. 
 
The characterisation matches with the data reported in literature: 
Robles O.; McDonald F. E. Org. Lett. 2008, 10, 1811. 
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(R)-3-(tert-Butyldiphenylsilyloxy)-2-methylpropanal, 179 
 
 
 
Oxalyl chloride (2.13 mL, 24.4 mmol) was dissolved in freshly distilled 
dichloromethane (195 ml) and the solution was cooled at -78 °C under argon. Then 
a solution of dimethylsulfoxide (3.46 mL, 48.7 mmol) in dichloromethane (8 mL) 
was added dropwise and stirred under argon at -78 °C for 30 minutes. Then a 
solution of (S)-3-(tert-butyldiphenylsilyloxy)-2-methylpropan-1-ol (4.02 g, 12.3 
mmol) in dichloromethane (8 mL), was added dropwise and the reaction mixture 
was allowed to stir at -78 °C for 1 hour. Then the reaction mixture was quenched at 
-78 °C by dropwise addition of triethylamine (13.6 mL, 97.4 mmol) with the use of a 
bleach trap and the obtained solution was allowed to stir at -78 °C for 10 minutes 
and then at room temperature for 30 minutes. Then the solution was washed with 
100 mL of NaHCO3 aqueous saturated solution and extracted with 
dichloromethane (3 × 100 mL). The organic layers were collected, washed with 
100 mL of brine, dried over Na2SO4, filtered and concentrated under vacuum to 
afford the product 179 as a yellow oil in quantitative yield (4.33 g, 13.3 mmol). The 
crude product was taken straight onto the next step without any further purification. 
Rf 0.38 (hexane:Et2O, 9:1); [α]
25
D -5.00 (c 2.0, CHCl3); IR νmax (film) 3073-2720, 
2114, 1738-1713, 1472, 1428, 1111, 1026, 1008, 808, 826, 739, 698, 689 and 615 
cm-1; 1H-NMR (400 MHz; CDCl3): δH 9.76 (1H, s, CHO), 7.75-7.65 (4H, m, CHAr), 
7.52-7.35 (6H, m, CHAr), 3.95-3.85 (2H, m, CH2), 2.65-2.50 (1H, m, CH), 1.20 (3H, 
d, J 6.7 Hz, CH3), 1.08 (9H, s, 3 × CH3); 
13C-NMR (100 MHz; CDCl3): δC 204.5 
(CO), 135.7 (CHAr), 133.2 (CAr), 129.8 (CHAr), 127.8 (CHAr), 64.2 (CH2), 48.8 (CH), 
26.8 (3 × CH3), 19.1 (C), 10.3 (CH3); HRMS (CI+/ISO) calc. for C20H27O2Si [M+H]
+: 
327.1780. Found: 327.1774. 
 
The characterisation matches with the data reported in literature: 
Robles O.; McDonald F. E. Org. Lett. 2008, 10, 1811. 
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(S,E)-Ethyl 5-(tert-butyldiphenylsilyloxy)-4-methylpent-2-enoate, 176 
 
 
 
(R)-3-(tert-butyldiphenylsilyloxy)-2-methylpropanal 179 (10.7 g, 32.7 mmol) and 
(tert-butoxycarbonylmethylene)triphenylphosphorane (17.2 g, 49.2 mmol) were 
dissolved in benzene (60 mL) and the reaction mixture was allowed to stir at 80 °C 
for 12 hours. Then the solution was concentrated under vacuum to afford a brown 
oil as crude product. It was purified through flash column chromatography on silica 
gel (from 0 to 10% ethyl acetate in hexane) to afford a colourless oil as pure 
product 176 (13.0 g, 32.7 mmol) in quantitative yield. Rf 0.41 (hexane:EtOAc, 9:1); 
[α]25D -10.40 (c 1.0, CHCl3); IR νmax (film) 3416, 2961, 2859, 1717, 1653, 1472, 
1427, 1368, 1267, 1182, 1111, 1094, 1034, 982, 824, 802, 741, 700, 689 and 613 
cm-1; 1H-NMR (400 MHz; CDCl3): δH 7.66-7.56 (4H, m, CHAr), 7.43-7.30 (6H, m, 
CHAr), 6.91 (1H, dd, J 7.5, 15.8 Hz, CH=), 5.80 (1H, dd, J 1.5, 15.8 Hz, 
EtOCOCH=), 4.17 (2H, q, J 7.1 Hz, CH2), 3.60-3.53 (2H, m, CH2), 2.61-2.42 (1H, 
m, CH), 1.29 (3H, t, J 7.0 Hz, CH3), 1.12 (3H, d, J 6.7 Hz, CH3), 1.01 (9H, s, 3 × 
CH3); 
13C-NMR (100 MHz; CDCl3): δC 166.7 (CO), 152.8 (EtOCOCH=), 135.9 
(CHAr), 133.6 (CAr), 130.0 (CHAr), 127.9 (CHAr), 121.5 (CH=), 67.6 (CH2), 60.2 
(CH2), 39.1 (CH), 26.9 (3 × CH3), 19.2 (C), 16.6 (CH3), 14.3 (CH3); HRMS 
(CI+/ISO) calc. for C24H33O3Si [M+H]
+: 397.2199. Found: 397.2203. 
 
The characterisation matches with the data reported in literature: 
Nicolaou K. C.; Schlawe D.; Kim D. W.; Longbottom D. A.; de Noronha R. G.; 
Lizos D. E.; Manam R. R.; Faulkner D. J. Chem. Eur. J. 2005, 11, 6197. 
 
(S,E)-5-(tert-Butyldiphenylsilyloxy)-4-methylpent-2-en-1-ol, 180 
 
 
 
The (S,E)-ethyl 5-(tert-butyldiphenylsilyloxy)-4-methylpent-2-enoate 176 (13.7 g, 
34.6 mmol) was dissolved in dry dichloromethane (180 mL) and the solution was 
cooled at 0 ° C. Then DIBAL-H (76.1 mL, 76.1 mmol, 1 M solution in hexane) was 
added dropwise and the reaction mixture was allowed to stir at 0 °C for 2 hours. 
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The reaction mixture was quenched carefully at 0 °C with 200 mL of a Rochelle’s 
salt saturated aqueous solution added dropwise and the biphasic system was 
allowed to stir at room temperature for 12 hours. Then the organic layer was saved 
and the aqueous layer was extracted with ethyl acetate (3 × 100 mL). All the 
organic layers were combined and washed with brine (200 mL), then dried over 
Na2SO4, filtered and concentrated under vacuum to afford a colourless oil as 
product 180 (12.4 g, 34.8 mmol) in quantitative yield . The product resulted very 
clean without necessity of any further purification. Rf 0.15 (hexane:EtOAc, 9:1); 
[α]25D -2.40 (c 1.0, CHCl3); IR νmax (film) 3323, 3071, 2959, 2858, 1589, 1473, 
1427, 1389, 1362, 1105, 1083, 1007, 998, 970, 824, 806, 738, 699, 689 and 613 
cm-1; 1H-NMR (400 MHz; CDCl3): δH 7.66-7.58 (4H, m, CHAr), 7.42-7.28 (6H, m, 
CHAr), 5.64-5.54 (2H, m, CH=CH), 4.07-3.95 (2H, m), 3.57-3.43 (2H, app bt, J 4.8 
Hz, CH2), 2.50-2.27 (1H, m, CH), 1.30 (1H, bt, J 5.8 Hz, OH), 1.12 (9H, s, 3 × 
CH3), 1.00 (3H, d, J 7.0 Hz, CH3); (400 MHz; C6D6): δH 7.80-7.74 (4H, m, CHAr), 
7.26-7.20 (6H, m, CHAr), 5.47-5.43 (2H, m, CH=CH), 3.80 (2H, t, J 5.1 Hz, 
CH2OH), 3.57 (1H, dd, J 6.2, 9.7 Hz, CHHOSi), 3.48 (1H, dd, J 7.4, 9.9 Hz, 
CHHOSi), 2.42-2.29 (1H, m, CH), 1.18 (9H, s, 3 × CH3), 0.99 (3H, d, J 6.7 Hz, 
CH3); 
13C-NMR (100 MHz; CDCl3): δC 135.6 (CHAr), 135.5 (CH=), 133.9 (CAr), 
129.6 (CHAr), 128.7 (CHAr), 127.6 (CH=), 68.5 (CH2OSi), 63.9 (CH2OH), 38.9 (CH), 
26.9 (3 × CH3), 19.3 (C), 16.4 (CH3); HRMS (CI+/ISO) calc. for C22H29OSi [M-
OH]+: 337.1988. Found: 337.1987. 
 
The characterisation matches with the data reported in literature: 
Chandrasekhar S.; Yaragorla S. R.; Sreelakshmi L.; Reddy C. H. R. Tetrahedron 
2008, 64, 5174. 
 
((2R,3R)-3-((R)-1-(tert-Butyldiphenylsilyloxy)propan-2-yl)oxiran-2-
yl)methanol, 175 
 
 
 
(-)-Diethyl tartrate (0.53 mL, 3.05 mmol) and powdered 4 Å molecular sieves (0.50 
g) were suspended in freshly distilled dichloromethane (15 mL) and the resulting 
suspension was cooled at -20 °C and then treated with Ti(O-iPr)4 (0.76 mL, 2.54 
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mmol) followed by vigorous stirring for 20 minutes at -20 °C. Then TBHP (1.4 mL, 
7.62 mmol) was added and the reaction mixture was stirred for 20 minutes at -20 
°C. A solution of (S,E)-5-(tert-butyldiphenylsilyloxy)-4-methylpent-2-en-1-ol 180 
(0.90 g, 2.54 mmol) in dichloromethane (5 mL) was finally added and the resulting 
mixture was stirred at -23 °C for 1 hour. The reaction mixture was diluted with 
diethyl ether (20 mL) and filtered through Celite® and silica gel. The solvent was 
removed under vacuum to afford a yellow-orange oil as crude product. The crude 
was purified by flash column chromatography on silica gel (from 10 to 40% ethyl 
acetate in hexane) to afford a colourless oil as pure product 175 (0.87 g, 2.35 
mmol) in 93% yield, 90% d.e. Rf 0.29 (hexane:EtOAc, 7:3); [α]
25
D -9.60 (c 1.25, 
CHCl3); IR νmax (film) 3429, 2859, 1749, 1473, 1427, 1111, 1007, 824, 739, 699 
and 614 cm-1; 1H-NMR (400 MHz; CDCl3): δH 7.66-7.58 (4H, m, CHAr), 7.42-7.28 
(6H, m, CHAr), 3.91-3.61 (4H, m, 2 × CH2), 3.22-3.18 (2H, m, 2 × CH), 2.19 (1H, 
bs, OH), 1.81-1.68 (1H, m, CHCH3), 1.11 (9H, s, 3 × CH3), 1.01 (3H, d, J 7.0 Hz, 
CH3); 
13C-NMR (100 MHz; CDCl3): δC 135.6 (CHAr), 133.6 (CAr), 129.8 (CHAr), 
127.8 (CHAr), 65.9 (CH2OSi), 61.9 (CH2OH), 57.5 (CHCHCH3), 56.9 (CHCH2OH), 
37.8 (CHCH3), 26.9 (3 × CH3), 19.4 (C), 12.9 (CH3); HRMS (CI+/ISO) calc. for 
C22H31O3Si [M+H]
+: 371.2042. Found: 371.2052. 
 
The characterisation matches with the data reported in literature: 
Chandrasekhar S.; Yaragorla S. R.; Sreelakshmi L.; Reddy C. H. R. Tetrahedron 
2008, 64, 5174. 
 
 ((2S,3S)-3-((R)-1-(tert-Butyldiphenylsilyloxy)propan-2-yl)oxiran-2-yl) 
methanol, 181 
 
 
1H-NMR (400 MHz; CDCl3): δH 7.72-7.67 (4H, m, CHAr), 7.47-7.37 (6H, m, CHAr), 
3.94-3.60 (4H, m, 2 × CH2), 3.18-3.13 (1H, m, CH), 2.98-2.95 (1H, m, CH), 2.19 
(1H, bs, OH), 1.75-1.65 (1H, m, CHCH3), 1.07 (9H, s, 3 × CH3), 0.99 (3H, d, J 7.0 
Hz, CH3).  
 
The characterisation matches with the data reported in literature: 
Fuwa H.; Sasaki M. Org. Lett. 2010, 12, 584. 
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(2S,3S,4R)-5-(tert-Butyldiphenylsilyloxy)-2,4-dimethylpentane-1,3-diol, 187 
 
 
CuI (2.50 g, 13.2 mmol) was dissolved in dry diethyl ether (8 mL) and the solution 
was cooled at -23 °C, then a solution of methyllithium 1.5M (17.6 mL, 26.4 mmol) 
was added dropwise and stirred to afford a colourless solution. The solution was 
cooled at -45 °C and ((2R,3R)-3-((R)-1-(tert-butyldiphenylsilyloxy)propan-2-
yl)oxiran-2-yl)methanol 175 (0.49 g, 1.32 mmol) in dry diethyl ether (2 mL) was 
added dropwise. The reaction mixture was allowed to warm from -45 °C to -20 °C 
and left to stir for 12 hours. The reaction mixture was quenched with a 2:1 mixture 
of saturated NH4Cl and 28% aqueous NH3 (10 mL) and separated. The organic 
layer was washed with brine (10 mL) and the aqueous layer was extracted with 
dichloromethane (3 × 10 mL). The combined organic layers were dried over 
Na2SO4 and concentrated under vacuum. The crude product was directly 
dissolved in 60% aqueous acetonitrile (10 mL) followed by slow addition of NaIO4 
(565 mg, 2.64 mmol) at 0 °C. After stirring for an hour at room temperature 
acetonitrile was removed under vacuum and the aqueous layer was extracted with 
dichloromethane. The combined organic layers were washed with brine (10 mL), 
dried over Na2SO4, filtered and concentrated under vacuum to afford a yellow oil 
as crude product. The crude product was purified by silica gel flash column 
chromatography (from 10 to 40% ethylacetate in hexane) to afford a colourless oil 
as pure product 187 (333 mg, 863 µmol) in 65% yield. Rf 0.40 (hexane:EtOAc, 
6:4); [α]25D -5.60 (c 0.5, CHCl3); IR νmax (film) 3425, 2961, 2858, 2360, 1427, 1112, 
1075, 984, 824, 740, 701, 692 and 613 cm-1; 1H-NMR (400 MHz; CDCl3): δH 7.72-
7.63 (4H, m, CHAr), 7.49-7.35 (6H, m, CHAr), 4.40 (1H, d, J 4.0 Hz, CHOH), 3.91-
3.78 (2H, m, CH2OSi), 3.70-3.46 (3H, m, CHOH and CH2OH), 1.81-1.68 (2H, m, 2 
× CH), 1.18-1.15 (1H, bm, CH2OH), 1.09 (9H, s, 3 × CH3), 1.02 (3H, d, J 7.0 Hz, 
CH3), 0.96 (3H, d, J 7.0 Hz, CH3); 
13C-NMR (100 MHz; CDCl3): δC 135.7 (CHAr), 
133.6 (CAr), 130.0 (CHAr), 127.9 (CHAr), 83.2 (CHOH), 68.3 (CH2OH), 66.8 
(CH2OSi), 37.1 (CH), 36.7 (CH), 26.9 (3 × CH3), 19.1 (C), 14.6 (CH3), 13.5 (CH3); 
HRMS (CI+/ISO) calc. for C23H35O3Si [M+H]
+: 387.2355. Found: 387.2361. 
 
The characterisation matches with the data reported in literature: 
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Chandrasekhar S.; Yaragorla S. R.; Sreelakshmi L.; Reddy C. H. R. Tetrahedron 
2008, 64, 5174. 
 
 (2S,3S,4R)-1-(Benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpentan-
3-ol, 189 
 
 
To a suspension of NaH (1.03 g, 25.7 mmol) in dry THF (150 mL) at 0 °C, a 
solution of (2S,3S,4R)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpentane-1,3-diol 
187 (3.30 g, 8.50 mmol) in THF (50 mL) was added. The resulting mixture was 
stirred at 0 °C for 30 minutes and then benzyl bromide (1.02 mL, 8.50 mmol) was 
added dropwise. The reaction mixture was allowed to stir at room temperature for 
12 hours. The reaction was quenched with NH4Cl saturated aqueous solution (100 
mL) and extracted with ethyl acetate (3 × 100 mL). The combined organic layers 
were washed with brine (100 mL), dried over Na2SO4, filtered and concentrated 
under vacuum to afford a yellow oil as crude product. The crude product was 
purified by silica gel column chromatography (from 0 to 20% ethyl acetate in 
hexane) to afford a colourless oil as pure product 189 (3.35 g, 7.03 mmol) in 83% 
yield. Rf 0.64 (hexane:EtOAc, 8:2); [α]
25
D -4.80 (c 1.0, CHCl3); IR νmax (film) 3503, 
2932, 2862, 1466, 1427, 1111, 1080, 995, 910, 818, 734, 694, 648 and 610 cm-1; 
1H-NMR (400 MHz; CDCl3): δH 7.86-7.63 (4H, m, CHAr), 7.41-7.21 (11H, m, CHAr), 
4.46 (2H, s, CH2Ph), 3.70 (2H, d, J 5.7 Hz, CH2OSi), 3.60-3.45 (2H, m, CH2OBn), 
3.39 (1H, m, CHOH), 2.05-1.82 (2H, m, 2 × CH), 1.10 (1H, bs, OH), 1.06 (9H, s, 3 
× CH3), 0.95 (3H, d, J 6.9 Hz, CH3), 0.93 (3H, d, J 6.9 Hz, CH3); 
13C-NMR (100 
MHz; CDCl3): δC 138.3 (CAr), 135.7 (CHAr), 135.2(CHAr), 133.3 (CAr), 129.7 (CHAr), 
128.4 (CHAr), 127.7 (CHAr), 127.6 (CHAr), 79.5 (CHOH), 73.6 (CH2OBn), 73.4 
(CH2Ph), 67.3 (CH2OSi), 37.8 (CH), 36.3 (CH), 26.9 (3 × CH3), 19.2 (C), 15.1 
(CH3), 14.6 (CH3); HRMS (CI+/ISO) calc. for C30H41O3Si [M+H]
+: 477.2825. Found: 
477.2824. 
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((2R,3S,4S)-5-(Benzyloxy)-3-methoxy-2,4-dimethylpentyloxy)(tert-butyl) 
diphenylsilane, 190 
 
 
 
To a  suspension of NaH (1.40 g, 35.0 mmol) in dry THF (25 mL), a solution of 
(2S,3S,4R)-1-(benzyloxy)-5-(tert-butyldiphenylsilyloxy)-2,4-dimethylpentan-3-ol 
189 (3.30 g, 7.00 mmol) in THF (25 mL) was added and the resulting mixture was 
allowed to stir at room temperature for 15 minutes. Then iodomethane (4.4 mL, 
70.0 mmol) and TBAI (0.26 g, 0.70 mmol) were added and the reaction mixture 
was let to stir at 60 °C for 12 hours. The reaction was quenched with a saturated 
solution of NH4Cl (50 mL)  and the 2 layers were separated. The organic layer was 
washed with brine (50 mL) and the aqueous layer was extracted with diethyl ether 
(3 × 50 mL). The organic layers were mixed, dried over Na2SO4, filtered and 
concentrated under vacuum to afford a pale yellow oil as crude product. The crude 
product was purified by silica gel flash column chromatography (5% ethyl acetate 
in hexane) to afford a colourless oil as pure product 190 (3.30 g, 6.74 mmol) in 
96% yield. Rf 0.39 (hexane:EtOAc, 9.5:0.5); [α]
25
D -4.00 (c 0.5, CHCl3); IR νmax 
(film) 3071, 2963, 2855, 1612, 1466, 1427, 1080, 995, 1003, 826, 741, 694 and 
610 cm-1; 1H-NMR (400 MHz; CDCl3): δH 7.86-7.63 (4H, m, CHAr), 7.41-7.21 (11H, 
m, CHAr), 4.46 (2H, s, CH2Ph), 3.59 (1H, dd, J 4.4, 9.6 Hz, CHHOSi), 3.49 (1H, dd, 
J 6.8, 10.0 Hz, CHHOSi), 3.47 (3H, s, OCH3), 3.35-3.42 (2H, m, CH2OBn), 2.93 
(1H, app t, J 6.4 Hz, CHOMe), 2.05-1.82 (2H, m, 2 × CH), 0.92 (9H, s, 3 × CH3), 
0.82 (3H, d, J 7.0 Hz, CH3), 0.78 (3H, d, J 7.0 Hz, CH3); 
13C-NMR (100 MHz; 
CDCl3): δC 138.9 (CAr), 135.7 (CHAr), 135.5 (CHAr), 133.9 (CAr), 129.6 (CHAr), 128.4 
(CHAr), 127.5 (CHAr), 127.3 (CHAr), 85.8 (CHOMe), 73.1 (CH2Ph), 72.2 (CH2OBn), 
65.2 (CH2OSi), 61.2 (OCH3), 37.9 (CH), 36.1 (CH), 26.9 (3 × CH3), 19.2 (C), 15.7 
(CH3), 15.1 (CH3); HRMS (CI+/ISO) calc. for C31H43O3Si [M+H]
+: 491.2981. Found: 
491.2985. 
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(2R,3R,4S)-5-(Benzyloxy)-3-methoxy-2,4-dimethylpentan-1-ol, 191 
 
 
((2R,3S,4S)-5-(benzyloxy)-3-methoxy-2,4-dimethylpentyloxy)(tert-butyl) diphenyl 
silane 190 (525 mg, 1.07 mmol) was dissolved in dry THF (15 mL) under argon 
and the solution obtained was cooled at 0 °C. Then TBAF (2.7 mL, 2.70 mmol, 1 M 
solution in THF) was added dropwise and the reaction mixture was allowed to stir 
at room temperature for 12 hours. The reaction was quenched with distilled water 
(15 mL), extracted with diethyl ether (3 × 20 mL), washed with brine (15 mL), dried 
over Na2SO4, filtered and concentrated under vacuum to afford a yellow/colourless 
oil as crude product. The crude product was purified by silica gel flash column 
chromatography (from 10 to 40% ethyl acetate in hexane) to afford a colourless oil 
as pure product 191 (0.22 g, 873 µmol) in 82% yield. Rf 0.14 (hexane:EtOAc, 8:2); 
[α]25D +3.20 (c 1.0, CHCl3); IR νmax (film) 3433, 2924, 1458, 1366, 1088, 1026, 978, 
903, 741 and 694 cm-1; 1H-NMR (400 MHz; CDCl3): δH 7.41-7.32 (5H, m, CHAr), 
4.50 (2H, s, CH2Ph), 3.75 (1H, dd, J 4.4 Hz, 9.6 Hz, CHHOH), 3.65-3.45 (3H, m, 
CHHOH and CH2OBn),  3.38 (3H, s, OCH3), 2.93 (1H, app t, J 6.4 Hz, CHOMe), 
2.89 (1H, bs, OH), 2.05-1.82 (2H, m, 2 × CH), 0.82 (3H, d, J 6.9 Hz, CH3), 0.78 
(3H, d, J 6.9 Hz, CH3); 
13C-NMR (100 MHz; CDCl3): δC 138.6 (CAr), 128.4 (CHAr), 
127.9 (CHAr), 127.5 (CHAr), 89.1 (CHOMe), 73.1 (CH2OPh), 72.2 (CH2OBn), 65.6 
(CH2OH), 61.1 (OCH3), 37.4 (CH), 36.4 (CH), 15.1 (CH3), 14.6 (CH3); HRMS 
(CI+/ISO) calc. for C15H25O3 [M+H]
+: 253.1804. Found: 253.1805. 
 
(2S,3S,4S)-5-(Benzyloxy)-3-methoxy-2,4-dimethylpentanal, 192 
 
 
 
Oxalyl chloride (0.10 mL, 1.08 mmol) was dissolved in freshly distilled 
dichloromethane (2 mL) and the solution was cooled at -78 °C under argon. Then 
a solution of dimethylsulfoxide  (0.16 mL, 2.16 mmol) in dichloromethane (2 mL) 
was added dropwise and stirred under argon at -78 °C for 30 minutes. Then a 
solution of (S)-3-(tert-butyldiphenylsilyloxy)-2-methylpropan-1-ol 191 (136 mg, 0.54 
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mmol) in dichloromethane (3 mL), was added dropwise and the reaction mixture 
was allowed to stir at -78 °C for 1 hour. Then the reaction mixture was quenched at 
-78 °C by dropwise addition of triethylamine (0.6 mL, 4.32 mmol) with the use of a 
bleach trap and the obtained solution was allowed to stir at -78 °C for 10 minutes 
and then at room temperature for 30 minutes. Then the solution was washed with 
10 mL of NaHCO3 aqueous saturated solution and extracted with dichloromethane 
(3 × 10 mL). The organic layers were collected, washed with 10 mL of brine, dried 
over Na2SO4, filtered and concentrated under vacuum to afford the product 192 as 
a yellow oil in quantitative yield (135 mg, 0.54 mmol). The crude product was 
taken straight onto the next step without any further purification. 
1H-NMR (400 MHz; CDCl3): δH 9.76 (1H, s, CHO), 7.40-7.32 (5H, m, CHAr), 4.50 
(2H, s, CH2Ph), 3.54-3.46 (2H, m, CH2OBn), 3.38 (3H, s, OCH3), 3.41-3.37 (1H, 
m, CHOMe), 2.69-2.61 (1H, m, CH), 2.11-2.05 (1H, m, CH), 1.14 (3H, d, J 6.8 Hz, 
CH3), 0.98 (3H, d, J 6.8 Hz, CH3).  
 
(3R,4R,5S,6S)-7-(Benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-1-yn-3-ol, 
193 
 
and 
(R,E)-5-(Benzyloxy)-2,4-dimethylpent-2-enal, 194 
 
 
 
To a suspension of zinc triflate (673 mg, 1.85 mmol) and (+)-N-methylephedrine 
(343 mg, 1.91 mmol) in dry toluene (3 mL), under argon at room temperature, 
triethylamine (0.3 mL, 1.91 mmol) was added dropwise and the resulting mixture 
was allowed to stir at room temperature for 2 hours. Then phenylacetylene (0.1 
mL, 0.74 mmol) was added by syringe in one portion and the reaction mixture was 
allowed to stir for 15 minutes. Finally, a solution of (2S,3S,4S)-5-(benzyloxy)-3-
methoxy-2,4-dimethylpentanal 192 (154 mg, 615 µmol) in 2 mL of dry toluene was 
added in one portion by syringe and the resulting mixture was allowed to stir at 60 
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°C for 48 hours. Then, the reaction was quenched with NH4Cl saturated aqueous 
solution (5 mL) and extracted with ethyl acetate (4 × 5 mL). The organic layers 
were combined, dried over Na2SO4 and concentrated under vacuum to afford a 
yellow-brown oil as crude product. The crude product was purified through flash 
column chromatography (from 0 to 30% diethyl ether in hexane) to afford the 
desired product 193 as a colourless oil in 5% yield (10.0 mg, 28.4 µmol), and the 
secondary product 194 as a pale yellow oil in 60% yield (80.0 mg, 367 µmol).  
Desired product 193: [α]26D -4.40 (c 0.1, CHCl3); IR νmax (film) 3047, 2964, 2939, 
2859, 1490, 1454, 1365, 1215, 1085, 1070, 1028, 970, 752, 737 and 691 cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.47-7.27 (10H, m, CHAr), 4.70 (1H, dd, J 2.4, 6.8 Hz, 
CHOH), 4.52 (2H, s, CH2Ph), 4.11 (1H, d, J 6.8 Hz, OH), 3.60-3.56 (1H, m, CH), 
3.55 (3H, s, OCH3), 3.47-3.42 (2H, m, CH2OBn), 2.27-2.11 (2H, m, 2 × CH), 1.17 
(3H, d, J 6.8 Hz, CH3), 1.12 (3H, d, J 6.8 Hz, CH3); 
13C NMR (100 MHz, CDCl3): δ 
138.5 (CAr), 131.7 (CHAr), 131.6 (CHAr), 128.4 (CHAr), 128.2 (CHAr), 127.9 (CHAr), 
127.8 (CHAr), 123.0 (CAr), 89.3 (C), 88.2 (CHOMe), 85.3 (C), 73.2 (CH2OBn), 70.2 
(CH2Ph), 66.4 (CHOH), 60.9 (OCH3), 40.5 (CHCH3), 36.5 (CHCH3), 15.6 (CH3), 
14.6 (CH3); HRMS (CI+/ISO) calc. for C23H27O2 [M-OH]
+: 335.2011. Found: 
335.2012. 
Undesired Byproduct 194: [α]26D +20.10 (c 1.0, CHCl3); 
1H NMR (500 MHz, 
CDCl3): δ 9.40 (1H, s, CHO), 7.37-7.26 (5H, m, CHAr), 6.34 (1H, dq, J 2.0, 9.6 Hz, 
CH=), 4.52 (2H, s, CH2Ph), 3.48-3.40 (2H, m, CH2OBn), 3.07-3.00 (1H, m, 
CHCH3), 1.78 (3H, s, CH3), 1.09 (3H, d, J 9.0 Hz, CH3). 
 
The characterisation matches with the data reported in literature: 
Meyers A. I.; Babiak K. A.; Campbell A. L.; Comins D. L.; Fleming M. P.; Henning 
R.; Heuschmann M.; Hudspeth J. P.; Kane J. M.; Reider P. J.; Roland D. M.; 
Shimizu K.; Tomioka K.; Walkup R. D. J. Am. Chem. Soc. 1983, 105, 5015. 
 
(E)-Tributyl(styryl)stannane, 200 
 
 
 
To a mixture of phenylacetylene 199 (2.1 mL, 19.0 mmol) and AIBN (0.14 g, 85.0 
µmol), under argon at room temperature, tributyltin hydride (5.4 mL, 20.0 mmol) 
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was added dropwise and the resulting mixture was allowed to stir at 50 °C for 24 
hours. The reaction was allowed to cool to room temperature to afford a yellow oil 
as crude product. The crude product was purified by distillation under vacuum 
(b.p. 134 °C, 0.1 mmHg) to afford the pure product 200 as a colourless oil in 73% 
yield (5.42 g, 13.8 mmol). 1H-NMR (400 MHz; CDCl3): δH 7.21-7.42 (5H, m, CHAr), 
6.93 (2H, s, CH=CH), 1.60-0.66 (27H, m, 9 × CH2 and 3 × CH3); 
13C-NMR (100 
MHz; CDCl3): δC 146.0 (CH=), 138.7 (CAr), 129.3 (CHAr), 128.3 (CHAr), 127.3 
(CHAr), 125.9 (CH=), 29.2 (CH2), 27.4 (CH2), 13.8 (CH2), 9.7 (CH3). 
 
The characterisation matches the data reported in literature: 
Labadie J. W.; Stille J. K. J. Am. Chem. Soc. 1983, 105, 6129. 
 
2-Phenyl(triphenylphosphoranylidene)ethan-2-one, 204 
 
 
 
Triphenylphosphine (2.62 g, 10.0 mmol) and 2-bromo-1-phenylethanone (1.99 g, 
10.0 mmol) were dissolved in dry THF (250 mL) under argon and the resulting 
mixture was allowed to stir at reflux for 4 hours. Then the mixture was allowed to 
cool to room temperature and the white precipitate was collected by filtration and 
washed with diethyl ether (100 mL) to afford the (2-oxo-2-
phenylethyl)triphenylphosphonium salt 203. 1H-NMR (400 MHz; CDCl3): δH 8.35-
8.30 (2H, m, CHAr), 7.89-7.48 (18H, m, CHAr), 6.35 (2H, d, J 12.0 Hz, CH2). The 
salt 203 was immediately dissolved in a mixture of methanol and H2O (100 mL + 
100 mL) and treated with an aqueous solution of NaOH 2 N (100 mL). The 
resulting mixture was allowed to stir at room temperature for 12 hours, then the 
methanol was removed under reduced pressure while the aqueous phase was 
extracted with chloroform (3 × 100 mL). The organic layer was wahed with brine 
(100 mL), dried over Na2SO4 and concentrated under reduced pressure to afford a 
light yellow solid as pure product 204 in 79% yield over the two steps (3.00 g, 7.90 
mmol). IR νmax (film) 1587, 1524, 1512, 1483, 1435, 1385, 1103, 891, 872, 843, 
748, 712 and 689 cm
-1
; 
1
H-NMR (400 MHz; CDCl3): δH 7.98-7.97 (2H, m, CHAr), 
7.75-7.35 (18H, m, CHAr), 4.43 (1H, d, J 24.4 Hz, CH=); 
13C-NMR (100 MHz; 
CDCl3): δC 184.0 (CO), 133.2 (CAr), 132.1 (CAr), 129.4 (CHAr), 128.9 (CHAr), 128.8 
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(CHAr), 127.7 (CHAr), 126.9 (CHAr), 126.6 (CHAr), 50.0 (CH=); HRMS (CI+/ISO) 
calc. for C26H22OP [M+H]
+: 381.1408. Found: 381.1408; m.p.184-185 °C. 
 
The characterisation matches the data reported in literature: 
Babu K. S.; Li X. C.; Jacob M. R.; Zhang Q. F.; Kahn S. I.; Ferreira D.; Clark A. M. 
J. Med. Chem. 2006, 49, 7877. 
 
(4R,5R,6S,E)-7-(Benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-2-en-1-one, 
201 
 
 
(2S,3S,4S)-5-(benzyloxy)-3-methoxy-2,4-dimethylpentanal 192 (135 mg, 0.54 
mmol) and 2-phenyl(triphenylphosphoranylidene)ethan-2-one 204 (616 mg, 1.62 
mmol) were dissolved in benzene (3 mL) and the reaction mixture was allowed to 
stir at 85 °C for 96 hours. Then the solution was concentrated under vacuum to 
afford a beige oil as crude product. The crude product was purified through flash 
column chromatography on silica gel (from 0 to 10% ethyl acetate in hexane) to 
afford a colourless oil as pure product 201 (73.0 mg, 0.21 mmol) in 39% yield. Rf 
0.12 (hexane:Et2O, 9:1); [α]
26
D +2.80 (c 1.0, CHCl3); IR νmax (film) 2967, 2932, 
2911, 2874, 2859, 2359, 1767, 1669, 1653, 1618, 1597, 1580, 1449, 1364, 1252, 
1215, 1090, 1047, 1015, 986, 974, 916, 845, 822, 775 and 735 cm-1; 1H-NMR (400 
MHz; CDCl3): δH 7.93-7.89 (2H, m, CHAr), 7.58-7.51 (1H, m, CHAr), 7.50-7.43 (2H, 
m, CHAr), 7.37-7.32 (5H, m, CHAr), 7.09 (1H, dd, J 8.6, 15.7 Hz, CH=), 6.84 (1H, d, 
J 15.7 Hz, COCH=), 4.50 (2H, s, CH2Ph), 3.52-3.50 (2H, m, CH2OBn), 3.42 (3H, s, 
OCH3), 3.13-3.10 (1H, m, CHOMe), 2.76-2.70 (1H, m, CH), 1.96-1.88 (1H, m, CH), 
1.21 (3H, d, J 6.8 Hz, CH3), 1.01 (3H, d, J 6.9 Hz, CH3); 
13C-NMR (100 MHz; 
CDCl3): δC 191.3 (CO), 151.2 (CH=), 138.8 (CAr), 138.2 (CAr), 132.7 (CHAr), 128.7 
(CHAr), 128.6 (CHAr), 128.5 (CHAr), 127.7 (CHAr), 127.6 (CHAr), 126.0 (COCH=) 
87.0 (CHOMe), 73.4 (CH2Ph), 72.4 (CH2OBn), 61.3 (OCH3), 40.3 (CHMe), 37.3 
(CHMe), 17.6 (CH3), 15.1 (CH3); HRMS (CI+/ISO) calc. for C23H29O3 [M+H]
+: 
353.2117. Found: 353.2112. 
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(3S,4S,5S,6S,E)-7-(Benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-1-en-3-
yl acetate, 208  
 
(S)-2-Methyl-CBS-oxazaborilidine (300 mg, 1.08 mmol) was dissolved in dry THF 
(12 mL) and cooled to -10 °C. Then BH3
.THF (1.08 mL, 1.08 mmol, 1 M solution in 
THF) was added. After 30 minutes, a solution of (4R,5R,6S,E)-7-(benzyloxy)-5-
methoxy-4,6-dimethyl-1-phenylhept-2-en-1-one 201 (312 mg, 0.88 mmol) was 
added and the reaction mixture was stirred at -10 °C for 1 hour. Evaporation of the 
solvent afforded a yellow oil as crude product, which was purified through flash 
column chromatography on silica gel (from 0 to 30% diethyl ether in hexane) to 
afford a colourless oil as pure product 205 (163 mg, 0.46 mmol) in 52% yield. 
(1R,4R,5R,6S,E)-7-(benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-2-en-1-ol 
205 (163 mg, 0.46 mmol) was immediately dissolved in dry dichloromethane (6 
mL), under argon at room temperature, and acetic anhydride (0.12 mL, 1.32 
mmol), triethylamine (0.30 mL, 1.76 mmol) and DMAP (5.0 mg, 0.04 mmol) were 
added. The reaction mixture was allowed to stir at room temperature for 12 hours. 
Then the solvent was removed under vacuum to afford a yellow-brown oil as crude 
product (166 mg, 0.42 mmol, 92%), which was taken straight onto the next step 
without any further purification. 1H-NMR (400 MHz; CDCl3): δH 7.36-7.26 (10H, m, 
CHAr), 6.24 (1H, dd, J 1.2, 6.4 Hz, CHOAc), 5.80 (1H, dd, J 10.0, 15.6 Hz, CH=), 
5.63 (1H, dd, J 10.0, 15.6 Hz, CH=), 4.48 (2H, s, CH2Ph), 3.55-3.42 (2H, m, 
CH2OBn), 3.37 (3H, s, OCH3), 2.98-2.94 (1H, m, CHOMe), 2.10 (3H, s, OCOCH3), 
1.95-1.78 (2H, m, 2 × CH), 1.10 (3H, d, J 6.9 Hz, CH3), 1.06 (3H, d, J 6.9 Hz, 
CH3).  
(1R,4R,5R,6S,E)-7-(benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-2-enyl 
acetate 207 (166 mg, 0.42 mmol), and PdCl2(CH3CN)2 (6.30 mg, 21.2 µmol) were 
dissolved in dry THF (2.1 mL) and the resulting mixture was allowed to stir at room 
temperature for 12 hours. Then it was filtered through Celite® and washed with 
ethyl acetate as eluent (40 mL). The eluate was concentrated under vacuum to 
afford a yellow-brown oil as crude product. The crude was purified through flash 
column chromatography on silica gel (from 0 to 30% ethyl acetate in hexane) to 
afford a yellow oil as pure product 208 (166 mg, 0.42 mmol) in quantitative yield. 
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1H-NMR (400 MHz; CDCl3): δH 7.41-7.27 (10H, m, CHAr), 6.63 (1H, d, J 15.4 Hz, 
CH=), 6.17 (1H, dd, J 9.3, 15.8 Hz, CH=), 4.53-4.46 (3H, m, CHOAc and CH2Ph), 
3.61-3.55 (2H, m, CH2OBn), 3.41 (3H, s, OCH3), 3.39-3.35 (1H, m, CHOMe), 3.06-
2.98 (2H, m, 2 × CH), 2.12 (3H, s, OCOCH3), 1.10 (3H, d, J 6.9 Hz, CH3), 0.99 
(3H, d, J 6.9 Hz, CH3). 
 
(3S,4R,5S,6S,E)-7-(Benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-1-en-3-
ol, 209  
 
Method A 
(3S,4S,5S,6S,E)-7-(benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-1-en-3-yl 
acetate 208 (0.04 g, 101 µmol) was dissolved in methanol/H2O (1 mL/1 mL) in 
presence of K2CO3 (42.0 mg, 30.3 µmol) and the resulting mixture was allowed to 
stir at room temperature for 2 hours. The reaction was quenched with H2O (2 mL) 
and extracted with ethyl acetate (3 × 1 mL). The combined organic layers were 
dried over Na2SO4, filtered and concentrated under vacuum to afford a yellow oil 
as crude product. The crude product was purified by silica gel flash column 
chromatography (from 0 to 15% ethyl acetate in hexane) to afford a colourless oil 
as pure product 209 (15.5 mg, 45.0 µmol) in 45% yield. 
Method B 
(3S,4S,5S,6S,E)-7-(benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-1-en-3-yl 
acetate 208 (126 mg, 0.32 mmol) was dissolved in dry dichloromethane (5.25 mL) 
and the solution was cooled to 0 °C and stirred for 10 minutes. Then DIBAL-H 
(0.71 mL, 709 µmol, 1 M solution in hexane) was added dropwise and the resulting 
mixture was allowed to stir at 0 °C for 2 hours. The reaction mixture was quenched 
carefully at 0 °C with 10 mL of a Rochelle’s salt saturated aqueous solution added 
dropwise and the biphasic system was allowed to stir at room temperature for 12 
hours. Then the organic layer was saved and the aqueous layer was extracted 
with ethyl acetate (3 × 10 mL). All the organic layers were combined and washed 
with brine (50 mL), then dried over Na2SO4, filtered and concentrated under 
vacuum to afford a yellow thick oil/solid as crude product. The crude product was 
quickly washed through a pad of silica gel (30% ethyl acetate in hexane) to afford 
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a yellow oil as semi pure product 209 in 99% yield (112 mg, 317 µmol). [α]26D 
+2.00 (c 1.0, CHCl3); 
1H-NMR (400 MHz; CDCl3): δH 7.43-7.25 (10H, m, CHAr), 
6.62 (1H, d, J 15.9 Hz, CH=), 6.25 (1H, dd, J 6.9, 15.9 Hz, CH=), 4.53 (2H, s, 
CH2Ph), 4.33 (1H, app t, J 7.3 Hz, CHOH), 3.63-3.56 (1H, m, CHHOBn), 3.53 (3H, 
s, OCH3), 3.48-3.42 (1H, m, CHHOBn), 3.18 (1H, dd, J 4.7, 7.2 Hz, CHOMe), 
2.22-2.19 (1H, m, CH), 2.06-2.01 (1H, m, CH), 1.63 (1H, bs, OH), 1.12 (3H, d, J 
7.0 Hz, CH3), 0.95 (3H, d, J 7.0 Hz, CH3).  
 
((3S,4R,5S,6S,E)-7-(Benzyloxy)-3,5-dimethoxy-4,6-dimethylhept-1-enyl) 
benzene, 210 
 
 
To a suspension of NaH (50.3 mg, 1.26 mmol) in dry THF (2 mL), a solution of 
(3S,4R,5S,6S,E)-7-(benzyloxy)-5-methoxy-4,6-dimethyl-1-phenylhept-1-en-3-ol 
209 (112 mg, 317 µmol) in dry THF (10 mL) was added and the resulting mixture 
was left to stir at room temperature for 10 minutes. Then iodomethane (0.16 mL, 
2.52 mmol) and TBAI (13.5 mg, 25.5 µmol) were added and the reaction mixture 
was allowed to stir at 60 °C for 12 hours. The reaction was quenched with a 
saturated aqueous solution of NH4Cl (8 mL) and the two layers were separated. 
The organic layer was washed with brine (8 mL) and the aqueous layer was 
extracted with diethyl ether (3 × 10 mL). The combined organic layers were dried 
over Na2SO4, filtered and concentrated under vacuum to afford a yellow oil as 
crude product 210 (109 mg, 295 μmol, 93% yield). 1H-NMR (400 MHz; CDCl3): δH 
7.41-7.23 (10H, m, CHAr), 6.56 (1H, d, J 16.0 Hz, CH=), 6.18 (1H, dd, J 7.2, 15.9 
Hz, CH=), 4.48 (2H, s, CH2Ph), 4.05 (1H, dd, J 2.5, 7.4 Hz, CHOMe), 3.60 (2H, m, 
CH2OBn), 3.50 (3H, s, OCH3), 3.32 (3H, s, OCH3), 3.20 (1H, dd, J 2.4, 9.3 Hz, 
CHOMe), 2.17-2.09 (1H, m, CH), 1.84-1.77 (1H, m, CH), 1.14 (3H, d, J 7.1 Hz, 
CH3), 0.93 (3H, d, J 7.1 Hz, CH3).  
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(2S,3S,4R,5S,E)-3,5-Dimethoxy-2,4-dimethyl-7-phenylhept-6-en-1-ol, 22 
 
 
 
((3S,4R,5S,6S,E)-7-(benzyloxy)-3,5-dimethoxy-4,6-dimethylhept-1-enyl) benzene, 
210 (109 mg, 295 µmol) and N,N-dimethylaniline (122 mg, 912 mmol) were 
dissolved in dry dichloromethane (15 mL) and aluminum trichloride (0.15 mL, 0.91 
mmol) was added. The resulting mixture was allowed to stir at room temperature 
for 12 hours. The reaction was quenched with distilled water (30 mL), extracted 
with ethyl acetate (3 × 20 mL), washed with brine (50 mL), dried over Na2SO4, 
filtered and concentrated under vacuum to afford a pale yellow oil as crude 
product. The crude product was purified by silica gel column chromatography 
(from 0 to 30% ethyl acetate in hexane) to afford a colourless oil as pure product 
22 (14.8 mg, 53.1 µmol) in 18% yield. Rf 0.14 (hexane:EtOAc, 8:2); [α]
22
D -5.2 (c 
1.0, CHCl3); IR νmax (film) 3440, 2972, 2935, 2831, 1497, 1449, 1100 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3): δH 7.43-7.39 (2H, m, CHAr), 7.36-7.31 (2H, m, CHAr), 
7.27-7.23 (1H, m, CHAr), 6.58 (1H, d, J 16.3 Hz, CH=), 6.19 (1H, dd, J 7.1, 15.8 
Hz, CH=), 4.08-4.05 (1H, m, CHOMe), 3.89-3.82 (1H, m, CHHOH), 3.57-3.51 (1H, 
m, CHOMe), 3.53 (3H, s, OCH3), 3.32 (3H, s, OCH3), 3.29 (1H, dd, J 2.7, 9.4 Hz, 
CHHOH), 2.92-2.87 (1H, m, OH), 1.92-1.82 (2H, m, 2 × CH), 1.21 (3H, d, J 7.2 Hz, 
CH3), 0.91 (3H, d, J 7.2 Hz, CH3); 
13C NMR (125 MHz, CDCl3): δC 136.9 (CAr), 
132.3 (CH=), 129.5 (CH=), 128.8 (CHAr), 127.8 (CHAr), 126.6 (CHAr), 88.6 
(CHOMe), 81.3 (CHOMe), 64.7 (CH2OH), 61.8 (OCH3), 56.5 (OCH3), 42.5 (CH), 
35.9 (CH), 16.4 (CH3), 10.5 (CH3); HRMS (ESI+) calc. for C17H26O3Na [M+Na]
+: 
301.1774. Found: 301.1772. 
 
The characterisation matches with the data reported in literature: 
Feutrill J. T.; Lilly M. J.; Rizzacasa M. A. Org. Lett. 2000, 2, 3365. 
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
Chakraborty T. K.; Jayaprakash S.; Laxman P. Tetrahedron 2001, 57, 9461. 
Candy M.; Audran G.; Bienayme H.; Bressy C.; Pons J.-M. J. Org. Chem. 2010, 
75, 1354. 
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(2R,3R,4R,5S,E)-3,5-Dimethoxy-2,4-dimethyl-7-phenylhept-6-enal, 28 
 
 
 
To a solution of (2S,3S,4R,5S,E)-3,5-dimethoxy-2,4-dimethyl-7-phenylhept-6-en-1-
ol 22 (30.0 mg, 108 µmol) in 2 mL of dry dichloromethane, DMP (92.0 mg, 216 
µmol) was added and the resulting mixture was allowed to stir under argon at 
room temperature until completion as indicated by TLC analysis (40 minutes). 
Then, Na2S2O3 aqueous saturated solution (2 mL), NaHCO3 aqueous saturated 
solution (2 mL) and diethyl ether (5 mL) were added and the resulting mixture was 
stirred for a further 20 minutes at room temperature. The organic phase was 
separated and the aqueous phase was extracted with diethyl ether (3 × 5 mL). The 
organic layers were combined, dried over Na2SO4 and concentrated under 
vacuum to afford a pale yellow oil as crude product 28 (29.8 mg, 108 µmol), which 
was taken straight onto the next step without any further purification. Rf 0.37 
(hexane:EtOAc, 8:2); 1H NMR (400 MHz, CDCl3): δH 9.77 (1H, d, J 1.8 Hz, CHO), 
7.43-7.23 (5H, m, CHAr), 6.57 (1H, d, J 16.0 Hz, CH=), 6.15 (1H, dd, J 7.3, 16.0 
Hz, CH=), 4.08 (1H, dd, J 2.4, 7.6 Hz, CHOMe), 3.55 (1H, dd, J 2.6, 9.3 Hz, 
CHOMe), 3.49 (3H, s, OCH3), 3.33 (3H, s, OCH3), 2.73-2.65 (1H, m, CH), 1.93-
1.82 (1H, m, CH), 1.20 (3H, d, J 7.1 Hz, CH3), 0.87 (3H, d, J 7.1 Hz, CH3). 
 
The characterisation matches with the data reported in literature: 
Chakraborty T. K.; Jayaprakash S.; Laxman P. Tetrahedron 2001, 57, 9461. 
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(E)-Ethyl 4-bromo-3-methylbut-2-enoate, 211 
 
and    
(Z)-Ethyl 4-bromo-3-methylbut-2-enoate, 212 
 
 
To a solution of ethyl 3-methylbut-2-enoate (5.42 mL, 39.0 mmol) in carbon 
tetrachloride (64 mL), were added N-bromosuccinimide (7.50 g, 42.5 mmol) and 
AIBN (10.0 mg, 61.0 µmol) and the resulting mixture was allowed to stir at 80 °C 
for 3 hours. Then the reaction mixture was allowed to cool to room temperature, it 
was filtered and the filtrate washed with chloroform (50 mL). The organic layers 
were combined and washed with Na2SO3 saturated aqueous solution (50 mL) and 
brine (50 mL), dried over Na2SO4 and concentrated under vacuum to afford a 
yellow oil as crude product. The crude product was purified through flash column 
chromatography on silica gel (from 0 to 1.5% diethyl ether in hexane) to afford the 
desired product 211 as a colourless oil in 28% yield (2.25 g, 10.9 mmol) and the 
undesired isomer 212 as a colourless oil in 22% yield (1.77 g, 8.58 mmol). 
Desired isomer 211: IR νmax (film) 1719, 1651, 1445, 1369, 1282, 1231, 1157, 
1042, 891, 863 and 736 cm-1; 1H-NMR (400 MHz; CDCl3): δH 5.96 (1H, q, J 1.2 Hz, 
CH=), 4.17 (2H, q, J 7.0 Hz, CH2), 3.93 (2H, s, CH2Br), 2.27 (3H, d, J 1.2 Hz, 
CH3), 1.28 (3H, t, J 7.0 Hz, CH3); 
13C-NMR (100 MHz; CDCl3): δC 166.1 (CO), 
152.5 (C), 119.7 (CH=), 60.3 (CH2), 38.4 (CH2Br), 17.3 (CH3), 14.4 (CH3); HRMS 
(CI+/ISO) calc. for C7H11O2Br [M]
+: 205.9942. Found: 205.9938. 
Undesired isomer 212: 1H-NMR (400 MHz; CDCl3): δH 5.74 (1H, q, J 1.2 Hz, 
CH=), 4.53 (2H, s, CH2Br), 4.15 (2H, q, J 7.2 Hz, CH2), 2.01 (3H, d, J 1.2 Hz, 
CH3), 1.26 (3H, t, J 7.2 Hz, CH3). 
 
The characterisation matches with the data reported in literature: 
Mata E.; Thomas E. J. J. Chem. Soc. Perkin Trans. 1 1995, 785. 
 
. 
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(E)-Ethyl 4-(diethoxyphosphoryl)-3-methylbut-2-enoate, 29 
 
 
 
To the neat (E)-ethyl 4-bromo-3-methylbut-2-enoate 211 (1.30 g, 6.31 mmol) was 
added triethyl phosphite (1.65 mL, 9.50 mmol) and the resulting mixture was 
allowed to stir at 170 °C for 1 hour. The crude brown oil so obtained was distilled 
under vacuum (180 °C, 1 mbar) to afford the desired product 29 as a colourless oil 
in 94% yield (1.55 g, 5.90 mmol). IR νmax (film) 1713, 1647, 1444, 1392, 1352, 
1211, 1144, 1097, 1018, 958, 854 and 778 cm-1; 1H-NMR (400 MHz; CDCl3): δH 
5.75-5.71 (1H, m, CH=), 4.16-3.99 (6H, m, 3 × CH2), 2.63 (2H, d, J 23.5 Hz, CH2), 
2.25 (3H, dd, J 1.3, 3,5 Hz, CH3), 1.30-1.20 (9H, m = overlapping t, 3 × CH3); 
13C-
NMR (100 MHz; CDCl3): δC 166.1 (CO), 149.7 (C=), 120.2 (CH=), 62.3 (CH2), 59.8 
(2 × CH2), 39.3 (CH2), 20.1 (CH3), 16.5 (2 × CH3), 14.4 (CH3); HRMS (CI+/ISO) 
calc. for C11H21O5P [M]
+: 264.1127. Found: 264.1126. 
 
The characterisation matches with the data reported in literature: 
Mata E.; Thomas E. J. J. Chem. Soc. Perkin Trans. 1 1995, 785. 
 
(2E,4E,6S,7S,8R,9S,10E)-Ethyl 7,9-dimethoxy-3,6,8-trimethyl-11-phenyl 
undeca-2,4,10-trienoate, 42 
 
 
 
To a solution of diisopropylamine (0.03 mL, 216 µmol) in dry THF (1 mL), under 
argon at -78 °C, nBuLi (0.09 mL, 216 µmol, 2.5 M in hexanes) was added 
dropwise and the resulting mixture was allowed to stir at -78 °C for 30 minutes, 
then DMPU (0.16 mL) was added and the reaction mixture was stirred for 5 
minutes. A solution of (2R,3R,4R,5S,E)-3,5-dimethoxy-2,4-dimethyl-7-phenylhept-
6-enal 28 (30.0 mg, 108 µmol) and (E)-ethyl 4-(diethoxyphosphoryl)-3-methylbut-
2-enoate 211 (57.0 mg, 216 µmol) in dry THF (1 mL) was added dropwise and the 
resulting mixture was allowed to stir at -78 °C for 12 hours. The reaction was 
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quenched with NH4Cl saturated aqueous solution (5 mL) at -78 °C and then it was 
allowed to warm to room temperature, diluted with ethyl acetate (5 mL), washed 
with brine (5 mL), dried over Na2SO4 and concentrated under vacuum to afford a 
yellow oil as crude product. The crude product was purified through flash column 
chromatography on silica gel (from 0 to 10% ethyl acetate in hexane) to afford the 
pure product 42 as a pale yellow oil in 86% yield (36.0 mg, 93.0 µmol). Rf 0.31 
(hexane:EtOAc, 9:1); [α]19D  − 10.00 (c 0.2, CHCl3); 
1H-NMR (500 MHz; CDCl3): δH 
7.32 (2H, d, J 8.1 Hz, 2 × CHAr), 7.24 (2H, dd, J 7.1, 8.3 Hz, 2 × CHAr), 7.16 (1H, 
m, CHAr), 6.48 (1H, d, J  16.1 Hz, CH=), 6.13-6.02 (2H, m, 2 × CH=), 6.08 (1H, d, J 
15.9 Hz, CH=), 5.60 (1H, d, J 1.0 Hz, CH=), 4.07 (2H, q, J  6.8 Hz, CH2), 4.02-3.96 
(1H, m, CHOMe), 3.46 (3H, s, OCH3), 3.25 (3H, s, OCH3), 3.12 (1H, dd, J 1.8, 9.9 
Hz, CHOMe), 2.54-2.46 (1H, m, CHMe), 2.17 (3H, d, J 1.0 Hz, CH3), 1.56-1.45 
(1H, m, CHMe), 1.21 (3H, t, J 6.8 Hz, CH3), 1.17 (3H, d, J  6.9 Hz, CH3), 0.88 (3H, 
d, J  6.9 Hz, CH3); 
13C-NMR (125 MHz; CDCl3): δC 167.3 (CO), 152.2 (C=), 137.9 
(CH=), 136.7(CHAr), 133.9 (CAr), 132.7 (CHAr), 129.2 (CH=), 128.4 (CH=), 127.5 
(CHAr), 125.7 (CH=), 118.8 (CH=), 87.1 (CHOMe), 81.9 (CHOMe), 61.5 (CH2), 
60.0 (OCH3), 56.6 (OCH3), 43.6 (CHMe), 40.9 (CHMe), 19.2 (CH3), 14.4 (CH3), 
13.9 (CH3), 10.2 (CH3). 
 
The characterisation matches with the data reported in literature: 
Chakraborty T. K.; Jayaprakash S.; Laxman P. Tetrahedron 2001, 57, 9461. 
 
3-Methylbut-2-enamide, 214 
 
 
 
To a solution of ethyl-3,3-dimethyl-acrylate (0.1 mL, 0.70 mmol) in dry methanol 
(2.25 mL) in a 2-5 mL microwave vial, at 0 °C under argon, magnesium nitride 
(0.36 g, 3.50 mmol) was added in one portion and the vial was immediately sealed 
and allowed to warm to room temperature in 1 hour. The initial beige-brown 
suspension gradually becomes white during this time. When the vial reaches room 
temperature, it is transferred in an oil bath and heated at 80 °C for 24 hours. The 
crude product is directly purified thorugh flash column chromatography on silica 
gel (from 50 to 100% ethyl acetate in hexane) to afford the pure product 214 as a 
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white solid in 43% yield (26.0 mg, 0.30 mmol).   IR νmax (film) 3366, 3169, 2980, 
2940, 2918, 2753, 1670, 1607, 1454, 1433, 1404, 1368, 1325, 1310, 1188, 1103, 
1078, 980, 957, 939, 854, 797, 714 and 679  cm-1; 1H NMR (500 MHz, CDCl3): δ 
5.62 (1H, sept, J 1.3 Hz, CH=), 5.60 (1H, bs, NH), 5.39 (1H, bs, NH), 2.14 (3H, d, 
J 1.3 Hz, CH3 trans), 1.84 (3H, d, J 1.3 Hz, CH3 cis); 
13C NMR (125 MHz, CDCl3): δ 
169.1 (CO), 152.8 (C=), 117.6 (CH=), 27.3 (CH3 trans), 19.9 (CH3 cis); HRMS 
(CI+/ISO) calc. for C5H10ON [M+H]
+: 100.0762. Found: 100.0759; m.p. 97-98 °C. 
 
The characterisation matches with the data reported in literature: 
Mathieson J. E.; Crawford J. J.; Schmidtmann M.; Marquez R. Org. Biomol. Chem. 
2009, 7, 2170. 
 
(4S,5S)-Diisopropyl-2-((E)-but-2-enyl)-1,3,2-dioxaborolane-4,5-dicarboxylate, 
216 
 
 
An oven-dried 100-mL, three-necked, round bottomed flask equipped with a 
magnetic stir bar and a thermometer was charged with potassium tert-butoxide 
(2.85 g, 25.3 mmol) and dry THF (30 mL). The resulting solution was flushed with 
argon and cooled to -78 °C, then trans-2-butene 218 (2.5 mL, 26.8 mmol) 
(previously condensed from a gas lecture bottle into a rubber-stoppered 10-mL 
graduated vial immersed in a -78 °C dry-ice/acetone bath) was added via canula. 
nBuLi (10.12 mL, 25.3 mmol) was added dropwise in a period of 20 minutes so 
that the internal temperature never rose above -65 °C. After the completion of the 
addition, the cooling bath was removed and the reaction mixture was allowed to 
warm until -50 °C. The reaction mixture is kept at -50 °C for exactly 15 minutes 
and then was immediately recooled to -78 °C. Triisopropylborate (5.8 mL, 25.3 
mmol) was added dropwise in a period of 20 minutes avoiding that the internal 
temperature goes above -65 °C. After the completion of the addition, the reaction 
mixture was stirred at -78 °C for other 10 minutes and then immediately poured in 
a 250-mL separatory funnel containing 50 mL of aqueous 1N HCl saturated with 
NaCl. The aqueous layer was adjusted at pH 1.00 using 1N HCl aqueous solution 
and then (S,S)-DIPT (5.25 mL, 25.3 mmol) in dry diethyl ether (10 mL) was added 
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to the funnel. The phases were separated and the aqueous phase was extracted 
again with diethyl ether (3 × 50 mL). The combined organic layers were dried over 
MgSO4 for 3 hours at room temperature, then filtered and concentrated under 
vacuum (it is necessary to stir under vacuum till the removal of any residual of 
THF), to afford the product 216 as a colourless oil in 75% yield (5.60 g, 18.9 
mmol).  The product was stored at -20 °C as a 1.0 M solution in dry toluene. [α]26D  
+1.58 (c 4.0, CHCl3); 
1H-NMR (400 MHz; CDCl3): δH 5.65-5.55 (1H, m, =CH), 5.45-
5.35 (1H, m, CH=), 4.81-5.02 (2H, m, 2 × CH), 4.90 (2H, s, 2 × CH), 1.85 (2H, bd, 
J 6.4 Hz, CH2), 1.55 (3H, d, J 6.4 Hz, CH3), 0.93 (12H, d, J 6.4 Hz, 4 × CH3). 
 
The characterisation matches with the data reported in literature:  
Roush W. R.; Ando K.; Powers D. B.; Palkowitz A. D.; Halterman R. L. J. Am. 
Chem. Soc. 1990, 112, 6339. 
 
(2S,3R,4R)-1-(tert-Butyldiphenylsilyloxy)-2,4-dimethylhex-5-en-3-ol, 217 
 
 
To a slurry of 300 mg of 4 Å powdered molecular sieves (previously dried under 
vacuum with the heat gun) in 15 mL of dry toluene under argon at room 
temperature, was added (4S,5S)-diisopropyl 2-((E)-but-2-enyl)-1,3,2-
dioxaborolane-4,5-dicarboxylate 216 (13.8 mL, 13.8 mmol, 1.0 M solution in dry 
toluene). After being stirred for 10 minutes at room temperature, the mixture was 
cooled to -78 °C. A solution of aldehyde (S)-3-(tert-butyldiphenylsilyloxy)-2-
methylpropanal 163 (crude, theoretically 3.00 g, 9.20 mmol) in 15 mL of dry 
toluene was then introduced dropwise via cannula over a 20 minutes period. After 
the addition was complete, the solution was maintained at -78 °C for 16 hours. 
Excess ethanolic NaBH4 (200 mg in 3 mL of absolute ethanol) was then added 
dropwise via pipet and the solution was allowed to warm to 0 °C. Then the reaction 
mixture was diluted with 25 mL of 1 N NaOH and stirred vigorously for 2 hours. 
The layers were separated and the aqueous layer was extracted with diethyl ether 
(5 × 150 mL). The organic layers were combined, dried over K2CO3 and 
concentrated under vacuum to afford a yellow oil as crude product. The crude 
product was purified by three rounds of silica gel flash column chromatography 
(from 0 to 10% diethyl ether in hexane) to afford a colourless oil as pure product 
A. E. Pasqua 2013 Chapter II Experimental 
  
338 
 
217 in 65% yield (2.30 g, 6.00 mmol). Rf 0.32 (hexane:Et2O, 9:1); [α]
28
D +14.6 (c 
4.0, CHCl3); {Lit.
[38] [α]20D +26.2 (c 0.8, CHCl3)}; IR νmax (film) 3050, 2062, 1430, 
1210, 1010, 915, 864, 702, 610, 420, 350 cm-1; 1H NMR (500 MHz, CDCl3): δH 
7.59-7.56 (4H, m, CHAr), 7.36-7.24 (6H, m, CHAr), 5.86 (1H, ddd, J 2.1, 8.4, 10.5 
Hz, CH=), 5.00-4.94 (2H, m, =CH2), 3.66-3.58 (2H, m, CH2OSi), 3.39 (1H, dd, J 
0.6, 3.3 Hz, OH), 3.36-3.32 (1H, m, CHOH), 2.33-2.22 (1H, m, CH), 1.77-1.70 (1H, 
m, CH), 1.02 (3H, d, J 7.0 Hz, CH3), 0.97 (9H, s, 3 × CH3), 0.72 (3H, d, J 7.0 Hz, 
CH3); 
13C NMR (125 MHz, CDCl3): δC 139.9 (CH=), 135.7 (CHAr), 132.9 (CAr), 
129.9 (CHAr), 127.8 (CHAr), 115.2 (=CH2), 79.7 (CHOH), 68.9 (CH2OSi), 41.2 
(CHMe), 37.9 (CHMe), 26.9 (3 × CH3), 19.1 (C), 17.8 (CH3), 13.6 (CH3); HRMS 
(CI+/ISO) calc. for C24H35O2Si [M+H]
+: 383.2406. Found: 383.2410. 
 
The characterisation matches with the data reported in literature: 
Roush W. R.; Palkowitz A. D.; Ando K. J. Am. Chem. Soc. 1990, 112, 6348. 
 
1-Phenylprop-2-en-1-ol 
 
 
Vinylmagnesium bromide (47.1 mL, 47.1 mmol, 1.0 M in THF) was added 
dropwise to a solution of benzaldehyde 225 (5.00 g, 47.1 mmol) in 250 mL of dry 
THF at 0 °C. After 10 minutes the reaction mixture was allowed to warm to room 
temperature and stirred for 4 hours. Then the reaction was quenched by addition 
of 200 mL of NH4Cl aqueous saturated solution and extracted with diethyl ether (3 
× 150 mL). The organic layers were combined, washed with brine, dried over 
Na2SO4 and concentrated under vacuum to afford a yellow oil as crude product in 
quantitative yield (6.23 g, 47.1 mmol). The crude product was taken directly onto 
the next step without any further purification. Rf 0.21 (hexane:Et2O, 8:2); IR νmax 
(film) 3371, 1667, 1451, 1119, 950, 865, 780, 706, 630, 410, 360 cm-1; 1H NMR 
(400 MHz, CDCl3): δH 7.38-7.36 (5H, m, CHAr), 6.05 (1H, ddd, J 6.1, 10.3, 17.1 Hz, 
CH=), 5.38-5.33 (1H, m, CHOH), 5.22-5.17 (2H, m, =CH2), 4.66 (1H, bs, OH); 
13C 
NMR (100 MHz, CDCl3): δC 142.7 (CH=), 140.3 (CAr), 128.7 (CHAr), 127.8 (CHAr), 
126.4 (CHAr), 115.2 (=CH2), 75.4 (CHOH); HRMS (EI+) calc. for C9H10O [M]
+: 
134.0732. Found: 134.0733. 
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The characterisation matches the data reported in literature: 
Tamura S.; Shiomi A.; Kaneko M.; Ye Y.; Yoshida M.; Yoshikawa M.; Kimura T.; 
Kobayashi M.; Murakami N. Bioorg. Med. Chem. Lett. 2009, 19, 2555. 
 
1-Phenylprop-2-en-1-one, 222 
 
The alcohol 1-phenylprop-2-en-1-ol (crude, theoretically 6.23 g, 47.1 mmol) was 
dissolved in 500 mL of dry dichloromethane under argon at room temperature. 
TEMPO (147 mg, 0.94 mmol) and iodobenzene diacetate (38.0 g, 118 mmol) were 
added and the resulting mixture was allowed to stir at room temperature for 12 
hours. The reaction mixture was quenched by addition of Na2S2O3 aqueous 
saturated solution (300 mL) and left to stir for 1 hour. The organic phase was 
separated and the aqueous phase was extracted with diethyl ether (3 × 200 mL). 
The organic layers were combined, dried over Na2SO4 and concentrated under 
vacuum to afford an orange-yellow oil as crude product. The crude product was 
purified by silica gel flash column chromatography (from 0 to 20% Et2O in hexane) 
to afford a yellow oil as pure product 222 in 85% yield (5.30 g, 40.1 mmol). Rf 0.37 
(hexane:Et2O, 8:2); IR νmax (film) 2967, 2932, 2874, 1768, 1668, 1618, 1449, 1364, 
1252, 1215, 1090, 1015, 916, 775, 735 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.97-
7.93 (2H, m, CHAr), 7.60-7.56 (1H, m, CHAr), 7.49-7.47 (2H, m, CHAr), 7.16 (1H, 
dd, J 10.6, 17.1 Hz, CH=), 6.45 (1H, dd, J 1.7, 17.1 Hz, =CHH), 5.94 (1H, dd, J 
1.7, 10.6 Hz, =CHH); 13C NMR (125 MHz, CDCl3): δC 191.2 (CO), 137.5 (CAr), 
133.1 (CHAr), 132.6 (CH=), 130.3 (=CH2), 128.8 (CHAr), 128.7 (CHAr); HRMS 
(CI+/ISO) calc. for C9H9O [M+H]
+: 133.0653. Found: 133.0650. 
 
(R)-1-Phenylprop-2-en-1-ol, 223 
 
To a solution of (S)-2-methyl-CBS-oxazaborilidine (514 mg, 1.52 mmol) in dry THF 
(4 mL), under argon at room temperature, BH3
.THF (1.86 mL, 1.86 mmol, 1.0 M 
solution in THF) was added dropwise and the resulting mixture was allowed to stir 
at room temperature for 30 minutes, then it was cooled to -40 °C and a solution of 
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1-phenylprop-2-en-1-one 222 (0.20 g, 1.52 mmol) in dry THF (4 mL) was added 
dropwise. The resulting mixture was allowed to stir at -40 °C for 4 hours and then it 
was immediately concentrated under vacuum to afford a yellow oil as crude 
product. The crude product was purified through flash column chromatography on 
silica gel (from 0 to 30% ethyl acetate in hexane) to afford the pure product 223 as 
a colourless oil in quantitative yield (204 mg, 1.52 mmol). [α]25D +1.60 (c 1.0, 
CHCl3); {Lit. [α]
20
D +1.30 (c 1.0, CHCl3); >99% e.e.}; 
1H NMR (400 MHz, CDCl3): 
δH 7.42-7.24 (5H, m, CHAr), 6.04 (1H, ddd, J 5.7, 10.4, 17.1 Hz, CH=), 5.34 (1H, 
ddd, J 1.8, 1.8 Hz, 17.1 Hz, CH=), 5.20-5.15 (2H, m, CH and CH=), 2.03 (1H, bs, 
OH). 
 
The characterisation matches the data reported in literature: 
Duveen D. I.; J. Kenyon J. Chem. Soc. 1939, 1697. 
Davis F. A.; Stringer O. D.; McCauley Jr. J. P. Tetrahedron 1985, 41, 4747. 
Lin H.; Liu Y.; Wu Z. L. Chem. Commun. 2011, 47, 2610. 
Kanbayashi N.; Onitsuka K. Angew. Chem. Int. Ed. 2011, 50, 5197. 
 
(R)-1-Phenylallyl acetate, 224 
 
 
To a solution of (R)-1-phenylprop-2-en-1-ol 223 (0.20 g, 1.52 mmol) in pyridine (28 
mL), at room temperature under argon, acetic anhydride (7.1 mL, 75.0 mmol) was 
added and the resulting mixture was allowed to stir at room temperature for 12 
hours. The reaction was quenched with NH4Cl saturated aqueous solution (30 mL) 
and extracted with diethyl ether (3 × 20 mL). The combined organic layers were 
dried over Na2SO4, filtered and concentrated under vacuum to afford a yellow oil 
as crude product. The crude product was purified through flash column 
chromatography on silica gel (from 0 to 5% diethyl ether in hexane) to afford the 
pure product 224 as a colourless oil in 90% yield (0.24 g, 1.37 mmol). Rf 0.47 
(hexane:Et2O, 8:2); [α]
26
D +25.0 (c 1.0, CHCl3); {Lit. [α]
25
D +30.42 (c 0.48, CHCl3); 
96% e.e.}; IR νmax (film) 3033, 2925, 2363, 1739, 1494, 1456, 1370, 1227, 1201, 
1100, 1074, 1019, 983, 931, 925, 846, 759, 749 and 698 cm-1; 1H NMR (500 MHz, 
CDCl3): δH 7.38-7.33 (5H, m, CHAr), 6.27 (1H, dt, J 1.4, 5.9 Hz, CH), 6.01 (1H, 
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ddd, J 6.0,  10.5, 17.0 Hz, CH=), 5.29 (1H, dt, J 1.4, 17.0 Hz, CH=), 5.25 (1H, dt, J 
1.4, 10.5 Hz, CH=), 2.12 (3H, s, CH3); 
13C NMR (125 MHz, CDCl3): δC 169.9 (CO), 
138.9 (CAr), 136.3 (CH=), 128.6 (CHAr), 128.2 (CHAr), 127.1 (CHAr), 116.9 (CH=), 
76.2 (CHOAc), 21.3 (CH3); HRMS (CI+/ISO) calc. for C11H12O2 [M+H]
+: 176.0837. 
Found: 176.0840. 
 
The characterisation matches the data reported in literature: 
Duveen D. I.; J. Kenyon J. Chem. Soc. 1939, 1697. 
Chen P.; Xiang P. Tetrahedron Lett. 2011, 52, 5758. 
Kanbayashi N.; Onitsuka K. Angew. Chem. Int. Ed. 2011, 50, 5197. 
 
(4R,5R,6S,E)-7-(tert-Butyldiphenylsilyloxy)-5-hydroxy-4,6-dimethyl-1-
phenylhept-2-en-1-one, 227 
 
 
 
A 0.5 – 2 mL microwave vial, fitted with a magnetic follower, was charged with 
Zhan 1B catalyst 226 (15.0 mg – 5 mol%). The vial was sealed with a rubber 
septum and purged with argon. Then a solution of the homoallylic alcohol 
(2S,3R,4R)-1-(tert-butyldiphenylsilyloxy)-2,4-dimethylhex-5-en-3-ol 217 (145 mg, 
379 µmol) and of the α,β-enone 1-phenylprop-2-en-1-one 222 (250 mg, 1.90 
mmol) in 1.5 mL of freeze-thaw degassed dichloromethane were added and the 
resulting green solution was stirred at 40 °C for 12 hours. After this period a further 
portion of Zhan 1B catalyst 226 (15.0 mg – 5 mol%) in 1.5 mL of freeze-thaw 
degassed dichloromethane was added and the brown solution was stirred  for an 
additional 12 hours. Then the reaction mixture was allowed to cool to room 
temperature and it was concentrated under vacuum to afford a dark brown oil as 
crude product. The crude product was purified by silica gel flash column 
chromatography (from 0 to 20% ethyl acetate in hexane) to afford a pale yellow oil 
as pure product 227 in 65% yield (120 mg, 0.25 mmol). Rf 0.29 (hexane:EtOAc, 
8:2); [α]25D +188.6 (c 0.1, CHCl3); IR νmax (film) 3450, 2974, 2931, 2857, 1670, 
1618, 1473, 1428, 1112, 998, 823, 741, 700 cm-1; 1H NMR (500 MHz, CDCl3): δH 
7.95-7.91 (2H, m, CHAr), 7.69-7.65 (4H, m, CHAr), 7.49-7.36 (9H, m, CHAr), 7.20 
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(1H, dd, J 8.6, 15.8 Hz, CH=), 6.86 (1H, d, J 15.7 Hz, =CHCO), 3.96 (1H, d, J 2.7 
Hz, OH), 3.74 (1H, dd, J 4.0, 10.4 Hz, CHHOSi), 3.66 (1H, dd, J 8.5, 10.5 Hz, 
CHHOSi), 3.61-3.58 (1H, m, CHOH), 2.69-2.61 (1H, m, CHMe), 1.88-1.80 (1H, m, 
CHMe), 1.23 (3H, d, J 6.9 Hz, CH3), 1.05 (9H, s, 3 × CH3), 0.80 (3H, d, J 6.9 Hz, 
CH3); 
13C NMR (125 MHz, CDCl3): δC 191.5 (CO), 151.2 (CH=), 138.2 (CAr), 135.8 
(CHAr), 132.8 (CAr), 132.7 (CHAr), 130.1 (CHAr), 128.8 (CHAr), 128.0 (CHAr), 127.9 
(CHAr), 126.9 (=CHCO), 80.2 (CHOH), 69.6 (CH2OSi), 40.7 (CHMe), 38.0 (CHMe), 
26.9 (3 × CH3), 19.2 (C), 17.4 (CH3), 13.6 (CH3); HRMS (EI+) calc. for C31H37O2Si 
[M-OH]+: 469.2563. Found: 469.2557. 
 
(1R,4R,5R,6S,E)-7-(tert-Butyldiphenylsilyloxy)-4,6-dimethyl-1-phenylhept-2-
ene-1,5-diol, 228 
 
 
 
(S)-CBS (348 mg, 1.25 mmol) was dissolved in 15 mL of dry THF under argon at 
room temperature and BH3
.THF (1.25 mL, 1.25 mmol, 1.0 M solution in THF) was 
added dropwise. The resulting mixture was vigorously stirred at room temperature 
for 0.5 hours, then it was cooled at -40 °C and  (4R,5R,6S,E)-7-(tert-
butyldiphenylsilyloxy)-5-hydroxy-4,6-dimethyl-1-phenylhept-2-en-1-one 227 (500 
mg, 1.03 mmol) in 15 mL of dry THF was added dropwise. The reaction mixture 
was allowed to stir at -40 °C till complete disappearance of the starting material by 
TLC (4 – 5 hours), then it was quenched with 10 mL of methanol and concentrated 
under vacuum to afford a yellow oil as crude product. The crude product was 
purified by silica gel flash column chromatography (from 10 to 40% ethyl acetate in 
hexane) to afford a colourless yellow oil as pure product 228 in 93% yield (467 mg, 
0.96 mmol). Rf 0.19 (hexane:EtOAc, 8:2); [α]
25
D -4.8 (c 0.1, CHCl3); IR νmax (film) 
2974, 2931, 2859, 1473, 1428, 1383, 1112, 986, 823, 741, 699 cm-1; 1H NMR (500 
MHz, CDCl3): δH 7.69-7.65 (4H, m, CHAr), 7.46-7.43 (2H, m, CHAr), 7.42-7.37 (6H, 
m, CHAr), 7.36-7.32 (2H, m, CHAr), 7.29-7.25 (1H, m, CHAr), 5.93 (1H, ddd, J 0.9, 
8.5, 15.6 Hz, CH=), 5.69 (1H, ddd, J 0.7, 7.1, 15.6 Hz, =CH), 5.22 (1H, dd, J 3.4, 
6.9 Hz, CHOH), 3.72-3.64 (3H, m, CH2OSi and OH), 3.46-3.43 (1H, m, CHOH), 
2.40-2.36 (1H, m, CHMe), 2.03 (1H, d, J 3.6 Hz, OH), 1.81-1.75 (1H, m, CHMe), 
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1.13 (3H, d, J 7.0 Hz, CH3), 1.06 (9H, s, 3 × CH3), 0.74 (3H, d, J 7.0 Hz, CH3); 
13C 
NMR (125 MHz, CDCl3): δC 143.5 (CAr), 135.8 (CH=), 135.6 (=CH), 133.3 (CAr), 
130.0 (CHAr), 128.6 (CHAr), 128.0 (CHAr), 127.9 (CHAr), 127.6 (CHAr), 126.2 (CHAr), 
80.2 (CHOH), 75.3 (CHOH), 69.2 (CH2OSi), 39.8 (CHMe), 37.9 (CHMe), 26.9 (3 × 
CH3), 19.2 (C), 18.1 (CH3), 13.6 (CH3); HRMS (ESI+) calc. for C31H37OSi [M-H2O-
OH]+: 453.2608. Found: 453.2609. 
 
(1R,4R,5R,6S,E)-7-(tert-Butyldiphenylsilyloxy)-4,6-dimethyl-1-phenylhept-2-
ene-1,5-diyl diacetate, 233 
 
 
 
To a solution of (1R,4R,5R,6S,E)-7-(tert-butyldiphenylsilyloxy)-4,6-dimethyl-1-
phenylhept-2-ene-1,5-diol 228 (500 mg, 873 mmol) in 50 mL of dry 
dichloromethane, acetic anhydride (1.0 mL, 10.5 mmol) and DMAP (11.0 mg, 873 
µmol) were added and the reaction mixture was allowed to stir at room 
temperature for 12 hours. Then the solvent was removed under vacuum to afford a 
yellow-brown oil as crude product. The crude product was purified by silica gel 
flash column chromatography (from 0 to 20% ethyl acetate in hexane) to afford a 
colourless oil as pure product 233 (495 mg, 864 mmol) in 99% yield. Rf 0.46 
(hexane:EtOAc, 8:2); [α]25D -8.4 (c 0.1, CHCl3); IR νmax (film) 2974, 2963, 2928, 
2857, 2360, 2343, 1739, 1472, 1428, 1370, 1233, 1112, 10018, 964, 824, 756, 
699 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.66-7.61 (4H, m, CHAr), 7.45-7.27 (11H, 
m, CHAr), 6.18 (1H, bd, J 4.6 Hz, CHOAc), 5.61-5.58 (2H, m, CH=CH), 4.76 (1H, 
app t, J 6.2 Hz, CHOAc), 3.61 (1H, dd, J 4.5 Hz, 10.0 Hz, CHHOSi), 3.43 (1H, dd, 
J 7.5, 9.5 Hz, CHHOSi), 2.59-2.46 (1H, m, CHMe), 2.08 (3H, s, COCH3), 1.99-1.89 
(1H, m, CHMe), 1.73 (3H, s, COCH3), 1.04 (9H, s, 3 × CH3), 0.95 (3H, d, J 6.8 Hz, 
CH3), 0.91 (3H, d, J 6.8 Hz, CH3); 
13C NMR (125 MHz, CDCl3): δC 170.7 (CO), 
170.1 (CO), 139.8 (CAr), 135.8 (CH=), 135.4 (CHAr), 133.8 (CAr), 129.7 (=CH), 
129.4 (CHAr), 128.7 (CHAr), 128.1 (CHAr), 127.7 (CHAr), 126.9 (CHAr), 77.9 
(CHOAc), 76.2 (CHOAc), 64.9 (CH2OSi), 39.0 (CHMe), 37.2 (CHMe), 26.9 (3 × 
CH3), 21.5 (COCH3), 20.7 (COCH3), 19.3 (C), 17.5 (CH3), 14.5 (CH3); HRMS 
(ESI+) calc. for C31H37OSi [M-AcOH-OAc]
+: 453.2608. Found: 453.2606. 
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(3S,4R,5S,6S,E)-7-(tert-Butyldiphenylsilyloxy)-4,6-dimethyl-1-phenylhept-1-
ene-3,5-diyl diacetate, 19 
 
 
 
(1R,4R,5R,6S,E)-7-(tert-butyldiphenylsilyloxy)-4,6-dimethyl-1-phenylhept-2-ene-
1,5-diyl diacetate 233 (420 mg, 733 µmol) and PdCl2(CH3CN)2 (10.0 mg, 37.0 
mmol, 5 mol%) were dissolved in dry THF (30 mL) and the resulting mixture was 
allowed to stir at room temperature for 12 hours. Then it was filtered through 
Celite® and washed with ethyl acetate as eluent (50 mL). The eluate was 
concentrated under vacuum to afford a yellow-brown oil as crude product. The 
crude product was purified by silica gel flash column chromatography (from 0 to 
20% ethyl acetate in hexane) to afford a yellow oil as pure product 19 (399 mg, 
696 µmol) in 95% yield. Rf 0.54 (hexane:EtOAc, 8:2); [α]
25
D -7.6 (c 0.1, CHCl3); IR 
νmax (film) 3071, 2961, 2932, 2857, 1739, 1237, 1112 cm
-1; 1H NMR (500 MHz, 
CDCl3): δH 7.70-7.65 (4H, m, CHAr), 7.42-7.37 (6H, m, CHAr), 7.35-7.21 (5H, m, 
CHAr), 6.46 (1H, dd, J 1.0, 16.1 Hz, CH=), 6.06 (1H, dd, J 5.8, 15.9 Hz, =CH), 
5.53-5.49 (1H, m, CHOAc), 4.94 (1H, dd, J 3.2, 9.7 Hz, CHOAc), 3.76 (1H, dd, J 
6.1, 10.2 Hz, CHHOSi), 3.47 (1H, dd, J 6.8, 10.3 Hz, CHHOSi), 2.32-2.25 (1H, m, 
CHMe), 2.21-2.13 (1H, m, CHMe), 2.08 (3H, s, COCH3), 1.99 (3H, s, COCH3), 
1.04 (9H, s, 3 × CH3), 0.96 (3H, d, J 6.9 Hz, CH3), 0.94 (3H, d, J 6.9 Hz, CH3); 
13C 
NMR (125 MHz, CDCl3): δC 170.8 (CO), 170.6 (CO), 136.6 (CAr), 135.6 (CHAr), 
133.8 (CH=), 133.7 (CAr), 131.8 (CHAr), 129.7 (CHAr), 128.7 (CHAr), 127.9 (CHAr), 
127.8 (=CH), 126.9 (CHAr), 76.3 (CHOAc), 73.0 (CHOAc), 64.7 (CH2OSi), 38.9 
(CHMe), 36.8 (CHMe), 26.9 (3 × CH3), 21.3 (COCH3), 20.9 (COCH3), 19.3 (C), 
15.3 (CH3), 11.1 (CH3); HRMS (ESI+) calc. for C35H44O5NaSi [M+Na]
+: 595.2850. 
Found: 595.2852. 
 
The characterisation matches with the data reported in literature: 
Feutrill J. T.; Lilly M. J.; Rizzacasa M. A. Org. Lett. 2000, 2, 3365. 
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(3S,4R,5S,6S,E)-7-(tert-Butyldiphenylsilyloxy)-4,6-dimethyl-1-phenylhept-1-
ene-3,5-diol, 20 
 
(2S,3S,4R,5S,E)-2,4-Dimethyl-7-phenylhept-6-ene-1,3,5-triol, 234 
 
 
To a stirred solution of (3S,4R,5S,6S,E)-7-(tert-butyldiphenylsilyloxy)-4,6-dimethyl-
1-phenylhept-1-ene-3,5-diyl diacetate 19 (195 mg, 341 µmol) in 10 mL of 
methanol, 1.7 mL of K2CO3 1.0 M in H2O was added dropwise and the resulting 
mixture was allowed to stir at room temperature for 12 hours. Then the reaction 
was quenched by addition of NH4Cl saturated aqueous solution (10 mL) and 
extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried 
over Na2SO4 and concentrated under vacuum to afford a pale yellow oil as crude 
product. The crude product was purified by silica gel flash column chromatography 
(80:20 hexane/ethyl acetate, then 60/40 hexane/ethyl acetate) to afford a 
colourless oil as pure product 20 (3.00 mg, 68.0 µmol) in 20% yield and also as a 
pale yellow oil the triol 234 (51.0 mg, 205 µmol), a secondary product, due to loss 
of the TBDPS group. The triol was selectively reprotected at the primary alcohol. 
To a stirred solution of the triol (51.0 mg, 205 µmol) and imidazole (18.0 mg, 267 
µmol) in 1 mL of dry dichloromethane, under argon at -5 °C, TBDPSCl (62.0 mg, 
226 µmol) in 1 mL of dry dichloromethane was added dropwise and the resulting 
mixture was allowed to stir at -5 °C till complete disappearance of the starting 
material by TLC (15 minutes – 40 minutes). The reaction was quenched by 
addition of H2O (5 mL) and extracted with ethyl acetate (3 × 10 mL). The combined 
organic layers were washed with brine (20 mL) and concentrated under vacuum to 
afford the silyl ether 20 as a colourless oil in 60% yield (100 mg, 205 µmol). The 
total yield for the silyl ether over the two steps was of 80% (133 mg, 272 µmol). Rf 
0.60 (hexane:EtOAc, 7:3); [α]27D +3.6 (c 1.0, CHCl3); IR νmax (film) 3418, 3072, 
2963, 2932, 2855, 1427, 1111 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.70-7.67 (4H, 
m, CHAr), 7.49-7.40 (8H, m, CHAr), 7.34-7.19 (3H, m, CHAr), 6.66 (1H, dd, J 1.2, 
15.9 Hz, =CH), 6.26 (1H, dd, J 5.4, 15.9 Hz, CH=), 4.78 (1H, d, J 2.8 Hz, OH), 
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4.73-4.68 (1H, m, CHOH), 4.28 (1H, d, J 2.8 Hz, OH), 3.87 (1 H, dd, J 3.7, 10.3 
Hz, CHHOSi), 3.75-3.70 (1H, m, CHOH), 3.67 (1H, dd, J 7.6, 10.3 Hz, CHHOSi), 
2.14-2.04 (1H, m, CHMe), 1.99-1.89 (1H, m, CHMe), 1.07 (9H, s, 3 × CH3), 1.04 
(3H, d, J 7.2 Hz, CH3), 0.86 (3H, d, J 7.2 Hz, CH3); 
13C NMR (125 MHz, CDCl3): δC 
137.4 (CAr), 135.8 (CHAr), 135.7 (CAr), 132.6 (=CH), 132.5 (CHAr), 131.2 (CHAr), 
130.2 (CHAr), 128.6 (CHAr), 127.4 (CH=), 126.6 (CHAr), 82.2 (CHOH), 73.0 
(CHOH), 69.5 (CH2OSi), 39.9 (CHMe), 36.9 (CHMe), 26.9 (3 × CH3), 19.2 (C), 
13.9 (CH3), 11.9 (CH3); HRMS (ESI+) calc. for C31H37OSi [M-H2O-OH]
+: 453.2608. 
Found: 453.2609. 
 
The characterisation of the diol 20 matches with the literature data:  
Feutrill J. T.; Lilly M. J.; Rizzacasa M. A. Org. Lett. 2000, 2, 3365. 
The characterisation of the triol 234 matches with the literature data:  
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
 
tert-Butyl((2S,3S,4R,5S,E)-3,5-dimethoxy-2,4-dimethyl-7-phenylhept-6-
enyloxy)diphenylsilane 
 
 
To a suspension of NaH (85.0 mg, 2.13 mmol) in dry THF (2 mL), a solution of 
(3S,4R,5S,6S,E)-7-(tert-butyldiphenylsilyloxy)-4,6-dimethyl-1-phenylhept-1-ene-
3,5-diol 20 (130 mg, 266 µmol) in dry THF (2 mL) was added and the resulting 
mixture was allowed to stir at room temperature for 10 minutes. Then iodomethane 
(0.3 mL, 4.26 mmol) and TBAI (8.00 mg, 21.3 µmol) were added and the reaction 
mixture was let to stir at 60 °C for 12 hours. The reaction was quenched with a 
saturated solution of NH4Cl (5 mL) and the two layers were separated. The 
organic layer was washed with brine (5 mL) and the aqueous layer was extracted 
with diethyl ether (3 × 5 mL). The organic layers were mixed, dried over Na2SO4, 
filtered and concentrated under vacuum to afford a pale yellow oil as crude 
product. The crude product resulted clean without necessity of any further 
purification. Rf 0.62 (hexane:EtOAc, 8:2); [α]
27
D -20.80 (c 1.0, CHCl3); 
1H NMR 
(500 MHz, CDCl3): δH 7.71-7.66 (4H, m, CHAr), 7.45-7.23 (11H, m, CHAr), 6.54 
(1H, d, J 16.0 Hz, CH=), 6.14 (1H, dd, J 7.2, 16.0 Hz, =CH), 4.03 (1H, dd, J 2.0, 
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7.2 Hz, CHOMe), 3.77 (1H, dd, J 5.3, 10.0 Hz, CHOMe), 3.58 (1H, dd, J 7.9, 9.9 
Hz, CHHOSi), 3.47 (3H, s, OCH3), 3.33 (3H, s, OCH3), 3.21 (1H, dd, J 2.6, 9.3 Hz, 
CHHOSi), 2.09-1.99 (1H, m, CHMe), 1.81-1.71 (1H, m, CHMe), 1.15 (3H, d, J 7.0 
Hz, CH3), 1.05 (9H, s, 3 × CH3), 0.83 (3H, d, J 7.0 Hz, CH3); 
13C NMR (125 MHz, 
CDCl3): δC 137.1 (CAr), 135.8 (CHAr), 135.7 (CAr), 131.8 (CH=), 129.7 (CHAr), 129.6 
(CHAr), 128.7 (CHAr), 127.7 (=CH), 127.6 (CHAr), 126.5 (CHAr), 85.6 (CHOMe), 
81.5 (CHOMe), 64.9 (CH2OSi), 61.5 (OCH3), 56.6 (OCH3), 41.8 (CHMe), 38.1 
(CHMe), 27.0 (3 × CH3), 19.4 (C), 16.0 (CH3), 10.5 (CH3). 
 
The characterisation matches with the literature data:  
Feutrill J. T.; Lilly M. J.; Rizzacasa M. A. Org. Lett. 2000, 2, 3365. 
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
 
 (E)-Ethyl 3-(tributylstannyl)but-2-enoate 
 
 
 
To a solution of diisopropylamine (0.3 mL, 1.87 mmol) in 1 mL of dry THF at 0 °C 
under argon, nBuli (1.2 mL, 1.87 mmol, 1.6 M in hexanes) was added dropwise 
and the resulting mixture was allowed to stir for 10 minutes. Then tributyltin 
hydride (0.5 mL, 1.78 mmol) was added dropwise and the resulting mixture was 
cooled at -50 °C. At this point the reaction mixture was added to a suspension of 
CuBr.Me2S (368 mg, 1.78 mmol) in 2 mL of dry THF at -50 °C and the reaction 
was allowed to stir for 30 minutes. Then a precooled solution of ethyl-2-butynoate 
(100 mg, 892 µmol) and dry methanol (0.01 mL, 1.52 mmol) in 3 mL of dry THF 
was added to the cuprate at -95 °C and the resulting mixture was stirred for 30 
minutes, then it was warmed at  -78 °C and stirred for an additional 2 hours. The 
reaction was quenched with 5% aqueous NH4OH (5 mL), the organic phase was 
separated and the aqueous phase was extracted with Et2O (3 × 5 mL). The 
combined organic layers were dried over Na2SO4, filtered and concentrated under 
vacuum to afford a yellow oil as crude product. The crude product was purified by 
silica gel flash column chromatography (hexane) to afford a colourless oil as pure 
product (343 mg, 0.86 mmol) in 96% yield. Rf 0.08 (hexane); IR νmax (film) 2957, 
2925, 2852, 1714, 1599, 1464, 1377, 1366, 1338, 1258, 1164, 1099, 1039, 960, 
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862, 689, 664 cm-1; 1H NMR (400 MHz, CDCl3): δH 5.96 (1H, q, J 1.8 Hz, CH=), 
4.16 (2H, q, J 7.1 Hz, CH2), 2.39 (3H, d, J 1.9 Hz, CH3), 1.54-1.45 (6H, m, 3 × 
CH2), 1.34-1.27 (9H, m, 3 × CH2 and CH3), 0.97-0.93 (6H, m, 3 × CH2), 0.93 (9H, t, 
J 7.3 Hz, 3 × CH3); 
13C NMR (100 MHz, CDCl3): δC 169.4 (CO), 164.6 (C=), 128.2 
(CH=), 59.7 (CH2OEt), 29.1 (3 × CH2), 27.5 (3 × CH2), 22.5 (CH3), 14.5 (3 × CH2), 
13.8 (3 × CH3), 9.5 (CH3); HRMS (ESI) calc. for C18H37O2Sn [M+H]
+: 405.1810. 
Found: 405.1813. 
 
 (E)-3-(Tributylstannyl)but-2-enamide, 44 
 
 
 
To a suspension of NH4Cl (170 mg, 3.18 mmol) in dry toluene (10 mL) under 
argon at 0 °C was added dropwise a solution of AlMe3 (1.6 mL, 3.18 mmol, 2 M in 
toluene) and the resulting solution was allowed to warm to room temperature and 
then recooled to 0 °C. A solution of (E)-ethyl 3-(tributylstannyl)but-2-enoate (343 
mg, 0.86 mmol) in dry toluene (5 mL) was added and the mixture was heated at 50 
°C for 16 hours. The reaction was diluted with ethyl acetate (10 mL) and quenched 
at 0 °C by addition of 10% HCl in saturated NaCl aqueous solution (20 mL). The 
organic phase was washed with NaHCO3 saturated aqueous solution (20 mL) and 
brine (20 mL), dried over Na2SO4, filtered and concentrated under vacuum to 
afford a pale yellow thick oil as crude product. The crude product was purified by 
silica gel flash column chromatography (20% ethyl acetate in hexane) to afford a 
white solid as pure product 44 (124 mg, 0.38 mmol) in 78% yield. Rf 0.62 (EtOAc); 
IR νmax (film) 3402, 3202, 2955, 2924, 2847, 2361, 1659, 1597, 1458, 1397, 1312, 
1072, 1312, 1072, 1003, 872, 733, 687 cm-1; 1H NMR (500 MHz, CDCl3): δH 5.92 
(1H, q, J 1.7 Hz, CH=), 5.64 (1H, bs, NHH), 5.39 (1H, bs, NHH), 2.35 (3H, d, J 1.8 
Hz, CH3), 1.54-1.44 (6H, m, 3 × CH2), 1.35-1.27 (6H, m, 3 × CH2), 0.96-0.92 (6H, 
m, 3 × CH2), 0.88 (9H, t, J 7.3 Hz, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 167.6 
(CO), 162.9 (C=), 130.5 (CH=), 29.1 (3 × CH2), 27.5 (3 × CH2), 22.2 (3 × CH2), 
13.8 (3 × CH3), 9.5 (CH3); HRMS (ESI) calc. for C16H34ONSn [M+H]
+: 376.1657. 
Found: 376.1651; mp: 32-33 °C. 
 
 
A. E. Pasqua 2013 Chapter II Experimental 
  
349 
 
((1E,3S,4R,5S,6S,7E)-8-Iodo-3,5-dimethoxy-4,6-dimethylocta-1,7-
dienyl)benzene, 43 
 
 
 
To a stirred suspension of anhydrous CrCl2 (226 mg, 1.84 mmol, gently flame 
dried under vacuum), in dry THF (2 mL) under argon, at room temperature, a 
solution of the aldehyde (2R,3R,4R,5S,E)-3,5-dimethoxy-2,4-dimethyl-7-
phenylhept-6-enal 28 (29.8 mg, 108 µmol) and iodoform (255 mg, 0.65 mmol) in 1 
mL of dry THF was added via cannula. The resulting brown mixture was stirred in 
the dark at room temperature until completion as indicated by TLC analysis (30 
minutes). The reaction mixture was quenched by addition of H2O (5 mL) and the 
phases were separated. The aqueous phase was extracted with diethyl ether (3 × 
10 mL) and the combined organic layers were washed with brine (10 mL), dried 
over Na2SO4 and concentrated under vacuum to afford a yellow solid as crude 
product. The crude product was purified by silica gel flash column chromatography 
(from 0 to 5% ethyl acetate in hexane) to afford a white solid as pure product 43 
(43.0 mg, 107 µmol) in 99% yield. Rf 0.64 (hexane:EtOAc, 7.5:2.5); [α]
24
D +1.84 (c 
1.0, CHCl3); IR νmax (film) 2963, 2924, 2361, 2334, 1728, 1651, 1585, 1597, 1497, 
1451, 1335, 1188, 1088, 972, 748, 694 cm-1; 1H NMR (500 MHz, C6D6): δH 7.24-
7.04 (5H, m, CHAr), 6.77 (1H, dd, J 9.2, 14.5 Hz, CH=), 6.44 (1H, d, J 16.0 Hz, 
=CHPh), 6.04 (1H, dd, J 7.0, 16.0 Hz, CH=), 5.74 (1H, d, J 14.6 Hz, =CHI), 4.09 
(1H, dd, J 1.0, 11.5 Hz, CHOMe), 3.31 (3H, s, OCH3), 3.16 (3H, s, OCH3), 3.02 
(1H, dd, J 2.1, 9.9 Hz, CHOMe), 2.23-2.12 (1H, m, CHMe), 1.71-1.60 (1H, m, 
CHMe), 0.94 (3H, d, J 7.0 Hz, CH3), 0.83 (3H, d, J 7.0 Hz, CH3); 
13C NMR (125 
MHz, C6D6): δC 147.9 (CH=), 137.2 (CAr), 132.1 (CHAr), 129.5 (CH=), 128.6 (CHAr), 
128.4 (=CHPh), 126.7 (CHAr), 85.9 (CHOMe), 80.9 (=CHI), 75.1 (CHOMe), 61.1 
(OCH3), 55.9 (OCH3), 43.5 (CHMe), 42.7 (CHMe), 18.2 (CH3), 9.8 (CH3). 
 
The characterisation matches with the literature data:  
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
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(E)-Methyl 3-iodobut-2-enoate, 104 
 
 
 
Method A: A 5 mL-flask was loaded with but-2-ynoic acid (0.50 g, 5.95 mmol) and 
HI 55% (0.977 mL, 7.14 mmol) and it was allowed to stir at 90 °C for 4 hours. The 
product was filtered, washed with cold water (10 mL) and dried under vacuum 
overnight  to provide (Z)-3-iodobut-2-enoic acid as light yellow needles in 78% 
yield (984 mg, 4.64 mmol). 1H NMR (400 MHz, CDCl3): δH 11.73 (1H, bs, OH), 
6.36 (1H, q, J 1.3 Hz, CH=), 2.74 (3H, d, J 1.3 Hz, CH3). A 10 mL-sealed tube was 
loaded with (Z)-3-iodobut-2-enoic acid (984 mg, 4.64 mmol) and it was heated at 
135 °C for 48 hours to provide a mixture of (E)-3-iodobut-2-enoic acid and (Z)-3-
iodobut-2-enoic acid (E/Z ratio: 1.7/1.0) in a total quantitative yield (984 mg, 4.64 
mmol). (E)-isomer: 1H NMR (400 MHz, CDCl3): δH 11.73 (1H, bs, OH), 6.68 (1H, q, 
J 1.3 Hz, CH=), 3.00 (3H, d, J 1.3 Hz, CH3).  The mixture of the two isomers was 
dissolved in dry THF (50 mL), Cs2CO3 (1.51 g, 4.64 mmol) was added and the 
resulting suspension was allowed to stir under argon at room temperature for 5 
minutes, then iodomethane (0.6 mL, 9.28 mmol) was added and the reaction 
mixture was allowed to stir at room temperature for 12 hours. The reaction was 
quenched with NH4Cl saturated aqueous solution (30 mL), the organic phase was 
separated and the aqueous phase was extracted with diethyl ether (3 × 50 mL). 
The combined organic layers were washed with brine (100 mL) and concentrated 
under vacuum to afford a brown-yellow thick oil as crude product. Interestingly, as 
proved by 1H NMR analysis of the crude, the product was a mixture of (E)-methyl 
3-iodobut-2-enoate and (Z)-methyl 3-iodobut-2-enoate in a very good ratio (E/Z 
ratio: 15/1) in favour of the desired isomer. The crude product was purified by 
silica gel flash column chromatography (5% ethyl acetate in petroleum ether) to 
afford a white solid as pure product (210 mg, 929 µmol) in 32% yield. 
Method B: To a suspension of CuCN (1.25 g, 14.0 mmol) in anhydrous THF (30 
mL), under argon at -78 °C, tributyltin hydride (7.53 mL, 28.0 mmol) was added 
dropwise, followed by the careful addition of nBuLi (11.2 mL, 28.0 mmol) and the 
resulting mixture was allowed to stir at -78 °C for 1 hour. Then a solution of but-2-
ynoic acid (0.51 g, 6.07 mmol) in 12 mL of THF was added and the resulting 
mixture was allowed to stir at -78 °C for 3 hours. The reaction was quenched with 
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NH4Cl saturated aqueous solution (40 mL), extracted with diethyl ether (3 × 20 
mL), washed with brine (50 mL), dried over Na2SO4, filtered and concentrated 
under vacuum to afford a yellow oil as crude product, which was carried directly 
onto the next step without purification (82% yield, 1.87 g, 4.99 mmol). (E)-3-
(tributylstannyl)but-2-enoic acid (1.87 g, 4.99 mmol) was dissolved in anhydrous 
diethyl ether (24 mL) and it was cooled to 0 °C. Iodine (1.50 g, 5.76 mmol) was 
added in one portion and the resulting mixture was allowed to stir room 
temperature for 2 hours. The reaction was quenched with KF saturated aqueous 
solution (25 mL) and Na2S2O3 saturated aqueous solution (25 mL), it was 
extracted with diethyl ether (3 × 20 mL), dried over Na2SO4, filtered and 
concentrated under vacuum to afford a yellow oil as crude product which was 
taken directly onto the next step without any further purification (96%, 1.02 g, 4.80 
mmol). (E)-3-iodobut-2-enoic acid (1.02 g, 4.80 mmol) was dissolved in 50 mL of 
anhydrous THF and the solution was cooled to 0 °C. Cs2CO3 (1.57 g, 4.80 mmol) 
was added in one portion and the resulting mixture was allowed to stir under argon 
at room temperature for 1 hour, then iodomethane (0.60 mL, 9.60 mmol) was 
added and the reaction mixture was allowed to stir at room temperature for 12 
hours. The reaction was quenched with NH4Cl saturated aqueous solution (50 
mL), the organic phase was separated and the aqueous phase was extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were washed with brine 
(150 mL) and concentrated under vacuum to afford a yellow oil as crude product. 
The crude product was purified by silica gel flash column chromatography (5% 
ethyl acetate in petroleum ether) to afford a white solid as pure product (549 mg, 
2.43 mmol) in 51% yield. (40% yield over the 3 steps). Rf 0.6 (PE:EtOAc, 9.5:0.5); 
IR νmax (film) 2954, 2922, 2853, 1718, 1617, 1456, 1444, 1331, 1263, 1176, 1073, 
907 cm-1; 1H NMR (500 MHz, CDCl3): δH 6.64 (1H, q, J 1.5 Hz, CH=), 3.70 (3H, s, 
OCH3), 2.98 (3H, d, J 1.5 Hz, CH3); 
13C NMR (125 MHz, CDCl3): δC 164.6 (CO), 
131.0 (C), 120.7 (CH=), 51.4 (OCH3), 31.0 (CH3); HRMS (CI+/ISO) calc. for 
C5H8O2I [M+H]
+: 226.9569. Found: 226.9566. 
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(E)-3-Iodobut-2-enamide, 7 
 
 
 
To a suspension of ammonium chloride (488 mg, 9.10 mmol) in dry toluene (8.5 
mL) under argon at 0 °C, AlMe3 (4.55 mL, 0.10 mmol, 2.0 M solution in toluene) 
was added dropwise and the resulting solution was allowed to warm to room 
temperature. After this period, the reaction was recooled to 0 °C and (E)-methyl 3-
iodobut-2-enoate (206 mg, 0.91 mmol) was added. The resulting mixture was 
stirred at 50 °C for 16 hours. The reaction mixture was diluted with ethyl acetate 
(10 mL) and quenched at 0 °C by addition of 10% HCl in saturated NaCl (20 mL) 
and the organic layer was washed with NaHCO3 saturated aqueous solution (20 
mL) and brine (20 mL), dried over Na2SO4 and concentrated under vacuum to 
afford a pale yellow oil as crude product. The crude product was purified by silica 
gel flash column chromatography (1:1 petroleum ether/ethyl acetate) to afford a 
white solid as pure product 7 (97.0 mg, 0.46 mmol) in 50% yield. Rf 0.27 
(PE:EtOAc, 1:1); IR νmax (film) 3354, 3181, 2359, 2330, 1651, 1597, 1397, 1364, 
1302, 1067 cm-1; 1H NMR (500 MHz, CDCl3): δH 6.58 (1H, q, J 1.5 Hz, CH=), 5.31 
(2H, bs, NH2), 2.99 (3H, d, J 1.5 Hz, CH3); 
13C NMR (125 MHz, CDCl3): δC 165.7 
(CO), 132.5 (C), 117.6 (CH=), 30.7 (CH3); HRMS (CI+/ISO) calc. for C4H7ONI 
[M+H]+: 211.9572. Found: 211.9574; mp: 105-106 °C. 
 
Tributyl(diiodomethyl)stannane 
 
 
 
To a solution of Bu3SnCHBr2 (300 mg, 0.65 mmol) in anhydrous acetone (4 mL), 
sodium iodide (390 mg, 2.60 mmol) was added and the reaction mixture was 
allowed to stir at room temperature in absence of light for 24 hours. The reaction 
mixture was concentrated, then diluted with hexane (5 mL) and filtered. The 
resultant solution was concentrated under vacuum in absence of light, diluted with 
chloroform (5 mL), refiltered and reconcentrated under vacuum in absence of light 
to afford a light yellow oil as product in quantitative yield (361 mg, 0.65 mmol). Rf 
0.50 (PE); 1H NMR (500 MHz, CDCl3): δH 4.25 (1H, s, CHI2), 1.64-1.58 (6H, m, 3 × 
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CH2), 1.33 (6H, sextet, J 7.2 Hz, 3 × CH2), 1.12-1.09 (6H, m, 3 × CH2), 0.92 (9H, t, 
J 7.2 Hz, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 28.6 (3 × CH2), 27.5 (CHI2), 
15.7 (3 × CH2), 13.8 (3 × CH3), 13.1 (3 × CH2). 
 
The characterisation matches the data reported in literature: 
Hodgson D. M.; Boulton L. T.; Maw G. M.Tetrahedron 1995, 51, 3713; Hodgson D. 
M.; Foley A. M.; Boulton L. T.; Lovell P. J.; Maw G. M. J. Chem. Soc., Perkin 
Trans. 1 1999, 2911. 
 
Tributyl((1E,3S,4S,5R,6S,7E)-4,6-dimethoxy-3,5-dimethyl-8-phenylocta-1,7-
dienyl)stannane, 8 
 
 
To a stirred bright green suspension of anhydrous CrCl2 (135 mg, 1.10 mmol, 
gently flame dried under vacuum), in freeze/thaw degassed DMF (1 mL) under 
argon, at 0 °C, in absence of light, a solution of the aldehyde (2R,3R,4R,5S,E)-3,5-
dimethoxy-2,4-dimethyl-7-phenylhept-6-enal 28 (21.8 mg, 0.08 mmol) in 
freeze/thaw degassed DMF (1 mL) containing freshly prepared diiodomethyl 
tributyltin (120 mg, 0.22 mmol) was added via cannula. The resulting mixture was 
allowed to warm to room temperature in the dark until completion as indicated by 
TLC analysis (10 hours). The reaction mixture was quenched by addition of H2O (5 
mL) and the phases were separated. The aqueous phase was extracted with 
diethyl ether (3 × 10 mL) and the combined organic layers were washed with brine 
(10 mL), dried over Na2SO4 and concentrated under vacuum to afford a yellow oil 
as crude product. The crude product was purified by fast vacuum filtration on silica 
gel (90:10 hexane/ethyl acetate + 1% Et3N) to afford a pale yellow oil as pure 
product 8 (22.3 mg, 0.04 mmol) in 50% yield. Rf 0.47 (PE:EtOAc, 40:1, 1% Et3N); 
[α]25D +18.4 (c 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3): δH 7.40-7.20 (5H, m, 
CHAr), 6.57 (1H, d, J 16.2 Hz, CH=), 6.17 (1H, dd, J 6.9, 16.2 Hz, =CH), 5.96 (1H, 
dd, J 7.2, 19.2 Hz, =CH), 5.86 (1H, d, J 19.2 Hz, CH=), 4.11 (1H, dd, J 1.1, 7.2 Hz, 
CHOMe), 3.53 (3H, s, OCH3), 3.34 (3H, s, OCH3), 3.14 (1H, dd, J 2.4, 10.2 Hz, 
CHOMe), 2.46 (1H, m, CHMe),  1.63 (1H, m, CHMe), 1.51-1.41 (6H, m, 3 × CH2), 
1.33-1.21 (12H, m, 6 × CH2), 1.15 (3H, d, J 7.1 Hz, CH3), 0.85 (3H, d, J 7.1 Hz, 
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CH3), 0.84 (9H, t, J 7.2 Hz, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 150.5 (CH=), 
137.1 (CAr), 131.8 (=CH), 129.7 (CHAr), 128.7 (CH=), 127.5 (CHAr), 127.2 (=CH), 
126.5 (CHAr), 86.4 (CHOMe), 81.4 (CHOMe), 61.3 (OCH3), 56.7 (OCH3), 44.9 
(CHMe), 42.7 (CHMe), 29.3 (3 × CH2), 27.4 (3 × CH2), 18.5 (CH3), 13.8 (3 × CH2), 
9.6 (3 × CH3), 9.5 (CH3). 
 
The characterisation matches with the data reported in literature: 
Feutrill J. T.; Lilly M. J.; Rizzacasa M. A. Org. Lett. 2000, 2, 3365. 
 
Ohira-Bestmann reagent: Dimethyl 1-diazo-2-oxopropylphosphonate, 237 
 
 
 
To a solution of dimethyl (2-oxopropyl)phosphonate (5.00 g, 30.0 mmol) in dry 
acetonitrile (50 mL) under argon at 0 °C, K2CO3 (4.58 g, 33.0 mmol) and tosyl 
azide (6.53 g, 33.0 mmol) were added sequentially and the resulting mixture was 
allowed to stir at room temperature for 3 hours. The solvent was removed in vacuo 
and the crude dissolved in dichloromethane (50 mL) and washed with water (50 
mL) and brine (50 mL) sequentially, dried over Na2SO4, filtered and concentrated 
under vacuum to afford a yellow oil as crude product. The crude product was 
purified through flash column chromatography on silica gel (from 0 to 30% ethyl 
acetate in petroleum ether) to afford the product 237 in quantitative yield (5.80 g, 
30.0 mmol). 1H NMR (400 MHz, CDCl3) δH 3.82 (6H, bd, J 12.0 Hz, 2 × CH3), 2.23 
(3H, bs, CH3). 
 
The characterisation matches with the data reported in literature: 
Callant P.; D'Haenens L.; Vandewalle M. Synth.Commun. 1984, 14, 155. 
Ghosh A. K.; Bischoff A.; Cappiello J. Eur. J. Org. Chem. 2003, 5, 821. 
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((3S,4R,5S,6S,E)-3,5-Dimethoxy-4,6-dimethyloct-1-ene-7-ynyl)benzene, 79 
 
 
 
To a cooled (-78 °C) solution of Ohira-Bestmann’s reagent 237 (138 mg, 0.72 
mmol) in dry THF (2.5 mL) was added NaOMe (0.17 mL, 25% in methanol, 0.72 
mmol) dropwise.  After stirring for 20 minutes a solution of aldehyde 28 (50.0 mg, 
0.18 mmol) in dry THF (2.5 mL) was added dropwise.  The reaction mixture was 
allowed to slowly warm to room temperature over 30 minutes and quenched with 
saturated aqueous NH4Cl (5 mL).  The mixture was then diluted with H2O (10 mL) 
and extracted with diethyl ether (3 × 20 mL). The combined organic layers were 
washed with brine (50 mL), dried over Na2SO4 and concentrated under vacuum to 
afford a yellow oil as crude product.  An initial round of flash column 
chromatography (from 0 to 10% ethyl acetate in hexane) followed by a second 
round (1:1 petroleum ether/dichloromethane) afforded the pure product 79 (49.0 
mg, 0.18 mmol, >99%) as a white solid. Rf 0.55 (hexane:EtOAc, 8:2); [α]
27
D +24.4 
(c 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3) δH 7.42-7.40 (2H, m, CHAr), 7.34-7.31 
(2H, m, CHAr), 7.26-7.23 (1H, m, CHAr), 6.59 (1H, d, J 16.0 Hz, CH=), 6.20 (1H, dd, 
J 7.2, 16.0 Hz, =CH), 4.15 (1H, ddd, J 1.1, 2.2, 7.2 Hz, CHOMe), 3.57 (3H, s, 
OCH3), 3.33 (3H, s, OCH3), 3.15 (1H, dd, J 2.5, 9.9 Hz, CHOMe), 2.77 (1H, m, 
CHMe), 2.06 (1H, d, J  2.5 Hz, CHalkyne), 1.99-1.93 (1H, m, CHMe), 1.35 (3H, d, J  
7.1 Hz, CH3), 0.93 (3H, d, J  7.1 Hz, CH3); 
13C NMR (125 MHz, CDCl3) δC 136.9 
(CAr), 132.2 (CH=), 129.4 (=CH), 128.7 (CHAr), 127.7 (CHAr), 126.5 (CHAr), 85.1 
(Calkyne), 84.9 (CHOMe), 81.1 (CHOMe), 70.1 (CHalkyne), 61.5 (OCH3), 56.6 (OCH3), 
42.9 (CHMe), 29.6 (CHMe), 18.4 (CH3), 10.1 (CH3). 
 
The characterisation matches with the data reported in literature: 
Candy M.; Audran G.; Bienayme H.; Bressy C.; Pons J.-M. J. Org. Chem. 2010, 
75, 1354. 
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(+)-crocacin C: (2E,4E,6S,7S,8R,9S,10E)-7,9-Dimethoxy-3,6,8-trimethyl-11-
phenylundeca-2,4,10-trienamide, 3 
 
 
 
Method A: To a solution of ((1E,3S,4R,5S,6S,7E)-8-iodo-3,5-dimethoxy-4,6-
dimethylocta-1,7-dienyl)benzene 43 (43.0 mg, 107 µmol) and (E)-3-
(tributylstannyl)but-2-enamide 44 (45.0 mg, 120 µmol)  in anhydrous THF (7 mL), 
under argon at room temperature, CuI (3.40 mg, 0.65 mmol), AsPh3 (4.50 mg, 
15.0 µmol) and Pd2(dba)3 (6.00 mg, 6.00 µmol) were added and the reaction 
mixture was allowed to stir at 60 °C for 6 hours. Then the reaction was quenched 
with H2O (5 mL), diluted with diethyl ether (5 mL) and the two phases were 
separated. The organic layer was washed with brine (5 mL) and dried over 
Na2SO4, filtered and concentrated under vacuum to afford a yellow oil as crude 
product. The sample was purified on a Varian HPLC from Agilent Technologies 
(Santa Clara, CA, USA) equipped with SD-1 pumps, a model 325 UV−vis detector, 
a model 410 autosampler, and a model 701 fraction collector. Mobile phase A was 
water with 0.1% ammonium hydroxide and mobile phase B was acetonitrile. The 
flow rate was 60 mL/min. The method started at 40% B for 1 min, then raised to 
80% B over the next 9 min, was held at 80% B for another minute, then raised to 
95% B in 0.2 min, held at 95% for 1.5 min, then lowered back to 40% B in 0.2 min, 
and held at 40% B for an additional 1.5 min. The column was a 30 mm × 100 mm, 
10 μm Gemini-NX from Phenomenex (Torrance, CA, USA). The UV collection was 
done using a wavelength of 254 nm. (+)-Crocacin C 3 eluted at 6.2 min. (+)-
Crocacin C and the two isomeric (Z) analogues 235 and 236 were isolated in a 
1.54/1.00/1.27 ratio, in a total yield of 11% (11.8 µmol, 4.20 mg total weight). 
Method B: In a flame-dried 2 – 5 mL MW vial, under argon, at room temperature, 
the stannane 8 (22.3 mg, 0.04 mmol) and the vinyl iodide 7 (13.0 mg, 43.6 µmol) 
were dissolved in 2 mL of freeze-thaw degassed THF and the catalyst 
PdCl2(PPh3)2 (1.40 mg, 2.00 µmol, 5 mol%). The vial was submitted to MW 
irradiation (15 minutes, 100 °C), then the reaction was filtered and concentrated 
under vacuum to afford a brown oil as crude product. The crude product was 
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purified by silica gel column chromatography (1:1 petroleum ether/ethyl acetate) to 
afford (+)-crocacin C 3 as a white solid (7.00 mg, 19.6 µmol) in 50% yield. 
Method C: In a flame-dried 5 mL microwave vial under an inert atmosphere, a 
solution of alkyne 79 (50.0 mg, 184 μmol) in anhydrous THF (2.5 mL) was 
degassed by three freeze−pump−thaw cycles. PdCl2(Ph3P)2 (7.00 mg, 10.3 μmol) 
was then incorporated, and the solution was cooled to 0 °C before tributyltin 
hydride (56.0 μL, 203 μmol) was added dropwise. The resultant brown solution 
was stirred at 0 °C until the starting material was consumed as indicated by TLC 
(25 minutes). Vinyl iodide 7 (42.0 mg, 197 μmol) was added, and the solution was 
heated to 100 °C in a microwave reactor for 15 minutes. The reaction mixture was 
filtered through a small pad of silica using ethyl acetate as the eluent (10 mL), and 
the filtrate was concentrated in vacuo to give crude yellow oil. Purification of the 
crude residue by flash column chromatography on silica gel (elution gradient 1:1 
PE/EtOAc to 2:3 PE/EtOAc) afforded (+)-crocacin C 3 as a white solid in 70% yield 
(46.0 mg, 129 µmol). Rf 0.25 (PE:EtOAc, 1:1); [α]
26
D +54.0 (c 0.1, MeOH); {Lit.
[2] 
[α]22D +52.2 (c 0.3, MeOH); Lit.
[4] [α]19D +61.3 (c 0.3, MeOH); Lit.
[6] [α]20D +53.8 (c 
0.2, MeOH); Lit.[8] [α]20D +59.8 (c 0.31, MeOH); Lit.
[10] [α]23D +46.3 (c 0.3, MeOH); 
Lit.[11] [α]25D +56.2 (c 0.5, MeOH); Lit.
[12] [α]23.5D +56.8 (c 0.3, MeOH)}; IR νmax (film) 
3479, 3395, 3343, 3184, 2963, 2926, 1655, 1601, 1449, 1368, 1261, 1088, 972 
cm-1; 1H NMR (500 MHz, acetone-d6): δH 7.47 (2H, d, J 8.0 Hz, CHAr), 7.32 (2H, 
dd, J 7.5, 8.0 Hz, CHAr), 7.23 (1H, dd, J 7.5, 7.5 Hz, CHAr), 6.70 (1H, bs, NHH), 
6.59 (1H, d, J 16.0 Hz, CH=), 6.26 (1H, dd, J 7.3, 16.1 Hz, =CH), 6.13 (1H, bs, 
NHH), 6.12-6.04 (2H, m, CH=CH), 5.80 (1H, s, CH=), 4.08 (1H, ddd, J 1.0, 2.4, 7.2 
Hz, CHOMe), 3.52 (3H, s, OCH3), 3.29 (3H, s, OCH3), 3.16 (1H, dd, J 2.0, 9.6 Hz, 
CHOMe), 2.58 (1H, ddq, J 2.2, 6.8, 8.1 Hz, CHMe), 2.22 (3H, d, J 1.1 Hz, CH3), 
1.56 (1H, ddq, J 2.5, 7.0, 9.5 Hz, CHMe), 1.17 (3H, d, J 6.9 Hz, CH3), 0.85 (3H, d, 
J 7.0 Hz, CH3); 
13C NMR (125 MHz, acetone-d6): δC 169.0 (CO), 148.1 (C=), 137.9 
(CAr), 137.0 (CH=), 135.1 (CH=), 132.6 (CH=), 130.5 (CH=), 129.4 (CHAr), 128.3 
(CHAr), 127.3 (CHAr), 122.1 (CH=), 87.1 (CHOMe), 81.8 (CHOMe), 61.5 (OCH3), 
56.5 (OCH3), 43.5 (CHMe), 40.8 (CHMe), 19.3 (CH3), 13.5 (CH3), 10.1 (CH3); 
HRMS (FAB+) calc. for C22H31O3NNa [M+Na]
+: 380.2202. Found: 380.2207; mp: 
95-100 °C. 
 
The characterisation matches with the data reported in literature: 
Feutrill J. T.; Lilly M. J.; Rizzacasa M. A. Org. Lett. 2000, 2, 3365. 
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Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
Candy M.; Audran G.; Bienayme H.; Bressy C.; Pons J.-M. J. Org. Chem. 2010, 
75, 1354. 
 
(2Z,4E,6S,7S,8R,9S,10E)-7,9-Dimethoxy-3,6,8-trimethyl-11-phenylundeca-
2,4,10-trienamide, 235 
 
[α]26D +32.0 (c 0.1, MeOH); IR νmax (film) 3460, 3391, 3339, 3086, 2972, 2928, 
1659, 1595, 1456, 1321, 1261, 1085, 1024, 750, 694, 677 cm-1; 1H NMR (500 
MHz, acetone-d6): δH 7.82 (1H, d, J 16.3 Hz, CH=), 7.51-7.47 (2H, m, CHAr), 7.38-
7.29 (2H, m, CHAr), 7.25-7.21 (1H, m, CHAr), 6.71 (1H, bs, NHH), 6.59 (1H, d, J 
16.0 Hz, CH=), 6.26 (1H, dd, J 7.1, 15.9 Hz, CH=), 6.07 (1H, bs, NHH), 6.05 (1H, 
dd, J 9.0, 16.2 Hz, CH=), 5.69 (1H, bs, CH=), 4.09-4.07 (1H, m, CHOMe), 3.54 
(3H, s, OCH3), 3.30 (3H, s, OCH3), 3.18 (1H, dd, J 2.1, 9.6 Hz, CHOMe), 2.65-2.55 
(1H, m, CHMe), 1.90 (3H, d, J 1.0 Hz, CH3), 1.58-1.52 (1H, m, CHMe), 1.18 (3H, 
d, J 7.2 Hz, CH3), 0.86 (3H, d, J 7.2 Hz, CH3); 
13C NMR (125 MHz, acetone-d6): δC 
169.0 (CO), 146.9 (C=), 137.9 (CH=), 137.8 (CAr), 132.7 (CH=), 130.5 (CH=), 
129.4 (CHAr), 129.3 (CH=), 128.3 (CHAr), 127.3 (CHAr), 120.1 (CH=), 87.2 
(CHOMe), 81.9 (CHOMe), 61.5 (OCH3), 56.5 (OCH3), 43.5 (CHMe), 41.2 (CHMe), 
21.0 (CH3), 19.3 (CH3), 10.1 (CH3). 
 
(2Z,4Z,6S,7S,8R,9S,10E)-7,9-Dimethoxy-3,6,8-trimethyl-11-phenylundeca-
2,4,10-trienamide, 236 
 
[α]26D -44.0 (c 0.1, MeOH); IR νmax (film) 3460, 3391, 3339, 3086, 2972, 2928, 
1659, 1595, 1456, 1368, 1296, 1088, 1017, 747, 669 cm-1; 1H NMR (500 MHz, 
acetone-d6): δH 7.50-7.47 (2H, m, CHAr), 7.35-7.31 (2H, m, CHAr), 7.26-7.23 (1H, 
m, CHAr), 6.83 (1H, bs, NHH), 6.60 (1H, d, J 16.0 Hz, CH=), 6.26 (1H, dd, J 7.4, 
16.1 Hz, CH=), 6.14 (1H, bs, NHH), 5.89 (1H, d, J 12.1 Hz, CH=), 5.84 (1H, s, 
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CH=), 5.60 (1H, dd, J 11.3, 12.2 Hz, CH=), 4.05-4.02 (1H, m, CHOMe), 3.52 (3H, 
s, OCH3), 3.29 (3H, s, OCH3), 3.10 (1H, dd, J 2.2, 9.6 Hz, CHOMe), 3.07-2.98 (1H, 
m, CHMe), 2.20 (3H, d, J 1.1 Hz, CH3), 1.58-1.50 (1H, m, CHMe), 1.18 (3H, d, J 
7.3 Hz, CH3), 0.79 (3H, d, J 7.3 Hz, CH3); 
13C NMR (125 MHz, acetone-d6): δC 
168.7 (CO), 148.9 (C=), 137.8 (CH=), 134.9 (CAr), 133.0 (CH=), 132.8 (CH=), 
130.6 (CHAr), 129.4 (CH=), 128.4 (CHAr), 127.3 (CHAr), 121.3 (CH=), 86.9 
(CHOMe), 81.9 (CHOMe), 61.6 (OCH3), 56.4 (OCH3), 43.8 (CHMe), 36.0 (CHMe), 
19.7 (CH3), 19.5 (CH3), 10.0 (CH3). 
 
5-(tert-Butyldiphenylsilyloxy)pentan-1-ol, 248 
 
 
 
To a solution of imidazole (477 mg, 7.00 mmol) in dichloromethane (50 mL) at 0°C 
under argon, was added pentane-1,5-diol 245 (1.05 mL, 10.0 mmol) and the 
reaction mixture was stirred for 5 minutes. Then TBDPSCl (0.87 mL, 3.33 mmol) 
was added dropwise and the resulting mixture was allowed to warm to room 
temperature and to stir for 12 hours. The reaction was quenched with  50 mL of 
NH4Cl saturated aqueous solution and  extracted with dichloromethane (3 × 50 
mL). The organic layers were collected, washed with brine, dried over Na2SO4, 
filtered and concentrated under vacuum to afford the crude product as a yellow oil. 
The crude product was purified by flash column chromatography on silica gel 
(EtOAc:PE, from 0:1 to 2:8) to afford the clean product 246 as a colourless oil in 
88% yield (1.00 g, 2.92 mmol). Rf 0.21 (PE:EtOAc, 9:1); IR νmax (film) 3335, 2932, 
2896, 2858, 2358, 1473, 1427, 1111, 998, 823, 739, 700, 687 cm-1; 1H NMR (500 
MHz, CDCl3): δH 7.68-7.65 (4H, m, CHAr), 7.44-7.36 (6H, m, CHAr), 3.67 (2H, t, J 
6.5 Hz, CH2OSi), 3.62 (2H, dd, J 6.5, 11.1 Hz, CH2OH), 1.62-1.52 (4H, m, 2 × 
CH2), 1.46-1.39 (2H, m, CH2), 1.22 (1H, bt, J 4.8 Hz, OH), 1.05 (9H, s, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 135.7 (CHAr), 134.2 (CAr), 129.7 (CHAr), 127.7 
(CHAr), 63.9 (CH2OSi), 63.1 (CH2OH), 32.6 (CH2), 32.4 (CH2), 27.0 (3 × CH3), 22.1 
(CH2), 19.4 (C); HRMS (CI+/ISO) calc. for C21H31O2Si [M+H]
+: 343.2093. Found: 
343.2097. 
 
The characterisation matches with the literature data:  
Young I. S.; Kerr M. A. J. Am. Chem. Soc. 2007, 129, 1465. 
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5-(tert-Butyldiphenylsilyloxy)pentanoic acid, 249 
 
 
 
To a solution of 5-(tert-butyldiphenylsilyloxy)pentan-1-ol 246 (1.00 g, 2.92 mmol) in 
dichloromethane (3 mL) and H2O (3 mL), cooled at 0
 °C, TEMPO (90.0 mg, 0.58 
mmol) and BAIB (2.07 g, 6.42 mmol) were added and the reaction mixture was 
allowed to warm to room temperature and to stir for 12 hours. Then the reaction 
was quenched with 10 mL of Na2S2O3 saturated aqueous solution and extracted 
with dichloromethane (3 × 10 mL) and ethyl acetate (3 × 10 mL). The organic 
layers were collected, dried over Na2SO4, filtered and concentrated under vacuum 
to afford the crude product as an orange oil. The crude product was purified by 
flash column chromatography (EtOAc:PE, from 0:1 to 2:8) to afford the clean 
product 247 as a colourless oil in 76% yield (0.79 g, 2.22 mmol). Rf 0.25 
(PE:EtOAc, 8:2); IR νmax (film) 3070, 2953, 2931, 2891, 2858, 2343, 1706, 1473, 
1427, 1390, 1362, 1293, 1245, 1105, 1091, 823, 797, 740, 699 cm-1; 1H NMR (500 
MHz, CDCl3): δH 11.46 (1H, bs, COOH), 7.73-7.68 (4H, m, CHAr), 7.47-7.39 (6H, 
m, CHAr), 3.72 (2H, t, J 6.2 Hz, CH2OSi), 2.40 (2H, t, J 8.2 Hz, CH2COO), 1.79 
(2H, qn, J 7.6 Hz, CH2), 1.68-1.62 (2H, m, CH2), 1.09 (9H, s, 3 × CH3); 
13C NMR 
(125 MHz, CDCl3): δC 180.3 (COOH), 135.7 (CHAr), 134.0 (CAr), 129.7 (CHAr), 
127.8 (CHAr), 63.4 (CH2OSi), 33.9 (CH2COOH), 31.9 (CH2), 26.9 (3 × CH3), 21.3 
(CH2), 19.3 (C); HRMS (CI+/ISO) calc. for C21H29O3Si [M+H]
+: 357.1886. Found: 
357.1883. 
 
The characterisation matches with the literature data:  
Jacobi P. A.; Li Y. Org. Lett. 2003, 5, 701. 
 
Methyl 2-(5-(tert-butyldiphenylsilyloxy)pentanamido)acetate, 250 
 
 
 
To a solution of 5-(tert-butyldiphenylsilyloxy)pentanoic acid 247 (0.79 g, 2.22 
mmol), glycine methylester 124 (335 mg, 2.66 mmol) and HBTU (1.01 g, 2.66 
mmol) in dichloromethane (20 mL) under argon, DIPEA (1.0 mL, 5.55 mmol) was 
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added dropwise and the reaction mixture was allowed to stir for 12 hours. Then 
the reaction was quenched with 20 mL of NH4Cl saturated aqueous solution and 
extracted with diethyl ether (3 × 20 mL). The organic layers were collected, dried 
over Na2SO4, filtered and concentrated under vacuum to afford the crude product 
as a yellow oil. The crude product was purified by flash column chromatography 
on silica gel (EtOAc:PE, from 0:1 to 2:8) to afford the clean product 248 as a pale 
yellow oil in 89% yield (0.84 g, 1.97 mmol). Rf 0.40 (PE:EtOAc, 1:1); IR νmax (film) 
3312, 3072, 2953, 2931, 2856, 1756, 1652, 1531, 1473, 1427, 1389, 1362, 1204, 
1177, 1105 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.71-7.62 (4H, m, CHAr), 7.45-
7.35 (6H, m, CHAr), 6.00 (1H, bs, NH), 4.02 (2H, d, J 5.7 Hz, CH2N), 3.75 (3H, s, 
OCH3), 3.68 (2H, t, J 6.7 Hz, CH2OSi), 2.23 (2H, t, J 8.1 Hz, CH2CO), 1.75 (2H, 
qn, J 7.7 Hz, CH2), 1.65-1.57 (2H, m, CH2), 1.05 (9H, s, 3 × CH3); 
13C NMR (125 
MHz, CDCl3): δC 173.2 (CONH), 170.6 (COO), 135.7 (CHAr), 134.0 (CAr), 129.7 
(CHAr), 127.7 (CHAr), 63.6 (CH2OSi), 52.4 (OCH3), 41.3 (CH2N), 36.1 (CH2CO), 
31.9 (CH2), 26.9 (3 × CH3), 22.1 (CH2), 19.3 (C); HRMS (CI+/ISO) calc. for 
C24H34O4NSi [M+H]
+: 428.2257. Found: 428.2258. 
 
Methyl 2-(5-hydroxypentanamido)acetate, 251 
 
 
 
To a solution of methyl 2-(5-(tert-butyldiphenylsilyloxy)pentanamido)acetate 248 
(0.83 g, 1.94 mmol) in anhydrous THF (20 mL) under argon at 0 °C, TBAF (4.90 
mL, 4.90 mmol, 1.0 M solution in THF) was added dropwise and the reaction 
mixture was allowed to stir for 12 hours. Then the reaction was quenched with 20 
mL of distilled water and extracted with diethyl ether (3 × 20 mL), ethyl acetate (3 
× 20 mL) and dichloromethane (3 × 20 mL). The organic layers were collected, 
dried over Na2SO4, filtered and concentrated under vacuum to afford the crude 
product as a yellow oil. The crude product was purified by flash column 
chromatography on silica gel (EtOAc:methanol:Et3N, 1:1:1) to afford the clean 
product 249 as a light yellow thick oil in 11% yield (0.04 g, 212 µmol). IR νmax (film) 
3312, 2955, 2920, 2851, 1740, 1651, 1549, 1462, 1362, 1260, 1207,  1182, 1121, 
1078, 978, 820 and 729 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.05 (1H, bt, J 5.6 
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Hz, NH), 6.10 (1H, bs, OH), 3.97 (2H, d, J 5.6 Hz, CH2N), 3.59 (3H, s, OCH3), 3.55 
(2H, t, J 6.4 Hz, CH2O), 2.26 (2H, t, J 7.6 Hz, CH2CO), 1.82-1.54 (4H, m, 2 × CH2); 
13C NMR (100 MHz, CDCl3): δC 172.8 (CONH), 169.9 (COO), 62.3 (CH2OH), 52.7 
(OCH3), 41.0 (CH2N), 36.1 (CH2CO), 31.5 (CH2), 22.0 (CH2); HRMS (CI+/ISO) 
calc. for C8H16O4N [M+H]
+: 190.1079. Found: 190.1079. 
 
Methyl 2-(N-(tert-butoxycarbonyl)-5-(tert-butyldiphenylsilyloxy) 
pentanamido)acetate, 253 
 
 
To a solution of methyl 2-(5-(tert-butyldiphenylsilyloxy)pentanamido)acetate 248 
(3.60 g, 8.43 mmol) in THF (37 mL), under argon and cooled at 0 °C , DIPEA (6.00 
mL, 33.7 mmol), DMAP (21.0 mg, 33.7 mmol) and Boc2O (7.40 g, 33.7 mmol) 
were added and the reaction mixture was allowed to warm to room temperature 
and to stir for 4 hours. Then the reaction was washed with 20 mL of brine and 
extracted with diethyl ether (3 × 20 mL). The organic layers were collected, dried 
over Na2SO4, filtered and concentrated under vacuum to afford the crude product 
as a yellow oil. The crude product was purified by flash column chromatography 
on silica gel (from 0 to 10% ethyl acetate in hexane) to afford the clean product 
251 as a colourless oil in 85% yield (3.80 g, 7.20 mmol). Rf 0.24 (hexane:EtOAc, 
9:1); IR νmax (film) 2932, 2858, 2360, 1757, 1742, 1700, 1690, 1473, 1428, 1369, 
1336, 1209, 1146, 1106, 1092, 1036, 987, 856, 823, 778, 740, 700 cm-1; 1H NMR 
(500 MHz, CDCl3): δH 7.71-7.67 (4H, m, CHAr), 7.44-7.37 (6H, m, CHAr), 4.47 (2H, 
s, CH2N), 3.74 (3H, s, OCH3), 3.71 (2H, t, J 6.3 Hz, CH2OSi), 2.96 (2H, t, J 7.4 Hz, 
CH2CO), 1.82-1.74 (2H, m, CH2), 1.68-1.61 (2H, m, CH2), 1.51 (9H, s, 3 × CH3), 
1.06 (9H, s, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 175.6 (CON), 169.6 
(COOMe), 152.2 (COOtBu), 135.6 (CHAr), 134.1 (CAr), 129.6 (CHAr), 127.7 (CHAr), 
83.7 (C), 63.7 (CH2OSi), 52.2 (OCH3), 45.2 (CH2N), 37.8 (CH2CO), 32.1 (CH2), 
27.9 (3 × CH3), 26.9 (3 × CH3), 21.5 (CH2), 19.3 (C); HRMS (CI+/ISO) calc. for 
C29H42O6NSi [M+H]
+
: 528.2781. Found: 528.2772. 
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Methyl 2-(N-(tert-butoxycarbonyl)-5-hydroxypentanamido)acetate, 254 
 
 
 
To a solution of methyl 2-(N-(tert-butoxycarbonyl)-5-(tert-butyldiphenylsilyloxy) 
pentanamido) acetate 251 (3.80 g, 7.20 mmol) in THF (50 mL), under argon and at 
0 °C , was added dropwise a solution of HF-Py/Py/THF (10 mL: 40 mL: 50 mL) 
and the reaction mixture was allowed to warm to room temperature and to stir for 
15 hours. Then the reaction was quenched at 0 °C with 1.60 g of NaHCO3 in 
powder. The resulting mixture was allowed to stir for 10 minutes, then it was 
filtered and concentrated under vacuum to afford the crude product as a colourless 
oil.  The crude product was purified by flash column chromatography on silica gel 
(from 50 to 100% ethyl acetate in hexane) to afford the clean product 252 as a 
colourless oil in 60% yield (1.24 g, 4.30 mmol). Rf 0.10 (hexane:EtOAc, 7:3); IR 
νmax (film) 3445, 2953, 2364, 1743, 1684, 1439, 1371, 1339, 1214, 1149, 1079, 
1140, 985, 855, 780 cm-1; 1H NMR (500 MHz, CDCl3): δH 4.45 (2H, s, CH2N), 3.73 
(3H, s, OCH3), 3.68-3.63 (2H, bm, CH2O), 2.97 (2H, t, J 7.5 Hz, CH2CO), 1.79-
1.72 (2H, m, CH2), 1.69-1.66 (1H, bm, OH), 1.65-1.59 (2H, m, CH2), 1.49 (9H, s, 3 
× CH3); 
13C NMR (125 MHz, CDCl3): δC 175.8 (CO), 169.7 (CO), 152.3 (CO), 84.0 
(C), 62.4 (CH2O), 52.3 (OCH3), 45.3 (CH2N), 37.6 (CH2CO), 32.1 (CH2), 28.0 (3 × 
CH3), 21.1 (CH2); HRMS (CI+/ISO) calc. for C13H24O6N [M+H]
+: 290.1604. Found: 
290.1596. 
 
Methyl 2-(N-(tert-butoxycarbonyl)-5-oxopentanamido)acetate, 131 
 
 
 
To a solution of methyl 2-(N-(tert-butoxycarbonyl)-5-hydroxypentanamido)acetate  
252 (100 mg, 346 µmol) in dichloromethane (1 mL), under argon and cooled at 0 
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°C, TEMPO (11.0 mg, 0.07 mmol) and BAIB (245 mg, 0.76 mmol) were added and 
the reaction mixture was allowed to warm to room temperature and to stir for 1 
hour. Then the reaction was quenched with 1 mL of Na2S2O3 saturated aqueous 
solution and extracted with diethyl ether (3 × 1 mL). The organic layers were 
collected, dried over Na2SO4, filtered and concentrated under vacuum to afford the 
crude product as an orange oil. The crude product was purified by flash column 
chromatography on silica gel (from 0 to 40% diethyl ether in hexane) to afford the 
clean product 131 as a colourless oil in 71% yield (70.0 mg, 244 µmol). Rf 0.37 
(hexane: EtOAc, 7:3); 1H NMR (500 MHz, CDCl3): δH 9.76 (1H, bt, J 1.4 Hz, CHO), 
4.43 (2H, s, CH2N), 3.72 (3H, s, OCH3), 2.99 (2H, t, J 7.1 Hz, CH2CO), 2.52 (2H, 
dt, J 1.4, 7.2 Hz, CH2CHO), 1.98 (2H, qn, J 7.2 Hz, CH2), 1.48 (9H, s, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 202.1 (CHO), 175.0 (CON), 169.6 (COOMe), 
152.2 (COOtBu), 84.1 (C), 52.3 (OCH3), 45.3 (CH2N), 43.2 (CH2CHO), 37.1 (CH2), 
28.0 (3 × CH3), 17.6 (CH2). 
 
The characterisation matches the data reported in literature: 
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
 
(Z)-Methyl 2-(N-(tert-butoxycarbonyl)-6-iodohex-5-enamido)acetate, 132 
 
 
 
To a suspension of Ph3PCH2I2 (186 mg, 0.35 mmol) in THF (3 mL), under argon, 
potassium tert-butoxide (31.0 mg, 0.25 mmol) was added and the reaction mixture 
was allowed to stir for 10 minutes at room temperature and then it was cooled to -
78 °C. The aldehyde methyl 2-(N-(tert-butoxycarbonyl)-5-oxopentanamido)acetate 
131 (20.0 mg, 0.07 mmol) in THF (2 mL) was added dropwise and the resulting 
mixture was allowed to stir at  -78 °C for 3 hours. Then the reaction was quenched 
with 5 mL of NH4Cl saturated aqueous solution and extracted with 
dichloromethane (3 × 5 mL) and diethyl ether (3 × 5 mL). The organic layers were 
collected, dried over Na2SO4, filtered and concentrated under vacuum to afford the 
crude product as a yellow-brown solid. The crude product was purified by flash 
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column chromatography on silica gel (from 0 to 20% ethyl acetate in hexane) to 
afford the clean product 132 as a white thick oil in quantitative yield (30.0 mg, 0.07 
mmol). Rf 0.37 (hexane:EtOAc, 8:2); IR νmax (film) 2953, 2916, 2849, 2357, 1740, 
1700, 1686, 1457, 1437, 1369, 1337, 1208, 1146, 1075, 1034, 986, 856, 778 cm-1; 
1H NMR (500 MHz, CDCl3): δH 6.23 (1H, d, J 7.2 Hz, =CHI), 6.19 (1H, q, J 7.0 Hz, 
CH=), 4.46 (2H, s, CH2N), 3.73 (3H, s, OCH3), 2.98 (2H, t, J 7.5 Hz, CH2CO), 2.21 
(2H, q, J 7.3 Hz, CH2), 1.81 (2H, qn, J 7.3 Hz, CH2), 1.50 (9H, s, 3 × CH3); (500 
MHz, C6D6): δH 5.83 (1H, dt, J 1.4, 7.3 Hz, =CHI), 5.66 (1H, q, J 7.1 Hz, CH=), 
4.43 (2H, s, CH2N), 3.23 (3H, s, OCH3), 2.84 (2H, t, J 7.1 Hz, CH2CO), 2.03 (2H, 
dq, J 1.2, 7.3 Hz, CH2), 1.69 (2H, qn, J 7.6 Hz, CH2), 1.28 (9H, s, 3 × CH3); 
13C 
NMR (125 MHz, CDCl3): δC 175.4 (CON), 169.6 (COOMe), 152.3 (COOtBu), 140.8 
(CH=), 84.0 (C), 83.2 (=CHI), 52.3 (OCH3), 45.4 (CH2N), 37.4 (CH2CO), 34.2 
(CH2CH=), 28.1 (3 × CH3), 23.4 (CH2); HRMS (CI+/ISO) calc. for C14H23O5NI 
[M+H]+: 412.0621. Found: 412.0613. 
 
The characterisation matches the data reported in literature: 
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
 
Methyl 2-hex-5-ynamidoacetate, 241 
 
 
 
To a solution of hex-5-ynoic acid 242 (1.00 g, 8.93 mmol), glycine methylester 124 
(1.35 g, 10.7 mmol) and HBTU (4.07 g, 10.7 mmol) in dichloromethane (25 mL) 
under argon, DIPEA (3.9 mL, 22.3 mmol) was added dropwise and the reaction 
mixture was allowed to stir for 16 hours. Then the reaction was quenched with 25 
mL of NH4Cl saturated aqueous solution and extracted with diethylether (3 × 25 
mL). The organic layers were collected, dried over Na2SO4, filtered and 
concentrated under vacuum to afford the crude product as a yellow oil. The crude 
product was purified by flash column chromatography on silica gel (from 0 to 30% 
ethyl acetate in petroleum ether) to afford the clean product 241 as a colourless oil 
in 92% yield (1.5 g, 8.19 mmol). Rf 0.55 (EtOAc); IR νmax (film) 3284, 2954, 1743, 
1652, 1539, 1436, 1409, 1370, 1205, 1181, 1038, 1010, 982, 639 cm-1; 1H NMR 
(500 MHz, CDCl3): δH 6.37 (1H, bs, NH), 3.97 (2H, d, J 5.2 Hz, CH2N), 3.69 (3H, s, 
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OCH3), 2.34 (2H, t, J 7.3 Hz, CH2CO), 2.21 (2H, td, J 2.6, 6.8 Hz, CH2CHalkyne), 
1.94 (1H, t, J 2.7 Hz, CHalkyne), 1.81 (2H, qn, J 7.2 Hz, CH2); 
13C NMR (125 MHz, 
CDCl3): δC 172.7 (CON), 170.5 (COO), 83.5 (Calkyne), 69.2 (CHalkyne), 52.3 (OCH3), 
41.2 (CH2N), 34.6 (CH2CO), 24.1 (CH2), 17.8 (CH2CHalkyne); HRMS (CI+/ISO) calc. 
for C9H13O3N [M]
+: 183.0895. Found: 183.0894. 
 
Methyl 2-(6-iodohex-5-ynamido)acetate, 255 
 
 
 
To a solution of methyl 2-hex-5-ynamido acetate 241 (100 mg, 546 µmol) and 
iodine (208 mg, 819 µmol) in benzene (5 mL), under argon, morpholine (0.24 mL, 
2.73 mmol) was added dropwise and the reaction mixture was allowed to stir at 45 
°C for 12 hours. Then the reaction was allowed to cool to room temperature and it 
was filtered and extracted with diethyl ether (3 × 5 mL). The organic layers were 
collected, washed with brine (20 mL), NaHCO3 saturated aqueous solution (20 
mL), Na2S2O3 saturated aqueous solution (20 mL), dried over Na2SO4, filtered and 
concentrated under vacuum to afford the crude product 253 as a yellow thick oil in 
a quantitative yield (169 mg, 546 µmol). The crude product was carried through 
without any further purification. Rf 0.32 (PE:EtOAc, 1:1); 
1H NMR (500 MHz, 
CDCl3): δH 5.91 (1H, bs, NH), 4.05 (2H, d, J 5.4 Hz, CH2N), 3.77 (3H, s, OCH3), 
2.47 (2H, t, J 7.0 Hz, CH2C), 2.37 (2H, t, J 7.0 Hz, CH2CO), 1.88 (2H, qn, J 7.0 Hz, 
CH2). 
 
(Z)-Methyl 2-(6-iodohex-5-enamido)acetate, 123 
 
 
 
Method A: To a solution of (Z)-methyl 2-(N-(tert-butoxycarbonyl)-6-iodohex-5-
enamido)acetate 132 (30.0 mg, 0.07 mmol) in dichloromethane (300 mL), under 
argon, TFA (2.0 mL) was added dropwise and the resulting mixture was allowed to 
stir at room temperature for 24 hours. Then the reaction mixture was concentrated 
under vacuum to afford the crude product as a yellow oil. The crude product was 
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purified by flash column chromatography on silica gel (from 0 to 40% ethyl acetate 
in hexane) to afford the clean product 123 as a colourless oil in quantitative yield 
(22.0 mg, 0.07 mmol). 
Method B: To a solution of BH3
.SMe2 (0.16 mL, 324 µmol) in diethyl ether (5 mL), 
cooled at 0 °C and under argon, cyclohexene (0.07 mL, 648 µmol) was added 
dropwise and the reaction mixture was allowed to warm to room temperature and 
to stir for 1 hour. The resulting white suspension was cooled to 0 °C and a solution 
of methyl 2-(6-iodohex-5-ynamido)acetate 253 (100 mg, 324 µmol) in dry diethyl 
ether (3 mL) was added dropwise and the reaction mixture was allowed to warm to 
room temperature and to stir for 1 hour. Then the reaction mixture was recooled to 
0 °C and it was quenched with 0.2 mL of glacial acetic acid. The resulting mixture 
was allowed to stir at room temperature for 2 hours, then it was washed with H2O 
(10 mL), dried over Na2SO4, filtered and concentrated under vacuum to afford the 
crude product as an orange oil. The crude product was purified by flash column 
chromatography on silica gel (from 0 to 40% ethyl acetate in hexane) to afford the 
clean product 123 as a colourless oil in 90% yield (91.0 mg, 293 µmol). Rf 0.21 
(PE:EtOAc, 1:1); IR νmax (film) 3287, 3082, 2949, 1748, 1649, 1537, 1456, 1437, 
1406, 1370, 1288, 1269, 1202, 1179, 1152, 1036, 982, 692 cm-1; 1H NMR (500 
MHz, CDCl3): δH 6.25 (1H, dt, J 1.2, 7.4 Hz, =CHI), 6.16 (1H, q, J 7.0 Hz, CH=), 
5.98 (1H, bs, NH), 4.06 (2H, d, J 4.4 Hz, CH2N), 3.77 (3H, s, OCH3), 2.28 (2H, t, J 
7.6 Hz, CH2CO), 2.21 (2H, dq, J 1.0, 7.3 Hz, CH2CH=), 1.81 (2H, qn, J 7.4 Hz, 
CH2); (500 MHz, C6D6): δH 5.85 (1H, dt, J 1.3, 7.3 Hz, =CHI), 5.63 (1H, q, J 6.9 Hz, 
CH=), 5.11 (1H, bs, NH), 3.73 (2H, d, J 5.0 Hz, CH2N), 3.20 (3H, s, OCH3), 1.97 
(2H, dq, J 1.3, 7.3 Hz, CH2CH=), 1.69 (2H, t, J 7.6 Hz, CH2CO), 1.60-1.54 (2H, m, 
CH2); 
13C NMR (125 MHz, CDCl3): δC 172.7 (CON), 170.6 (COO), 140.4 (CH=), 
83.5 (=CHI), 52.5 (OCH3), 41.4 (CH2N), 35.5 (CH2CO), 34.2 (CH2CH=), 23.8 
(CH2); HRMS (CI+/ISO) calc. for C9H15O3NI [M+H]
+: 312.0097. Found: 312.0099. 
 
The characterisation matches the data reported in literature: 
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
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(+)-crocacin D: Methyl 2-((Z)-6-((2E,4E,6S,7S,8R,9S,10E)-7,9-dimethoxy-3,6,8-
trimethyl-11-phenylundeca-2,4,10-trienamido)hex-5-enamido)acetate, 4 
 
 
 
 
To a suspension of (+)-crocacin C 3 (8.50 mg, 24.0 µmol), cesium carbonate (7.40 
mg, 23.0 µmol), CuI (1.00 mg, 5.00 µmol) and N,N’-dimethyl ethylenediamine (1 
µL, 9.50 µmol) in degassed and dry THF (0.5 mL) in a 2.0-5.0 mL microwave vial, 
a solution of (Z)-methyl 2-(6-iodohex-5-enamido)acetate 123 (6.60 mg, 21.0 µmol) 
in degassed and dry THF (0.5 mL) was added dropwise and the reaction mixture 
was allowed stir at 70 °C for 24 hours. The resulting blue-purple suspension was 
diluted with 1 mL of ethyl acetate and filtered through a short pad of silica gel 
(previously deactivated with Et3N) using EtOAc (10 mL) as eluent. Then the filtrate 
was concentrated under vacuum to afford a green-yellow oil as crude product. The 
crude product was purified by flash column chromatography on silica gel 
previously deactivated with triethylamine (EtOAc:DCM:Et3N, 2.9:7:0.1) to afford 
the semipure product 4 as a yellow gum in 70% yield (8.00 mg, 15.0 µmol). Rf 0.38 
(EtOAc:PE:Et3N 4.9:5:0.1); IR νmax (film) 3302, 2924, 1744, 1653, 1603, 1514, 
1262, 1089 and 972 cm-1; 1H NMR (500 MHz, Acetone-d6): δH 9.21 (1H, bd, J 10.5 
Hz, NH), 7.61-7.52 (1H, m, NH), 7.51 (2H, d, J 7.3 Hz, 2 × ortho CHAr), 7.35 (2H, 
dd, J 7.4, 7.4 Hz, 2 × meta CHAr), 7.27 (1H, dd, J 7.4, 7.4 Hz, para CHAr), 6.80 
(1H, dd, J 9.0, 10.4 Hz, CH=), 6.62 (1H, d, J 16.0 Hz, PhCH=), 6.29 (1H, dd, J 7.3, 
16.1 Hz, CH=), 6.15-6.10 (2H, m, CH=CH), 5.95 (1H, d, J 1.0 Hz, CH=), 4.71 (1H, 
dt, J 7.3, 9.0 Hz, CH=), 4.12 (1H, dd, J 1.6, 7.4 Hz, CHOMe), 3.98 (2H, d, J 6.0 
Hz, CH2N), 3.71 (3H, s, OCH3), 3.56 (3H, s, OCH3), 3.30 (3H, s, OCH3), 3.22 (1H, 
dd, J 2.4, 9.5 Hz, CHOMe), 2.65-2.57 (1H, m, CHMe), 2.31 (3H, d, J 1.0 Hz, CH3), 
2.29 (2H, t, J 7.1 Hz, CH2CO), 2.11 (2H, dt, J 6.8, 7.2 Hz, CH2), 1.67 (2H, tt, J 6.8, 
7.2 Hz, CH2), 1.56-1.55 (1H, m, CHMe), 1.22 (3H, d, J 6.8 Hz,  CH3), 0.91 (3H, d, 
J 7.1 Hz,  CH3); LRMS (ES+): [M+H]
+: 541.8; [M+Na]+: 563.8 
 
The characterisation matches the data reported in literature: 
Dias L. C.; de Oliveira L. G. Org. Lett. 2001, 3, 3951. 
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(Z)-Methyl 2-(6-benzamidohex-5-enamido)acetate, 244 
 
 
 
Method A: To a suspension of benzamide 243 (5.30 mg, 44.0 µmol), cesium 
carbonate (14.0 mg, 44.0 µmol), CuI (1.00 mg, 5.00 µmol) and N,N’-dimethyl 
ethylenediamine (1 µL, 9.50 µmol) in degassed and dry THF (0.5 mL) in a 2.0-5.0 
mL microwave vial, a solution of (Z)-methyl 2-(6-iodohex-5-enamido)acetate 123 
(10.0 mg, 38.0 µmol) in degassed and dry THF (0.5 mL) was added dropwise and 
the reaction mixture was allowed stir at 70 °C for 24 hours. The resulting blue-
purple suspension was diluted with 1 mL of EtOAc and filtered through a short pad 
of silica gel (previously deactivated with Et3N) using EtOAc as eluent. Then the 
filtrate was concentrated under vacuum to afford a green-yellow oil as crude 
product. The crude product was purified by flash column chromatography 
(EtOAc:DCM:Et3N, 2.9:7:0.1) to afford the clean product 244 as a white gum in 
75% yield (10.0 mg, 33.0 µmol).  
Method B: To a suspension of benzamide 243 (24.0 mg, 0.20 mmol), 
(cod)Ru(met)2 (3.20 mg, 1.00 µmol), Yb(OTf)3 (5.00 mg, 8.00 µmol) and dcybd 
(5.40 mg, 12.0 µmol) in anhydrous DMF (0.6 mL), the alkyne 241 (73.0 mg, 0.40 
mmol) was added and the resulting mixture was allowed to stir at 60 °C for 36 
hours. Then the reaction was quenched with NaHCO3 saturated aqueous solution 
(1 mL) and extracted with diethyl ether (3 × 2 mL). The organic layers were 
collected, dried over Na2SO4, filtered and concentrated under vacuum to afford a 
yellow solid as crude product. The crude product was purified by flash column 
chromatography (EtOAc:DCM:Et3N, 2.9:7:0.1) to afford the clean product 244 as a 
white gum in 10% yield (6.10 mg, 0.02 mmol). 
Rf 0.42 (EtOAc:PE:Et3N 2.9:7:0.1); IR νmax (film) 3304, 2953, 2923, 2854, 1745, 
1646, 1515, 1484, 1457, 1437, 1375, 1281, 1207, 1030 and 708 cm-1; 1H NMR 
(500 MHz, Acetone-d6): δH 9.67 (1H, bs, NH), 8.10 (2H, d, J 7.1 Hz, 2 × ortho 
CHAr), 7.75 (1H, bs, NH), 7.58 (1H, dd, J 7.1, 7.1 Hz, para CHAr), 7.52 (2H, dd, J 
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7.4, 7.4 Hz, 2 × meta CHAr), 7.01 (1H, td, J 1.0, 9.0 Hz, CH=), 4.89 (1H, q, J 8.2 
Hz, =CH), 4.03 (2H, d, J 5.8 Hz, CH2N), 3.66 (3H, s, OCH3), 2.39-2.29 (4H, m, 2 × 
CH2), 1.82-1.75 (2H, qn, J 6.6 Hz, CH2); 
13C NMR (125 MHz, Acetone-d6): δC 
175.7 (CONH), 171.8 (COO), 166.0 (CONH), 135.8 (CAr), 133.1 (para CHAr), 129.8 
(2 × meta CHAr), 129.5 (2 × ortho CHAr), 125.2 (CH=), 112.4 (=CH), 52.9 (OCH3), 
42.4 (CH2N), 34.8 (CH2CO), 26.9 (CH2), 26.1 (CH2); HRMS (EI+) calc. for 
C16H20O4N2 [M]
+: 304.1423. Found: 304.1417. 
 
Methyl 2-naphthoate, 257 
 
 
 
To a solution of naphtoic acid 256 (1.00 g, 5.80 mmol) in methanol (40 mL), 
concentrated hydrochloric acid (2 mL) was added and the resulting mixture was 
allowed to stir at 55 °C for 20 hours. Then the reaction was concentrated under 
vacuum, diluted with dichloromethane (40 mL) and washed with Na2CO3 saturated 
aqueous solution (2 × 50 mL). The organic layer was dried over Na2SO4, filtered 
and concentrated under vacuum to afford the product as a yellow oil. The crude 
product was purified by flash column chromatography on silica gel (from 0 to 30% 
ethyl acetate in hexane) to afford the clean product 257 as a white solid in 83% 
yield (899 mg, 4.83 mmol). Rf 0.81 (PE:EtOAc, 7:3); IR νmax (film) 3070, 2949, 
1709, 1470, 1437, 1352, 1292, 1231, 1199, 1155, 1130, 1099, 972, 961, 920, 878, 
835, 781, 766 cm-1; 1H NMR (500 MHz, CDCl3): δH 8.61 (1H, s, CHAr), 8.07 (1H, 
dd, J 1.6, 8.5 Hz, CHAr), 7.92 (1H, d, J 8.5 Hz, CHAr), 7.84 (2H, dd, J 4.3, 8.6 Hz, 2 
× CHAr), 7.58-7.49 (2H, m, 2 × CHAr), 3.97 (3H, s, OCH3); 
13C NMR (125 MHz, 
CDCl3): δC 167.2 (CO), 135.5 (CAr), 132.5 (CAr), 131.0 (CHAr), 129.3 (CHAr), 128.2 
(CHAr), 127.7 (CHAr), 127.4 (CAr), 126.6 (CHAr), 125.2 (CHAr), 52.2 (OCH3); HRMS 
(CI+/ISO) calc. for C12H11O2 [M+H]
+: 187.0759. Found: 187.0761; m.p. 70-71 °C. 
 
The characterisation matches with the literature data:  
Wu X. F. Chem. Eur. J. 2012, 18, 8912. 
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2-Naphthamide, 258 
 
 
 
To a suspension of ammonium chloride (2.61 g, 48.3 mmol) in dry toluene (20 mL) 
at 0 °C, AlMe3 (2.0 M solution in toluene, 24.2 mL, 48.3 mmol) was added 
dropwise and the resulting mixture was allowed to stir for 30 minutes, then a 
solution of methyl-2-naphtoate 257 (899 mg, 4.83 mmol) in dry toluene (20 mL) 
was added and the resulting mixture was allowed to stir at 50 °C for 16 hours. The 
reaction was cooled to 0 °C, quenched with 10 mL of HCl solution (1 N) and the 
organic layer was washed with NaHCO3 saturated aqueous solution (20 mL) and 
brine (20 mL), dried over Na2SO4 and concentrated under vacuum to afford a pale 
yellow oil as crude product. The crude product was purified by silica gel flash 
column chromatography (1:1 PE/EtOAc) to afford a white solid as pure product 
258 (659 mg, 3.85 mmol) in 80% yield. Rf 0.31 (EtOAc); IR νmax (film) 3381, 3194, 
1655, 1611, 1574, 1476, 1406, 1364, 1117, 916, 872, 839 and 787 cm-1; 1H NMR 
(500 MHz, Acetone-d6): δH 8.56 (1H, s, CHAr), 8.09-7.99 (4H, m, CHAr), 7.67 (1H, 
bs, NHH), 7.63 (2H, app dqn, J 1.5, 6.8 Hz, CHAr), 7.69 (1H, bs, NHH); 
13C NMR 
(125 MHz, Acetone-d6): δC 169.8 (CO), 136.5 (CAr), 134.4 (CAr), 133.5 (CAr), 130.6 
(CHAr), 129.6 (CHAr), 129.5 (CHAr), 129.3 (CHAr), 129.2 (CHAr), 128.2 (CHAr), 126.1 
(CHAr); HRMS (CI+/ISO) calc. for C11H10ON [M+H]
+
: 172.0762. Found: 172.0758; 
m.p. 189-190 °C 
 
The characterisation matches with the literature data:  
Cacchi S.; Misiti D.; La Torre F. Synthesis 1980, 3, 243. 
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(Z)-Methyl 2-(6-(2-naphthamido)hex-5-enamido)acetate, 259 
 
 
 
To a suspension of 2-naphtamide 258 (30.0 mg, 175 µmol), cesium carbonate 
(57.0 mg, 175 µmol), CuI (1.70 mg, 8.80 µmol) and N,N’-dimethyl ethylenediamine 
(1.8 µL, 16.6 µmol) in degassed and dry THF (1 mL) in a 2.0-5.0 mL microwave 
vial, a solution of (Z)-methyl 2-(6-iodohex-5-enamido)acetate 123 (48.0 mg, 0.16 
mmol) in degassed and dry THF (2 mL) was added dropwise and the reaction 
mixture was allowed stir at 70 °C for 18 hours. The resulting light-green 
suspension was diluted with 3 mL of ethyl acetate and filtered through a short pad 
of silica gel (previously deactivated with Et3N) using ethyl acetate as eluent. Then 
the filtrate was concentrated under vacuum to afford a green-yellow oil as crude 
product. The crude product was purified by flash column chromatography on silica 
gel (EtOAc:DCM:Et3N, 2.9:7:0.1) to afford the clean product 259 as a white gum in 
51% yield (29.0 mg, 82.0 µmol). Rf 0.46 (EtOAc:PE:Et3N 2.9:7:0.1); IR νmax (film) 
3300, 3071, 2951, 2928, 2855, 1748, 1647, 1520, 1499, 1437, 1370, 1294, 1204 
and 1180 cm-1; 1H NMR (500 MHz, Acetone-d6): δH 9.90 (1H, bd, J 7.2 Hz, NH), 
8.78 (1H, s, CHAr), 8.17 (1H, dd, J 1.7, 8.6 Hz, CHAr), 8.09 (1H, d, J 7.7 Hz, CHAr), 
8.02 (2H, d, J 9.0 Hz, 2 × CHAr), 7.81 (1H, bs, NH), 7.65 (2H, app dqn, J 1.5, 6.9 
Hz, 2 × CHAr), 7.07 (1H, t, J 9.0 Hz, CH=), 4.93 (1H, q, J 8.6 Hz, =CH), 4.08 (2H, 
d, J 5.5 Hz, CH2N), 3.59 (3H, s, OCH3), 2.44-2.34 (4H, m, 2 × CH2), 1.82 (2H, qn, 
J 6.9 Hz, CH2); 
13
C NMR (125 MHz, Acetone-d6): δC 175.8 (CON), 171.8 (COO), 
166.0 (CON), 136.6 (CAr), 134.4 (CAr), 132.9 (CAr), 130.7 (CHAr), 129.9 (CHAr), 
129.5 (CHAr), 129.3 (CHAr), 129.2 (CHAr), 128.2 (CHAr), 126.3 (CHAr), 125.4 (CH=), 
112.3 (=CH), 52.8 (OCH3), 42.5 (CH2N), 34.9 (CH2CO), 26.9 (CH2), 26.1 (CH2); 
HRMS (CI+/ISO) calc. for C20H22O4N2 [M]
+: 354.1580. Found: 354.1581. 
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Methyl cinnamate, 261 
 
 
 
To a solution of cinnamoic acid 260 (1.00 g, 6.76 mmol) in methanol (40 mL), 
concentrated hydrochloric acid (2 mL) was added and the resulting mixture was 
allowed to stir at 55 °C for 20 hours. Then the reaction was concentrated under 
vacuum, diluted with dichloromethane (40 mL) and washed with Na2CO3 saturated 
aqueous solution (2 × 50 mL). The organic layer was dried over Na2SO4, filtered 
and concentrated under vacuum to afford the product as a yellow oil. The crude 
product was purified by flash column chromatography on silica gel (from 0 to 30% 
ethyl acetate in hexane) to afford the clean product 261 as a light yellow solid in 
70% yield (770 mg, 4.75 mmol). Rf 0.82 (EtOAc:PE, 3:7); IR νmax (film) 2998, 2364, 
1713, 1636, 1578, 1497, 1451, 1435, 1329, 1314, 1273, 1202, 1167, 978, 766, 
731, 712 and 683 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.68 (1H, d, J 15.9 Hz, 
CH=), 7.50-7.46 (2H, m, 2 × ortho CHAr), 7.36-7.32 (3H, m, 3 × meta and para 
CHAr), 6.43 (1H, d, J 16.2 Hz, =CH), 3.77 (3H, s, OCH3); 
13C NMR (125 MHz, 
CDCl3): δC 167.2 (CO), 144.7 (CH=), 134.3 (CAr), 130.2 (CHAr), 128.8 (CHAr), 
128.0 (CHAr), 117.8 (=CH), 51.5 (OCH3); HRMS (CI+/ISO) calc. for C10H11O2 
[M+H]+: 163.0754. Found: 163.0762; m.p. 30-31 °C. 
 
The characterisation matches with the literature data:  
Hosangadi B. D.; Dave R. H. Tetrahedron Lett. 1996, 37, 6375. 
 
Cinnamamide, 245 
 
 
 
To a suspension of ammonium chloride (2.57 g, 47.5 mmol) in dry toluene (15 mL) 
at 0 °C, AlMe3 (2 M solution in toluene, 23.8 mL, 47.5 mmol) was added dropwise 
and the resulting mixture was allowed to stir for 30 minutes, then a solution of 
methyl cinnamate 261 (770 mg, 4.75 mmol) in dry toluene (20 mL) was added and 
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the resulting mixture was allowed to stir at 50 °C for 16 hours. The reaction was 
cooled to 0 °C, quenched with 10 mL of HCl solution (1 N) and the organic layer 
was washed with NaHCO3 saturated aqueous solution (10 mL) and brine (10 mL), 
dried over Na2SO4 and concentrated under vacuum to afford a pale yellow oil as 
crude product. The crude product was purified by silica gel flash column 
chromatography (1:1 PE/EtOAc) to afford a white solid as pure product 245 (337 
mg, 2.29 mmol) in 48% yield. Rf 0.30 (EtOAc); IR νmax (film) 3372, 3167, 1736, 
1661, 1607, 1493, 1451, 1398, 1246, 1202, 1115, 968 and 698 cm-1; 1H NMR (500 
MHz, Acetone-d6): δH 7.62 (2H, dd, J 1.9, 7.9 Hz, 2 × ortho CHAr), 7.60 (1H, d, J 
15.9 Hz, CH=), 7.46-7.37 (3H, m, 3 × meta and para CHAr), 7.14 (1H, bs, NHH), 
6.78 (1H, d, J 15.8 Hz, =CH), 6.70 (1H, bs, NHH); 13C NMR (125 MHz, Acetone-
d6): δC 168.6 (CO), 141.7 (CH=), 136.9 (CAr), 131.0 (CHAr), 130.5 (CHAr), 129.3 
(CHAr), 123.3 (=CH); HRMS (CI+/ISO) calc. for C9H10ON [M+H]
+: 148.0762. 
Found: 148.0764; m.p. 110-111 °C 
 
The characterisation matches with the literature data:  
Tian J.; Moeller K. D. Org. Lett. 2005, 7, 5381. 
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Methyl 2-((Z)-6-cinnamamidohex-5-enamido)acetate, 262 
 
 
 
Method A: To a suspension of cinnamamide 245 (30.0 mg, 204 µmol), cesium 
carbonate (66.0 mg, 204 µmol), CuI (2.00 mg, 10.2 µmol) and N,N’-dimethyl 
ethylenediamine (2.2 µL, 20.4 µmol) in degassed and dry THF (1 mL) in a 2.0-5.0 
mL microwave vial, a solution of (Z)-methyl 2-(6-iodohex-5-enamido)acetate  123 
(55.0 mg, 186 µmol) in degassed and dry THF (2 mL) was added dropwise and 
the reaction mixture was allowed stir at 70 °C for 18 hours. The resulting pale blue 
suspension was diluted with 3 mL of ethyl acetate and filtered through a short pad 
of silica (previously deactivated with Et3N) using ethyl acetate as eluent. Then the 
filtrate was concentrated under vacuum to afford a green-yellow oil as crude 
product. The crude product was purified by flash column chromatography on silica 
gel (EtOAc:DCM:Et3N, 2.9:7:0.1) to afford the clean product 262 as a white gum in 
55% yield (34.0 mg, 103 µmol).  
Method B: To a suspension of trans-cinnamamide 245 (20.0 mg, 136 µmol), 
(cod)Ru(met)2 (4.50 mg, 14.0 µmol), Yb(OTf)3 (6.75 mg, 10.0 µmol) and dcybd 
(7.20 mg, 16.0 µmol) in anhydrous DMF (0.6 mL), the alkyne 241 (75.0 mg, 0.41 
mmol) was added and the resulting mixture was allowed to stir at 60 °C for 52 
hours. Then the reaction was quenched with NaHCO3 saturated aqueous solution 
(1 mL) and extracted with diethyl ether (3 × 2 mL). The organic layers were 
collected, dried over Na2SO4, filtered and concentrated under vacuum to afford a 
yellow solid as crude product. The crude product was purified by flash column 
chromatography (EtOAc:DCM:Et3N, 2.9:7:0.1) to afford the clean product 262 as a 
white gum in 8% yield (3.60 mg, 10.9 µmol). 
Rf 0.21 (EtOAc:DCM:Et3N 2.9:7:0.1); IR νmax (film) 3297, 2951, 2361, 1750, 1651, 
1520, 1206, 1182, 980, 766 and 682 cm-1; 1H NMR (500 MHz, Acetone-d6): δH 
9.59 (1H, bd, J 9.5 Hz, NH), 7.77 (1H, bs, NH), 7.66 (1H, d, J 15.9 Hz, CH=), 7.65-
7.63 (2H, m, 2 × ortho CHAr), 7.49-7.40 (3H, m, 3 × meta and para CHAr), 6.91 
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(1H, t, J 8.9 Hz, CH=), 6.89 (1H, d, J 15.9 Hz, =CH), 4.84 (1H, q, J 8.6 Hz, =CH), 
4.07 (2H, d, J 5.6 Hz, CH2N), 3.71 (3H, s, OCH3), 2.36 (2H, t, J 6.6 Hz, CH2CO), 
2.22 (2H, q, J 6.7 Hz, CH2), 1.77 (2H, qn, J 6.7 Hz, CH2); 
13C NMR (125 MHz, 
Acetone-d6): δC 175.6 (CON), 171.9 (COO), 164.2 (CON), 142.1 (CH=), 137.0 
(CAr), 131.2 (CHAr), 130.5 (CHAr), 129.3 (CHAr), 124.8 (CH=), 123.1 (=CH), 111.5 
(=CH), 52.9 (OCH3), 42.5 (CH2N), 35.2 (CH2CO), 26.8 (CH2), 26.2 (CH2); HRMS 
(CI+/ISO) calc. for C18H22O4N2 [M]
+: 330.1580. Found: 330.1577. 
 
(Z)-Ethyl 3-iodoacrylate, 275 
 
 
 
To a solution of ethyl propiolate 274 (1 mL, 9.85 mmol) in glacial acetic acid (5 
mL), sodium iodide (1.50 g, 10.0 mmol) was added and the reaction mixture was 
allowed to warm to room 70 °C and to stir for 16 hours. Then the reaction was 
quenched with H2O (5 mL) and NaOH (1N, 5 mL) and extracted with diethylether 
(3 × 5 mL). The organic layers were collected, dried over Na2SO4, filtered and 
concentrated under vacuum to afford the product as an orange oil in a quantitative 
yield (2.23 g, 9.85 mmol). The crude product 275 resulted clean without necessity 
of any further purification. Rf 0.59 (Et2O:PE, 2.5:7.5); IR νmax (film) 1721, 1597, 
1321, 1192, 1159, 1024 and 804 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.31 (1H, d, 
J 8.8 Hz, IHC=), 6.74 (1H, d, J 8.9 Hz, =CH), 4.06 (2H, q, J  7.2 Hz, CH2), 1.14 
(3H, t, J 7.2 Hz, CH3); 
13C NMR (125 MHz, CDCl3): δC 164.0 (CO), 129.6 (=CH), 
94.7 (IHC=), 60.4 (CH2), 13.9 (CH3); HRMS (EI+) calc. for C5H7O2I [M]
+: 225.9491. 
Found: 225.9494. 
 
The characterisation matches with the literature data:  
Trost B. M.; Papillon J. P. N.; Nussbaumer T. J. Am. Chem. Soc. 2005, 127, 
17921. 
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(Z)-Ethyl 3-(2-naphthamido)acrylate, 276 
 
 
 
To a suspension of 2-naphtamide 258 (50.0 mg, 292 µmol), cesium carbonate 
(95.0 mg, 292 µmol), CuI (3.00 mg, 15.0 µmol) and N,N’-dimethyl ethylenediamine 
(3.2 µL, 30.0 µmol) in degassed and dry THF (2 mL) in a 2.0-5.0 mL microwave 
vial, a solution of (Z)-ethyl 3-iodoacrylate 275 (60.0 mg, 266 µmol) in degassed 
and dry THF (2 mL) was added dropwise and the reaction mixture was allowed stir 
at 70 °C for 18 hours. The resulting pale blue suspension was diluted with 4 mL of 
ethyl acetate and filtered through a short pad of silica (previously deactivated with 
Et3N) using ethyl acetate as eluent. Then the filtrate was concentrated under 
vacuum to afford a green-yellow oil as crude product. The crude product was 
purified by flash column chromatography on silica gel (from 0 to 5% ethyl acetate 
in petroleum ether) to afford the clean product 276 as a pale yellow gum in 48% 
yield (34.3 mg, 128 µmol). Rf 0.16 (EtOAc:PE, 0.4:9.6); IR νmax (film) 3327, 1678, 
1622, 1487, 1397, 1381 and 1199 cm-1; 1H NMR (500 MHz, Acetone-d6): δH 11.69 
(1H, bd, J 8.8 Hz, NH), 8.59 (1H, s, CHAr), 8.20 (1H, d, J 7.9 Hz, CHAr), 8.17 (1H, 
d, J 8.9 Hz, CHAr), 8.09 (1H, d, J 7.6 Hz, CHAr), 8.03 (1H, dd, J 1.9, 8.5 Hz, CHAr), 
7.86 (1H, dd, J 8.9, 11.1 Hz, CH=), 7.72 (2H, app dqn, J 1.6, 7.0 Hz, 2 × CHAr), 
5.38 (1H, d, J 8.9 Hz, =CH), 4.31 (2H, q, J 7.1 Hz, CH2), 1.36 (3H, t, J 7.1 Hz, 
CH3); 
13C NMR (125 MHz, Acetone-d6): δC 170.9 (CON), 165.5 (COO), 140.5 
(CH=), 140.3 (CHAr), 137.1 (CAr), 134.4 (CAr), 131.4 (CAr), 130.9 (CHAr), 130.7 
(CHAr), 130.2 (CHAr), 129.5 (CHAr), 128.9 (CHAr), 125.0 (CHAr), 98.5 (=CH), 61.7 
(CH2), 15.3 (CH3); HRMS (CI+/ISO) calc. for C16H16O3N [M+H]
+: 270.1130. Found: 
270.1136. 
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(Z)-Ethyl 3-cinnamamidoacrylate, 277 
 
 
 
To a suspension of cinnamamide 245 (50.0 mg, 0.34 mmol), cesium carbonate 
(111 mg, 0.34 mmol), CuI (3.10 mg, 16.0 µmol) and N,N’-dimethyl 
ethylenediamine (3.4 µL, 32.0 µmol) in degassed and dry THF (2 mL) in a 2.0-5.0 
mL microwave vial, a solution of (Z)-ethyl 3-iodoacrylate 275 (70.0 mg, 0.31 mmol) 
in degassed and dry THF (2 mL) was added dropwise and the reaction mixture 
was allowed stir at 70 °C for 18 hours. The resulting pale blue suspension was 
diluted with 4 mL of ethyl acetate and filtered through a short pad of silica 
(previously deactivated with Et3N) using ethyl acetate as eluent. Then the filtrate 
was concentrated under vacuum to afford a green-yellow oil as crude product. The 
crude product was purified by flash column chromatography on silica gel (from 0 to 
5% ethyl acetate in petroleum ether) to afford the clean product 277 as a white 
gum in 55% yield (36.0 mg, 147 µmol). Rf 0.1 (EtOAc:PE, 0.4:9.6); IR νmax (film) 
3333, 2983, 1713, 1676, 1620, 1379, 1260, 1198 and 1138 cm-1; 1H NMR (500 
MHz, Acetone-d6): δH 10.65 (1H, bd, J 8.3 Hz, NH), 7.83-7.78 (2H, m, 2 × CHAr), 
7.79 (1H, d, J 16.0 Hz, CH=), 7.69 (1H, dd, J 9.0, 11.4 Hz, CH=), 7.54-7.46 (3H, 
m, 3 × CHAr), 7.10 (1H, d, J 16.0 Hz, =CH), 5.24 (1H, d, J 9.2 Hz, =CH), 4.23 (2H, 
q, J 6.9 Hz, CH2), 1.31 (3H, t, J 7.2 Hz, CH3); 
13C NMR (125 MHz, Acetone-d6): δC 
170.2 (CON), 164.9 (COO), 145.4 (CH=), 139.9 (CH=), 136.4 (CAr), 131.9 (CHAr), 
130.6 (CHAr), 129.9 (CHAr), 121.7 (=CH), 97.7 (=CH), 61.4 (CH2), 15.3 (CH3); 
HRMS (CI+/ISO) calc. for C14H16O3N [M+H]
+: 246.1130. Found: 246.1130. 
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(But-3-ynyloxy)(tert-butyl)diphenylsilane, 285 
 
 
 
To a solution of but-3-yn-1-ol 284 (2.00 g, 28.5 mmol), imidazole (2.72 g, 39.9 
mmol) and DMAP (35.0 mg, 285 µmol) in dry dichloromethane (40 mL), under 
argon and at 0 °C, TBDPSCl (8.9 mL, 34.2 mmol) was added dropwise and the 
resulting mixture was allowed to warm to room temperature and to stir for 12 
hours. Then the reaction was quenched by addition of 40 mL of distilled water. The 
aqueous phase was extracted with dichloromethane (3 × 50 mL) and the organic 
layers were combined, washed with brine, dried over Na2SO4 and concentrated 
under vacuum to afford a pale yellow oil as crude product. The crude product 285 
was taken directly onto the next step without any further purification and the 
reaction was considered quantitative (8.79 g, 28.5 mmol). IR νmax (film) 3308, 
2957, 2932, 2859, 1738, 1472, 1427, 1385, 1362, 1217, 1105, 908, 822, 802, 733, 
700 and 689 cm-1; 1H NMR (400 MHz, CDCl3): δH 7.73-7.71 (4H, m, CHAr), 7.46-
7.42 (6H, m, CHAr), 3.82 (2H, t, J 7.2 Hz, CH2), 2.48 (2H, td, J 2.5, 7.0 Hz, 
CH2CHalkyne), 1.97 (1H, t, J 2.7 Hz, CHalkyne), 1.10 (9H, s, 3 × CH3); HRMS 
(CI+/ISO) calc. for C20H25OSi [M+H]
+: 309.1675. Found: 309.1668. 
 
The characterisation matches with the data reported in literature: 
Ohtsuki K.; Matsuo K.; Yoshikawa T.; Moriya C.; Tomita-Yokotani K.; Shishido K.; 
Shindo M. Org. Lett. 2008, 10, 1247. 
 
5-(tert-Butyldiphenylsilyloxy)pent-2-yn-1-ol, 286 
 
 
 
To a solution of (but-3-ynyloxy)(tert-butyl)diphenylsilane 285 (8.80 g, 28.5 mmol) in 
dry THF (80 mL), under argon at -78 °C, n-BuLi (11.98 mL, 29.9 mmol, 2.5 M 
solution in hexanes) was added dropwise and the resulting mixture was stirred at -
78 °C for 30 minutes. Then paraformaldehyde (2.05 g, 68.5 mmol) was added in 
one portion and the resulting mixture was allowed to warm to room temperature 
and to stir for 3 hours. The reaction was quenched by addition of distilled water 
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(100 mL), it was diluted with diethyl ether (100 mL) and washed with brine (100 
mL). The organic phase was dried over Na2SO4 and concentrated under vacuum 
to afford a yellow-orange oil as crude product. The crude product was purified 
through flash column chromatography on silica gel (from 0 to 20% ethyl acetate in 
hexane) to afford the pure product 286 as a yellow oil in quantitative yield (9.66 g, 
28.5 mmol). Rf 0.44 (hexane:EtOAc, 8:2); IR νmax (film) 3381, 2953, 2932, 2859, 
2363, 2249, 1736, 1589, 1472, 1427, 1385, 1362, 1105, 1007, 999, 908, 822, 731, 
700 and 689 cm-1; 1H NMR (500 MHz, CDCl3): δH 7.74-7.72 (4H, m, CHAr), 7.47-
7.41 (6H, m, CHAr), 4.21-4.20 (2H, m, CH2OH), 3.82 (2H, t, J 7.3 Hz, CH2OSi), 
2.54-2.51 (2H, m, CH2), 1.99-1.97 (1H, m, OH), 1.12 (9H, s, 3 × CH3); 
13C NMR 
(125 MHz, CDCl3): δC 135.7 (CHAr), 133.7 (CAr), 129.8 (CHAr), 127.8 (CHAr), 83.4 
(Calkyne), 79.7 (Calkyne), 62.5 (CH2OSi), 51.3 (CH2OH), 26.9 (3 × CH3), 22.9 (CH2), 
19.3 (C); HRMS (CI+/ISO) calc. for C21H27O2Si [M+H]
+: 339.1780. Found: 
339.1781. 
 
The characterisation matches with the literature data:  
Chakraborty T. K.; Purkait S.; Sanjib D. Tetrahedron 2003, 59, 9127. 
 
5-(tert-Butyldiphenylsilyloxy)pent-2-ynoic acid, 287 
 
 
 
To a solution of 5-(tert-butyldiphenylsilyloxy)pent-2-yn-1-ol 286 (9.66 g, 28.5 
mmol) in dichloromethane (30 mL) and distilled water (30 mL), under argon, 
TEMPO (892 mg, 5.71 mmol) and BAIB (20.2 g, 62.8 mmol) were added and the 
resulting mixture was allowed to stir at room temperature for 12 hours. Then the 
reaction was extracted with dichloromethane (3 × 30 mL) and ethyl acetate (3 × 30 
mL). The organic layers were combined, dried over Na2SO4 and concentrated 
under vacuum to afford an orange oil as crude product. The crude product was 
purified through flash column chromatography on silica gel (from 0 to 30% ethyl 
acetate in petroleum ether) to afford the pure product 287 as a yellow oil in 61% 
yield (6.20 g, 17.5 mmol). Rf 0.5 (PET:EtOAc, 7:3); IR νmax (film) 2241, 1686, 1472, 
1427, 1219, 1105, 910, 822, 735, 700 and 687 cm-1; 1H NMR (500 MHz, CDCl3): 
δH 11.21 (1H, bs, OH), 7.73-7.71 (4H, m, CHAr), 7.47-7.42 (6H, m, CHAr), 3.88 (2H, 
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t, J 6.8 Hz, OCH2), 2.64 (2H, t, J 6.8 Hz, CH2), 1.11 (9H, s, 3 × CH3); 
13C NMR 
(125 MHz, CDCl3): δC 157.9 (CO), 135.7 (CHAr), 133.3 (CAr), 129.9 (CHAr), 127.9 
(CHAr), 88.1 (C), 74.4 (C), 61.4 (CH2O), 26.9 (3 × CH3), 23.0 (CH2), 19.3 (SiC); 
HRMS (CI+/ISO) calc. for C20H25OSi [M-CO2+H]
+: 309.1675. Found: 309.1678. 
 
The characterisation matches with the literature data:  
Wipf P.; Thomas H. Org. Biomol. Chem. 2005, 3, 31. 
 
Methyl 2-(5-(tert-butyldiphenylsilyloxy)pent-2-ynamido)acetate, 288 
 
 
 
To a solution of 5-(tert-butyldiphenylsilyloxy)pent-2-ynoic acid 287 (5.85 g, 16.5 
mmol), HBTU (7.51 g, 19.8 mmol) and glycine methyl ester 124 (2.49 g, 19.8 
mmol) in dry  dichloromethane (150 mL), under argon at 0 °C, DIPEA (7.2 mL, 
41.3 mmol) was added dropwise and the resulting mixture was allowed to warm to 
room temperature and stir for 12 hours. The reaction was quenched with a 
saturated solution of NH4Cl (100 mL) and extracted with diethyl ether (3 × 50 mL). 
The organic layers were combined, dried over Na2SO4 and concentrated under 
vacuum to afford a brown oil as crude product. The crude product was purified 
through flash column chromatography on silica gel (from 0 to 50% ethyl acetate in 
petroleum ether) to afford the pure product 288 as a yellow oil in 60% yield (4.61 
g, 9.98 mmol). Rf 0.56 (PET:EtOAc, 1:1); IR νmax (film) 1748, 1647, 1518, 1427, 
1368, 1294, 1207, 1182, 1105, 908, 822, 729, 700 and 689 cm-1; 1H NMR (500 
MHz, CDCl3): δH 7.69-7.67 (4H, m, CHAr), 7.44-7.38 (6H, m, CHAr), 6.22 (1H, bs, 
NH), 4.05 (2H, d, J 5.3 Hz, NCH2), 3.81 (2H, t, J 6.8 Hz, CH2O), 3.75 (3H, s, 
OCH3), 2.56 (2H, t, J 7.6 Hz, CH2), 1.07 (9H, s, 3 × CH3); 
13C NMR (125 MHz, 
CDCl3): δC 169.7 (CO), 153.2 (CO), 135.6 (CHAr), 133.4 (CAr), 129.9 (CHAr), 127.9 
(CHAr), 85.6 (C), 75.9 (C), 61.5 (CH2O), 52.6 (OCH3), 41.4 (NCH2), 26.9 (3 × CH3), 
22.9 (CH2), 19.3 (SiC); HRMS (CI+/ISO) calc. for C24H30O4NSi [M+H]
+: 424.1944. 
Found: 424.1943. 
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Methyl 2-(N-(tert-butoxycarbonyl)-5-(tert-butyldiphenylsilyloxy)pent-2-
ynamido)acetate, 289 
 
 
 
To a solution of methyl 2-(5-(tert-butyldiphenylsilyloxy)pent-2-ynamido)acetate 288 
(4.61 g, 9.98 mmol), DMAP (24.0 mg, 199 µmol) and Boc2O (8.70 g, 39.9 mmol) in 
dry THF (40 mL), under argon at 0 °C, DIPEA (7 mL, 39.9 mmol) was added 
dropwise and the resulting mixture was allowed to warm to room temperature and 
to stir for 12 hours. Then the reaction mixture was poured in 50 mL of brine and 
extracted with diethyl ether (3 × 50 mL). The combined organic layers were dried 
over Na2SO4 and concentrated under vacuum to afford a brown oil as crude 
product 289. The crude product was taken directly onto the next step without any 
further purification. Rf 0.26 (Hexane:EtOAc, 8:2); IR νmax (film) 1755, 1736, 1653, 
1369, 1333, 1217, 1148, 1105, 908, 729, 700 and 689 cm-1; 1H NMR (500 MHz, 
CDCl3): δH 7.71-7.67 (4H, m, CHAr), 7.44-7.38 (6H, m, CHAr), 4.46 (2H, s, NCH2), 
3.87 (2H, t, J 6.9 Hz, CH2O), 3.69 (3H, s, OCH3), 2.68 (2H, t, J 6.8 Hz, CH2), 1.49 
(9H, s, 3 × CH3), 1.08 (9H, s, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 168.4 
(CO), 152.9 (CO), 150.9 (CO), 135.4 (CHAr), 133.1 (CAr), 129.7 (CHAr), 127.7 
(CHAr), 94.2 (C), 84.2 (C), 76.2 (C), 61.3 (CH2O), 52.1 (OCH3), 44.7 (NCH2), 27.7 
(3 × CH3), 26.7 (3 × CH3), 23.4 (CH2), 19.0 (SiC). 
 
Methyl 2-(N-(tert-butoxycarbonyl)-5-hydroxypent-2-ynamido)acetate, 290 
 
 
 
To a solution of methyl 2-(N-(tert-butoxycarbonyl)-5-(tert-butyldiphenyl silyloxy) 
pent-2-ynamido)acetate 289 (4.00 g, 7.12 mmol) in dry THF (25 mL), under argon 
at 0 °C, was added dropwise a mixture of glacial acetic acid (1.02 mL, 17.8 mmol) 
and TBAF (17.8 mL, 17.8 mmol, 1M solution in THF). The resulting mixture was 
allowed to warm to room temperature and stir for 12 hours. Then it was quenched 
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with distilled water (20 mL) and extracted with diethyl ether (20 mL), ethyl acetate 
(20 mL) and dichloromethane (20 mL). The combined organic layers were dried 
over Na2SO4 and concentrated under vacuum to afford a yellow oil as crude 
product. The crude product was purified through flash column chromatography on 
silica gel (from 0 to 50% ethyl acetate in hexane) to afford a colourless oil as pure 
product 290 in 59% yield (1.20 g, 4.19 mmol). Rf 0.28 (hexane:EtOAc, 1:1); IR νmax 
(film) 1736, 1651, 1369, 1331, 1217, 1144, 1117, 1053, 972, 914, 847, 775, 729 
and 646 cm-1; 1H NMR (500 MHz, CDCl3): δH 4.65 (1H, bs, OH), 4.27 (2H, s, 
NCH2), 3.62 (2H, t, J 5.6 Hz, CH2O), 3.64 (3H, s, OCH3), 2.48 (2H, t, J 5.4 Hz, 
CH2), 1.34 (9H, s, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 168.5 (CO), 152.7 
(CO), 150.8 (CO), 94.8 (C), 84.6 (C), 76.4 (C), 59.6 (CH2OH), 52.0 (CH3), 44.5 
(NCH2), 27.5 (3 × CH3), 23.5 (CH2); HRMS (FAB+) calc. for C13H20O6N [M+H]
+: 
286.1291. Found: 286.1286. 
 
(Z)-Methyl 2-(N-(tert-butoxycarbonyl)-5-hydroxypent-2-enamido)acetate, 292 
 
 
 
To a suspension of methyl 2-(N-(tert-butoxycarbonyl)-5-hydroxypent-2-
ynamido)acetate 290 (189 mg, 663 µmol) and Lindlar’s catalyst (3.50 mg, 332 
µmol) in dry toluene (6 mL) was allowed to stir under H2 atmosphere at room 
temperature for 4 hours. Then it was diluted with toluene (10 mL) and filtered 
through Celite® to afford the product 292 as a colourless thick oil in quantitative 
yield (0.19 g, 663 µmol). The crude product was very clean without necessity of 
any further purification. Rf 0.35 (hexane:EtOAc, 1:1); IR νmax (film) 1739, 1733, 
1680, 1438, 1419, 1369, 1337, 1205, 1143, 1051, 852 and 775 cm-1; 1H NMR (500 
MHz, CDCl3): δH 6.64 (1H, d, J 11.5 Hz, CH), 6.15 (1H, dt, J 8.0, 11.5 Hz, CH), 
4.38 (2H, s, NCH2), 3.68 (3H, s, OCH3), 3.66 (2H, t, J 6.0 Hz, CH2O), 2.45 (2H, q, 
J 6.0 Hz, CH2), 1.43 (9H, s, 3 × CH3); 
13C NMR (125 MHz, CDCl3): δC 169.3 (CO), 
168.5 (CO), 151.9 (CO), 141.5 (CH), 125.9 (CH), 84.2 (C), 61.2 (CH2), 52.2 
(OCH3), 45.1 (NCH2), 31.9 (CH2), 27.8 (3 × CH3); HRMS (CI+/ISO) calc. for 
C13H22O6N [M+H]
+: 288.1447. Found: 288.1441. 
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Methyl 2-(N-(tert-butoxycarbonyl)-5-hydroxypent-2-ynamido)acetate-cobalt 
carbonyl complex, 293 
 
 
 
To a solution of methyl 2-(N-(tert-butoxycarbonyl)-5-hydroxypent-2-ynamido) 
acetate 290 (0.15 g, 526 µmol) in toluene (5 mL), the cobalt carbonyl (0.36 g, 1.05 
mmol) was added and the resulting suspension was allowed to stir at room 
temperature for 12 hours. Then, the resulting mixture was filtered through Celite® 
using toluene as eluent (20 mL), concentrated under vacuum to afford a light 
brown solid as crude product (0.29 g, 508 µmol, 97%). The crude product was 
carried through the next step without any further purification.  
1H NMR (400 MHz, CDCl3): δH 3.92 (2H, m, CH2), 3.76 (3H, s, OCH3), 3.65 (2H, 
m, CH2), 1.52 (2H, m, CH2), 1.48 (9H, s, 3 × CH3).
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